Left-right asymmetry variation in the pond snail, Lymnaea stagnalis: exploring patterns of gene expression by Johnson, Harriet F.
0 
 
UNIVERSITY OF NOTTINGHAM 
Left-right asymmetry variation in the 
pond snail, Lymnaea stagnalis: 
exploring patterns of gene expression 
 
 
Harriet F Johnson 
 
 
 
 
 
 
 
 
 
 
 
 
Thesis submitted for the degree of Doctor of Philosophy, November 2015 
 
1 
 
Thesis abstract 
The establishment of left-right (LR) asymmetry in animal development remains an unanswered, 
fundamental question in biology. Many mechanisms of symmetry-breaking have been proposed and 
supported, although as yet no universal mechanism has been verified across bilaterian animals. 
Snails provide an invaluable study organism for understanding LR asymmetry, due to the prevalence 
of chirally variable species. In the pond snail Lymnaea stagnalis LR asymmetry and resulting shell-
coiling direction is a well described genetically tractable trait, inherited through a maternal effect. 
However, the ‘chirality gene’ is still unknown. 
In L. stagnalis, clockwise (dextral) coiling is the dominant genotype, therefore snails with 
homozygote genotype ‘DD’ or heterozygote ‘Dd’ both produce dextral offspring, whereas those with 
the homozygote recessive genotype ‘dd’ have anticlockwise (sinistral) coiling offspring. To further 
the Davison research group’s ongoing characterisation of the chirality gene in L. stagnalis, this 
project focussed on gene expression patterns exhibited between chiral genotypes. Differential gene 
expression was explored via a candidate gene approach, performing quantitative real-time PCR 
(qPCR) experiments on specific genes of interest, and also a transcriptomic sweep, utilising next 
generation sequencing. 
To enable accurate quantification of gene expression by relative qPCR, first, stable endogenous 
control genes had to be established. In light of general failings of the previously published control 
genes to meet the criteria for appropriate use of qPCR, five genes were verified for use as stable 
endogenous controls in L. stagnalis embryo, ovotestis and foot tissue, for the accurate comparison 
of gene expression between and within chiral genotypes. These endogenous control genes will 
enable other researchers of L. stagnalis to rapidly identify stable controls for relative qPCR 
experiments. 
qPCR experiments were performed to compare gene expression of 13 candidate genes between 
chiral genotypes in the single-cell embryo, ovotestis and foot tissues. Significant differential 
expression was observed between chiral genotypes only in the diaphanous related formin gene, 
Ldia2, and two actin-related protein genes, Larp2/3 1a and Larp2/3 3.  
A frameshift mutation in the sinistral copy of Ldia2, discovered by the Davison research group, has 
identified Ldia2 as the primary candidate for the causal gene in LR asymmetry determination in L. 
stagnalis. In support of this, Ldia2 mRNA was found to be dramatically underrepresented in the 
sinistral one cell embryo and significantly reduced in the sinistral ovotestis tissue, yet not in the 
somatic foot tissue. Ldia2 was also the only gene found to be overrepresented in the embryo tissue 
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relative to the ovotestis and foot tissue, providing further support for the functional importance the 
gene in early development. The expression level of Ldia2 in the heterozygote genotype groups was 
calculated to be halfway between that of the homozygote groups, indicating equal expression 
dominance of the alleles at the chirality locus. The expression pattern observed in the actin-related 
proteins was less clear and will require further analysis to infer any true biological meaning. 
However due to the close interaction of actin-related proteins and formins the differential 
expression observed in the embryo tissue provides functional support for the role of Ldia2 in chiral 
dimorphism. 
Next generation transcriptome sequencing methods were employed to gain a transcriptome-wide 
scan of patterns of gene expression in the ovotestis tissue of snails of differing chiral genotype. A 
comparative analysis was initiated trialling a novel reduced-representation sequencing method, 
expression RAD sequencing (eRAD) and traditional RNA Seq. eRAD applies the method of restriction-
site associated DNA Sequencing (RADSeq) to the transcriptome by utilising double-stranded 
complementary DNA (cDNA) in place of genomic DNA. Due to delays in sequencing, the RNA Seq 
data was not received in sufficient time to perform the comparative assessment within this thesis. 
Consequently, only the eRAD data is presented here. 
The eRAD data failed to identify reliable differences in gene expression between chiral genotypes, 
although did provide a transcriptomic resource of de novo assembled contigs, which has been 
verified through further analyses. Overall the lack of differential expression identified between chiral 
genotypes in both the qPCR and eRAD analyses has indicated that the sinistral morph of L. stagnalis 
does not exhibit a large-scale loss of gene function and pleiotropic effects on gene expression. 
Therefore, the negative consequences of chiral reversal in L. stagnalis, such as the low hatch rate 
observed in sinistral broods, may all result from the single chirality gene polymorphism.  
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Chapter 1: 
General Introduction 
Left-Right asymmetry 
Defining Chirality 
Left-right (LR) asymmetry occurs frequently in nature, observed on varying scales ranging from the 
directional spiralling of galaxies to the structure of the molecules they are composed of. 
The term ‘chiral’ was coined to describe any geometrical figure as having ‘chirality’ if its mirror-
image cannot be superimposed onto itself (Kelvin 1904, Thompson 1910, cited in McManus 2002). A 
relatable example of a chiral object is the human hand. When looking at the pair of hands together 
they reflect mirror images of each other (with the exception of a few environmental 
differences/fluctuating asymmetries), as such one hand cannot be put on top of the other without 
inversion.  
Chirality is frequently discussed in molecular chemistry. Pasteur in the 1840s recognised that many 
organic molecules are found in two mirror-image structural forms (McManus 2002) (Figure 1a). It 
was found that laboratory synthesised chiral molecules would produce equal amounts of left-
handed (L- for laevo) and right-handed (D- for dextro) forms, creating a 50/50 racemic mixture. 
Biosynthetic processes however only produced one of the two chiral forms. This chiral consistency is 
observed in all living things, which are made of entirely L-amino acids and D-sugars (Fischer 1894, 
cited in Mason 1991). The dominance of L-amino acids has been observed to extend to those found 
on extra-terrestrial asteroids (Engel and Macko 1997). The question of whether this chiral 
consistency on a molecular level leads to limitations on larger level asymmetries remains debated. 
Chiral organisms 
The bilataria represent 99% of animal species, most often described as having originated from a 
radially symmetrical common ancestor (Ruppert, Fox et al. 2004). This however, is still a subject of 
debate, as is the overall phylogeny of the origins of the metazoa.  
The bilateral body plan, exhibits external bilateral symmetry, which is present when only one plane 
of bisection, produces left and right mirror images (Figure 1c). Although externally bilaterally 
symmetrical, the vast majority of bilatarians exhibit LR asymmetry in their internal organisation and 
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of the organs themselves (Figure 1d). This internal asymmetry represents a fundamental feature of 
multicellular organisms and is believed to further date back to the earliest life on Earth (Babcock 
2005). It is still open to discussion whether bilateral symmetry was superimposed onto an originally 
asymmetrical body plan, ie. an asymmetrical common ancestor, or vice versa (Wolpert, 1991).  
There is interesting variation in the early developmental body plans within the metazoa. Some 
examples would indicate an initially symmetrical body plan, such as the equal radially cleaving 
embryos of the deuterostomes, which later develop LR asymetries in body plan. Conversely there 
are also initially asymmetrical embryos which later aquire bilateral symmetry, for example within 
nematodes and ciliates (Wolpert, 1991). Cnidarians provide an insightful reference point in this 
debate as they are 'pre-bilaterians'. Interestingly, the most radially symmetrical species, are found 
within the most derived group of cnidarians, the Hydrozoa (Martindale, 2005). This supports 
asymmetry as the primitive state in the common ancestor prior to cnidarians and bilatarians. 
Corbalis and Morgan (1978) argued that lateral asymmetries result from a LR maturation gradient, in 
which there is earlier and more rapid development on the left side compared to the right. The 
resulting fundamental LR asymmetry is no different to the mechanisms required for the 
determination of the AP or DV axis specification. Many big questions remain regarding the origins of 
axial patterning, largely as a consequence of, yet also a contributing factor to, the remaining 
uncertainty within the phylogeny of the early metazoa. 
It is important to define the difference between primary asymmetry and secondary asymmetry. The 
former refers to the polarity of LR patterning in early development, which corresponds to 
subsequent visceral asymmetry of the heart and lungs, for example. Secondary asymmetry, such as 
the handedness of lobster claws (Govind 1989) or the mouth of scale eating fish (Hori 1993), 
develops independently of primary asymmetry and exhibits much higher levels of variation 
(Sutcharit, Asami et al. 2007). 
Asymmetry also occurs at incrementing scales, ranging from organ positioning and brain 
lateralisation, to hair whorls and behavioural lateralisation such as handedness, all of which show 
varied and perplexing associations to visceral asymmetry (Neville 1976, McManus 2002). However, 
these lateralisation relationships are beyond the scope of this thesis. The focus here surrounds 
primary LR asymmetry in animal body plans, and more specifically how LR asymmetry can vary 
during early development of the animal body plan. Hereafter, the term asymmetry refers to 
primary/visceral asymmetry. 
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Potential benefits to asymmetrical internal organisation have been proposed, such as fluid dynamics 
in the heart (Kilner, Yang et al. 2000), however there is no apparent reason for the overwhelming 
consistency in the sidedness of LR asymmetry exhibited in the majority of animals. 
Deviations from normal LR patterning can result in serious clinical consequences. The main classes of 
laterality defects that occur during early development in humans are described here. In the rare 
condition ‘situs inversus totalis’, present in 0.01% of the population (Burn 1991) the entire body plan 
is reversed, displaying a mirror-image of the normal internal organisation, ‘situs solitus’. No 
impairment to function is specifically caused by this condition (Torgersen 1950). However, the group 
of individuals with situs inversus totalis includes those that suffer from Kartagener’s syndrome, 
which is linked to ciliary dysfunction (Kartagener and Stucki 1962, Afzelius 1976). Another condition; 
situs ambiguus, occurs from the failure to control asymmetry, resulting in independent LR patterning 
of organs. This condition is often associated with cases of isomerism, in which the individual displays 
LR symmetry across the midline, resulting in two left sides or two right sides (Burn 1991, Peeters and 
Devriendt 2006). 
Due to the diversity and overlap of the morphological effects resulting from variant forms of 
heterotaxia, gaining accurate estimates of the occurrence of each condition in humans proves 
difficult, yet it is estimated that combined, LR laterality malformations effect 1 in 5000 births (Casey 
and Hackett 2000). Situs ambiguus and isomerism frequently result in cardiac and gastrointestinal 
defects. With 80% of situs ambiguus cases presenting complex congenital heart disease (Peeters and 
Devriendt 2006), LR laterality defects represent an important area of developmental research.  
There is an unmistakable necessity for LR patterning to be conserved for the functioning of organs, 
yet in light of the lack of pathologies associated with situs inversus totalis, there is no clear indication 
for a need for directional asymmetry, especially between species (Wood 1997). True enantiomorphs; 
‘mirror-image’ organisms displaying reversed primary asymmetry, have only been observed in 
gastropods and nematodes (Vermeij 1975, Robertson 1993, Wood 1997, Okumura, Utsuno et al. 
2008) and are therefore key in exploring potential selection of chiral morphs and the evolutionary 
dynamics of chirality variation. 
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Figure 1 Examples of left-right patterning. a: The chiral amino acid alanine and it’s mirror image counterpart, image 
courtesy of: The Nobel Prize in Chemistry 2001 - Popular Information (Nobelprize.org). b: Enantiomorphs of the pond 
snail Lymnaea stagnalis, the dextral form is indicated by a ‘D’ and the sinistral form by an ‘S’, photo credit: Ester de Roij 
(esterderoij@gmail.com). C: Leonardo Da Vinci’s Vitruvian man c1490, original image credit: Luc Viatour 
(www.Lucnix.be), adapted to include indicator of bilateral plane of symmetry (dashed line). d: Situs solitus organisation 
of human heart and lungs, drawing from Gray’s anatomy of the human body (Gray 1918), adapted to include indicator of 
bilateral plane of symmetry (dashed line).  
Symmetry-breaking event 
Telling left from right 
How LR asymmetry is established in early development represents a fundamental question in 
developmental biology and has been an ongoing area of research for over a century (Crampton 
1894). Because no macromolecular force differentiates left from right, it poses a puzzle of how the 
initially symmetrical embryo can orientate its LR axis consistently with respect to the dorsal-ventral 
(DV) and anterior-posterior (AP) axes. This problem was considered by the eighteenth century 
philosopher Immanuel Kant, who early on acknowledged that for left and right to be distinct, there 
must be an immovable reference point of absolute space (Harper 1991). A more modern example of 
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this same question has been posed as ‘the Ozma problem’. Summarised, it asks whether there is any 
way to communicate the meaning of ‘left’ to an extra-terrestrial via radio with no common 
asymmetric reference (Gardner 1990). 
There is general agreement that there are three steps in the generation of asymmetry in the 
developing embryo. Firstly, the radially symmetrical embryo undergoes a symmetry breaking event, 
in which the LR axis is generated relative to the already established dorsal-ventral (DV) and anterior-
posterior (AP) axes. Secondly these asymmetries are translated into differential bilateral gene 
expression. Finally, the cascade of asymmetrical gene expression determines asymmetric organ 
positioning and morphology (Vandenberg, Lemire et al. 2013). 
There are well documented examples of an asymmetrical cascade of gene expression in the 
developing embryo resulting in the situs of organ development. The earliest observed asymmetrical 
signalling pathway in development is the nodal pathway. Nodal is a transforming growth factor beta 
(TGF-β) ligand, first described in the mouse embryo (Zhou, Sasaki et al. 1993). Expression of nodal on 
one side of the embryo initiates further asymmetrical gene expression of downstream targets, which 
ultimately determine the lateral positioning of organs (a more in depth description on the regulation 
and downstream targets of nodal can be found in Shen 2007 and, Grande, Martin-Duran et al. 2014, 
however this is beyond the scope of this introduction). It has further been shown that expression of 
nodal on both sides of the embryo results in randomised LR asymmetry (Levin, Johnson et al. 1995, 
Nonaka, Tanaka et al. 1998). Sided nodal expression as an initiator of an asymmetric gene cascade 
has been described in a number of species (recently reviewed in Grande, Martin-Duran et al. 2014), 
however the cause of this initial asymmetrical gene expression remains debated. 
A number of mechanisms by which an embryo can become polarised have been described, however 
a large amount of uncertainty remains regarding the level of conservation of mechanisms across 
species and how LR asymmetry is, in most cases, consistently established on one of two possible 
sides (Aw and Levin 2008). 
Mechanisms of symmetry-breaking 
Ciliary Flow  
The most frequently quoted textbook mechanism for the establishment of LR asymmetry is the 
ciliary flow model (Tabin and Vogan 2003, Aw and Levin 2008). In this model it is proposed that the 
movement of inherently chiral motile cilia, create a directional fluid flow within a pocket of tissue in 
the fluid-filled developing embryo prior to gastrulation (Nonaka, Tanaka et al. 1998). The specific 
details vary according to the model, yet the most popular model assumes the directional flow results 
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in an asymmetric distribution of particles (Vogan and Tabin 1999), which is then detected by 
mechano-sensory cilia and ultimately results in asymmetric gene expression (McGrath, Somlo et al. 
2003, Tabin and Vogan 2003). In the original mouse model system this directional flow originates at 
the node (Okada, Nonaka et al. 1999). Ciliary flow has also been exhibited originating from the 
similar gastrocoel roof plate in Xenopus and the Kupffer’s vesicle in zebrafish amongst others 
(Essner, Vogan et al. 2002, Okada, Takeda et al. 2005). 
The ciliary flow model provided a convincing explanation for the LR reversals exhibited in iv (inverted 
viscera) mutant mice (Okada, Nonaka et al. 1999) and correlates with the associations of situs 
inversus and ciliopathies, such as Kartagener’s syndrome (Afzelius 1976, Burn 1991, Badano, 
Mitsuma et al. 2006). It also importantly provides a mechanism in which the LR axis could be 
established de novo due to the inherently chiral motion of the motile cilia (Vogan and Tabin 1999). 
However, there are many instances in which the ciliary flow model cannot explain the causal 
mechanism for LR asymmetry. For example occurrences of situs inversus in the presence of 
functional cilia and vice versa (Burn 1991) and additionally body asymmetry is observed in organisms 
prior to the development of cilia or that lack cilia entirely (Manner 2001, Speder, Petzoldt et al. 
2007, Okumura, Utsuno et al. 2008). 
F molecule 
The ability to establish LR asymmetry in organisms without cilia, indicates the existence of an 
intracellular mechanism to establish LR asymmetry (Levin and Palmer 2007).  
Brown and Wolpert (1990) proposed the existence of an inherently chiral molecule, the F molecule, 
which once oriented with respect to the AP and DV axes would provide a reference point able to 
distinguish the left side of the embryo from the right within the cell (Figure 2a). This initial 
asymmetry is then ‘converted’ into downstream asymmetric pathways and ultimately chirality of the 
body plan (Brown and Wolpert 1990). This theoretical molecule does not require any ‘decision 
making’ to determine left from right, it is intrinsically distinguishable via its structure and provides a 
molecular method of concordance. 
Indeed, the motile cilia responsible for the ciliary flow model represent a potential F-molecule, in 
that the direction of movement is inherently chiral due to the chiral structure of the cilia (Figure 2b) 
and not susceptible to change though a reference point, subsequently the ciliary flow model can be 
considered to encompass the F molecule theory (Levin and Palmer 2007). 
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Figure 2 a: Theoretical representation of how a chiral ‘F molecule’ would enable detection of gradients and subsequently 
distinguish between left and right within a single cell. Image reproduced from (Brown and Wolpert 1990). b: 
Composition of cilia, revealing chiral basal body and cytoskeletal functions. Image reproduced from (Levin and Palmer 
2007). 
 
Cytoskeletal processes 
Cytoskeletal components have been associated with the mechanism of establishing LR asymmetry 
presented in a number of models. Due to the chiral nature of the cytoskeleton, it provides the 
possibility for very early determination of LR sides, perhaps as early as the first cell cleavage 
(Vandenberg, Lemire et al. 2013). 
The chromatid segregation model postulates that the chiral cytoskeleton generates an asymmetric 
distribution of the chromatids during the first cell cleavage, resulting in differentially imprinted 
chromatids, which are therefore able to differentiate between the two cells/ left and right halves of 
the embryo (Klar 1994, Klar 2008). 
The microtubule organising centre (MTOC), includes the centrosome, and comprises the site of 
microtubule nucleation and plays a key role in cell division through mitotic spindle organisation 
(Karsenti and Vernos 2001, Bornens 2012). However, there are some notable exceptions and some 
organisms lack centrosomes completely (Calarcogillam, Siebert et al. 1983, Mahoney, Goshima et al. 
2006, Azimzadeh, Wong et al. 2012). The MTOC is considered to hold functional and structural 
asymmetries considered essential to maintain cell polarity and asymmetry (Bornens 2012). The 
other major function of the MTOC is it organises and forms the components of cilia (Figure 2b) (Levin 
and Palmer 2007). 
Cytoskeletal components actin and tubulin have been implicated in the early establishment of LR 
asymmetry in a number of organisms (Baum 2006, Lobikin, Wang et al. 2012). Although the precise 
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mechanisms are unclear, the inactivation of actin polymerisation resulted in a loss of asymmetry in 
early developmental stages of the pond snail Lymnaea stagnalis (Shibazaki, Shimizu et al. 2004). 
Actin molecules have also been shown to undergo spontaneous symmetry breaking in-vitro and self-
organisation, facilitating a mechanism of symmetry-breaking within a single cell (Abu Shah and Keren 
2014, Mogilner and Fogelson 2015). 
Cytoskeletal dynamics have also been incorporated into mechanisms of symmetry breaking based on 
gap junctions and ion flux gradients (Levin 2003, Oviedo and Levin 2007), which are described in 
more detail next. It has been proposed that the cytoskeleton actively directs the asymmetric 
distribution of proteins, including K+ channels and H+ pumps, via motor proteins (Levin and Palmer 
2007). It has also been shown that actin inhibition results in a failure of the mechanisms described in 
ion flux models (Adams, Robinson et al. 2006, Ayerscough 1998, De Brabander, Geuens, et al. 1986). 
Gap junctions and Ion flux models 
Potassium (K+) channels and Hydrogen (H+) pumps produce consistent biases in the transmembrane 
voltage and pH, which are able to drive the asymmetric distribution of small molecules through gap 
junctions from one side to the other. The hydrogen potassium (H+/K+) ATPase transporter has been 
identified as obligatory for correct LR patterning in early chick and Xenopus embryos. Perturbation of 
the endogenous H+/K+ -ATPase resulted in randomisation of LR asymmetry in both species (Levin, 
Thorlin et al. 2002). Furthermore, this channel results in the asymmetric localisation of maternal 
ATPase within 2 hours of fertilisation in the Xenopus embryo, indicating that LR asymmetry 
determination via this mechanism occurs very early in development (Levin, Thorlin et al. 2002). It has 
since been shown that ion flux is involved in LR asymmetry determination in a number of 
vertebrates and non-vertebrates (summarised in Adams, Robinson et al. 2006). 
Ion transporter proteins and gap junctions also represent a promising model as they allow for 
subcellular asymmetries to spread, providing a method for how the symmetry breaking event is then 
amplified across the organism (Levin and Palmer 2007). Finally, an increasing number of studies have 
documented the function of maternal serotonin in the establishment of LR asymmetry in Xenopus 
and chick embryos (Vandenberg, Lemire et al. 2013). Maternal serotonin, asymmetrically localised 
by gap junctions, has been implicated in the epigenetic repression of asymmetric gene expression of 
nodal and consequent randomised LR asymmetry (Carneiro, Donnet et al. 2011). 
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Conservation between organisms 
Nodal signalling 
Nodal signalling is involved in a number of different functions and activates various downstream 
targets in different organisms, however the asymmetric expression of Nodal and it’s downstream 
target ‘Pitx’ have been shown to be conserved across vertebrates in the establishment of LR 
asymmetry and regulating gastrulation in embryogenesis (reviewed in Tian and Meng 2006). The 
apparent absence of Nodal expression in ecdysozoans and platyhelminthes led to the previous 
assumption that this pathway was specific to the vertebrate development. More recent observations 
have identified orthologs of Nodal in a number of non-vertebrate deuterostomes (Morokuma, Ueno 
et al. 2002, Yu, Holland et al. 2002, Duboc, Rottinger et al. 2005) and non-deuterostome groups 
including Mollusca (Grande and Patel 2009), brachiopoda, chaetognatha (Grande, Martin-Duran et 
al. 2014) and Cnidaria (Watanabe, Schmidt et al. 2014). It therefore seems likely that Nodal signalling 
appeared very early in the evolution of the Bilataria.  
 
Although the presence of Nodal is conserved across much of the bilateria, variations in downstream 
targets, expression domains and characterised functions obscure inferences regarding the ancestral 
role of the Nodal pathway in the establishment of LR asymmetry (reviewed in Tian and Meng 2006, 
Grande, Martin-Duran et al. 2014). For example, expression of Nodal in deuterostomes first appears 
symmetrically expressed on both sides of the embryo and then is restricted to the left side (Levin 
1998, Nonaka, Tanaka et al. 1998, Morokuma, Ueno et al. 2002, Yu, Holland et al. 2002) with one 
notable reversal observed in the sea urchin (Duboc, Rottinger et al. 2005). In the non- deuterostome 
snail and brachiopod, however, Nodal expression is observed initially asymmetrical on the right side 
of the embryo (Grande and Patel 2009, Grande, Martin-Duran et al. 2014). This reveals two key 
differences in the Nodal pathway. Firstly, in the deuterostomes, nodal is restricted from initially 
symmetrical expression to sided expression, indicating a regulating factor to localise the symmetric 
nodal expression, whereas in the non-deuterostomes, an upstream factor is directing initially 
asymmetric Nodal expression (Grande and Patel 2009). Secondly the side of Nodal expression is 
reversed. The right-sided nodal expression in the snail and brachiopod, in addition to proposals that 
the ancestral state of snail chirality is dextral (Ponder and Lindberg 1997), suggest that the ancestral 
pattern of Nodal expression is on the right side. However, it is important to assess more non-
deuterostome groups to establish ancestral relationships.  
 
Another major difference observed in the Nodal signalling pathway in is timing. For example, in 
vertebrate embryos, nodal expression occurs prior to gastrulation (Grande, Martin-Duran et al. 
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2014), whereas nodal signalling in snails is only observed at a much later developmental stage, 
notably after LR asymmetry has been established (Grande and Patel 2009). Therefore, although 
nodal signalling initially arises asymmetrically, it does not represent a symmetry breaking event in 
the snail. 
Timing 
The timing of observed symmetry breaking can provide support or outright disprove proposed 
mechanisms of establishment of LR asymmetry in an organism. As described earlier asymmetries 
have been observed prior to the formation of cilia and therefore the cilia model cannot explain 
symmetry breaking in these organisms (Vandenberg and Levin 2010). Furthermore, phenomena such 
as gynandromorphy, in which an organism is both male and female due to failure for chromosomes 
to separate properly in first cell division (Barranco, Cabrero et al. 1995), and the dermatological 
‘CHILD’ syndrome, which presents LR bilateral segregation of pigmentation in humans (Happle, 
Mittag et al. 1995) both reveal striking asymmetrical external morphology apparent across the 
midline. The chromosomal segregation associations with these disorders indicate the formation of 
the midline may occur as early as the first cell division (a selection of examples and images are 
presented in Aw and Levin 2008).  
It is important to acknowledge that the earliest observed asymmetry in development is not directly 
indicative of when asymmetry is established. The initiation of asymmetry is indicated to be as early 
as the 32 cell stage in Xenopus (Vandenberg and Levin 2010) and mouse embryos have been 
observed to not be LR equivalent by the 8-cell stage (Gardner 2010), far earlier than the appearance 
of the furrow or node equivalent. Furthermore, certain embryo injection experiments in Xenopus, 
have been shown to only be effective if administered prior to first cell cleavage (Lobikin, Wang et al. 
2012). Consequently, timing of LR asymmetry manipulation experiments must be considered very 
carefully for appropriate interpretation of the outcome. A further important consideration is that of 
maternal RNAs which will not be effected by experimental inhibitors of gene expression, as they 
have already been transcribed. 
The intracellular models allow for a very early establishment of asymmetry. The plausibility of 
intracellular symmetry breaking is supported by the establishment of consistent LR asymmetries 
exhibited at the cellular level (Heacock and Agranoff 1977, Hagmann 1993, Xu, Van Keymeulen et al. 
2007, Wan, Ronaldson et al. 2011, Chen, Hsu et al. 2012). The common feature of these systems is 
the presence of a cytoskeleton. It has also been demonstrated that cytoskeletal components self-
organise into chiral structures (Mogilner and Fogelson 2015). What remains to be recognized is the 
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mechanism by which these intracellular chiral components are translated into larger scale 
asymmetries. 
A unifying model?  
It is important to note that the models described here are not mutually exclusive and evidence 
which supports one model does not necessarily refute another. For example, a number of studies 
have contested the role of serotonin, ion flux and gap junctions in early establishment of LR 
asymmetry due to their roles identified within ciliary processes later in development (Beyer, 
Danilchik et al. 2012, Walentek, Beyer et al. 2012). However, processes that are involved in later LR 
patterning does not exclude their possibility of performing roles in the early establishment in LR 
patterning, and it is still possible that the ciliary mechanisms are a by-product or downstream 
amplifier of an earlier establishment of LR asymmetry by these processes (reviewed in Vandenberg 
and Levin 2013) 
It is also important to make the appropriate conclusions from LR manipulation experiments. Many of 
the studies in support of the cilia model, refer to the involvement of ‘ciliary’ proteins of which also 
perform non-ciliary functions, and many do not specify the localisation of the effect i.e. at the node 
(Vandenberg and Levin 2013). In a quantitative analysis of the literature approximately half of all 
studies implicating cilia in the establishment of LR asymmetry provide no measure of morphology or 
function of the effected cilia and therefore offer unclear definitions of normal/abnormal cilia 
(Vandenberg 2012). It is likely therefore that many of these studies are affecting cytoskeletal 
components outside the roles of cilia motility. 
Cytoskeletal dynamics perform fundamental roles within all of the intracellular models described, 
and the MTOC provides the chiral component within the cilia model. Therefore, the cytoskeleton 
represents a common process in how all organisms establish LR asymmetry. Thus it has been 
proposed that the establishment of asymmetry is deeply conserved and the cytoskeleton provides 
the ancestral origin of asymmetry, with the MTOC playing the role of the F molecule proposed by 
Brown & Wolpert (1990) (Vandenberg and Levin 2013)  
It has alternatively been proposed that the developing embryo makes a ‘choice’ to stochastically 
utilise one of several available pathways of establishing LR asymmetry (Vandenberg and Levin 2013). 
Resulting LR interference studies would thus only affect those individuals that had undertaken the 
pathway being manipulated. This model provides an explanation for the low penetrance of 
disruption of LR patterning and lack of 100% reversals observed in experimental manipulations.  
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Each model is supported to a varying extent in different species. Vandenberg et al. (2013) provide an 
insightful quantitative summary of literature cited implicating mechanisms involved in the 
establishment of LR asymmetry in different species. For example, the cilia model is highly supported 
in mouse studies yet not so strongly in other vertebrates and not at all in invertebrates. Similarly, the 
full details of gap junction models have only been characterised in Xenopus, although processes have 
been implicated in a number of other species. Finally, cytoskeletal dynamics are by far the most 
cited in non-vertebrate model systems and single cells.  
If there are, as it appears, different mechanisms across species it is important to identify the best 
model system for insight into the human condition. The mouse model of nodal flow has shown a 
number of differences compared to other amniotes, for example the chick embryo has a node but 
does not have motile cilia, similarly to the pig (Gros, Feistel et al. 2009). Additionally, in syndromes 
such as CHILD mentioned previously, the mouse does not show pigmentation divided across the 
midline, yet demonstrates a mosaic pattern (Konig, Happle et al. 2000). Thus the mouse may not 
represent the best model for medical inferences. It is crucial therefore, to look at multiple model 
systems to gain insight into which mechanisms are conserved, and thus likely to represent the 
ancestral state, and establish the level of integration of these processes within derived mechanisms. 
LR asymmetry in snails 
Spiralian development 
The four most frequently used model organisms in the study of LR asymmetry in development, chick, 
mouse, Xenopus, and zebrafish, are all vertebrates. Invertebrates however can provide useful insight 
into ancestral traits and a potential universal system of establishing asymmetry. A number of 
invertebrates are known to exhibit LR asymmetries to varying degrees including, sea urchins, 
molluscs, Amphioxus (an ancestor of vertebrates), Drosophila and nematodes (reviewed in Levin 
2005, Okumura, Utsuno et al. 2008). 
The Spiralia (often used synonymously with Lophotrocozoa) represent one of three major clades 
within the bilataria and comprise nearly half of the extant metazoans, yet receive far less attention 
when compared to the other two clades, deuterostomes and ecdysozoans (Henry, 2014, Figure 3a). 
Within the spiralia there are a number of debated clades, and due to the variability of features in 
development and the adult body plan, an agreement of the phylogeny continues to be a challenge. A 
more detailed discussion of the current phylogeny of spiralia is well presented in Henry, 2014. 
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However, many spiralians are especially useful when studying LR asymmetry due to the method of 
spiral cleavage in early development. 
The spiral cleavage pattern reveals chirality from the third cell cleavage in which the four 
micromeres do not emerge directly above the four macromeres but are rotationally displaced. This 
twist occurs either clockwise (dextral) or anticlockwise (sinistral) with respect to the macromeres 
(Figure 3c) and alternates direction through subsequent cleavage cycles (van den Biggelaar 1991). 
This is the earliest observed whole-body LR asymmetry in development (Brown and Wolpert 1990). 
This method of spiral cleavage however, is not universal amongst the spiralia, or even within phyla. 
Figures 3a and 3b highlight representative spiralian groups and their method of cell cleavage. 
All spiral cleavers exhibit this early developmental asymmetry, although many larvae resulting from 
spiral cleavage are bilaterally symmetrical. Snails, within the phylum Mollusca, provide a valuable 
study organism because the direction of initial spiral cleavage is continued into their visceral 
asymmetry and, in most cases, is conserved in the direction of external shell coiling (Crampton 1894, 
Robertson 1993). As a result, reversals in chirality are easily observed and monitored in snail 
populations
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         Figure 3 Spiralian phylogenetic relationships and early developmental mechanisms. Full details within image.
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True enantiomorphs 
Snails are rare in that they present true enantiomorphs with multiple chiral reversals having 
occurred within a number of phylogenetically independent families (Schilthuizen and Davison 2005). 
Estimates of the frequency of sinistral morphs in snails vary, and regional variation can be quite 
substantial (Okumura, Utsuno et al. 2008), but it is generally assumed to be less than 10% of species 
(Asami 1993, VanBatenburg and Gittenberger 1996, Schilthuizen and Davison 2005). The reason for 
the flexibility of chiral reversals in gastropods is unknown. However, a contributing factor to the 
number of documented cases may be the ease of observation from shell-coiling direction that far 
more sinistral species have been reported in snails than other organisms, including slugs, which are 
derived from snails (Reise, Benke et al. 2002). Conversely it may be that the conspicuous nature of 
the external shell drives selection not apparent in the slug. It is also possible that there has been an 
overestimate of reversals in snails, as a result of primary asymmetry wrongly being assumed from 
the observed secondary asymmetry of shell-coiling (Robertson 1993, McMillen and Goriely 2002), 
yet the number of chiral reversals reliably documented remains dramatically higher than in other 
species classes. 
Perhaps surprisingly given the frequency of chiral reversals within gastropoda, most species exhibit 
only one chiral morph. There are many interesting facets of the ecological implications of chiral 
reversal including barriers to inter-chiral mating due to the incompatible lateral positioning of sexual 
organs or behavioural biases resulting in the reduced probability of reproduction in the rarer morph 
(Johnson 1982, Schilthuizen, Scott et al. 2005, Schilthuizen, Craze et al. 2007, Davison, Frend et al. 
2009, Koene and Cosijn 2012). This led to the proposal of a possible single-gene speciation event 
occurring from the emergence of immediately reproductively isolated reversed chiral morphs 
(Gittenberger 1988, Ueshima and Asami 2003). However, this theory remains contentious. Because 
of the maternal inheritance of chirality exhibited in the experimentally observed cases of chirality 
inheritance (described in further detail in section ‘Lymnaea as a model system’), it is believed that 
gene flow would prevail between opposite chiral morphs (Davison, Chiba et al. 2005). Alternative 
frequency dependent selection mechanisms have been proposed for dimorphic populations in the 
presence of chiral predators. For example, sinistral morphs have been shown to survive predation by 
the snail-eating snake, Pareas iwasakii, which bears asymmetric mouth parts apparently adapted to 
eating dextral coiling snail (Hoso, Kameda et al. 2010).  
In light of the potential barriers to mating between chiral morphs, it is notable that there are still 
limited examples of chiral dimorphism within externally fertilising species which do not suffer the 
same behavioural or physical barriers, and significantly fewer recorded examples of sinistral snails in 
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the sea (Hendricks 2009). Therefore, although there is undoubtedly selection on chiral dimorphism, 
it is unlikely to be the only factor limiting the prevalence of sinistral species, as such there may 
instead be a selective constraint on the propagation of sinistrality (Vermeij 1975) although there is 
limited evidence to support this (Davison, Barton et al. 2009).   
Species which maintain chiral dimorphism are therefore essential to the study of the inheritance of 
chirality. Pulmonate snail species from phylogenetically independent families (Wade, Mordan et al. 
2006) in which interchiral mating is possible, have shown inheritance of directional LR asymmetry 
through a maternal effect gene. Interestingly the genetic dominance of the sinistral or dextral form 
varies between species. Lymnaea spp. show dextral coiling is dominant to sinistral (Sturtevant 1923, 
Boycott, Diver et al. 1930) whereas Partula spp. show sinistral coiling to be dominant to dextral 
(Murray and Clarke 1966). 
Expression of nodal has also been documented in a number of snail species (Grande and Patel 2009, 
Kuroda, Endo et al. 2009). Originally identified in the dextral, Lottia gigantea and the sinistral 
Biomphalaria glabrata each exhibited opposite patterns of lateral nodal expression (Grande and 
Patel 2009). Dextral snails expressed nodal and the downstream target Pitx on the right side 
whereas the sinistral snails expressed them on the left. This is of great significance due to the 
apparent absence of nodal in Drosophila and nematodes. It has been suggested that their absence of 
nodal expression may reflect the more derived modes of mesendoderm and LR specification in these 
systems (Schier 2009). 
Lymnaea as a model system 
It was observed that primary LR asymmetry in snails (indicated by the direction of shell/whole-body 
coiling) is determined by a single heritable unit over a century ago (Crampton 1894). Boycott and 
Diver (1923) documented the inheritance of chirality in the pond snail, Lymnaea peregra via multiple 
laboratory mating crosses between snails of opposite shell-coiling. They described in detail, an 
unknown pattern of inheritence with five possible outcomes for the resulting ratio of chiral 
phenotypes within the offspring/broods, including the phenomenon of mixed broods, in which a 
single clutch of eggs contains offspring of both chiral morphs. 
It was shortly thereafter proposed by Sturtevant (1923) to follow a much simpler Mendelian mode 
of inheritance with a maternal effect, in which the classic Mendelian dominant/recessive mode of 
phenotype expression is delayed a generation. Therefore, the genotype of mother is expressed 
through the phenotype of their offspring.  This is the presumed mechanism of inheritance of chirality 
in all chirally dimorphic pulmonate snail species (Asami, Gittenberger et al. 2008). In Lymnaea spp. 
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the dextral form is dominant to the sinistral form. Therefore, the offspring from a heterozygote 
mother will bear a dextral-coiling body plan. It is important to note that the occurence of mixed 
broods in Lymnaea spp. is more often documented with dextral coiling offspring occuring in what 
should be a sinistral brood. Sinistral offspring in a dextral brood was only documented once in the 
original Boycott and Diver observations (Boycott and Diver 1923). 
The sinistral population of L. peregra has since been lost, and now the sister species: L. stagnalis is 
used (Morrill 1982, Meshcheryakov 1990). It is believed that the chiral determinant in L. peregra and 
L. stagnalis functions in a common manner, albeit with a few minor differences (Kuroda 2014). L. 
stagnalis provides a valuable study system for LR asymmetry for a number of reasons. In addition to 
the maintained chiral dimorphism, it produces relatively large transparent eggs, approximately 1 mm 
in diameter, with the yellow embryo visible with the naked eye. It is a hermaphrodite and can 
reproduce either through self-fertilisation or with a sexual partner (preference), facilitating rapid and 
effective inbreeding and backcrossing to reduce genetic variability (Hosoiri, Harada et al. 2003). 
The direction of spiral rotation of micromeres at the third cell cleavage correlates almost perfectly 
with eventual organ situs and shell coiling (one exception has been observed (Kuroda 2014)) and as 
such provides an informative signal of chirality early in development. However, it has recently 
become apparent that the chiral morphs of L. stagnalis are not true enantiomorphs in these early 
cleavage steps. In the dextral embryo, the third cell cleavage results in the four micromeres 
emerging at a 45° angle on top on the sister macromeres, whereas in the sinistral embryo, this 
rotation does not occur immediately and the emergent micromeres sit directly on top of the 
macromeres with no rotation (Figure 3c) (Shibazaki, Shimizu et al. 2004). 
The cytoskeletal components during this phase have been observed, revealing two key steps 
involving mitotic spindles and microfilaments. In the dextral embryo, firstly ‘spindle inclination’, 
reveals a helical orientation of the mitotic spindles with respect to the animal-vegetal axis, which 
corresponds to the following dextral cleavage of the 4-8 cell embryo. Secondly, filamentous actin, 
which appears concentrated at each cell boundary and cleavage furrow, precedes a ‘spiral 
deformation’ of the blastomeres, which results in the helical emerging micromeres (Figure 3c). The 
sinistral L. stagnalis embryos however, do not undergo either spindle inclination or spiral 
deformation, yet exhibit radial symmetry throughout the third cell cleavage, and only exhibit 
sinistral rotation after the emergence of the micromeres (Figure 3c) (Shibazaki, Shimizu et al. 2004).  
Although there is no apparent reduction in fitness of the adult sinistral L. stagnalis, they are 
vulnerable in development and suffer a reduced hatch rate (Davison, Barton et al. 2009, Utsuno, 
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Asami et al. 2011). Developing sinistral Lymnaea are also susceptible to reversion to dextrality 
through unspecified physical manipulation. This was previously believed to be due to the 
transplanting of the cytoplasmic fluid which surrounds the embryo (ooplasm) from the dominant 
dextral form (Freeman and Lundelius, 1982). However, this is not the case in L. stagnalis and a 
dextral reversion can occur just through physical disruption (Kuroda 2014). 
Due to the observed pathologies (of unknown mechanism) and differences in cleavage pattern in the 
sinistral developing embryo (Shibazaki, Shimizu et al. 2004), L. stagnalis does not provide a perfect 
comparison of chiral reversal. Still in light of the ease of laboratory rearing and interchiral breeding, 
L. stagnalis provides an invaluable model to study LR asymmetry in development and holds a strong 
background of previous studies. 
Although the gene causing reversal of chirality has not yet been isolated, the mechanism of 
establishing asymmetry has been highlighted to involve the cytoskeleton. Inhibition of actin 
polymerisation in genetically dextral embryos resulted in a failure of the emerging micromeres to 
rotate (spindle deformation and subsequent spindle inclination), mimicking the sinistral wild-type 
form (described above). Treatment with the same agents on the sinistral embryos had no discernible 
effect (Shibazaki, Shimizu et al. 2004). Conversely, inhibition of microtubule polymerisation actually 
enhanced the spindle deformation in the dextral embryos and did not inhibit spindle inclination. 
Again no change was seen in the sinistral embryos (Shibazaki, Shimizu et al. 2004). This study 
indicates that the actin cytoskeleton is essential for correct dextral spiral cleavage, whereas 
microtubule actions occur as a result of the already formed blastomeres. Additionally, it implies that 
the sinistral form is lacking a functional step in spiral cleavage (spindle inclination). 
Further supporting the role of the cytoskeletal structural components in determining chirality was a 
key study, which physically reversed the orientation of dextral and sinistral L. stagnalis embryos by 
micromanipulation, resulting in 78% successfully LR reversed organisms (Kuroda, Endo et al. 2009). 
The reversed organisms that reach adulthood produced offspring in accordance with their original 
coiling direction, indicating that there had been no genetic change in the individuals. This 
experiment also revealed factors regarding the timing of asymmetry determination. If manipulated 
prior to the third cell cleavage the embryos would correct themselves to their genetically disposed 
orientation. Therefore, the cell contacts between macro- and micromeres appear to be the 
determining step in LR asymmetric patterning (Kuroda, Endo et al. 2009). 
Asymmetrical gene expression of Nodal and the downstream Pitx, have been observed in L. 
stagnalis. First detected at cell stages 33-49 and therefore present much earlier in development than 
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observed in the vertebrates. The physically reversed embryos described above, exhibited reversed 
asymmetric expression of nodal (Kuroda, Endo et al. 2009). This indicates that the reversal had 
successfully redirected cell-cell communication and ultimately that the nodal pathway occurs 
downstream of the symmetry determining step in L. stagnalis, which is governed by cytoskeletal 
dynamics, which are very strongly associated with inheritance of the maternal effect gene. 
Whereas the mechanism of establishing LR asymmetry in L. stagnalis remains unknown, the method 
of its inheritance has been known for nearly a century (Sturtevant 1923). Therefore, the Davison 
research group has focussed on genetic mapping of the ‘chirality locus’ to identify the causal gene 
‘D’. There is not yet a fully annotated genome available for L. stagnalis, however linkage mapping, 
via high-throughput sequencing of genetic crosses between lab-reared monomorphic chiral 
populations, identified three anonymous markers which are tightly linked to the chiral phenotype 
(Liu, Davey et al. 2013).  
This has enabled genotyping of a large number of individual snails according to the chirality locus, as 
homozygous dominant ‘DD’, heterozygous ‘Dd’ or homozygous recessive ‘dd’. Throughout this thesis 
individual samples and populations will be referred to by this nomenclature of chiral genotype. It is 
important to note that snails are scored by their chiral genotype, which corresponds to the coiling 
direction of their offspring, not necessarily their own shell coiling direction.  
The chirality locus has been localised further through pachytene FISH (fluorescent in situ 
hybridisation) and fibre-FISH mapping, which enable visualisation of specific genetic transcripts 
hybridised to whole chromosomes (for a more in-depth description of these techniques please see; 
Weier, Wang et al. 1995, Garimberti and Tosi 2010). The chromosomal FISH mapping revealed that 
the three chirality-linked markers all occur on the same chromosome, providing strong evidence that 
the chirality locus lies within this region (Liu, Davey et al. 2013). Further sequencing via a method 
called BAC (bacterial artificial clone) walking, which enables genetic sequencing of unknown regions 
when initiated from an area of known sequence, have provided additional genetic sequence 
information within this region (for more information regarding this technique please see Kubat 
2007). Combined with sequence comparisons of other mollusc species, the distance between the 
two most tightly linked markers, assumed to contain the chirality gene, has been estimated between 
0.4 and 0.6 megabases (Liu, Davey et al. 2013). 
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Gene expression analysis 
RNA: a versatile molecular tool 
Sequence data from genomic DNA provides information regarding both protein coding genes and 
non-coding regions and accordingly holds a significant amount of genetic information not 
transcribed into RNA. However, RNA expression data offers a wealth of functional information that 
DNA cannot. 
One of the main functional classes of RNAs used in gene function studies are messenger RNAs 
(mRNAs). The code for each gene is stored in DNA present in almost every cell in an organism. This 
sequence is transcribed into mRNA when activated. The mRNA sequence then specifies the amino 
acid sequence to generate the particular protein (Meneely 2009). Thus mRNA represents an 
intermediate molecule between DNA and the eventual protein and can provide information on 
which genes are being transcribed, or ‘switched on’, in the cell. 
One of the defining properties of mRNA when it was first discovered in the mid-20th century was the 
transient nature of the molecule. In yeast the half-life of mRNA varies from 1-100 minutes, whereas 
in mammals it varies from less than 20 minutes to up to 50 hours. mRNA decays at varying rates, 
partly this can be attributed to tertiary structure of the mRNA, however there are a number of 
documented mechanisms affecting the stability or active degradation of mRNAs, revealing another 
method in which gene expression is regulated within the cell (Elliot and Ladomery 2011, pp. 307-
321). 
RNA analysis can provide much more information than simply which genes are being transcribed and 
quantitatively regulated. This was made apparent through the genome sequencing project, which 
identified substantially fewer protein coding genes than the number of actual proteins known to be 
present in humans (the proteome). This discrepancy has been explained through post-transcriptional 
RNA processing. Transcriptional regulation determines which genes are switched on or off in a cell, 
whereas the complexity of the proteome is in a large part due to post-transcriptional RNA 
processing, such as alternative splicing (Elliot and Ladomery 2011, pp. 158-192). Alternative splicing 
produces different mRNA sequences from the same gene, as such these isoforms would not be 
observable from DNA sequencing.  
It has now become apparent that the functional aspects of RNA are not limited to the protein-coding 
mRNAs. Non-coding RNAs (ncRNAs) can be divided into long and short. Long ncRNAs are considered 
to be >200 nucleotides (nt) in length, arbitrarily due to RNA extraction protocols which omit short 
RNAs (Mercer, Dinger et al. 2009). The field of long ncRNA research is relatively recent. Although 
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many predicted functions are uncharacterised, long ncRNAs are predicted to have widespread 
functionality including chromatin modification and modulating protein binding interactions, pre and 
post-transcriptional regulation (Mercer, Dinger et al. 2009, Wilusz, Sunwoo et al. 2009). Small 
ncRNAs have been better characterised and are largely involved in the regulation of gene expression 
and particularly gene silencing, although many classes likely remain to be identified (Mattick and 
Makunin 2006). There is a growing body of evidence highlighting that micro RNAs (19-25 nt in 
length) and recently classified Piwi-interacting RNAs (24-30 nt in length) play key roles in the 
regulation of animal development (Stefani and Slack 2008). 
A number of other features of RNA provide insight into the workings of the cell and gene expression, 
such as catalytic enzymatic functions, recognition site and protein interactions, complex secondary 
and tertiary structures resulting in varied reactivity and structural components such as the ribosome 
(Elliot and Ladomery 2011). Although these facets are beyond the scope of this project, it is 
important to recognise the vast potential of RNA analysis.   
Patterns of gene expression 
To infer biological meaning from RNA data, patterns of gene expression must be identified. A 
common assessment of gene expression simply compares the quantitative level of gene expression 
between two samples. This directly implicates genes, or specific isoforms, which are being affected 
by the variable considered. Due to the transient nature of RNA, quantitative comparisons can be 
performed between samples or within samples over time to gain both temporal and spatial 
comparisons of gene expression. Quantitative patterns of gene expression can reveal differences 
between organisms indistinguishable through genomic approaches (as demonstrated by Wolf, Bayer 
et al. 2010). 
The locality of gene expression can reveal insightful functional clues regarding the role of the RNA 
transcript. Therefore, it is essential to compare specific tissues within quantitative experiments. 
Additionally, techniques such as in situ hybridisation, allow for the visualisation of gene expression 
within tissues or in the case of whole-mount in situ hybridisation even whole organisms (due to size 
limitations this is usually limited to developmental stages) (Hemmati-brivanlou, Frank et al. 1990). 
It is important to remember than specific gene expression is almost always in combination with that 
of other transcripts. Observing expression patterns of multiple target transcripts can reveal gene 
networks and clusters. Similarities in gene expression patterns can indicate similar functions of the 
genes involved and expression pathways, thus enabling functional interpretations of undescribed 
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genes (Chua, Robinson et al. 2004, Janky, van Helden et al. 2009). This however, requires a certain 
level of functional annotation available, which is not the case for the majority of species. 
Proving causality 
It is essential when exploring genetic relationships linked with an observed phenotype to clarify 
whether the gene causes the phenotype or is simply associated with phenotype. This is especially 
apparent with the advent of next generation sequencing and the growth of large sequence datasets, 
where the need to justify cause as opposed to correlation is of increasing concern. 
This is not a new problem and represents a natural caveat of any experiment. How does one prove 
the order of cause and effect? Further still, proving that a factor precedes an effect does not denote 
that it caused it. Entire books have been written on the mathematical and philosophical properties 
of causality (Pearl 2000) however this thesis is not one of them. This problem can be minimised by 
performing highly controlled randomised experiments. In genetics however, experimental conditions 
(genotypes) cannot be randomly allocated and therefore studies are outside the statistical requisites 
of true experimentation and leave room for doubt (Rubin 1991, Rosenbaum 1995). Therefore, the 
role of the experimenter is to minimise residual doubt.  
This process has been coherently reviewed in (Page, George et al. 2003), in which they summarise 
possible origins of an association between a gene/polymorphism and a phenotype. Firstly, it may be 
that the gene does in fact cause the observed phenotype, a true causal relationship. Alternatively, 
statistically significant associations may represent false positives identified due to chance. The gene 
may be associated with the trait due to disequilibrium together with the true causative gene. Finally, 
the association may have been identified through systematic bias within the experiment. In order to 
support the first hypothesis that the gene is a true causative polymorphism, the other specious 
possibilities must be eliminated. 
Reducing the occurrence of false positives by chance can be achieved by increasing the probability 
(p) value threshold for statistical significance. Such is the case for p value corrections to account for 
false discovery rate (FDR) due to multiple comparisons (Benjamini and Hochberg 1995, Benjamini, 
Drai et al. 2001). However, simply increasing the p value will not correct for the alternative sources 
of erroneous associations.  
Identifying a polymorphism in linkage disequilibrium provides a primary indicator of its association 
with the observed trait. However, in order to ascertain whether it represents the causative 
polymorphism, efforts must be taken to classify (and subsequently eliminate) all other 
33 
 
polymorphisms within the region of DNA, which may also be in disequilibrium (Demuth and Wade 
2006).  
Systematic bias can arise in two forms, experimental bias or biological bias. All experimental studies 
include a level of error. Replication, although an assumed part of any scientific experiment should be 
considered for both technical or ‘operational replication’, in which the same methodology is 
employed in order to achieve the same result, and ‘constructive replication’ in which the same result 
is achieved via a different methodology (outlined and exemplified in Lykken 1968). Each of these 
forms of replication highlights different sources of experimental error. It is subsequently essential to 
appropriately calculate and incorporate error into the resulting analyses and inferences. For 
example, if the data does not fit the statistical model employed, the resulting p value will be 
irrelevant, no matter how ‘significant’ the value.  
Knowing the biological system being examined is critical in order to design an experiment free of 
systematic bias. For example, the study populations, if not able to be controlled must have their 
evolutionary or population history known to enable incorporation of error due to admixture or other 
confounding genetic effects, such as environmental effects on gene function (Page, George et al. 
2003).  
Although many have proffered guidelines for the minimum requirements to infer causation (Koch 
1882 cited in: Page et al. 2003, Hill 1965, Glazier, Nadeau et al. 2002, MacArthur, Manolio et al. 
2014, amongst others), a universal definition is not appropriate as the capabilities for experiments 
are not equal across study systems. For example, genomic studies of wild subpopulations on an 
ecological genetics grant cannot gain the same level of proof as a controlled laboratory population 
with access to an annotated reference genome. Therefore, with the aim to prove causality of an 
associated candidate gene via the inability to refute it, the advised methods of proving causality 
applicable to the Davison research group’s chirality gene study in L. stagnalis are outlined below 
(Glazier, Nadeau et al. 2002, Page, George et al. 2003, Weigel and Nordborg 2005). 
The initial step in identifying causal genes is firstly identifying linkage of the genetic polymorphism 
with the observed phenotype, enabling accurate genotyping of samples. The associated 
polymorphism must subsequently be located to a specific region of the genome by fine-scale 
mapping and further sequence analysis to describe the genes present within the region. As 
described earlier (section ‘Lymnaea as a model system’), the Davison research group have already 
finely mapped the region of the genome tightly linked with the chirality phenotype (Liu, Davey et al. 
2013). Through further sequencing analysis a number of genes have been identified that lie within 
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the region, which could represent the cause of inherited chirality. A frame-shift mutation has been 
identified in the gene coding for a diaphanous formin in the sinistral genotype (Davison et al., 
awaiting publication). This gene represents the primary candidate as the ‘chirality gene’ in L. 
stagnalis and is described in further detail in Chapter 3. 
The presence of a mechanistic link between the candidate gene and the observed phenotype will 
provide ‘biological plausibility’ to support the causal relationship of the gene. As L. stagnalis lacks a 
fully annotated reference genome this may not be considered essential, however those genes with 
functions considered likely to be involved in axis specification and structural developmental will 
need to be eliminated as candidates with stronger evidence than those that do not.  
Support can also be gained for a causal gene by recognition of the same genetic polymorphism 
resulting in the altered phenotype in another population or species. Unfortunately, there is only one 
sinistral population of L. stagnalis currently available. Therefore, all findings of genetic linkage 
between chiral morphs are unable to be supported through independent populations. New sinistral 
individuals of Lymnaea spp. have recently been recovered in Kauai, Hawaii and efforts are underway 
to establish a new laboratory line (Dr Angus Davison, University of Nottingham, Dr. Kenneth Hayes, 
Howard University, Dr Norine Yeung, Bishop Museum, Hawaii, pers. comm.). Yet presently the 
primary candidate diaphanous formin has not been found to be associated with chirality in other 
chirally dimorphic snails, Euhadra and Partula (Davison et al., awaiting publication). 
Further functional tests will be necessary to support the causative role of the candidate gene. Ideally 
gene knock-down experiments would provide the proof that the specific candidate gene is directing 
chirality determination in L. stagnalis. Due to the maternal effect of the chirality gene, the mRNA 
transcripts and likely the gene product are already present and as such, expression interference 
methods will not be effective in the developing embryo. However, the development of genome 
editing technologies such as CRISPR-cas (clustered regularly interspaced short palindromic repeats - 
cas), enable permanent gene modification which is subsequently passed to the next generation 
(Cong, Ran et al. 2013, Friedland, Tzur et al. 2013). Accordingly, this method of gene knock-down 
could be effective in disrupting the chirality phenotype. The CRISPR-cas approach needs only a 
specified target gene sequence similar to PCR primer design (Sander and Joung 2014) and so can be 
readily applied to L. stagnalis. However, the method of delivery to the target genome remains a 
challenge. As such gene knock-down is a growing possibility for this system, although currently 
beyond the current capabilities of the Davison research group.  
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In the absence of gene knock-down experiments, functional properties can be inferred by alternative 
means. For example, drug treatments, which interfere with protein function specific to the 
candidate gene, can mimic the effects of gene knockdown (Davison et al., awaiting publication). 
Additionally, gene expression patterns can highlight tissue (spatially) and temporally specific 
functionality of candidate genes between chiral genotypes. 
Project Aims 
The aim of this project was to elucidate gene expression patterns associated with chiral variants of L. 
stagnalis. With the intention of providing support for the causal relationship of the primary 
candidate diaphanous formin and likely downstream effects, whilst also identifying possible 
mechanistic explanations for the negative pleiotropic effects observed in sinistral L. stagnalis 
embryos (Davison, Barton et al. 2009), this was performed using two different scales of expression 
analysis. Gene-specific quantitative expression differences were assessed for a number of candidate 
genes using quantitative real-time PCR (qPCR). Additionally, a transcriptomic sweep was performed 
using a novel next generation RNA sequencing method to explore the extent of gene expression 
differences between the three chiral genotypes. 
Due to the inherent importance of locality of expression in the determination of LR asymmetry, in 
situ hybridisation methods were also undertaken to explore the localised expression of a number of 
key candidate genes in L. stagnalis embryos. This was performed thanks to collaboration with Dr 
Daniel Jackson at the Georg August Unversitӓt Gӧttingen, Germany. However due to limited time to 
develop the gene-specific assays, results were inconclusive and subsequently not presented in depth 
within this thesis. A summary of the project is presented in the supplementary information (SI).  
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Chapter 2:  
Validating endogenous control genes 
for use in quantitative real-time PCR in 
Lymnaea stagnalis 
Introduction 
The use and misuse of quantitative real-time PCR 
Quantitative real-time PCR (qPCR) has become the principal technique for detection and 
quantification of gene expression and ultimately determining whether varying conditions have an 
effect on the expression of a specific gene. qPCR offers a flexible method, facilitating a dynamic 
range of input quantities and accurate within a two-fold range (AppliedBiosystems 2014). A brief 
description of the principles of qPCR follows. For a historical review of the technique and its 
development please see Van Guilder et al. (2008).  
qPCR employs the conventional polymerase chain reaction (PCR) to amplify a specific DNA sequence 
within a sample via a pair of complementary sequence primers. qPCR however uses complementary 
DNA (cDNA) reverse-transcribed from RNA as a template. The level of gene expression is assumed to 
be reflected in the amount of gene-specific RNA transcripts and subsequently cDNA present within 
each sample. The addition of a fluorescent dye, which binds to double-stranded DNA, allows the 
qPCR machine to record a quantitative measure of the amount of PCR product within each reaction, 
inferred from the intensity of the fluorescent signal after each thermodynamic cycle.  Using this 
information, the qPCR system can generate a real-time amplification curve for each reaction 
(AppliedBiosystems 2014).  
Once the fluorescent signal in a sample has exceeded that of the background fluorescence, it 
signposts the exponential phase of the reaction and the start of the amplification curve. During the 
exponential phase of the qPCR, the fluorescent signal will be directly proportional to the amount of 
template. A cycle threshold (Cq) value can then be calculated from the intersection of the 
amplification curve and the ‘threshold line’ (Figure 4). This value corresponds to the number of 
cycles required to exceed the threshold. Therefore, a high Cq value indicates a low starting quantity 
of the specific transcript. The threshold line will be the same for all samples compared within the 
same run (AppliedBiosystems 2011). The Cq value is also frequently referred to as the CT, CP, or 
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occasionally TOP. Here ‘Cq’ is the term used, as advised by the MIQE guidelines and the Real-time 
PCR Data Mark-up Language, RDML (www.rdml.org , Bustin, Benes et al. 2009).  
There are two different approaches to qPCR; absolute and relative quantification. The analyses 
throughout this project were intended to determine whether there are differences in gene 
expression between the chiral genotypes of Lymnaea stagnalis. As such absolute quantification was 
not required, simply to detect whether one genotypic group has a significantly different quantity of 
transcript relative to the others. Therefore, only relative quantification was performed. In order to 
calculate the relative quantities of a transcript, one sample within the analysis functions as a 
reference or calibrator sample. All Cq values are then converted to a fold-change expression level 
relative to the calibrator sample.  However, ensuring that samples are accurately measured relative 
to one another can prove to be a not insignificant challenge. 
 
 
 
 
 
Figure 4 Graphical representation of the calculation of cycle threshold (Cq) values from qPCR data. The fluorescence of 
the reporter dye, normalised to the passive reference dye and background fluorescence, (ΔRn) is shown according to 
reaction ‘cycle number’. Image adapted from (AppliedBiosystems 2011). 
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Recently it has become apparent that the ease of access and flexibility of the qPCR technique has led 
to potentially misleading results, some of which in medical research may have harmful 
consequences (Baker 2011, Bustin, Benes et al. 2013). The MIQE guidelines published in 2009 
(Bustin, Benes et al. 2009) have provided a well-regarded checklist for the Minimum Information for 
publication of Quantitative real-time PCR Experiments (MIQE). The guidelines contain 85 check 
points for quality control assessment. To complete the entire check checklist however, may not be 
feasible for all experimental designs due to limited sample, resources and time. A summary of the 
most important guidelines are described in the following section in order to highlight and explain the 
potential pitfalls common to previous qPCR methodologies. 
Priorities for experimental design 
Sample quality 
The RNA sample provides the initial template for the qPCR. Thus to ensure biologically meaningful 
results, samples must be of high quality. Firstly, the presence of chemical impurities (often occurring 
from carryover in extraction methods, for example, phenol) can inhibit both reverse transcription 
reactions and qPCR. Contaminating carryover DNA will also significantly compromise the accuracy of 
the qPCR due to the potential amplification of non-specific products. Therefore, appropriate 
measures must be taken to ensure a clean and specific method of RNA extraction, including the 
removal of DNA from samples prior to reverse transcription (AppliedBiosystems 2008).  
Secondly the RNA must be structurally intact to provide a reliable template for reverse transcription. 
RNA integrity can be better maintained by appropriate handling and storage of tissues and RNA 
samples. ‘RNase’ is a term which refers to the numerous enzymes which accelerate the degradation 
of RNA molecules. Due to the general prevalence of RNases, minimal handling and immediate 
reverse transcription of RNA is recommended to minimise sample degradation (Taylor, Wakem et al. 
2010). Furthermore, RNA sampling time/conditions should be controlled between samples. The 
temporal nature of RNA provides a wealth of biological information, however to make accurate 
inferences between experimental groups, confounding factors, such as age, diet, diurnal cycle, which 
may influence expression of the target gene must be minimised. 
The vast majority of total RNA consists of ribosomal and other non-coding RNAs, whilst messenger 
RNAs (mRNAs) are predicted to only represent 1-3% (Palmer and Prediger 2015). mRNAs are more 
likely to reveal functional variation due to their essential role in protein coding. Therefore, it is 
common to enrich for mRNA by treating the total RNA sample prior to cDNA synthesis, using Oligo 
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dT binding. Oligo dTs bind to the distinctive polyadenylated (poly(A)) tail present at the 3’ end of 
mRNAs and as a result can select for mRNA molecules (Aviv and Leder 1972, DeFranscesco 1998). 
This mechanism has also been applied to enrich for mRNAs during cDNA synthesis. Reverse 
transcription requires a short primer sequence complimentary to the RNA strand to initiate the 
reaction, which follows to generate a copy of the template sequence in the 5’-3’ direction. By using 
oligo dT primers, which complement the poly-A tail present at the 3’ end of mRNA, reverse 
transcription is initiated only on mRNAs. However, with increasing levels of research indicating the 
functional importance of non-coding RNAs (Mattick and Makunin 2006, Stefani and Slack 2008, 
Wilusz, Sunwoo et al. 2009), over-enrichment may be obscuring overall expression patterns. 
Moreover, mRNA enrichment of this manner does not only filter out non-coding RNAs; due to 
reverse transcription being initiated at the 3’ end, long genes may struggle to gain even coverage 
and suffer a significant underrepresentation of the 5’ region. Therefore, a combination of Oligo dT 
and random hexamer primers are recommended for a well-balanced cDNA synthesis (Taylor, Wakem 
et al. 2010). 
Amplification efficiency 
Theoretically during the exponential phase of a qPCR reaction, every copy of the target transcript is 
doubled after each thermodynamic cycle. However, this assumption is not always met. To reliably 
quantify relative expression levels requires the Cq values of the target gene to be normalised to 
those of a stable endogenous control gene (described in greater detail in section ‘Endogenous 
control genes’). To be compared accurately, all primer pairs must perform with the same 
amplification efficiency, or alternatively, the comparative Cq calculation must incorporate 
differences in amplification efficiency. Therefore, average primer efficiencies must be known for 
each primer pair used in the qPCR experiment. 
Inter-run calibration 
There are two sources of variation in a qPCR experiment; technical and biological. Each qPCR 
reaction will be slightly different from the last by some level of variation. Therefore, technical 
replicates must be performed in addition to biological replicates. Three technical replicates per 
sample is preferred (AppliedBiosystems 2014). If the total number of samples to be assessed in the 
experiment exceeds one 96 well plate, which is highly likely considering the advised number of 
controls undertaken, plate-plate technical variation will also be introduced.  
If all samples to be compared within the same target gene occur on the same plate, plate-plate noise 
will not affect the relative comparisons within that gene. However, if samples are to be compared 
over multiple plates, plate-plate error must be corrected for by the inclusion of the selected 
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calibrator sample on all experimental plates to be compared. This can become costly in both samples 
and reagents and it is therefore worth considering plate design for sample maximisation as opposed 
to gene maximisation (Hellemans, Mortier et al. 2007).  
Endogenous control genes 
To verify that quantitative differences observed from the qPCR experiment are a true reflection of 
the relative gene expression between the individuals assessed and not a consequence of technical 
differences in sample quantity or quality, samples must be standardised across the experiment. 
There are ways to control for starting quantity across samples, for example, using an equal number 
of cells in RNA extraction or an equal starting quantity of RNA in cDNA synthesis. However, these 
methods are not precise enough. A robust method for standardising starting concentrations 
between samples is to ‘normalise’ the relative quantities of each target gene of interest (GOI) to 
those of an internal reference gene, hereafter referred to as an ‘endogenous control gene’. 
Previously commonly referred to as ‘housekeeping genes’, perhaps exacerbating the misconception 
that any ‘cell maintenance’ gene can be used as a stable calibrator. It is now becoming widely 
accepted that there are no universal endogenous control genes, and each gene intended for use as 
an endogenous control must be validated as consistently expressed across all experimental 
conditions. It is also recommended to use a minimum of three endogenous control genes 
(Vandesompele, De Preter et al. 2002). 
Candidates for stable endogenous control genes in L. stagnalis 
Of the ten published studies using relative qPCR in L. stagnalis (Web of Science, November 2015), 
only one has described any method of validation of the endogenous control genes used (Bouetard, 
Besnard et al. 2013). The research areas of these studies for the most part, involve the central 
nervous system and as such are not likely to be using chiral variants. Consequently, to date, no 
stable control genes have been described for use across chiral variants. With one notable exception 
(Bulloch, Diep et al. 2005), the majority of experiments default to the use of ribosomal RNA (rRNA), 
actins or tubulins as generalised endogenous controls (van Kesteren, Carter et al. 2006, van Nierop, 
Bertrand et al. 2006, Ribeiro, Schofield et al. 2010, Bavan, Straub et al. 2012, Bouetard, Besnard et 
al. 2013, Carter, Rand et al. 2015). Others have not used endogenous control genes at all 
(Hatakeyama, Sadamoto et al. 2004, Wagatsuma, Sadamoto et al. 2005, Azami, Wagatsuma et al. 
2006). 
rRNAs, such as 18S and 28S rRNA, although commonly employed, are generally not considered to 
provide suitable endogenous control genes due to a number of reasons. Firstly, if the sample has not 
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been enriched for mRNA, the over-abundance of rRNAs relative to the target mRNA sequence can 
lead to problems in accurate normalisation. If the sample has in fact been selected for mRNAs, the 
rRNAs will not be present in the sample, due to their lack of a poly-A tail (although exceptions have 
been observed (Slomovic, Laufer et al. 2006)). Additionally, rRNAs are transcribed through an 
independent pathway from mRNAs and therefore not being regulated in the same manner, and 
therefore may not relative to the mRNAs being quantified (Radonic, Thulke et al. 2004). In many 
cases the use of actin and tubulin could provide an appropriate endogenous control, however, due 
to the focus of this study on cytoskeletal processes, it would have been contradictory to propose 
genes from within the functional groups expected to vary between conditions as stably expressed 
control genes.  
In the absence of verified stable control genes for use in qPCR studies in L. stagnalis, applicable to 
the analysis of chirality, it was essential to design and evaluate new primers to provide suitable 
control genes for the intended differential expression analysis of candidate chirality genes. 
This experiment aimed to identify differential expression between maternal transcripts and 
developmental processes. Therefore, endogenous control genes that had been verified as stable in 
reproductive tissue and throughout developmental stages in a wide range of other species including; 
frog (Sindelka, Ferjentsik et al. 2006), plant (Pellino, Sharbel et al. 2011), pig (Kuijk, du Puy et al. 
2007), and mouse (Jeong, Choi et al. 2005) were considered to be suitable candidates for control 
genes in this system. Additionally, those genes found to be most stable across a variety of tissues in 
the original geNorm study (human) (Vandesompele, De Preter et al. 2002), were included as 
candidates to better accommodate the inclusion of somatic foot tissue. 
Endogenous control genes must be validated as stable in all tissues that are to be used in the qPCR 
experiments. However, the same gene does not have to be used across all experiments. For 
example, one set of control genes may be used to standardise an analysis of foot tissue samples, 
whereas another gene may be more appropriate for use in single cell embryo tissue. 
Measures of gene expression stability 
Three different freely available algorithms, namely; geNorm, (Vandesompele, De Preter et al. 2002), 
NormFinder (Andersen, Jensen et al. 2004) and BestKeeper (Pfaffl, Tichopad et al. 2004) were 
employed and their capabilities evaluated. Each of the three methods for calculating gene 
expression stability includes a unique aspect and therefore using multiple methods will not only 
support inferences through repeated analysis but will provide additional information. 
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Methods 
Sample Preparation 
Three separate tissues were assessed in this study from laboratory reared populations of L. stagnalis 
each with an inbreeding coefficient of more than 98% whilst maintaining chiral dimorphism. 
Single-cell embryos of individual self-fertilised mothers were decapsulated and stored in RNAlater® 
solution (Ambion) at 4°C. Once a sufficient number of embryos had been collected per individual 
snail (>100), total RNA was extracted using the RNeasy micro kit (Qiagen), yielding approximately 0.5 
ng total RNA per embryo (Table 1). All protocols were carried out under the product guidelines. 
The ovotestis (hermaphrodite gonad) and foot tissue samples were dissected from individual adult 
snails and snap frozen using a dry ice/ethanol slurry and total RNA was immediately extracted using 
TRI Reagent® solution (Applied Biosystems) (Table 2, Table 3). 
Complementary DNA (cDNA) was then synthesised from a maximum of 500 ng total RNA, using the 
first strand synthesis procedure within the home-brew protocol provided by Dr. Susan Bassham 
(University of Oregon) (Box 1). 
The RNeasy micro kit included a DNase treatment in the protocol. The TRI Reagent extracted 
samples however, required additional steps to remove residual DNA carryover. The total RNA from 
the ten foot samples was re-extracted using the RNeasy micro kit as a trial to remove carryover DNA 
using the DNase I provided within the kit.  Due to the failure of this process to sufficiently remove 
carryover DNA, this was not performed on the ovotestis samples. Consequently, no DNase 
treatment was performed on the ovotestis samples used in this experiment. 
The genotypes of the snails used in the ovotestis tissue analyses were inferred from additional DNA 
extractions and subsequent PCRs using genetic markers previously established for this population. 
The generalised PCR protocol is described in Box 2. The specific PCR used is referred to in Table 3 
and the primer sequences are described in the SI (S2). PCRs were performed using 1 µl of a 1:10 
dilution of the DNA sample. The homozygote single cell egg samples were collected from mothers 
descended from homozygous dominant ‘DD’ or recessive ‘dd’ lines originating from the same 
heterozygote (Dd) virgin and therefore of known genotype. The foot tissue samples were also 
extracted from the same homozygote populations and therefore were of known genotype. 
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Box 1 In-house laboratory protocol for the synthesis of single-stranded cDNA from total RNA. The volume of template 
varied between reactions and as such is represented by ‘x’. The volume of H2O was adjusted to the input volume of 
template to attain a final reaction volume of 20 µl thus is also represented by ‘x’. 
 
The total RNA samples were often too small to allow for a thorough sample quality assessment. 
However, every sample was quantified via a spectrophotometer (NanoDrop2000, Thermo Fisher 
Scientific). Additionally, a small aliquot of a number of total RNA samples were visualised via 
electrophoresis on agarose gel to provide a visual overview of the sample quality. This was 
performed at least once for each RNA extraction method (S3). 
cDNA synthesis protocol 
Combine: 
   2 μl Random Primer Mix (NEB) 
0.8 μl 10 mM dNTP mix 
   X μl (up to 0.5 μg) RNA 
   X μl (if necessary) RNase free water to bring total to 13 μl  Total: 13 μl 
Heat to 65°C for 5 minutes, then ice 
Collect contents at bottom of tube by brief centrifugation. 
Add: 
4 μl 5x First-Strand Buffer (Invitrogen) 
1 μl 0.1 mM DTT (Invitrogen) 
1 μl RNase inhibitor (RNAseOUTTM 40u/μl, Invitrogen) 
1 μl Superscript III reverse transcriptase (200 u/μl, Invitrogen) Total: 20 μl 
Mix by gentle aspiration 
25°C for 10 min. 
[Reaction can be scaled up to accommodate more starting RNA] 
Synthesis: Incubate at 50°C for 50 minutes. 
Inactivation: 85°C for 5 minutes. Chill on ice, collect contents to bottom by short spin. 
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Non-quantitative PCRs were also performed on all cDNA samples according to the protocol 
described in Box 2. PCR amplification of the target gene sequences functioned as a positive control 
for both the primer pair and the cDNA sample prior to commencing the qPCR reactions. Another PCR 
employing primers specific to an intronic sequence region was performed on all samples to test for 
the presence of carryover genomic DNA (S5). A consistent genomic DNA sample of an individual ‘DD’ 
L. stagnalis was used as a positive control and PCR grade water as a negative control in all reactions. 
The PCR products were visualised via gel electrophoresis using ethidium bromide as a fluorescent 
marker. 
All RNA samples were stored at -80°C and all cDNA samples were stored at -20°C. Aliquots were 
made of the experimental working concentration dilutions of cDNA to reduce freeze-thaw cycles, 
whereas serial dilutions were performed independently for each standard curve experiment. All 
cDNA samples were moderately vortexed before use and prior to each serial dilution step. 
 
Non-quantitative PCR reaction setup and cycle parameters 
Per reaction: 
   2 μl  10x PCR Buffer (ThermoFisher Scientific) 
1.2 μl MgCl2 solution (ThermoFisher Scientific) 
0.8 μl  8 μM dNTP mix 
   2 μl  10 μM forward & reverse primer mix 
0.1 μl  AmpliTaq Gold® DNA polymerase (ThermoFisher Scientific) 
   x μl  Template (DNA/cDNA) 
   x μl  H2O (PCR grade) 
 
         [Total reaction volume = 20 μl] 
 
Thermocycling parameters:  
1. 98°C  10 mins 
2. 98°C  30 secs  
3. 58°C  30 secs  
4. 72°C  60 secs    
5. Cycle from step 2, 34 more times  
6. 72°C   5 mins 
         -END- 
Box 2 Generalised non-quantitative PCR protocol. The volume of template varied between reactions and as such is 
represented by ‘x’. The volume of H2O was adjusted to the input volume of template to attain a final reaction volume of 
20 µl thus is also represented by ‘x’. 
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Table 1 Details of RNA extraction and cDNA synthesis for the single cell embryo samples used in the endogenous control gene stability assessment. Table includes: sample identifier (ID) 
and genotype (Geno) of the mother snail; Spectrophotometry data of the Total RNA sample including sample concentration (ng/μl) and 260/280 & 260/230 absorbance ratios; volume (μl 
RNA) and quantity (ng RNA) of total RNA used for cDNA synthesis.  
ID Tissue Geno Extraction 
Date 
RNA extraction method DNase 
Treatment 
Total RNA cDNA synthesis 
ng/μl 260/280 260/230 μl RNA ng RNA 
11289 Embryo DD 25/11/2014 RNeasy micro kit DNase I 13.80 1.80 0.22 10.0 138.0 
11292 Embryo DD 07/11/2014 RNeasy micro kit DNase I 9.90 2.40 0.73 9.3 92.1 
11293 Embryo DD 20/11/2014 RNeasy micro kit DNase I 15.10 2.20 0.41 10.0 151.0 
11295 Embryo DD 25/11/2014 RNeasy micro kit DNase I 10.20 1.74 1.28 10.0 102.0 
11297 Embryo DD 07/11/2014 RNeasy micro kit DNase I 11.60 1.83 0.87 9.4 108.5 
11298 Embryo DD 28/10/2014 RNeasy micro kit DNase I 21.00 1.82 1.05 9.0 189.0 
11282 Embryo dd 03/11/2014 RNeasy micro kit DNase I 13.70 2.44 0.60 8.8 120.6 
11283 Embryo dd 05/11/2014 RNeasy micro kit DNase I 9.80 1.92 0.44 10.0 98.0 
11284 Embryo dd 27/10/2014 RNeasy micro kit DNase I 12.90 1.73 1.12 9.3 120.0 
11287 Embryo dd 05/11/2014 RNeasy micro kit DNase I 8.00 2.02 1.51 9.4 75.2 
11301 Embryo dd 20/11/2014 RNeasy micro kit DNase I 12.10 2.23 0.65 10.0 121.0 
11303 Embryo dd 25/11/2014 RNeasy micro kit DNase I 13.30 2.30 1.60 10.0 133.0 
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Table 2 Details of RNA extraction and cDNA synthesis for the foot tissue samples used in the endogenous control gene stability assessment. Table includes: sample identifier (ID) and 
genotype (Geno) of the individual snail; Spectrophotometry data of the total RNA sample including sample concentration (ng/μl) and 260/280 & 260/230 absorbance ratios; volume (μl 
RNA) and quantity (ng RNA) of total RNA used for cDNA synthesis. 
ID Tissue Geno Extraction 
Date 
RNA extraction method DNase 
Treatment 
Total RNA cDNA synthesis 
ng/µl 260/280 260/230 µl RNA ng RNA 
11347 Foot DD  11/03/2015  TRIreagent, RNeasy micro kit DNase I 72.02 1.95 1.40 6.9 496.9 
11350 Foot DD  12/03/2015  TRIreagent, RNeasy micro kit DNase I 49.54 1.96 1.51 10.1 500.4 
11351 Foot DD  12/03/2015  TRIreagent, RNeasy micro kit DNase I 85.33 2.19 2.26 5.9 503.4 
11352 Foot DD  12/03/2015  TRIreagent, RNeasy micro kit DNase I 67.62 2.10 1.95 7.4 500.4 
11357 Foot DD  13/03/2015  TRIreagent, RNeasy micro kit DNase I 62.15 2.23 1.25 8.0 497.2 
11348 Foot dd  12/03/2015  TRIreagent, RNeasy micro kit DNase I 74.69 2.03 2.12 6.7 500.4 
11349 Foot dd  12/03/2015  TRIreagent, RNeasy micro kit DNase I 70.75 2.05 2.03 7.1 502.3 
11353 Foot dd  13/03/2015  TRIreagent, RNeasy micro kit DNase I 69.2 2.41 1.36 7.2 498.2 
11354 Foot dd  13/03/2015  TRIreagent, RNeasy micro kit DNase I 78.2 2.07 1.72 6.4 500.5 
11356 Foot dd  13/03/2015  TRIreagent, RNeasy micro kit DNase I 76.98 2.09 1.98 6.5 500.4 
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Table 3 Details of RNA extraction and cDNA synthesis for the ovotestis tissue samples used in the endogenous control gene stability assessment. Table includes: sample identifier (ID) and 
genotype (Geno) of the individual snail, 2 PCR 1315-507 used to identify genotype; Spectrophotometry data of the total RNA sample including sample concentration (ng/μl) and 260/280 & 
260/230 absorbance ratios; volume (μl RNA) and quantity (ng RNA) of total RNA used for cDNA synthesis. † sample removed from analysis. 
ID Tissue Geno Extraction 
Date 
RNA extraction method DNase 
Treatment 
Total RNA cDNA synthesis 
ng/µl 260/280 260/230 µl RNA ng RNA 
10627† Ovotestis DD2 25/09/2013 TRIreagent n/a 60.1 1.8 1.5 16.6 498.9 
10633 Ovotestis DD2 12/09/2013 TRIreagent n/a 57.8 1.9 0.9 17.3 499.9 
10636 Ovotestis DD2 25/09/2013 TRIreagent n/a 82.4 1.8 1.8 12.1 498.6 
10638 Ovotestis DD2 13/09/2013 TRIreagent n/a 67.5 1.8 1.9 14.8 499.2 
10622 Ovotestis Dd2 25/09/2013 TRIreagent n/a 62.1 1.8 1.6 16.1 499.7 
10629 Ovotestis Dd2 13/09/2013 TRIreagent n/a 59.5 1.9 1.7 16.8 499.7 
10631† Ovotestis Dd2 11/09/2013 TRIreagent n/a 68.6 1.9 1.1 14.6 500.4 
10639 Ovotestis Dd2 11/09/2013 TRIreagent n/a 208.9 1.9 1.8 4.7 490.9 
10626 Ovotestis dd2 25/09/2013 TRIreagent n/a 74.2 1.9 1.0 13.4 497.2 
10630 Ovotestis dd2 12/09/2013 TRIreagent n/a 64.1 1.8 1.0 15.6 499.7 
10640† Ovotestis dd2 11/09/2013 TRIreagent n/a 73.1 1.8 1.3 13.7 500.9 
10642 Ovotestis dd2 13/09/2013 TRIreagent n/a 53.2 1.9 1.7 18.7 497.4 
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Primer design 
Targets 
Candidate endogenous control genes were selected based on a number of previously published 
qPCR studies which indicated good potential normalising controls for the reproductive tissue and 
developmental stages. Of the studies which demonstrated good validation of their endogenous 
controls, common control genes included; elongation factors, various ubiquitin genes, Actin 2, 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and various histone proteins (Vandesompele, 
De Preter et al. 2002, Jeong, Choi et al. 2005, Sindelka, Ferjentsik et al. 2006, Kuijk, du Puy et al. 
2007, Pellino, Sharbel et al. 2011). Finally, those identified as the most stably expressed in the 
original geNorm paper, including GAPDH, Hypoxanthine phosphoribosyl-transferase 1 (HPRTI), 
Ubiquitin C (UBC), Ribosomal protein L13a (RPL13A), succinate dehydrogenase (SDHA) and Tyrosine 
3-monooxygenase/ tryptophan 5-monooxygenase activation protein, zeta polypeptide (YWHAZ), 
represented wider-ranging candidate genes likely to be stably expressed in multiple tissues 
(Vandesompele, De Preter et al. 2002).  
Although actin variants frequently appear as stable normalising control genes, none were included in 
this analysis because cytoskeletal processes are likely to be involved in the processes investigated. 
Using transcriptome resources of 1-2 cell stage L. stagnalis embryos (Liu, Davey et al. 2014), six 
genes relating to those highlighted above were selected for analysis. Gene functions were predicted 
from sequence similarity to published human housekeeping genes. These included; short-chain 
specific acyl-CoA dehydrogenase (Lacads), as a substitution for SDHA; elongation factor 1-alpha 
(Lef1a); histone protein, H2A (Lhis2a); 60S ribosomal protein L14 (Lrpl14); Ubiquitin-conjugating 
enzyme E2 (Lube2); and 14-3-3 protein zeta (Lywhaz). This provided species specific sequence 
information and the confidence that the transcripts were present in the one cell stage embryo and 
ovotestis. Additionally, the level of expression was predicted to be neither extremely high nor low 
inferred from human housekeeping gene expression data (data presented in the SI, S4 (Eisenberg 
and Levanon 2013, Liu, Davey et al. 2014)). All gene abbreviations were given the prefix ‘L’ to denote 
the L. stagnalis specific gene sequence (Table 5). 
All primer pairs were designed from the aforementioned 1-2 cell stage transcriptome sequence data, 
using freely available software Primer 3 (Untergasser, Cutcutache et al. 2012). Primer pairs were 
designed to have a Tm range within 2°C of each other and amplicon product size between 110-
130bp. GC clamps where included where possible, and primer pairs were selected with the lowest 
available ‘Th’ scores. The increased strength of bonding between G and C bases help to promote 
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specific binding at the 3’ end of the primer and ‘Th’ scores provide a measure of the likelihood of the 
primer binding to a region other than that specified based on thermodynamic secondary structure 
alignments. Both of these features were included in attempt to increase primer specificity. The 
melting temperature of all primer pairs ranged from 57.45°C-59.75°C (Table 5). Due to the limited 
variability in melting temperature, the same cycling parameters were used for all qPCR experiments. 
All primers pairs were also designed to be exon-spanning. The position of introns was inferred by 
performing a local blast of the transcriptome sequence against the current Lymnaea genome 
assembly (version 10), generated by the Davison research group. Pairwise alignments of the two 
sequences were then generated using NCBI blast online (www.ncbi.nlm.nih.gov). Consequently, in 
the event of genomic contamination, the primers were either unable to span the length of the intron 
and did not amplify a genomic product, or amplified a product at a substantially different size, 
detectable during the melt curve stage of the qPCR (described in section ‘Quantitative real-time 
PCR’).  
Primer specificity 
All primer pairs were first tested in a conventional non-quantitative PCR alongside a genomic control 
sample (described in section ‘Sample Preparation’) and the products visualised on an agarose gel to 
verify the expected size of products. Additionally, the sequence specificity of the amplicons of all six 
primer pairs was verified through Sanger sequencing of conventional PCR products generated from 
pooled heterozygote single cell embryo cDNA samples.  
Primer amplification efficiency 
To calculate the primer efficiencies, standard curve qPCR experiments were performed on each 
primer pair used in this experiment. Five standardised concentrations were used with an additional 
negative control. Because absolute concentrations of the cDNA samples were unknown, standard 
concentrations were produced by using serial dilutions of the original cDNA sample. Five step serial 
dilutions were performed using a dilution factor of 1:5, 1 part cDNA/previous cDNA dilution, plus 4 
parts PCR grade water. Primer efficiencies for all six endogenous control gene primer pairs were 
established using the same reference sample, created from pooling all 12 ovotestis cDNA samples. 
The starting concentration of the serial dilutions alternated between a 1:3 or 1:6 dilution of the 
original concentration. Therefore, some primer efficiency trials provide results for the amplification 
efficiency of cDNA sample quantities ranging from 33.33% - 0.05% of the original concentration, 
whereas others assessed 16.67% - 0.03% (full details of the range of concentrations assessed are 
presented in Table 4). The standard curve qPCR was carried out by the same method as that for the 
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comparative qPCR described in section ‘Quantitative real-time PCR’. Accordingly, 3 µl of cDNA was 
used in each reaction (Box 3).  
Average primer efficiencies for each primer pair were calculated via the arithmetic mean of a 
minimum of two successful standard curve experiments. A standard curve experiment was 
considered successful if it produced a R2 value of >0.98. Values from the lowest concentration 
dilutions were omitted if they dramatically reduced the amplification efficiency or R2 value of an 
experiment. The average primer efficiencies are quoted as the amplification efficiency within the 
concentration range they were successfully calculated from. This range indicates the limits of 
acceptable working concentration/dilution factor for an experimental qPCR assessment. 
Table 4 Details of the five-step serial dilutions used for standard curve qPCR experiments to assess amplification 
efficiency using a starting concentration of 1:3 full or 1:6. Concentrations are represented as both a percentage of the 
full concentration cDNA (% full conc.) and dilution ratio (ratio). 
Serial dilutions 
Starting Conc. 1:5 1:25 1:125 1:625 
1 2 3 4 5 
% full conc., / ratio 
33.33 / 1:3 6.67 / 1:15 1.33 / 1:75 0.27 / 1:375 0.05 / 1:1875 
16.67 / 1:6 3.33 / 1:30 0.67 / 1:150 0.13 / 1:750 0.03 / 1:3750 
 
Quantitative real-time PCR 
It cannot be assumed that the pattern of gene expression will be equal across different tissues. 
Therefore, separate analyses were performed for each of the three tissues included in this study. All 
tissue samples were extracted from separate individual snails. 
The embryo analysis was performed on cDNA from pools of single-cell embryos collected from 12 
individual L. stagnalis. These comprised six DD, and six dd individuals (Table 1). The foot tissue 
analysis was performed on cDNA of ten adult L. stagnalis individuals. These comprised five DD, and 
five dd individuals (Table 2). The ovotestis tissue analysis was performed on cDNA of nine adult L. 
stagnalis individuals. These comprised of three dextral homozygous (DD), three dextral 
heterozygous (Dd) and three sinistral homozygous individuals (dd) (Table 3). 
Cq values were obtained from qPCR experiments using the AB 7500 fast system (Applied Biosystems) 
and Primer Design’s fast SYBR® green master mix. 3 µl of cDNA were used in each well. All samples 
were used at a 1:30 dilution of the original cDNA concentration (alternately described as 3.33% of 
the full concentration). Because 3 µl were used instead of the more commonly used 1 µl, this could 
be considered to represent a 1:10 dilution. Mastermixes were prepared for each target gene 
experiment following the reaction setup described in Box 3. Also presented in Box 3 are the 
thermocycling parameters used in each qPCR experiment.  
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Table 5 Primer sequence information for amplification of endogenous control gene targets including: primer name and associated protein with accession number (Acc. No.) of its most 
closely related human gene; gene abbreviation (Abv.) used throughout this analysis; Primer sequence in the 5’ to 3’ direction; Primer length (P.L) & amplicon length in nucleotides (A.L); 
primer melting temperature (Tm) and the difference between melting temperature within each primer pair (Tm diff); the estimate of mispriming to any sequence (Any th) and specifically 
mispriming at the 3’ end (3’ th); and the predicted intron size between the two primers. * primer lies on an exon boundary. †full intron information unknown due to the transcriptomic 
sequence crossing two genomic contigs, the minimum intron size is presented. 
Primer Name Associated Protein Acc. No. Abv. Sequence 5’-3’ P.L A.L Tm Tm diff %GC 
Any 
th 
3’ 
th 
Predicted 
Intron 
ACA_11210_F1 Short-chain specific 
acyl-CoA 
dehydrogenase 
NM_014049 Lacads 
TGCACTCTCTAAACGAACTTCC 22 
117 
58.35 
0.42 
45.45 0 0 
866 
ACA_11210_R1 TCCCTTGATTGTGCTGTTGAC 21 58.77 47.62 0 0 
EF1_8940_F1 Elongation factor 1-
alpha 
NM_006620 Lef1a 
CGTCACAACCAGCATATCCC 20 
113 
58.7 
0.77 
55 0 0 
663 
EF1_8940_R1 AGAGTTCGAGGGCTGCTTAC* 20 59.47 55 0 0 
HiS_8200_F1 
Histone H2A NM_012412 Lhis2a 
TCAGAGGAGATGAGGAGTTGG 21 
123 
58.26 
0.63 
52.38 0 0 
785† 
HiS_8200_R1 CCCCAAGTTATGCTGCCTTC 20 58.89 55 0 0 
RPL_2341_F2 60S ribosomal 
protein L14 
NM_003973 Lrpl14 
TAATAAGTCGGTTGCGCGC* 19 
114 
59 
1.55 
52.63 27.26 27.26 
1255 
RPL_2341_R2 GGGAACAGTCTACTTGGGC 19 57.45 57.89 0 0 
UB_3288_F2 Ubiquitin-
conjugating 
enzyme E2 
NM_003336 Lube2 
GCGGATCCTCTTGCAATCTT* 20 
131 
58.33 
0.3 
50 0 0 
3224 
UB_3288_R2 TCTGTGGACTGCATATCACTCT 22 58.63 45.45 0 0 
YWHAZ_562_F1 
14-3-3 protein zeta NM_006761 Lywhaz 
GGAGGAGCTGAAGTCAATATGC 22 
125 
58.86 
0.78 
50 0 0 
711 
YWHAZ_562_R1 AGTCACCCTGCATTTTGAGG 20 58.08 50 0 0 
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All samples were performed in triplicate repeat for each of the six reference genes and negative 
control wells were included per mastermix in duplicate repeat. This necessitated the use of 192, 174 
and 228 wells for the foot, ovotestis and embryo analyses respectively.  The whole analysis for each 
tissue exceeded the capacity for one 96 well plate and consequently was divided across multiple 
plates.  All samples per gene were included on the same plate. No experiment exceeded three plates 
and when multiple plates were used all master mixes and plates were prepared at the same time to 
reduce experimental noise (Figure 5). 
A temperature melt curve step was included at the end of all qPCR reactions. During this step the 
temperature of the reaction was incrementally increased whilst continuing to record fluorescence 
(Box 3). Because the SYBR® green dye fluoresces when associated with double stranded DNA, the 
signal will decrease as the DNA is melted and becomes single-stranded. A sharp single peak in the 
melt curve indicates that only one specific PCR product has been amplified  
 
 
Box 3 Details of qPCR reaction setup per well and the following thermal cycling parameters used for all qPCR 
experiments described. 
qPCR reaction setup & cycle parameters 
Per well: 
   5μl  SYBR green Mastermix (2x) (Primer Design) 
0.5μl  forward & reverse primer mix (4μM) 
   3μl  cDNA (concentration specified per experiment) 
1.5μl  H2O (PCR grade)     
[Total reaction volume = 10μl] 
 
Thermal cycling parameters: 
1. 95°C 20s                   [initial temperature ramp & hold] 
2. 95°C 3s  
3. 60°C 30s (data collection, Cq)      [cycle to step 2; 39 more times] 
4. 95°C 15s 
5. 60°C 60s 
6. slow ramp 1% (data collection; Tm melt curve) 
7. 95°C 15s 
8. 60°C 15s        
-END- 
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Cq values were exported for each well of the experiment using the 7500 software. Average Cq values 
derived from triplicate repeats of each sample were used in analyses. Only samples with standard 
deviation (SD) of <0.5 were used in the analysis. This occasionally involved removing perceived 
outliers (observable from the presence of a substantially different shaped amplification curve) from 
the dataset, leaving some individual samples in only duplicate repeat. Due to failure to amplify in 
two of the 3 replicates, one sample was included with no data from technical replicates. 
Normalising control software: 
Three algorithms were used to assess the same qPCR data, all of which run as macros within 
Microsoft Excel 2003. The BestKeeper applet used raw Cq values, whereas NormFinder and geNorm 
required linearised Cq values. All could accommodate corrections for amplification efficiency.  
Linearised relative Cq values were calculated for each sample by first subtracting the average Cq 
value of the nominated calibrator sample from the average Cq of the sample to create a relative, or 
delta, Cq value (ΔCq). Amplification efficiency corrected ΔCq values were then calculated by 
multiplying the efficiency by the power of the ΔCq value (Equation 1). The BestKeeper applet ran 
entirely from raw Cq values and corrected for amplification efficiency via the inbuilt formulas within 
the applet using the manually input amplification efficiency values.  
 
Equation 1 Formula based on Pfaffl’s method (Hellemans, Mortier et al. 2007) to calculate linearised Cq values which 
incorporate the amplification efficiency of each target. E = amplification efficiency, represented as a value between 1 
and 2. 
EΔCq(Sample Cq- Calibrator Cq) 
Results 
General QC: 
Primer specificity 
Sanger sequencing confirmed that the amplicons of all six primer pairs were specific to the transcript 
they were designed from. Additional PCRs on cDNA and genomic DNA analysed via fluorescent gel 
electrophoresis, showed amplified products to be of the expected size and additionally 
demonstrated the difference in amplicon size of a product generated from a cDNA or a genomic DNA 
reaction. There was no visible amplification of multiple products from any of the samples (Figure 6, 
cDNA product).  
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Figure 5 qPCR endogenous control experimental plate setup. The total number of embryo samples included plus the 
negative controls (H2O) enabled the analysis of two control genes per plate (indicted by the different background 
colour)(a), whereas the fewer samples in the foot experiments (b) and the ovotestis experiments (c) enabled the 
inclusion of three control genes per plate. Unused wells are indicated by ‘x’.  
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All of the primer pairs used in this experiment were designed to contain introns. As a result, some 
could not amplify a product from a genomic template. This was the case for Lef1a, Lrpl14 and Lube2. 
It was not always possible to generate the best primers over a long intron. As such, some primer 
pairs could amplify a genomic product, although the resulting amplicon was of a substantial size 
difference, as seen in Lacads, Lhis2a and Lywhaz (Figure 6, genomic DNA product).  
The melt temperature (Tm) curves of all qPCR reactions showed distinct peaks for experimental 
samples. A smaller peak at a lower Tm was occasionally visible in the negative controls of some 
genes, namely Lhis2a, Lrpl14, Lube2 and Lywhaz (Figure 7). This is indicative of primer dimer. 
Sample quality/Genomic contamination 
The representative total RNA samples that were visualised by gel electrophoresis, generally 
displayed two distinct bands, which are indicative of the abundant size-specific rRNA transcripts (gels 
are presented in the SI). Therefore, the samples were assumed to be non-degraded (S3). The intronic 
PCRs showed no amplification of a genomic product in any of the embryo sample, whereas the 
ovotestis and foot samples all amplified a genomic product (S5). 
 
Figure 6 UV visualisation via agarose gel electrophoresis of PCR products of the six endogenous control genes, amplified 
from three different templates: cDNA, genomic DNA (Ge) and a negative control (H2O). 100 base pair ladder was 
included as a size marker (M). 
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Figure 7 Representative temperature melt (Tm) curves of qPCR amplification of Lacads (a); Lef1a (b); Lhis2a (c); Lrpl14 
(d); Lube2 (e) and Lube2 (f). Tm curves were produced from DD (blue) and dd (red) embryo samples. Negative controls 
are shown in grey. The melt curves are presented to demonstrate specificity via shape not absolute values. 
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Primer efficiencies 
Amplification efficiencies of each primer pair were estimated by performing standard curve 
quantification of serial dilutions of a pooled cDNA sample. Primer pairs demonstrated amplification 
efficiencies between 1.906 and 2.115 with R2 values exceeding 0.98 and are presented in Table 6. 
The minimum detectability template concentrations are presented as a percentage of the undiluted 
full concentration cDNA required for the qPCR reaction to perform within the estimated 
amplification efficiency. All primers demonstrated acceptable amplification efficiency in dilutions of 
up to 1:150/0.67% of full concentration (Table 6). The working concentration of a 1:30 dilution used 
in the qPCR experiments falls well within these limits. 
Raw Cq data and linearised Cq values 
The raw Cq data is presented in Table 7, Table 8 and Table 9. The linearised Cq data for each tissue is 
shown in Table 10. The omission of perceived outliers in technical replicates is denoted for each 
sample by the n value.  Descriptive details of the omitted data points are presented in the SI (S6). 
 
 
 
Table 6 Amplification efficiency estimates of each primer pair for the six endogenous control genes assessed 
represented by their gene abbreviation (Abv.). The average efficiency is quoted as the amount each template will 
increase per qPCR cycle (between 1 and 2). The minimum dilution is presented as a percentage of the undiluted original 
cDNA concentration required in the qPCR reaction. Additionally, the number of runs included to generate the average 
amplification efficiency is quoted and the tissue the experiments were performed on: O = Ovotestis reference sample. 
Primer Pair Abv. 
Efficiency 
(R2 > 0.98) 
Minimum 
Dilution (%) 
No. of runs 
included 
ACA_11210_F1R1 Lacads 1.912 0.27 2
O 
EF1_8940_F1R1 Lef1a 2.115 0.67 2
O 
HiS_8200_F1R1 Lhis2a 1.943 0.03 2
O 
RPL_2341_F2R2 Lrpl14 1.906 0.03 2
O 
UB_3288_F2R2 Lube2 1.923 0.03 2
O 
YWHAZ_562_F1R1 Lywhaz 1.918 0.03 3
O 
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Table 7 Average Cq values (Cq Mean) and associated standard deviation (SD) calculated from technical replicates (n) of 12 embryo samples for six endogenous control genes. Including 
sample ID, genotype (Geno) and tissue description. *amplification observed in negative controls 
Raw Cq data Lacads Lef1a Lhis2a* Lrpl14* Lube2 Lywhaz* 
ID Geno Tissue Cq Mean Cq SD n Cq Mean Cq SD n Cq Mean Cq SD n Cq Mean Cq SD n Cq Mean Cq SD n Cq Mean Cq SD n 
11289 DD 
Embryo 
23.177 0.052 3 26.868 0.266 3 22.167 0.032 3 23.116 0.110 3 25.927 0.222 3 24.757 0.071 3 
11292 DD 22.558 0.183 3 26.268 0.429 3 21.881 0.064 3 22.823 0.060 2 25.326 0.065 3 23.833 0.063 3 
11293 DD 22.811 0.046 3 26.508 0.322 3 21.989 0.061 3 22.708 0.078 3 25.710 0.134 3 24.356 0.065 3 
11295 DD 23.891 0.091 3 27.805 0.239 2 22.687 0.045 3 23.802 0.145 3 26.286 0.077 3 24.937 0.092 3 
11297 DD 22.836 0.106 3 26.682 0.406 3 21.901 0.053 3 22.633 0.077 3 25.584 0.157 3 24.201 0.067 3 
11298 DD 22.042 0.083 3 25.773 0.021 3 21.177 0.088 3 21.857 0.088 3 24.819 0.130 3 23.413 0.019 3 
11282 dd 22.572 0.115 3 26.430 0.158 3 21.841 0.119 3 22.910 0.109 3 25.315 0.084 3 23.616 0.103 3 
11283 dd 23.455 0.062 3 27.424 0.132 3 22.801 0.033 3 23.260 0.100 3 26.304 0.076 3 24.803 0.117 3 
11284 dd 22.066 0.109 3 26.075 0.276 3 21.528 0.027 3 22.166 0.112 3 25.065 0.089 3 23.782 0.029 3 
11287 dd 23.403 0.122 3 27.768 0.468 2 22.653 0.164 3 23.838 0.072 3 26.785 0.346 3 24.556 0.167 3 
11301 dd 23.630 0.251 3 27.355 0.296 3 22.531 0.048 3 23.483 0.042 3 26.393 0.068 3 24.906 0.062 3 
11303 dd 22.600 0.118 3 27.442 0.130 2 22.373 0.182 3 23.309 0.108 3 26.294 0.065 3 23.988 0.144 3 
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Table 8 Average Cq values (Cq Mean) and associated standard deviation (SD) calculated from technical replicates (n) of 10 foot samples for six endogenous control genes. Including sample 
ID, genotype (Geno) and tissue description. *amplification observed in negative controls 
Raw Cq data Lacads Lef1a Lhis2a* Lrpl14* Lube2 Lywhaz* 
ID Geno Tissue Cq Mean Cq SD n Cq Mean Cq SD n Cq Mean Cq SD n Cq Mean Cq SD n Cq Mean Cq SD n Cq Mean Cq SD n 
11347 DD 
Foot 
28.918 0.137 3 35.870 n/a 1 25.899 0.120 3 21.493 0.045 3 25.341 0.123 3 24.361 0.026 3 
11350 DD 25.876 0.068 3 32.601 0.003 2 21.520 0.032 3 18.721 0.037 3 21.208 0.077 3 20.685 0.031 3 
11351 DD 27.559 0.078 3 34.042 0.225 2 23.825 0.050 3 19.724 0.066 3 23.440 0.021 3 22.670 0.086 3 
11352 DD 26.685 0.033 3 33.649 0.204 2 22.327 0.066 3 18.921 0.038 3 21.822 0.058 3 21.318 0.050 3 
11357 DD 26.187 0.073 3 32.478 0.358 2 21.777 0.105 3 18.975 0.010 3 21.374 0.175 3 20.930 0.019 3 
11348 dd 27.463 0.084 3 33.350 0.070 2 23.649 0.135 3 19.446 0.056 3 22.626 0.115 3 22.173 0.064 3 
11349 dd 27.470 0.204 3 33.394 0.495 3 23.436 0.107 3 19.408 0.046 3 22.577 0.073 3 22.151 0.024 3 
11353 dd 27.246 0.166 3 33.218 0.418 3 23.788 0.008 3 19.563 0.078 3 22.647 0.058 3 22.150 0.076 3 
11354 dd 26.498 0.035 3 32.317 0.266 3 22.591 0.020 3 19.267 0.087 3 21.428 0.088 3 21.277 0.115 3 
11356 dd 27.035 0.089 3 32.778 0.137 3 23.559 0.109 3 19.876 0.035 3 22.955 0.059 3 22.236 0.023 3 
 
Table 9 Average Cq values (Cq Mean) and associated standard deviation (SD) calculated from technical replicates (n) of 9 ovotestis samples for six endogenous control genes. Including 
sample ID, genotype (Geno) and tissue description. *amplification observed in negative controls 
Raw Cq data Lacads Lef1a Lhis2a* Lrpl14* Lube2 Lywhaz* 
ID Geno Tissue Cq Mean Cq SD n Cq Mean Cq SD n Cq Mean Cq SD n Cq Mean Cq SD n Cq Mean Cq SD n Cq Mean Cq SD n 
10633 DD 
Ovotestis 
23.422 0.072 3 30.233 0.400 3 21.929 0.282 3 18.914 0.060 3 22.924 0.220 3 20.008 0.055 3 
10636 DD 23.613 0.043 3 30.285 0.175 3 21.762 0.103 3 19.229 0.075 3 23.139 0.246 3 19.947 0.015 3 
10638 DD 24.060 0.029 3 31.212 0.256 3 22.477 0.024 3 19.550 0.073 3 23.945 0.168 3 20.971 0.030 3 
10622 Dd 22.699 0.060 3 30.869 0.341 3 21.822 0.014 3 19.094 0.194 3 22.578 0.100 3 19.391 0.031 3 
10629 Dd 23.421 0.042 3 31.568 0.301 3 22.451 0.016 3 19.252 0.058 3 22.893 0.060 3 20.174 0.027 3 
10639 Dd 24.107 0.039 3 30.927 0.254 3 21.763 0.011 3 19.415 0.009 3 23.367 0.061 3 19.673 0.024 3 
10626 dd 22.598 0.034 3 30.756 0.144 3 21.729 0.143 3 18.899 0.070 3 22.582 0.298 3 19.386 0.020 3 
10630 dd 24.505 0.030 3 31.694 0.457 3 22.591 0.066 3 19.381 0.045 3 23.333 0.024 3 20.412 0.046 3 
10642 dd 23.953 0.046 3 30.971 0.024 2 22.358 0.125 3 19.128 0.038 3 23.110 0.062 3 19.854 0.051 3 
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Table 10 Linearised Cq values for each tissue analysis. Including sample ID, genotype (Geno) and tissue description. 
Linearised Cq values 
ID Geno Tissue Lacads Lef1a Lhis2a Lrpl14 Lube2 Lywhaz 
11289 DD 
Embryo 
0.629 0.496 0.664 0.627 0.571 0.890 
11292 DD 0.421 0.316 0.552 0.520 0.385 0.487 
11293 DD 0.497 0.378 0.592 0.482 0.495 0.685 
11295 DD 1.000 1.000 0.929 0.977 0.722 1.000 
11297 DD 0.505 0.431 0.560 0.460 0.456 0.619 
11298 DD 0.302 0.218 0.351 0.279 0.277 0.371 
11282 dd 0.425 0.357 0.538 0.550 0.382 0.423 
11283 dd 0.754 0.751 1.000 0.689 0.730 0.917 
11284 dd 0.306 0.274 0.440 0.340 0.325 0.471 
11287 dd 0.729 0.973 0.909 1.000 1.000 0.780 
11301 dd 0.845 0.714 0.840 0.795 0.774 0.980 
11303 dd 0.433 0.762 0.759 0.711 0.726 0.539 
 
11347 DD 
Foot 
1.000 1.000 1.000 1.000 1.000 1.000 
11350 DD 0.139 0.086 0.055 0.167 0.067 0.091 
11351 DD 0.415 0.254 0.252 0.319 0.289 0.332 
11352 DD 0.235 0.189 0.093 0.190 0.100 0.138 
11357 DD 0.170 0.079 0.065 0.197 0.075 0.107 
11348 dd 0.390 0.151 0.224 0.267 0.169 0.241 
11349 dd 0.391 0.157 0.195 0.261 0.164 0.237 
11353 dd 0.338 0.137 0.246 0.288 0.172 0.237 
11354 dd 0.208 0.070 0.111 0.238 0.077 0.134 
11356 dd 0.295 0.099 0.211 0.352 0.210 0.251 
 
10633 DD 
Ovotestis 
0.495 0.335 0.644 0.664 0.513 0.534 
10636 DD 0.561 0.348 0.577 0.813 0.590 0.513 
10638 DD 0.749 0.697 0.927 1.000 1.000 1.000 
10622 Dd 0.310 0.539 0.600 0.745 0.409 0.357 
10629 Dd 0.495 0.910 0.912 0.825 0.503 0.595 
10639 Dd 0.772 0.563 0.577 0.917 0.686 0.430 
10626 dd 0.291 0.495 0.564 0.657 0.410 0.356 
10630 dd 1.000 1.000 1.000 0.897 0.670 0.695 
10642 dd 0.699 0.582 0.857 0.762 0.579 0.483 
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geNorm Analysis 
geNorm provides a stability value ‘M value’ for each gene; a lower M value indicates a more stable 
gene. A graphical output of the most stable genes is then produced, culminating in the most stable 
pair of genes. Due to the algorithms within geNorm, it can only output the most stable pair of genes, 
not a single best gene. A second graph is produced, indicating the optimal number of genes to 
include in the experiment to provide the most stable normalisation. An advised cut-off value of less 
than 0.15 indicates that that combination of genes will provide a reliable normalisation factor 
(PrimerDesign 2014). The results are presented in Table 11 and Figure 8 and described below per 
tissue.  
Embryo  
geNorm placed Lhis2a and Lube2 as the most stable pair of genes, with a combined stability score of 
0.196. The inclusion of any number of the genes provided a V score of <0.15, although the lowest V 
score was achieved with the inclusion of the five genes; Lhis2a, Lube2, Lrpl14, Lacads and Lywhaz. 
 
Table 11 geNorm results per tissue, including the number of samples included in analysis (n). Endogenous control genes 
(Target) are ranked in order of decreasing stability 1-6, based upon their stability score. Calculated V scores and 
individual M scores are also provided. 
geNorm Results 
Tissue Ranking Target Stability score V score M score 
Embryo, n=12 
1/2 Lhis2a/Lube2 0.196 0.061 0.246/0.259 
3 Lrpl14 0.204 0.064 0.267 
4 Lacads 0.242 0.052 0.282 
5 Lywhaz 0.262 0.049 0.324 
6 Lef1a 0.285 n/a 0.330 
 
Foot, n=10 
1/2 Lywhaz/Lube2 0.217 0.092 0.325/0.401 
3 Lhis2a 0.269 0.091 0.461 
4 Lacads 0.327 0.082 0.407 
5 Lrpl14 0.376 0.088 0.489 
6 Lef1a 0.444 n/a 0.579 
 
Ovotestis, n=9 
1/2 Lrpl14/Lube2 0.250 0.097 0.367/0.363 
3 Lywhaz 0.292 0.070 0.384 
4 Lhis2a 0.309 0.079 0.360 
5 Lacads 0.360 0.077 0.473 
6 Lef1a 0.409 n/a 0.507 
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Figure 8 Graphical output of the geNorm analysis. Each tissue analysis generates one graph displaying the average 
expression stability values of remaining control genes (left) and one graph showing the optimum number of control 
genes for normalisation (right). 
Foot 
geNorm placed Lywhaz and Lube2 as the most stable pair of genes with a combined stability score of 
0.217. The inclusion of any number of the genes provided a V score of <0.15, although the lowest V 
score was achieved with the inclusion of the four genes; Lywhaz, Lube2, Lhis2a and Lacads. 
Ovotestis  
geNorm placed Lrpl14 and Lube2 as the most stable pair of control genes with a combined score of 
0.250. Lhis2a bore the lowest M score of all the target genes, at 0.360, yet it was placed fourth in the 
combined stability score. The inclusion of any number of the genes provided a V score of <0.15, 
although the lowest V score was achieved with the inclusion of the three genes; Lrpl14, Lube2 and 
Lywhaz. 
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Of all the tissues, the embryo analyses yielded the lowest V scores, followed by ovotestis and then 
foot. Lef1a was consistently found to be the least stable gene in all tissues.  
NormFinder 
NormFinder outputs an estimation of both the most stable pair of genes and the single most stable 
gene.  It also has the capacity to incorporate a grouping factor, in this instance genotype. A ‘stability 
score’ is calculated for each gene and a combined stability score is output for the best pair of genes. 
A low stability score indicates better expression stability. The results are presented in Table 12 and 
described below per tissue. 
Embryo: 
Lhis2a was identified as the single most stable gene in the embryo analysis with a stability value of 
0.058. However, it was not included in the best combined pair, which comprised Lacads and Lube2, 
with a score of 0.047. 
Foot: 
Lywhaz was identified as the most stable gene in the foot tissue, with a stability score of 0.074. 
When combined with Lube2, this was reduced to 0.066.  
Ovotestis: 
Lhis2a was identified as the single most stable gene in the ovotestis tissue, generating an individual 
stability score of 0.124. However, the best pair of genes was calculated to be Lef1a and Lywhaz, with 
a combined stability value of 0.083, despite the fact that Lef1a presented the worst single gene 
stability value: 0.243. 
Across all tissues, the single cell embryo analysis yielded the lowest stability values, followed by foot 
tissue and ovotestis. With the exception of the embryo analysis, in which it ranked second least 
stable, Lef1a was found to be the least stable gene in all tissues. In all analyses, the stability value of 
the best combined pair of genes was lower than that of any individual gene stability score.  
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Table 12 NormFinder results per tissue, including the number of samples included in analysis (n). Endogenous control 
genes (Target) are ranked in order of decreasing stability 1-6, based upon their individual stability score. The best 
combined pair of genes is also presented with its associated stability score. 
NormFinder Results 
Tissue Ranking Target Stability score Best Combined Pair Stability Value 
Embryo, n=12 
1 Lhis2a 0.058 
Lacads/Lube2 0.047 
2 Lrpl14 0.076 
3 Lube2 0.086 
4 Lacads 0.104 
5 Lef1a 0.122 
6 Lywhaz 0.124 
 
Foot, n=10 
1 Lywhaz 0.074 
Lube2/Lywhaz 0.066 
2 Lube2 0.133 
3 Lacads 0.151 
4 Lrpl14 0.176 
5 Lhis2a 0.215 
6 Lef1a 0.298 
 
Ovotestis, n=9 
1 Lhis2a 0.124 
Lef1a/Lywhaz 0.083 
2 Lrpl14 0.147 
3 Lube2 0.153 
4 Lywhaz 0.171 
5 Lacads 0.206 
6 Lef1a 0.243 
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BestKeeper 
BestKeeper firstly calculated the SD values associated with the geometric mean Cq of all samples 
within each gene. Those genes with a SD of <1 are considered stable and their Cq data is included in 
the generation of the ‘BestKeeper index’ (BK index). All of the endogenous control genes assessed 
exhibited a SD less than 1 and therefore all contributed to the generation of the BK index. A 
regression model was then fitted to estimate the correlation (r value) of the Cq data of each gene to 
the BK index. Consequently, the BestKeeper applet provides two measures of gene stability. A low 
SD and a high r value indicate a more stable control gene. The results of the BestKeeper analysis are 
presented in Table 13 and described below per tissue. 
Embryo 
The gene ranked as most stable in the embryo tissue according to SD was Lhis2a (0.408), whereas 
the least stable gene was Lef1a (0.577). Every gene in the single cell embryo analysis resulted in a 
highly significant positive correlation with the BK index (p = 0.001). Lhis2a demonstrated the highest 
correlation with the BK index, with an r value of 0.979, and Lywhaz the lowest with an r value of 
0.900. 
Foot 
The gene ranked as most stable in the foot tissue according to SD was Lrpl14 (0.500), whereas the 
least stable gene was Lhis2a (0.947). Each gene resulted in a highly significant positive correlation 
with the BK index (p = 0.001). Lywhaz had the strongest correlation bearing an r value of 0.998, and 
Lef1a the lowest correlation, with an r value of 0.907. 
Ovotestis 
The gene ranked as most stable in the ovotestis tissue according to SD was Lrpl14 (0.176), whereas 
the least stable gene was Lacads (0.500). With the exception of Lef1a, every gene resulted in a 
significant correlation with the BK index. Lywhaz had the strongest correlation, with an r value of 
0.894. Lef1a did show a positive correlation with the BK index generating an r value of 0.655; 
however this correlation only resulted in a p value of 0.056 and is therefore not considered 
statistically significant. 
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Table 13 BestKeeper results per tissue, including the number of samples included in analysis (n). Endogenous control 
genes (Target) are ranked in order of decreasing stability 1-6, based upon either their correlation with the BestKeeper 
index (r) or the standard deviation (SD) associated with the average Cq per gene (Mean Cq). Included also are the 
associated probability values (p) of the correlation. 
BestKeeper Results 
Tissue Ranking, r Ranking, SD Target r p Mean Cq SD 
Embryo, n=12 
1 1 Lhis2a 0.979 0.001 22.122 0.408 
2 6 Lef1a 0.969 0.001 26.859 0.577 
3 5 Lube2 0.962 0.001 25.811 0.514 
4 3 Lrpl14 0.957 0.001 22.985 0.476 
5 4 Lacads 0.949 0.001 22.913 0.493 
6 2 Lywhaz 0.900 0.001 24.257 0.457 
 
Foot, n=10 
1 4 Lywhaz 0.998 0.001 21.973 0.754 
2 5 Lube2 0.993 0.001 22.512 0.867 
3 6 Lhis2a 0.984 0.001 23.207 0.947 
4 2 Lacads 0.981 0.001 27.082 0.638 
5 1 Lrpl14 0.964 0.001 19.526 0.500 
6 3 Lef1a 0.907 0.001 33.356 0.695 
 
Ovotestis, n=9 
1 4 Lywhaz 0.894 0.001 19.974 0.366 
2 2 Lube2 0.877 0.002 23.093 0.313 
3 6 Lacads 0.876 0.002 23.590 0.500 
4 1 Lrpl14 0.853 0.003 19.206 0.176 
5 3 Lhis2a 0.831 0.005 22.095 0.330 
6 5 Lef1a 0.655 0.056 30.942 0.369 
 
 
Table 14 Ranking summary of endogenous control gene (Target) stability decreasing from 1-6 as estimated through 
geNorm (GN), NormFinder (NF) & BestKeeper according to correlation with the BestKeeper index (BK, r) and the 
standard deviation (BK, SD). Genes included in the ‘best-combined pair’ within NormFinder are indicated with *. 
Target 
Embryo Foot Ovotestis 
GN NF BK, r BK, SD GN NF BK, r BK, SD GN NF BK, r BK, SD 
Lacads 4   4* 5 4 4 3 4 2 5 5 3 6 
Lef1a 6 5 2 6 6 6 6 3 6   6* 6 5 
Lhis2a 1/2 1 1 1 3 5 3 6 4 1 5 3 
Lrpl14 3 2 4 3 5 4 5 1 1/2 2 4 1 
Lube2 1/2   3* 3 5 1/2   2* 2 5 1/2 3 2 2 
Lywhaz 5 6 6 2 1/2   1* 1 4 3   4* 1 4 
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Discussion 
Indication of best genes to use as endogenous controls 
Embryo 
geNorm listed Lhis2a and Lube2 and the two most stable genes in the embryo tissue. Interestingly 
the addition of a third gene decreased stability, yet the optimal stability value is gained from 
including all of the genes, except Lef1a (Table 11). This is not necessarily because the inclusion of 
Lef1a will significantly reduce the stability, but a consequence of how geNorm calculates the V score 
by removing the least stable gene, followed by the next least stable and so on. Just as you can only 
ever have an estimation of the two most stable genes, you can only have a V score of all genes minus 
one. All genes exhibited good M values. Such that the highest M value observed in the embryo 
analysis (Lef1a, M=0.330), was still lower than the lowest M value in the ovotestis analysis (Lhis2a, 
M=0.360) and comparable to that in the foot analysis (Lywhaz, M=0.325). 
NormFinder ranked Lhis2a as the most stable gene in the single cell embryo, with a stability score of 
0.058. However, the combined best pair was comprised of Lube2 and Lacads, which individually 
ranked 3rd and 4th most stable respectively (Table 12). This discrepancy reflects the variation in 
stability assessment when utilising the full capabilities of NormFinder, including the group identifiers 
to incorporate inter and intra group effects, compared to only using the individual stability values.  
BestKeeper found highly significant (p=0.001) positive correlations with all genes and the BK index 
and as such any choice of gene is considered acceptable for use as a reference. Lhis2a was ranked as 
most stable using both the correlation with the BestKeeper index and the SD (Table 13). The 
BestKeeper rankings display larger discrepancies between the stability rankings based upon r value 
or SD than comparisons across software. It is important to acknowledge both of the measures of 
gene stability. Nevertheless, if using more than one endogenous control gene (which is strongly 
recommended), and given that all of the endogenous control genes assessed have an acceptable 
range of SD to be included in the BestKeeper index, the correlation of patterns of gene expression, 
would likely provide a more informative measure of expression variation, as opposed to the level of 
perhaps negligible SD within a single gene. 
All three algorithms ranked Lhis2a as the single most stable single gene. However, there is less of a 
consensus for the rankings of the remaining endogenous controls (Table 14). Generally, Lhis2a, 
Lrpl14 and Lube2 remain in the top three most stable genes across software.  
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Foot 
The results of the geNorm analysis show that even the minimum inclusion of the two most stable 
genes, Lywhaz and Lube2 provide an acceptable endogenous control measure (V score <0.15). 
Indeed, the addition of 5/6 of the genes would still provide a stable endogenous control measure 
(Table 11). This indicates that all of the genes could provide stable endogenous control genes in the 
foot tissue, with the possible exclusion of Lef1a because, for reasons described previously, it was not 
included in the calculation of the V score.  
The optimum number of genes to include according to geNorm is four, however due to finite 
amount of sample and the cost associated with running qPCR plates, the proposed increase in 
stability must be counterbalanced with realistic laboratory practice. Three is often quoted as the 
minimum number of controls to use (Vandesompele, De Preter et al. 2002) although here, the 
addition of a third control gene provides little increase in stability, V score from 0.92 to 0.91.  
NormFinder and BestKeeper (r value) also found Lywhaz and Lube2 to be the most stable pair of 
genes in the analysis (Table 14). It is of note again that the BestKeeper rankings according to SD are 
substantially different to those for r value, but for the reasons described previously, the r values are 
assumed to be more informative in this instance. 
Due to the agreement of the different algorithms it is assumed that Lywhaz and Lube2 should be 
used as endogenous normalising controls for analyses in foot tissue. It will depend on the individual 
experiment whether or not the small increase in stability gained from the addition of a third control 
gene, as calculated by geNorm, will be worth the additional time and resources in accommodating 
another endogenous control gene into the experimental design. 
Ovotestis 
The results of the geNorm analysis in the ovotestis show that even the minimum inclusion of the two 
most stable genes, Lrpl14 and Lube2, provide an acceptable endogenous control measure with a V 
score of 0.097. The inclusion of a third gene substantially improves this score to 0.070, and also 
indicates the most stable combination of genes (Table 11).  
It is interesting however, that the gene with the lowest M value, Lhis2a, was placed fourth in the 
combination of genes to use together. This is inferred as a reflection of how stable Lhis2a is when 
calculated based on its own variability, compared to how it correlates with other genes. 
The NormFinder results of the ovotestis tissue were also a little conflicting with regards to the 
individual gene stability score and that of the best combined pair.  Lhis2a was clearly ranked as the 
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most stable gene, with a stability score of 0.124 and Lef1a as the least stable with a score of 0.243, 
almost double that of Lhis2a. However, the top combined genes were revealed to be Lef1a and 
Lywhaz, which were ranked the 6th and 4th most stable genes, respectively.  
These discrepancies are believed to reflect the difference in calculation of expression variability 
when measured within a single gene and when utilising the full capabilities of the NormFinder 
software. Although useful insights can be gained by incorporating the inter and intra-group effects, it 
seems improbable that Lef1a truly represents one of the most stable genes in the ovotestis. This is 
largely due the high average Cq values (Table 9), which are likely to result more variable data 
(AppliedBiosystems 2014) and additionally due to its poor performance within the other software 
analyses. 
BestKeeper ranked Lywhaz, followed by Lube2 as the most stable genes based on r value (Table 13). 
The top two genes according to BestKeeper’s calculation of SD were Lrpl14 and Lube2, the same top 
two genes as calculated by geNorm. Lhis2a however was ranked in 5th place according to r value and 
3rd place according to SD, contrary to its individual top ranking in geNorm and NormFinder (Table 
14). 
It appears that Lhis2a, if used alone may provide a more stable reference gene than any other, 
however when using, as recommended, more than one endogenous control gene, Lhis2a fails to be 
the most stable choice. 
Comparisons across tissue analyses 
Lube2 indicates overall most stable endogenous control 
All of the six genes presented acceptable endogenous controls for use in all of the tissues assessed 
with the potential exception of Lef1a. Across all of the tissues, Lef1a and Lacads were generally 
ranked the least stable. Lube2 represented one of the two most stable genes in the geNorm analysis 
of all three tissues (Table 14). Therefore, if the same endogenous control genes must be used for all 
tissue analyses, Lube2 should be included. 
Lef1a represents the least stable endogenous control 
Lef1a was consistently ranked least stable in all analyses of foot and ovotestis tissue, and often in 
the embryo. It is important to note that it is still considered acceptable for use within an experiment 
as a stable endogenous control, however would not be selected as the gene of choice.  
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The reason for the poor performance of Lef1a may be due to its low level of expression rather than 
any true expression variability of this gene. The average Cq values for Lef1a in the foot and ovotestis 
analyses are all above 30 (Table 8, Table 9). This is above the Cq for optimal qPCR analysis and may 
result in greater variability during the qPCR (AppliedBiosystems 2008). Additionally, Lef1a exhibited 
the amplification efficiency furthest from 100%/2 and the only gene to show efficiency >100% which 
is indicative of inhibition (Table 6) which may lead to skewed results (AppliedBiosystems 2014). 
Furthermore, it is listed in the BestKeeper requirements that genes with values over 30 are not 
suitable for analysis in the current version of BestKeeper and that the issues will be addressed in 
another version awaiting release (Pfaffl, Tichopad et al. 2004). Of the analyses described here, the 
only instance where a gene has not been considered stable for use as an endogenous control gene, 
was that of Lef1a in the BestKeeper analysis of the ovotestis tissue, however with an average Cq of 
over 30, this gene data was technically not suitable for analysis within BestKeeper and therefore 
should be inferred with caution. The same applies for the foot analysis within BestKeeper in which 
the Lef1a Cq values also exceeded 30 (Table 13). 
The lower expression level of Lef1a was indicated in the amplification efficiency experiments, which 
showed a higher minimum working concentration for Lef1a compared to the other genes (Table 6). 
Lef1a may provide a reliable endogenous control gene when using an increased cDNA concentration.  
The ovotestis tissue was found to be the most variable 
Compared to the other tissues assessed, the ovotestis analysis was generally shown to be more 
variable. There are many reasons why some tissues may be more variable than others. The only 
systematic difference between the populations of Lymnaea within each tissue analysis is their chiral 
genotype. It may be that there are greater chirality-associated variations in expression of the 
endogenous control genes in the ovotestis, than compared to the embryo and foot tissue. However, 
the sampling method of the ovotestis tissue holds greater potential for inconsistency than that of 
the embryo and foot tissue, which may better account for the increased variability. 
Extraction of the individual snails’ ovotestis was not rigorously temporally controlled. RNA 
extractions were performed in the morning and each snail was observed to be sexually mature 
(having lain at least one clutch of eggs in its lifespan). Ideally the ovotestis would have been 
extracted shortly before egg laying, resulting in an ovotestis sample containing both sperm and eggs. 
However, this is close to impossible, as the snails lay eggs at varied intervals, which are largely 
unpredictable and because the ovotestis is inside the snail, it is impossible to view to condition of 
the tissue prior to dissection.  
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In addition to the temporal variation in the ovotestis tissue samples, there is the inevitable 
contamination of the ‘liver’ tissue, (this organ represents an overall digestive gland however is 
commonly referred to as the liver). Due to the internal organisation of L. stagnalis, the ovotestis is 
closely associated with the liver (Figure 9). When dissecting, the ovotestis can be pulled up out of 
the liver and is generally free of the dark brown liver tissue, which is clearly distinguishable from the 
cream coloured ovotestis. However, liver tissue carryover is inevitable, albeit reduced and each 
individual ovotestis sample will have a varying amount of liver contamination. 
The foot tissue was also not temporally controlled beyond morning extractions and that the 
individual snails were of a similar age. The increased overall consistency of the endogenous control 
genes in the foot tissue compared to that of the ovotestis is perhaps an indication of the general 
stability of the foot tissue expression compared to the ovotestis tissue, which contains potentially 
more variable factors i.e. time since egg-laying. Additionally, the foot tissue does not have the same 
issues with carryover of non-specific tissues as does the ovotestis, although care must be taken not 
to include mouth parts or brain tissue.  
It is clear however that the embryo samples exhibit much less variation than both of the other 
tissues. The embryo samples represent a very clean and temporally controlled sample, with RNA 
storage occurring almost immediately after decapsulation of the egg within hours of it being laid. 
Additionally, no new transcripts are being generated within the single cell embryo, which would 
further reduce variability. 
 
Figure 9 Internal organisation of Lymnaea stagnalis. The liver is highlighted in red and the ovotestis highlighted in blue. 
Adapted from original image from Wisconsin Academy of Science, Arts and Letters. 
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Choice of endogenous controls for between tissue comparisons 
It must be noted that if making comparisons between tissue analyses, the tissues were firstly 
extracted by different methods resulting in potential variation in sample quality and especially 
genomic contamination. The snails used in the ovotestis analysis were also of an earlier lab 
population than those used in the embryo and foot tissue analysis. 
The gene stability assessments here indicate the most suitable endogenous control gene to 
normalise expression patterns between genotype within the same tissue. No controlled stability 
assessments have been compared across the different tissues. However due to the general 
agreement of the stability of Lube2 and Lhis2a in all tissues, these likely represent stable genes 
across all three tissues (Table 14). 
Quality controls 
Sample quality 
It must be acknowledged that the quality of each total RNA sample was not been exhaustively 
assessed prior to cDNA synthesis. When representative samples were visualised via gel 
electrophoresis, the total RNA showed distinct bands. These are assumed to represent specific-sized 
abundant rRNA and the general lack of smearing indicated that the transcripts had maintained their 
full length and ultimately that the samples were of good quality (presented in SI, S3). Nevertheless, 
not all samples were visualised on a gel, as such there may have been differences in sample quality 
that were not detected in the Nanodrop quantification, for example degradation of long transcripts. 
However, no sample included in the analyses indicated a tendency for error, due to each instance of 
omitted replicates having occurred in different individuals.  
Additionally, there was no mRNA enrichment performed on any of the samples. This may have 
reduced the quality of the samples through interference of dominating rRNA transcripts during 
qPCR. Yet this is not considered to be of concern due to the success of the amplification efficiency 
tests. 
Of greater concern, may be the genomic DNA present in the foot and ovotestis tissue samples. Due 
to the lack of multiple Tm peaks in any of the experimental samples, there is no evidence that any 
confounding genomic transcripts have been amplified. If there has been amplification of genomic 
transcripts it was at a level undetectable by the qPCR instrument and therefore considered 
negligible. Carryover genomic DNA if not able to amplify, may still negatively impact the qPCR 
reaction through interference. The level of interference would vary with the extent of genomic 
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carryover. However, again due to the success of the amplification efficiency tests, which were 
performed using the ovotestis sample, which demonstrated the highest level of genomic carryover, 
this is not considered to be of concern. The difference in performance of the DNase treatments is 
still of technical interest however, and so a discussion of the protocols follows in the SI (S5.4). 
Primer quality 
The presence of Tm peaks in the negative controls of genes; Lhis2a, Lrpl14, Lube2, and Lywhaz may 
lead to some concern over the specificity of the primers used. Due to these peaks being of 
significantly lower Tm and generally lower signal intensity, the peaks are assumed to represent 
primer dimer created from the primer pairs binding to each other as opposed to the target sequence 
(Figure 7).  
It is also possible that the multiple Tm peaks were created from a single amplicon. As described in 
the introduction, the Tm curve is generated through the reduction in the fluorescent signal as the 
double-stranded amplicon melts and the SYBR® green dye dissociates. Therefore if a region of the 
amplicon melted slower than another (GC rich regions for example) then it is possible that two peaks 
could be created (Downey 2014).The peaks observed in this experiment however, do not occur in 
the experimental samples, which supports the assumption that they represent primer dimer, which 
is more likely to occur in the absence of a target sequence. 
It is generally advised to redesign any primer pair which generates primer dimer because the primer 
dimers will still be formed within the experimental samples (AppliedBiosystems 2014). However, the 
lack of multiple Tm peaks in the experimental samples indicates that this too represents a negligible 
limitation on the accuracy of the qPCR and should not create a systematic bias between the 
genotypes compared. 
Experimental design 
Number of samples 
The minimum recommended number of samples to include in a geNorm experiment is ten, these 
should also represent all experimental conditions (PrimerDesign 2014). As the establishment of 
endogenous controls is ideally the first step in a relative qPCR experiment it is usually performed on 
the preliminary samples and minimum experimental setup.  
The embryo experiment was initially planned to compare only the two homozygous chiral genotypes 
and included six samples of each. Heterozygote samples were later added to the qPCR experiments. 
Therefore, the endogenous controls have not strictly been assessed in all genotypes within the 
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embryo. Due to the limited variability observed in endogenous controls within the embryo tissue, it 
is unlikely that the heterozygotes would behave differently.  
Only the homozygous genotypes were selected for comparison in the foot tissue, which included five 
samples of each. All ten of the foot samples used in the qPCR experiments were used in the 
endogenous control assessment.  
Initially twelve ovotestis samples were prepared for use in the endogenous control gene assessment, 
four DD, four Dd and four dd. However, after an initial qPCR run it was quickly apparent that one of 
the samples, namely 10631; a Dd sample, frequently generated high SD and a failure to amplify. This 
sample was removed from analyses. However, due to the comparative nature of the stability 
assessment, it is recommended to include equal numbers of each experimental condition/genotype 
(PrimerDesign 2014) and so another DD and dd sample were also removed from the experimental 
setup. Therefore, the ovotestis endogenous control assessment, with nine samples, falls just under 
the advised minimum input, although due to the overall good levels of stability in the endogenous 
control genes this is not believed to significantly compromise the findings. 
This experiment was originally designed to compare expression differences between chiral 
genotypes, although it became apparent that tissue comparisons would also be possible and 
potentially very informative. However, an additional gene expression stability experiment was not 
factored into the experimental design and as such there is no stability information for endogenous 
control genes across tissues.  
Number of genes 
The number of genes to include in the search to find multiple stable endogenous control genes 
largely depends on resources. The more genes tested, the higher the chance of finding the most 
suitable endogenous controls. However, qPCR experiments are costly and especially when the RNA 
sample is limited, as was the case with the embryo samples, it is not advisable to test more genes 
than necessary. The company Primer Design produce kits for establishing endogenous controls with 
the geNorm software (PrimerDesign 2014). The kits are provided with either six or twelve candidate 
endogenous controls to test. It was therefore assumed that six candidate endogenous control genes 
would be a sufficient starting point to identify stable control genes.  
Choice of reporter dye 
SYBR® green was chosen as the reporter dye for the experiments due to its flexibility of use, which 
can be considered a benefit or a limitation. Alternatives such as TaqMan® require specific 
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fluorescent primers to be made for each target gene. This method greatly increases specificity of the 
quantitative data since the fluorescent signal will only be omitted from the specific target sequence 
(as opposed to any double stranded product, as is the case with SYBR® green). However, each 
TaqMan® probe is considerably more expensive than the standard oligo which can be used with 
SYBR® green. The use of SYBR® green additionally allows for the Tm curve to be produced, providing 
a valuable indication of the specificity of every qPCR reaction, which is not possible with the 
TaqMan® probe. 
Capabilities of software 
Of the three methods chosen here, geNorm and BestKeeper both function through pairwise 
comparisons, whereas NormFinder is model based, calculating variability resulting from the 
experimental grouping factors. Each method provides a unique aspect of analysis. 
The geNorm applet calculates gene stability by performing pairwise comparisons between all genes 
included and provides an ‘M value’ based upon the geometric mean of the SD of each pairwise 
comparison per gene, therefore a low M value indicates lower variability/greater stability. The 
software then follows to progressively omit the most variable gene pairs until the most stable pair of 
genes remains. As a result of this method, any genes exhibiting a similar expression pattern will be 
considered more stable. Therefore, it is of great importance to ensure that the any potential control 
genes are not co-regulated. None of the genes included here are believed to be co-regulated based 
on their largely unrelated functions, however this does not completely eliminate the possibility of 
co-regulation.  
The step-wise process of the stability assessment of the endogenous control genes performed in 
geNorm additionally allows for the calculation of the optimum number of genes to include, whether 
this results from the most stable pair of genes or the inclusion of more. However, as a result of the 
step wise omission of the least stable gene, there is only ever a calculation for all genes minus one, 
therefore the most stable combination may be generated from the inclusion of all genes, yet this is 
not calculated. 
For geNorm, or indeed any pairwise comparison approach, to work it must have a stable gene 
included in the analysis. NormFinder however, estimates gene stability using a ‘model-based 
approach’ which evaluates the level of intra- and inter-group variation within each gene. This is 
believed to provide a more robust estimation as the genes are classified by the level of systematic 
error as opposed to their similarity of expression pattern to the other genes included in the analysis. 
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As such NormFinder is less sensitive to the risk of co-regulated genes and accommodates the 
grouping factors of the experimental analysis. 
BestKeeper provides two measures of gene stability. The first simply provides a measure of the SD of 
the average Cq values per gene. Any gene with an SD of less than 1 is considered stable and is 
included in the calculation of the BestKeeper index. A Pearson correlation coefficient (r) is then 
performed providing probability (p) values to evaluate the relatedness of each gene’s expression 
pattern with the BestKeeper index.  Genes can then be ranked according to the strength of their 
correlation and associated p-values. This provides a measure of how similar one gene’s expression 
pattern is compared to that of the other genes included and thus works in a similar way to geNorm. 
Therefore, it is again of great importance to ensure no genes are co-regulated. 
A number of previous studies citing the use of BestKeeper have simply ranked to genes using the SD 
score (Hibbeler, Scharsack et al. 2008, Bouhaddioui, Provost et al. 2014). This method omits the 
pairwise comparison element of the BestKeeper applets function, and simply classifies genes based 
upon their independent variability. This does provide a useful measure of how the gene performs 
and is not biased by the relationship of the other genes included, however this should be combined 
with the inferences based upon the similarities of gene expression, especially if the study intends to 
use multiple control genes (Taki, Abdel-Rahman et al. 2014). 
Some more comprehensive analyses of endogenous control genes have included some approaches 
that were not used here (Jacob, Guertler et al. 2013, Taki, Abdel-Rahman et al. 2014), namely the 
delta CT method (Silver, Best et al. 2006) and RefFinder (Xie, Xiao et al. 2012). The delta CT method 
also performs pairwise comparisons and as such was not believed to add a substantial amount of 
additional information to warrant the additional analysis. RefFinder provides the useful capability of 
combining the results of multiple methods, and calculating a geometric mean of the multiple 
rankings (Xie, Xiao et al. 2012). RefFinder was not employed here, partly due to difficulty in accessing 
the web-based program at the cited address, yet largely due to doubt surrounding the 
appropriateness of combining alternative methods to create a summative ranking. For example, if 
three pairwise comparison approaches have been performed and only one model based method, 
the rankings will be biased according to the methodology. 
Of the approaches discussed here, geNorm is the most cited at 4,352 times. Studies citing the use of 
NormFinder are less than half of this number at 1,734 and BestKeeper 1,215 times. Thus geNorm is 
the most widely accepted as the method of choice for verifying the stability of endogenous control 
genes. The latest geNorm software is also provided in kits by the qPCR company Primer Design, 
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providing increased accessibility of this method. The paper introducing the delta/comparative CT 
method for verifying stability of endogenous controls has only been cited 215 times, although 
because no actual software package is required for this method, it may not be cited in the same 
manner. RefFinder is the most recent of the methods discussed here (September 2012), which may 
account for its relatively low 37 citations (All citation counts are quoted from Web of ScienceTM 
correct as of the 24th September 2015). 
All three methods used here have provided a unique aspect of the data analysis. geNorm provides a 
measure of the optimum number of genes to include in the analysis and an advised cut-off value (V, 
<0.15) for an acceptable endogenous control gene combination. BestKeeper outputs a quotable 
measure of SD for each gene and a statistical measure of the relatedness of gene expression. Finally, 
NormFinder provides valuable information on the experimental design; calculating variation created 
both within and between experimental groups and importantly provides an alternative to pairwise 
comparison methods. 
Conclusion 
It has been established that any of the six genes would provide acceptable endogenous controls to 
standardise gene expression between chiral genotypes within any of the three different tissues, 
perhaps with the exception of Lef1a.  Once published, these primers will enable other researchers of 
L. stagnalis to quickly verify endogenous controls suitable for use in qPCR experiments assessing 
ovotestis, foot and embryo tissue within and between chiral variants, which was lacking previously. 
Additionally, the apparent unsuitability of Lef1a is of interest as it is a common choice for 
endogenous control genes. 
The software is largely in agreement that Lef1a and Lacads are the least stable genes across all 
tissues. BestKeeper provides no information on the stability of pairings or trios, yet provides a 
convenient measure of SD for each gene and valuable support to the inferences of the other 
methods. NormFinder is informative in its independent rankings and ability to incorporate 
experimental group into the analysis, yet does not provide ‘best combined trio’. Due to some of the 
surprising inclusions of lower ranked genes in the best combined pair, it would be difficult to 
estimate which, if any, additional genes would increase stability. 
If the experiment could only employ one endogenous control gene, which is not advised, however in 
some circumstances, such as very small starting material, becomes necessary; Lhis2a represents the 
most stable choice of gene for the embryo and ovotestis tissue based on its individual SD. However, 
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when using more than one endogenous control, other genes provide more stable alternatives. 
Lywhaz largely represents the single most stable gene in the foot tissue. Furthermore, if the 
experiment could only employ one endogenous control gene across the three tissues, Lube2 
represents a common top ranked gene. 
Due to frequent recommendations to use a minimum of three endogenous control genes if possible, 
the results from the geNorm analysis appear to be the most informative as this software provides 
information on the stability of more than two genes. 
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Chapter 3: 
Quantitative gene expression analysis 
in Lymnaea stagnalis 
Introduction 
Quantitative gene expression analysis 
One of the fundamental aims of this project was to identify expression variation between chiral 
variants of L. stagnalis. A total of thirteen candidate genes, potentially associated with chirality 
determination in L. stagnalis were selected for qPCR analysis. As introduced in the previous chapter, 
qPCR represents a gold standard technique in quantitative expression analysis, yet common misuse 
can often lead to misinterpretation of data. The experimental priorities already outlined were 
employed here to ensure correct experimental practice. Any significant differences in the pattern of 
gene expression were hoped to elucidate functional processes associated with chiral dimorphism.  
Selecting genes of interest 
Functional targets 
The original project aim was to further analyse a selection of candidate genes identified as 
differentially expressed (DE) from the eRAD dataset described in Chapter 4. Any conclusions from 
the high throughput bioinformatic analysis would ideally be supported in an in situ experiment, 
assessing more individuals under better controlled settings. Preliminary DE analysis of the eRAD 
dataset identified a number of loci as significantly DE between chiral genotypes. A selection of loci 
representing genes bearing functions likely associated with laterality determination or cytoskeletal 
processes were selected for further analysis via qPCR. The eRAD analysis which identified the DE loci 
was obtained through unsuitable parameters and as such is not presented in Chapter 4. However, 
the target genes selected still hold functional associations with laterality determination and so are 
still of interest to assess via qPCR. The original eRAD data provided the sequence information 
required to assess the specific gene targets in L. stagnalis. 
Actin-related proteins 
Cytoskeletal processes have been highlighted in the majority of models of symmetry-breaking and 
especially those in early development (as introduced in Chapter 1). Cytoskeletal actins have been 
specifically implicated in LR axis specification in L. stagnalis (Shibazaki, Shimizu et al. 2004) and 
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therefore represent likely targets for expression variation or regulation in chiral variants. 
Additionally, the primary candidate for the chirality gene identified in the Davison research group is 
a diaphanous related formin, a Rho GTPase protein which is known to regulate actin assembly (Li 
and Higgs 2003, Kovar 2006). 
Myosins 
Similarly, motor proteins, such as myosins, have been highlighted with potential functions in 
intracellular symmetry breaking, by controlling asymmetric distribution of polarity determinants, 
(molecular cargo transport) (Vandenberg, Lemire et al. 2013). It is also expected that the myosins 
will interact with other cytoskeletal processes, especially actin dynamics as they largely represent 
actin-dependent motor proteins which are often involved in forming actin filaments (Sellers 2000) 
and have been previously linked with the establishment of LR asymmetry (Baum 2006, Hozumi, 
Maeda et al. 2006, Speder, Adam et al. 2006). 
Additional candidates 
A collagen-related target gene was also selected for further analysis representing an alternative 
extracellular structural component. Additionally, a staufen-related gene was assessed. Staufen is a 
gene which has been associated with regulation of gene expression and asymmetric mRNA 
localisation in Drosophila embryos (Matsuzaki, Ohshiro et al. 1998, Houchmandzadeh, Wieschaus et 
al. 2002, Martin and Ephrussi 2009). Finally, a largely uncharacterised gene unc93a was included, 
which has shown potential phenotypes relating to egg laying (de la Cruz, Levin et al. 2003) and 
ovarian membranes (Liu, Dodds et al. 2002) in addition to muscle function (Hoebe and Beutler 
2008). It is hoped any patterns of gene expression identified in unc93a may contribute to the 
functional characterisation of this gene. 
Proximal targets 
As described in Chapter 1, the region of the chromosome which contains the single heritable unit 
that determines chirality in L. stagnalis has been identified by the Davison research group through 
continued genetic analysis of chiral variants. This involved mating crosses between chiral lines and 
creating linkage maps to identify genetic markers tightly linked to the chirality phenotype. Due to 
the lack of a reference genome for L. stagnalis, a method called BAC walking was employed to 
obtain sequence information within this region and identify the genes present (Liu, Davey et al. 
2013). This has provided a selection of candidate genes in close proximity to, and in linkage with the 
chirality locus.  
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The primary candidate as the causal gene for establishing LR asymmetry in L. stagnalis is a 
diaphanous formin related gene, hereafter referred to as ‘Ldia2’. A single base deletion has been 
identified in the sinistral copy of the gene, present in the very early coding region (Davison et al. 
awaiting publication). This deletion creates a coding frameshift and will likely result in a number of 
downstream consequences (Streisin.G, Okada et al. 1966). It is unknown whether this will affect the 
quantitative levels of the transcript. There is nothing currently known to be inhibiting the 
transcription of the mRNA and so consequences of the frameshift may only be observable at the 
protein level. Yet regulatory processes such as nonsense mediated decay may result in quantitative 
differences between the chiral genotypes (Neu-Yilik, Gehring et al. 2004, Conti and Izaurralde 2005). 
There is another diaphanous formin gene, Ldia1, in close proximity to the primary candidate gene 
with a small number of genetic sequence differences, maintaining approximately 90% conserved 
sequence with Ldia2 (Davison et al, awaiting publication). These two highly conserved genes are 
likely to have resulted from a previous gene duplication in L. stagnalis. The gene lacking the 
frameshift in the coding region is indicative of being the ancestral form prior to the duplication 
event, due to its greater sequence similarity to the single gene copy present in the closely related 
snail species Biomphalaria and Physa and is therefore referred to as ‘Ldia1’. It will be essential to 
identify whether there are also expression differences in this gene to ascertain whether it is the 
frameshift in Ldia2 or generally an associated function of the diaphanous formins causing any 
observed pattern of gene expression. 
There are a number of other genes within this region of the chromosome which represent 
alternative candidates for the causal gene of LR determination in L. stagnalis and therefore must 
also be compared alongside the main candidate Ldia2. Two additional genes were chosen for qPCR 
analysis based on both their close proximity to the chirality locus and associated functions. 
The first, within the ‘fat’ group of the cadherins, which have functions in cell adhesions, is a fat1 like 
gene, hereafter referred to as ‘Lfat1’. It has been suggested that the more divergent cadherins, such 
as those in the fat group, have a range of more diverse cell functions (Suzuki 2000, Tanoue and 
Takeichi 2005, Halbleib and Nelson 2006). The fat group has been linked to the actin dynamics in the 
cytoskeleton, and specifically f-actin (Tanoue and Takeichi 2004), therefore it will be important to 
investigate gene expression patterns in addition to the primary candidate Ldia2. 
The second, is a gene involved in maintaining integrity of polarised cellular extensions in 
morphogenesis, described in Drosophila, known as ‘furry’ here referred to as ‘Lfry’ (Cong, Geng et al. 
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2001). The cellular extensions are composed of cytoskeletal components, and therefore may have 
important interactions with cytoskeletal dynamics in development. 
Selecting tissues for comparison 
One of the major benefits of RNA analysis, as introduced in Chapter 1, is the ability to gain insight 
into the dynamics of gene regulation, revealing which genes are being ‘switched on’ or 
overexpressed relative to another individual or tissue. Therefore, it is important to select, not only 
representative individuals but also appropriate tissues to be used within the gene expression 
comparison.  
Chirality associated differences represent a significant factor during L. stagnalis development, 
exemplified by the low hatch rate observed in sinistral embryos (Davison, Barton et al. 2009), 
whereas the functional differences between genotypes later in life are apparently negligible, with 
the exception of some behavioural traits (Davison, Frend et al. 2009). As such it is predicted that 
chirality-associated differences will be most prevalent during development and reproduction. 
Furthermore, the establishment of chirality is known to arise from a maternal effect and occur 
before the third cell cleavage. To identify expression differences associated with the causal gene and 
not later downstream processes, the ideal tissue would be unfertilised eggs. Accordingly, this 
experiment examined the ovotestes of sexually mature L. stagnalis to provide a representative 
sample of gametic expression patterns and potentially very early stage zygote.  
Single cell embryos pooled from individual snails of known genotype were also included in the 
experiment. The zygote is believed not to start expressing its own transcripts until the 24 cell stage 
(Morrill 1982) although zygotic nuclear transcription has been observed from the 8 cell stage (Liu, 
Davey et al. 2014). Therefore, when assessing the one cell stage embryo tissue, it can be assumed 
that only the maternal transcripts will be present. 
In addition to these functionally related tissues, the foot tissue was included in analyses to provide a 
somatic control tissue comparison.  
Predicted outcomes 
Genotype associated patterns of gene expression provide insight into the functional consequences 
of genetic variation. Furthermore, allele specific expression patterns can reveal regulatory 
mechanisms effecting only one allele, such as x chromosome silencing and epigenetic gene 
imprinting, although are not limited to such occurrences (Lo, Wang et al. 2003, Serre, Gurd et al. 
2008, Yang, Graze et al. 2011). Due to the high level of genetic similarity of the Davison laboratory 
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population of L. stagnalis (>98%) whilst maintaining chiral dimorphism, it is expected most 
differences in gene expression will be associated with chirality. Additionally, the inclusion of the 
heterozygote genotype is hoped to reveal quantitative expression patterns regarding genetic 
dominance at the chirality locus.  
In light of previous studies describing that sinistral developing L. stagnalis lack a functional step 
during spiral cleavage (Shibazaki, Shimizu et al. 2004) and suffer a reduced hatch rate (Davison, 
Barton et al. 2009), sinistrals may be exhibiting loss of function through reduced or interrupted gene 
expression in a number of genes.  
Specifically, the primary candidate gene, Ldia2, has a deletion in the sinistral copy resulting in a 
frameshift very near the start of the coding sequence (Davison et al, awaiting publication). If not 
observable through quantification of the missense transcript, the resulting protein level changes will 
likely result in downstream consequences in other genes. For example, diaphanous formin is directly 
involved in actin polymerisation and self-assembly. Consequently, it is likely that the expression of 
the arp2/3 complex genes will be effected.  
The gene-duplication of the diaphanous formin related gene may function to ‘rescue’ the faulty 
Ldia2. This would provide an explanation for why the sinistral L. stagnalis do not exhibit a complete 
loss of function, and may even assume overexpression of the Ldia1 gene to compensate. The foot 
tissue was included as a somatic tissue control. Due to the limited observations of effects of chirality 
in adult L. stagnalis (Davison, Barton et al. 2009), chirality-associated differences in expression were 
not expected. However, if the frameshift in the sinistral Ldia2 gene, results in a transcript monitoring 
response, such as non-sense mediated mRNA decay, this would be expected to occur in all tissues. 
In addition to the genotypic comparisons, differences in gene expression between tissues may 
provide functional inferences. For example, the transcripts already present in the one-cell embryo 
direct development until the onset of zygotic transcription, and potentially after (Baroux, Autran et 
al. 2008, Liu, Davey et al. 2014). Therefore, any transcripts relatively overexpressed in the one-cell 
embryo compared to the foot will likely have increased functional significance in early development. 
The experiments performed here will not provide comprehensive answers to these questions; 
however quantitative patterns in gene expression can elucidate potential regulatory processes and 
highlight functional importance of these 13 candidate genes in chiral variants. 
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Methods 
Sample Preparation 
Three separate tissues from laboratory reared populations of L. stagnalis were assessed in this 
study. The samples included offspring from multiple specific mating crosses. Each population was 
generated from the main laboratory population of the Davison research group, although the level of 
inbreeding is present to different extents. All samples have an inbreeding coefficient of more than 
98% similarity whilst maintaining chiral dimorphism.  
Embryo 
The same embryonic cDNA samples used in the validation of endogenous control genes experiment 
(Chapter 2) were used for the differential expression analyses described here with the addition of 
the heterozygote, Dd, samples described below. 
Five single-cell embryo samples collected from individual Dd mothers were added to the embryo 
analysis. Having observed self-fertilised, anticlockwise shell-coiling mothers to produce clockwise-
coiling offspring, the genotype of the mother was known to be Dd. Egg collection, RNA extraction 
and cDNA synthesis protocols followed those described in Chapter 2. Due to the later extraction 
date, the Dd samples are not representative of same single genetic cross as the DD and dd embryo 
samples. A pooled Dd sample was also generated by pooling single cell embryos from multiple Dd 
mothers prior to RNA extraction. This sample was run as an additional reference sample in the 
embryo and foot experiments. In total, the embryo dataset comprised of six DD, five Dd and six dd 
individual samples with an additional reference sample extracted from multiple individuals, referred 
to as ‘1 cell pool’ (Table 15). 
Due to the limited quantity of the embryonic RNA samples, only one round of cDNA synthesis could 
be performed resulting in a maximum of 12 µl full concentration cDNA. Additionally, the cDNA was 
synthesised from less than the standardised 500 ng total RNA (Table 15). 
Foot 
The foot samples used in this experiment are the same as those described in Chapter 3. There are no 
Dd representative genotypes in the foot tissue (Table 16). 
Ovotestis 
In addition to the nine ovotestis samples used in Chapter 3, three ovotestis samples that were not 
utilised in the endogenous control analyses, although were generated at the same time and 
therefore of the same genetic cross, were included (sample ID: 10627, 10631 & 10640). Another 
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fifteen ovotestis samples were included (sample ID: 8515-9014): these cDNA samples were 
synthesised from total RNA extracted from the individual snails included in eRAD library 3 & library 4 
of the same ID, prior to mRNA enrichment (described in Chapter 4). A final ten samples were added 
to the ovotestis analysis (sample ID: 11347-11357). These cDNA samples were synthesised from total 
RNA extracted from the ovotestis of the same individual snails as the foot tissue samples. In 
summary the ovotestis datasets contained fourteen DD, nine Dd and fourteen dd individual samples. 
The samples span three different genetic crosses and varying sample storage duration (Table 17). 
DNase treatment 
As described in Chapter 3, (Methods, Sample Preparation), the embryo samples were extracted 
using the RNeasy micro kit (Qiagen), which includes a DNase treatment step, DNase I. Total RNA of 
the ten foot samples was subsequently re-extracted using the RNeasy micro kit and therefore 
treated with DNase I. 
No DNase treatment was performed on the earlier two rounds of ovotestis RNA extractions (sample 
ID: 8515-9014; 10627-10642). Two alternative DNase treatments were tested on ten of the ovotestis 
total RNA samples (11347-11357). Firstly, Ambion’s DNA FreeTM method was used and cDNA was 
then synthesised from 500 ng of the treated total RNA as per the protocol described in Chapter 2.  
Having failed to prevent intronic amplification from the cDNA generated (see SI, S5 for further 
details), another DNase treatment, Primer Design’s Precision DNase, was applied to the same RNA 
sample. cDNA was then synthesised from 500 ng of the treated RNA. Both DNase treatments were 
applied in accordance with the protocols provided. 
As in the previous chapter, at least one standard non-quantitative PCR was performed on all cDNA 
samples. PCR amplification of the gene of interest (GOI) functioned as a positive control for both the 
primer pair and the cDNA sample prior to commencing the more expensive qPCR reactions. Another 
PCR, utilising primers specific to intronic regions, was performed on all samples to test for the 
presence of contaminating carryover genomic DNA. A consistent genomic DNA sample of an 
individual DD L. stagnalis was used as a positive control and PCR grade water as a negative control in 
all reactions. The PCR products were visualised via gel electrophoresis using ethidium bromide as a 
fluorescent marker. 
All RNA samples were stored at -80°C and all cDNA samples were stored at -20°C. Aliquots were 
made of the experimental working concentration dilutions of cDNA to reduce freeze-thaw cycles, 
whereas serial dilutions were performed independently for each standard curve experiment. All 
cDNA samples were moderately vortexed before use and prior to each serial dilution step. 
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Table 15 Details of RNA extraction and cDNA synthesis for the single cell embryo samples used in the qPCR experiments. Table includes: sample identifier (ID) and genotype (Geno) of the 
mother snail; Spectrophotometry data of the Total RNA sample including sample concentration (ng/μl) and 260/280 & 260/230 absorbance ratios; volume (μl RNA) and quantity (ng RNA) 
of total RNA used for cDNA synthesis. The individual used as the calibrator sample in the genotype analysis is indicated by ‘C’. 
ID Tissue Geno Extraction Date Extraction method DNase Treatment 
Total RNA cDNA synthesis 
ng/µl 260/280 260/230 µl RNA ng RNA 
11289 Embryo DD 25/11/2014 RNeasy micro kit DNase I 13.80 1.80 0.22 10.0 138.0 
11292 Embryo DD 07/11/2014 RNeasy micro kit DNase I 9.90 2.40 0.73 9.3 92.1 
11293 Embryo DD 20/11/2014 RNeasy micro kit DNase I 15.10 2.20 0.41 10.0 151.0 
 11295C Embryo DD 25/11/2014 RNeasy micro kit DNase I 10.20 1.74 1.28 10.0 102.0 
11297 Embryo DD 07/11/2014 RNeasy micro kit DNase I 11.60 1.83 0.87 9.4 108.5 
11298 Embryo DD 28/10/2014 RNeasy micro kit DNase I 21.00 1.82 1.05 9.0 189.0 
11358 Embryo Dd 20/04/2015 RNeasy micro kit DNase I 14.40 1.72 0.60 10.0 144.0 
11359 Embryo Dd 20/04/2015 RNeasy micro kit DNase I 13.90 2.40 0.87 9.0 125.1 
11360 Embryo Dd 30/04/2015 RNeasy micro kit DNase I 23.30 1.84 0.63 10.0 233.0 
11361 Embryo Dd 30/04/2015 RNeasy micro kit DNase I 15.80 2.04 0.80 10.0 158.0 
11363 Embryo Dd 11/05/2015 RNeasy micro kit DNase I 18.60 2.56 1.30 10.0 186.0 
1 cell pool Embryo Dd 11/05/2015 RNeasy micro kit DNase I 12.00 2.57 0.46 10.0 120.0 
11282 Embryo dd 03/11/2014 RNeasy micro kit DNase I 13.70 2.44 0.60 8.8 120.6 
11283 Embryo dd 05/11/2014 RNeasy micro kit DNase I 9.80 1.92 0.44 10.0 98.0 
11284 Embryo dd 27/10/2014 RNeasy micro kit DNase I 12.90 1.73 1.12 9.3 120.0 
11287 Embryo dd 05/11/2014 RNeasy micro kit DNase I 8.00 2.02 1.51 9.4 75.2 
11301 Embryo dd 20/11/2014 RNeasy micro kit DNase I 12.10 2.23 0.65 10.0 121.0 
11303 Embryo dd 25/11/2014 RNeasy micro kit DNase I 13.30 2.30 1.60 10.0 133.0 
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Table 16 Details of RNA extraction and cDNA synthesis for the foot tissue samples used in the qPCR experiments. Table includes: sample identifier (ID) and genotype (Geno) of the 
individual snail; Spectrophotometry data of the total RNA sample including sample concentration (ng/μl) and 260/280 & 260/230 absorbance ratios; volume (μl RNA) and quantity (ng 
RNA) of total RNA used for cDNA synthesis. The individual used as the calibrator sample in the genotype analysis is indicated by ‘C’. 
ID Tissue Geno Extraction Date Extraction method DNase Treatment 
Total RNA cDNA synthesis 
ng/µl 260/280 260/230 µl RNA ng RNA 
11347 Foot DD 11/03/2015 TRI Reagent, RNeasy micro kit DNase I 72.02 1.95 1.4 6.9 496.9 
 11350C Foot DD 12/03/2015 TRI Reagent, RNeasy micro kit DNase I 49.54 1.96 1.51 10.1 500.4 
11351 Foot DD 12/03/2015 TRI Reagent, RNeasy micro kit DNase I 85.33 2.19 2.26 5.9 503.4 
11352 Foot DD 12/03/2015 TRI Reagent, RNeasy micro kit DNase I 67.62 2.1 1.95 7.4 500.4 
11357 Foot DD 13/03/2015 TRI Reagent, RNeasy micro kit DNase I 62.15 2.23 1.25 8 497.2 
11348 Foot dd 12/03/2015 TRI Reagent, RNeasy micro kit DNase I 74.69 2.03 2.12 6.7 500.4 
11349 Foot dd 12/03/2015 TRI Reagent, RNeasy micro kit DNase I 70.75 2.05 2.03 7.1 502.3 
11353 Foot dd 13/03/2015 TRI Reagent, RNeasy micro kit DNase I 69.2 2.41 1.36 7.2 498.2 
11354 Foot dd 13/03/2015 TRI Reagent, RNeasy micro kit DNase I 78.2 2.07 1.72 6.4 500.5 
11356 Foot dd 13/03/2015 TRI Reagent, RNeasy micro kit DNase I 76.98 2.09 1.98 6.5 500.4 
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Table 17 Details of RNA extraction and cDNA synthesis for the ovotestis tissue samples used in the qPCR experiments. Table includes: sample identifier (ID) and genotype (Geno) of the 
individual snail, PCR used to identify genotype: 1: cb3g FP1 F8R8, 2: 1315-507, 3: n/a (homozygous lines); Spectrophotometry data of the total RNA sample including sample concentration 
(ng/μl) and 260/280 & 260/230 absorbance ratios; volume (μl RNA) and quantity (ng RNA) of total RNA used for cDNA synthesis. The individual used as the calibrator sample in the 
genotype analysis is indicated by ‘C’. 
ID Tissue Geno Extraction Date Extraction method DNase Treatment 
Total RNA cDNA synthesis 
ng/µl 260/280 260/230 µl RNA ng RNA 
8515 Ovotestis DD1 25/06/2012 TRI Reagent n/a 89.4 1.8 1.0 12.6 375.3 
  8548C Ovotestis DD1 19/06/2012 TRI Reagent n/a 112.6 1.8 1.3 13.5 506.6 
8582 Ovotestis DD1 18/06/2012 TRI Reagent n/a 61.4 1.7 1.4 25.5 522.1 
8583 Ovotestis DD1 26/06/2012 TRI Reagent n/a 77.8 1.8 0.9 22.1 571.8 
9014 Ovotestis DD1 29/06/2012 TRI Reagent n/a 169.7 1.8 1.8 8.7 492.1 
8554 Ovotestis Dd1 18/06/2012 TRI Reagent n/a 141.6 1.9 1.4 12.0 566.4 
8555 Ovotestis Dd1 18/06/2012 TRI Reagent n/a 143.1 1.9 0.4 10.8 515.0 
8559 Ovotestis Dd1 18/06/2012 TRI Reagent n/a 137.0 1.8 1.1 11.1 506.8 
8562 Ovotestis Dd1 18/06/2012 TRI Reagent n/a 141.0 1.8 1.3 12.0 563.8 
9013 Ovotestis Dd1 29/06/2012 TRI Reagent n/a 149.3 1.8 1.8 10.2 507.8 
8806 Ovotestis dd1 19/06/2012 TRI Reagent n/a 149.5 1.9 1.1 10.5 523.1 
8808 Ovotestis dd1 25/06/2012 TRI Reagent n/a 110.3 1.8 1.5 12.6 463.1 
8996 Ovotestis dd1 29/06/2012 TRI Reagent n/a 106.1 1.7 1.5 15.0 530.5 
9005 Ovotestis dd1 26/06/2012 TRI Reagent n/a 110.0 1.7 1.5 14.1 517.0 
9007 Ovotestis dd1 29/06/2012 TRI Reagent n/a 107.3 1.8 1.1 15.0 536.7 
10627 Ovotestis DD2 25/09/2013 TRI Reagent n/a 60.1 1.8 1.5 16.6 498.9 
10633 Ovotestis DD2 12/09/2013 TRI Reagent n/a 57.8 1.9 0.9 17.3 499.9 
10636 Ovotestis DD2 25/09/2013 TRI Reagent n/a 82.4 1.8 1.8 12.1 498.6 
10638 Ovotestis DD2 13/09/2013 TRI Reagent n/a 67.5 1.8 1.9 14.8 499.2 
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10622 Ovotestis Dd2 25/09/2013 TRI Reagent n/a 62.1 1.8 1.6 16.1 499.7 
10629 Ovotestis Dd2 13/09/2013 TRI Reagent n/a 59.5 1.9 1.7 16.8 499.7 
10631 Ovotestis Dd2 11/09/2013 TRI Reagent n/a 68.6 1.9 1.1 14.6 500.4 
10639 Ovotestis Dd2 11/09/2013 TRI Reagent n/a 208.9 1.9 1.8 4.7 490.9 
10626 Ovotestis dd2 25/09/2013 TRI Reagent n/a 74.2 1.9 1.0 13.4 497.2 
10630 Ovotestis dd2 12/09/2013 TRI Reagent n/a 64.1 1.8 1.0 15.6 499.7 
10640 Ovotestis dd2 11/09/2013 TRI Reagent n/a 73.1 1.8 1.3 13.7 500.9 
10642 Ovotestis dd2 13/09/2013 TRI Reagent n/a 53.2 1.9 1.7 18.7 497.4 
11347 Ovotestis DD3 11/03/2015 TRI Reagent DNA-freeTM& Precision DNase 58.9 1.1 0.4 8.5 500.7 
11350 Ovotestis DD3 12/03/2015 TRI Reagent DNA-freeTM& Precision DNase 95.8 1.5 0.7 5.2 497.9 
11351 Ovotestis DD3 12/03/2015 TRI Reagent DNA-freeTM& Precision DNase 67.7 1.5 0.3 7.4 500.9 
11352 Ovotestis DD3 12/03/2015 TRI Reagent DNA-freeTM& Precision DNase 79.1 1.3 0.3 6.3 498.2 
11357 Ovotestis DD3 13/03/2015 TRI Reagent DNA-freeTM& Precision DNase 61.1 1.4 0.2 8.2 500.8 
11348 Ovotestis dd3 12/03/2015 TRI Reagent DNA-freeTM& Precision DNase 63.7 1.2 0.2 7.8 496.7 
11349 Ovotestis dd3 12/03/2015 TRI Reagent DNA-freeTM& Precision DNase 48.0 1.0 0.3 10.2 489.8 
11353 Ovotestis dd3 13/03/2015 TRI Reagent DNA-freeTM& Precision DNase 68.7 1.3 0.4 7.3 501.7 
11354 Ovotestis dd3 13/03/2015 TRI Reagent DNA-freeTM& Precision DNase 63.3 1.3 0.3 7.9 499.7 
11356 Ovotestis dd3 13/03/2015 TRI Reagent DNA-freeTM& Precision DNase 94.5 1.5 0.7 5.3 500.7 
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Primer Design 
All primers were designed using Primer 3 (Untergasser, Cutcutache et al. 2012). All primer pairs were 
designed to have a Tm range within 2°C of each other and amplicon product size between 110-130 
base pairs (bp). As described in Chapter 2 (Methods; Primer design), to improve amplification 
specificity GC clamps were included where possible, and primer pairs were selected with the lowest 
possible ‘Th’ (‘Th’ermodynamic secondary structure alignments) scores (Table 18, Table 19). 
Where possible the primer pairs were designed to include an intron. As a result, the pair either did 
not amplify a product from contaminating genomic material or the product produced was of a larger 
size than that amplified from transcriptomic cDNA, detectable through gel electrophoresis and the 
Tm melt curve step. The only primer pairs in this experiment that did not span multiple exons were 
Ldia1 3’ UTR and Ldia2 3’ UTR. This was due to the lack of an intron being present in the 3’ UTR 
region. These were the only primer pairs which amplified the same sized amplicon from both 
genomic and cDNA templates. 
Functional targets 
The DE loci selected for further analysis identified through the previous eRAD sequencing analysis, 
also contained a paired-end (pe) contig sequence, which was assembled from the eRAD dataset (full 
details of the method are described in Chapter 4, although these specific loci were described from a 
previous analysis not presented). The contig was matched to a predicted protein in the UniRef90 
database via ‘Blast’ to identify the closest related cluster sequence and associated gene/protein 
description. The pe-contig was paired with a genomic contig from the latest alignment of Lymnaea 
genomic sequence data (version 10, note that this has since been updated) via a local Blast, to 
identify the position of introns to enable the design of exon-spanning primer pairs, and additionally 
to ascertain whether or not there were multiple regions within the L. stagnalis genome that the 
contig sequence may specify.  
The name and predicted functions of the nine GOIs selected for further analysis are described below. 
Actin-related protein complex 2/3 
Two separate genes specific to different subunits of the actin-related protein (Arp) 2/3 complex 
were identified in the eRAD sequence data. The Arp 2/3 complex is comprised of seven separate 
subunits and is recognised to regulate the nucleation process of actin filaments and have strong 
interactions with formins (Welch, DePace et al. 1997, Goley and Welch 2006, Pollard 2007). There 
have been indications that the subunits of the Arp 2/3 complex may have specialisations and as a 
result be differentially regulated (Gournier, Goley et al. 2001). Therefore both subunit genes were 
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included in the experiment. These represent the Arp 2/3 complex subunit 1a, and Arp 2/3 complex 
subunit 3, referred to here as ‘Larp2/3 1a’ and ‘Larp2/3 3’ respectively. 
Heavy chain myosin 
Transcripts relating to two forms of heavy chain myosin (mhc) were identified, one muscle and one 
non-muscle form, referred to here as ‘Lmhc’ and ‘Lmhc nm’ respectively. The Lmhc transcript was 
found most closely related in sequence to a form of mhc called ‘catchin’ which is formed from a 
splice variant of the mhc, and is specific to the Molluscan catch muscle (Yamada, Yoshio et al. 2000). 
Because L. stagnalis does not contain a catch muscle, it is likely that this transcript is not actually 
specific to catchin but instead represents a similar mhc gene. 
The non-muscle myosin represents an isoform of myosin II, which is associated with actin-binding 
and cell-cell adhesion (Vicente-Manzanares, Ma et al. 2009). Although Lmhc nm has more functional 
implications with embryonic polarity than Lmhc (Guo and Kemphues 1996, Vicente-Manzanares, Ma 
et al. 2009), both were included within the experiment for comparison. 
Unconventional myosins 
Unconventional myosins are expected to have a diverse range of functions within the cell (Wu, Jung 
et al. 2000, Redowicz 2007, Maravillas-Montero and Santos-Argumedo 2012) and have been directly 
linked to LR asymmetry in Drosophila (Hozumi, Maeda et al. 2006, Speder, Adam et al. 2006). Two 
specific unconventional myosin related genes were included in this experiment: myosin Va and 
myosin XVIIIa, here referred to as ‘Lmyo5a’ and ‘Lmyo18a’ respectively. 
Myosin V has been characterised as a processive actin-based motor, transporting cargo along actin 
tracks, however does not form actin filaments (Cheney, Oshea et al. 1993, Mehta, Rock et al. 1999, 
Sellers and Veigel 2006). Myosin V has also been observed to interact with a number of cytoskeletal 
elements not just actin (Nagashima, Torii et al. 2002). 
 
Myosin XVIIIa, is a more recently described myosin class (Furusawa, Ikawa et al. 2000) and as such is 
less studied, yet has been observed to co-localise with microfilaments and may have roles associated 
with the golgi membrane (Yamashita, Sellers et al. 2000, Dippold, Ng et al. 2009). 
Collagen, staufen & unc-93a 
The collagen included is specific to the collagen type XI alpha subunit 2 or 1 and is here referred to 
as ‘Lcol11a 2/1’. The group XI collagens are recognised as fibrillar collagens, which self-assemble to 
form a structural network of striated fibrils which function to resist pulling forces (Keene, Oxford et 
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al. 1995, Kadler, Holmes et al. 1996). Although collagen fibrils are a major component of the 
cartilage, their expression is not restricted to cartilaginous tissues (Bernard, Yoshioka et al. 1988). 
The transcript specific to the RNA binding protein staufen, identified in the eRAD sequence data was 
included in the experiment to explore alternatives to direct structural associations, and is here 
referred to as ‘Lstau’. This is the only gene included, which has specific functions linked to maternal 
mRNAs (St Johnston, Beuchle et al. 1991). 
The unc93a like gene represents somewhat more of a wild card addition to the experiment. The 
protein is largely uncharacterised in function, however has been linked to egg laying and the ovaries 
in other species (Liu, Dodds et al. 2002, de la Cruz, Levin et al. 2003).  
Proximal targets 
The gene sequences for targets identified through regional genomic analyses were obtained by the 
Davison group. Intronic regions were located by performing a local blast of the genomic gene 
sequence to the transcriptomic resources for L. stagnalis also available in the Davison research 
group (Liu, Davey et al. 2013, Liu, Davey et al. 2014). Pairwise alignments were then generated of 
the two sequences using NCBI blast online (http://blast.ncbi.nlm.nih.gov/Blast.cgi).  
Due to the highly conserved sequence similarity between the diaphanous formins, Ldia1 and Ldia2, 
regions of gene specific sequence large enough to design primers were scarce. The untranslated 
regions (UTRs) held the largest number of sequence variations between the two genes. 
Consequently, primers were designed for each gene in the 3’ UTR; ‘Ldia1 3’UTR’ and ‘Ldia2 3’UTR’.  
Another pair of primers was designed to target the region of the open reading frame (ORF) in Ldia2, 
which includes the frameshift suspected to cause chiral reversal in L. stagnalis; ‘Ldia2 ORF’. This 
additional target was included in attempt to infer any information about the regulation of the ORF 
compared to the 3’ UTR. However, there were far less sequence differences between Ldia1 and 
Ldia2 in the ORF. The primers were designed to amplify the Ldia2 candidate gene and contain three 
bases different from the Ldia1 sequence, including the last two consecutive bases on the leading 
edge of the forward primer, increasing the likelihood of amplifying only the Ldia2 ORF.  
Primer specificity 
All primer pairs were first tested via a conventional non-quantitative PCR using a representative 
cDNA sample and a genomic control sample and water negative control. The products were 
visualised via fluorescent agarose gel electrophoresis to verify the expected size of products (Box 2).  
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In addition, the sequence specificity of the amplicons generated from Ldia1 3’ UTR, Ldia2 3’ UTR & 
Ldia2 ORF were verified through Sanger sequencing of conventional PCR products generated from a 
pooled DD single cell embryo cDNA template. Due to the presence of variable Tm peaks in the dd 
samples in the Ldia2 ORF qPCR experiments, Sanger sequencing of Ldia2 ORF was additionally 
performed on a PCR product generated from cDNA of both a pooled DD and a pooled dd embryo 
template. Sanger sequencing was performed in both forward and reverse directions using the 
original qPCR primers. No cloning was undertaken. The protocols for the Sanger sequencing sample 
preparation are available in the SI (S7). 
Primer amplification efficiency 
Primer efficiencies were calculated for each of the fourteen primer pairs used in the qPCR 
experiments using the same methodology as described in Chapter 2 (Methods, Primer amplification 
efficiency) although a different reference sample was used. The standard curve experiments of the 
functional GOIs (Larp2/3 1a, Larp2/3 3, Lmhc, Lmhc nm, Lcol11a 2/1, Lmyo5a, Lmyo18a, Lstau and 
Lunc93a), were assessed using an ovotestis reference pool sample, equal to that used in the 
amplification efficiency experiments of the endogenous control genes. The standard curve 
experiments for the proximal GOIs (Ldia1, Ldia2 3’ UTR, Ldia2 ORF, Lfat1 and Lfry) were calculated 
using a single-cell embryo reference sample. This sample was created by pooling equal amounts of 
cDNA generated from an RNA sample extracted from single-cell embryos from multiple DD 
individuals and another sample pooled from multiple dd individuals, using the RNA extraction and 
cDNA synthesis protocol already described. The Ldia2 3’ UTR primer pair was also assessed for 
amplification efficiency using a foot tissue reference sample. The reference foot sample was created 
by pooling equal volumes of cDNA from all ten foot samples together. 
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Table 18 Primer sequence information for amplification of the nine functional GOIs including: primer name and associated protein from the UniRef90 hit of its most closely related protein 
product; gene abbreviation (Abv.) used throughout this analysis; Primer sequence in the 5’ to 3’ direction; Primer length (P.L) & amplicon length (A.L) in nucleotides; primer melting 
temperature (Tm) and the difference between melting temperature within each primer pair (Tm diff); the estimate of mispriming to any sequence (Any th) and specifically mispriming at 
the 3’ end (3’ th); and the predicted intron size between the two primers. * primer lies on an exon boundary. †full intron information unknown due to the transcriptomic sequence 
crossing two genomic contigs, the minimum intron size is presented. 
Primer Name Associated Protein UniRef90 hit Abv. Sequence 5’-3’ P.L A.L Tm (°C) Tm diff %GC Any th 3’ th 
Predicted 
Intron (bp) 
ARPI_1-2ab_F Actin-related protein 
2/3 subunit 1a 
UniRef90_K1R488 Larp2/3 1a 
CTGAAAATAGCCTTGTTGCAGC 22 
115 
58.75 
1.25 
45.45 0 0 
341 
ARPI_1-2b_R CCAGACTCCTTTTCCTGGGAC 21 60.00 57.14 0 0 
ARPII_1-3a_F Actin-related protein 
2/3 subunit 3 
UniRef90_C3KIX3 Larp2/3 3 
AGCCAGCTAACAAGGGAGAAG 21 
129 
59.72 
0.20 
52.38 0 0 
>900† 
ARPII_1-3a_R AGCATAGCCACCATTTGCTTG* 21 59.52 47.62 0 0 
COL2A_3-4a_F Collagen type XI 
alpha 2/1 
UniRef90_G3HQS2 Lcol11a 2/1 
TGGTCGACTTGGAAAGGATGG 21 
110 
60.00 
0.23 
52.38 16.46 0 
728 
COL2A_3-4a_R CTCTGTGTCCTTTCTCTCCTGG 22 59.77 54.55 0 0 
MHCI_1-2a_F 
Myosin heavy chain UniRef90_Q9NJ19 Lmhc 
TCAGATTGAGGAGGCCAACG 20 
125 
59.75 
0.50 
55 0 0 
210 
MHCI_1-2a_R TCTCCAACTCGTGTGTGCTG 20 60.25 55 0 0 
MHCII_2-3a_F Myosin heavy chain 
non-muscle 
UniRef90_Q45R40 Lmhc nm 
GCTACAGACAACAAGGGCTTC 21 
111 
59.19 
0.65 
52.38 0 0 
338 
MHCII_2-3a_R ACAAATCAATGCCATCCGTGTC 22 59.84 45.45 0 0 
MV_F2 
Myosin Va UniRef90_F6K356 Lmyo5a 
TTCAGCCCAGTATTGTCCCC* 20 
115 
59.38 
0.89 
55 0 0 
1658 
MV_R2 TCCTCTGTTTCCCTGGCATTG 21 60.27 52.38 0 0 
Staufen_3-4a_F RNA binding protein 
Staufen 
UniRef90_E2QDA4 Lstau 
CTTGCGCAGAAACATGCCTG 20 
116 
60.73 
0.52 
55 6.12 6.12 
125 
Staufen_3-4a_R TCCCCTCTCCTTCTGTCACC 20 60.25 60 0 0 
UMVIII_F2 Unconventional myosin 
-XVIIIa 
UniRef90_K1QV80 Lmyo18a 
GTCCAGCAGTCCTTTGAGAAC 21 
129 
58.85 
0.32 
52.38 0 0 
497 
UMVIII_R2 AAACTGGGGCTTGTTGTTGG 20 59.17 50 0 0 
UNC-93_F 
unc-93 homolog a UniRef90_K1P6Z5 Lunc93a 
GAAGGAGGTCAGGGCGATG 19 
115 
59.86 
0.23 
63.16 0 0 
>1.8kb† 
UNC-93_R GCTGCTTTGTAGACTCTGTAACG 23 59.63 47.83 0 0 
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Table 19 Primer sequence information for amplification of the four proximal GOIs including: primer name and associated protein according to Blastx top hits; gene abbreviation (Abv.) 
used throughout this analysis; Primer sequence in the 5’ to 3’ direction; Primer length (P.L) & amplicon length (A.L) in nucleotides; primer melting temperature (Tm) and the difference 
between melting temperature within each primer pair (Tm diff); the estimate of mispriming to any sequence (Any th) and specifically mispriming at the 3’ end (3’ th); and the predicted 
intron size between the two primers. 
Primer Name Associated Protein Abv. 5’-3’ Sequence P.L A.L Tm (°C) Tm Diff %GC Any th 3’ th 
Predicted 
Intron (bp) 
qPCR_PARA_3'UTR_F1 
diaphanous formin Ldia1 3’ UTR 
AGTGGTGTGGGCAAAAGATG 20 
117 
58.67 
0.05 
50 0 0 
n/a 
qPCR_PARA_3'UTR_R1 TATTCTGTTGATGCACGGCC 20 58.62 50 0 0 
qPCR_FOR_3'UTR_F1 
diaphanous formin Ldia2 3’ UTR 
GGGAGTTCAAGTTCAAGCCTATC 23 
122 
59.06 
0.98 
47.83 0 0 
n/a 
qPCR_FOR_3'UTR_R1 GGCAAGCTACGACTCTTCTC 20 58.08 55 0 0 
qPCR_FOR_ORF_F1 
diaphanous formin Ldia2 ORF 
GGGTGACAATGAAGTGGACC 20 
126 
58.47 
0.58 
55 0 0 
713 
qPCR_FOR_ORF_R1 ACATGCATCTGTAACATCTGCC 22 59.05 45.45 11.53 0 
qPCR_CAD_F1 
protocadherin FAT1 Lfat1 
TGCCCATGTTGCTAAGTTCAG 21 
126 
58.84 
0.49 
47.62 6.1 0 
1345 
qPCR_CAD_R1 CCTCTATCCCAGTTCGACGG 20 59.33 60 0 0 
qPCR_FURRY_F1 
Furry (gene) Lfry 
ACTTACCCTGCTCAAATGCC 20 
121 
58.16 
1.25 
50 0 0 
715 
qPCR_FURRY_R1 ATGTTTCTTGTGCTGCCGTC 20 59.41 50 0 0 
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qPCR 
cDNA samples were diluted to an appropriate working concentration (indicated through the results 
of the amplification efficiency experiments) using PCR grade water and divided into aliquots. These 
were not strictly single use but allowed storage of samples in multiple tubes to minimise freeze thaw 
cycles. One aliquot provided enough sample to perform six target gene experiments. All cDNA 
samples were vortexed before each run. Working concentrations of cDNA used in the qPCR varied 
between tissues, however within tissue analyses, all cDNA samples were used at the same dilution. 
All qPCR reactions were performed as described in Box 3. PCR grade water was used as a negative 
control for all mastermixes. 
Plate setup 
Inter-run calibration 
A reference sample was created by pooling multiple ovotestis cDNA samples of all genotypes, 
hereafter referred to as ‘OvoRef’. The OvoRef sample can loosely be considered as representing a 
heterozygote. The OvoRef sample was diluted to a working concentration of 1:30 and separated into 
smaller aliquots to minimise freeze-thaws. The single working dilution was made to a volume 
sufficient to be included on all experimental plates and provides an appropriate calibrator sample for 
calculating relative expression ratios across all tissues/plates.  
All qPCR experiments were performed within 20 days. A new tube of SYBR green was defrosted and 
used within the day (no freeze-thaws) and light-exposure of mastermixes was kept to a minimum. 
Embryo and foot tissue experiments 
All samples, including the negative control and OvoRef sample were performed in triplicate repeat 
within the single-cell embryo and foot experiments. 
The single-cell embryo experiment consisted of 17 samples plus an embryo reference sample (P1c), 
diluted to a working concentration of 1:15, necessitating the use of 54 wells per GOI. Therefore, a 
maximum of one GOI could be performed on all samples within a single 96 well plate. The foot 
experiment comprised only 10 samples, diluted to a working concentration of 1:30, necessitating the 
use of 30 wells per GOI. Subsequently the foot samples were run on the same plate as the embryo 
samples, requiring a total 84 wells. A single master-mix was created for each embryo and foot qPCR 
plate and therefore the same negative control (water) and OvoRef samples functioned for both 
experiments, requiring an additional 6 wells and therefore a total of 90 wells per GOI/plate (Figure 
10a). 
97 
 
Three endogenous control genes were quantified in the embryo and foot tissue experiments, namely 
Lhis2a, Lube2 and Lywhaz (as described in Chapter 2). 
Due to the reduced amount of single cell embryo sample only eight GOIs could be included in 
addition to the three endogenous control genes in the embryo experiment. The following GOIs were 
selected to be quantified in the embryo and foot tissue: Larp2/3 1a; Larp2/3 3; Ldia1 3’ UTR; Ldia2 3’ 
UTR; Ldia2 ORF; Lfat1, Lfry & Lmhc.  
Therefore, the remaining six GOIs (Lcol11a 2/1; Lmhc nm; Lmyo5a; Lmyo18a; Lstau & Lunc93a) were 
assessed in the foot tissue alone. The 10 foot samples, the negative control and the OvoRef sample 
were again performed in triplicate repeat, requiring a total of 36 wells per GOI. Therefore, two GOIs 
could be assessed within one 96 well plate (Figure 10b). 
Ovotestis experiments 
The ovotestis experiment comprised of 37 samples, diluted to a working concentration of 1:30. The 
ovotestis experimental samples, in addition to the negative control were performed in duplicate 
repeat, whereas the OvoRef sample was performed in quadruplicate repeat, thus requiring a total of 
80 wells per GOI. Subsequently only one GOI was included per 96 well plate (Figure 10c). Three 
endogenous control genes were quantified in the ovotestis tissue, namely Lhis2a, Lube2 and Lrpl14 
(as described in Chapter 2). 
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Figure 10 qPCR experimental plate setup. The embryo and foot combined experiments (a), the remaining foot 
experiments, including two GOIs per plate (indicted by the different background colour) (b) and the ovotestis 
experiments (c). Unused wells are indicated by ‘x’. 
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Data Analysis 
Cq data export 
Cq values were exported for each well of the experiment using the 7500 software. Average Cq values 
derived from triplicate or duplicate repeats of each sample were used in analyses. Ideally only 
samples with standard deviation of <0.5 were used in the analysis. This occasionally involved 
removing perceived outliers, as described in Chapter 2, from the dataset. However, in some 
instances it was not possible to reliably designate a value for removal and subsequently a small 
number of average Cq values are included with high (>0.5) standard deviation (Table 21 - Table 28).  
Ovotestis sample 10631 was removed from all analyses due to numerous failures to amplify a 
product.  
The Cq data obtained from embryo samples included in the Lmhc qPCR were omitted from analysis 
due to high standard deviation and a failure to amplify a product in the majority of samples. 
Expression Ratios 
Normalised expression ratio or ‘normalised relative quantity’ (NRQ) values were calculated from the 
average Cq value of each sample using the Pfaffl method (Pfaffl 2001, Pfaffl, Tichopad et al. 2004, 
Hellemans, Mortier et al. 2007) (Equation 2). For each sample, firstly the relative quantity per target 
gene (ΔCq target) was calculated by subtracting the average Cq value of the sample from that of the 
calibrator sample. This delta Cq (ΔCq) value was then corrected for amplification efficiency (E) by 
multiplying delta Cq to the base percentage amplification efficiency (represented as a value between 
1 and 2). The efficiency corrected relative quantities were then normalised to the endogenous 
control genes by dividing by the geometric mean (geoM) of the efficiency corrected delta Cq values 
calculated for each of the control genes (ΔCq ref) in the same manner as described above.  
 
 
Equation 2 Formula according to Pfaffl’s method to calculate normalised expression ratios relative to a calibrator sample 
whilst incorporating the amplification efficiency of each target. Formula explanation in main text. 
Normalised expression ratio = (Etarget)ΔCq target(calibrator-sample) 
            geoM(Eref) ΔCq ref(calibrator-sample) 
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The calculations were performed in Microsoft Excel 2010. All values were corrected for primer 
efficiencies using the average efficiency calculated via standard curve experiments described 
previously (Table 20). 
NRQ values were calculated separately for the genotype analysis and tissue analysis. These were 
generated from the same raw Cq data, but relative to a different calibrator sample and normalised 
to a different combination of endogenous controls. 
Genotype Analysis 
A DD sample with a relatively high Cq value was used as the calibrator sample for the genotype 
comparison analysis within each tissue. Sample 11295 functioned as the calibrator for the embryo 
genotype analysis. Sample 11350 was the calibrator for the foot genotype analysis, and sample 8548 
was used for the ovotestis genotype analysis. Consequently, all NRQs in the genotype analyses 
represent an expression ratio relative to a conspecific individual DD sample. All three endogenous 
control genes quantified within each tissue, contributed to the geometric mean of the endogenous 
control genes. 
Tissue Analysis 
The ovotestis reference sample, OvoRef, provided the calibrator for the tissue comparison analysis. 
The NRQ value for each experimental sample was calculated relative to the average Cq value only of 
the OvoRef sample which was quantified on the same experimental plate. The NRQs in the tissue 
analysis represent an expression ratio relative to an ovotestis sample of mixed genotype. NRQ values 
were normalised to the geometric mean of the two endogenous control genes quantified in all 
tissues, namely Lhis2a and Lube2.  
Differential expression analysis 
All statistical calculations were performed in the basic R package (http//cran.r-project.org, R version 
2.15.3). Graphs were produced using the addition of graphics packages ggplot2, 0.9.3.1, (Wickham 
2009) and gcookbook, version 1.0, (Chang 2013). All statistical tests were performed on NRQ values 
log transformed to the base 10. No probability corrections were performed to accommodate for 
multiple comparisons. Summary statistics were generated in the R package. Additional calculations 
were performed in Microsoft Excel 2010 to calculate the standard error of the means. 
Genotype Analysis 
Boxplots and histograms were created of the log transformed (base10) NRQs (LOG NRQ) calculated 
for each gene of interest grouped according to genotype. 
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Embryo  
Non-parametric pairwise comparisons of the group means of LOGNRQ values for each genotype 
were performed using the Wilcoxon-Mann-Whitney test. Pairwise comparisons were made between 
all genotypes for the seven GOIs assessed, resulting in a total of 21 pairwise comparisons.  
Ovotestis 
Non-parametric pairwise comparisons of the group means of LOGNRQ values for each genotype 
were performed using the Wilcoxon-Mann-Whitney test. Pairwise comparisons were made between 
all genotypes for the 14 GOIs assessed, resulting in a total of 42 pairwise comparisons. 
Foot 
Non-parametric pairwise comparisons of the group means of LOGNRQ values for each genotype 
were performed using the Wilcoxon-Mann-Whitney test. Pairwise comparisons were made between 
both genotypes for the 14 GOIs assessed, resulting in a total of 14 pairwise comparisons.  
Tissue Analysis 
Boxplots and histograms were created of the LOG NRQs calculated for each gene of interest grouped 
by either genotypic group or tissue, or both genotypic group and tissue. 
Within each genotype, non-parametric pairwise comparisons of the group means of LOGNRQ values 
for each tissue were performed using the Wilcoxon-Mann-Whitney test. The number of comparisons 
per genotype is described below.  
Within the DD samples, pairwise comparisons were made between all three tissues assessed for 
seven genes of interest and between the foot and ovotestis tissues for the additional seven genes 
assessed in those tissues; a total of 28 comparisons. 
Comparisons of the foot tissue cannot be performed for the Dd genotype group due to a lack of 
representative samples. Therefore, pairwise comparisons of the Dd samples were made only 
between the embryo and ovotestis tissue for the seven genes of interest assessed in both tissues; a 
total of seven comparisons. 
Within the dd samples, pairwise comparisons were made between all three tissues assessed for 
seven genes of interest and between the foot and ovotestis tissues for the additional seven genes 
assessed in those tissues; a total of 28 comparisons. 
An overall total of 63 pairwise comparisons in the tissue analysis and 77 pairwise comparisons in the 
genotype analysis resulted in a grand total of 140 pairwise comparisons.  
102 
 
Results 
General QC 
Primer specificity 
Conventional non-quantitative PCRs of cDNA and genomic DNA analysed via fluorescent agarose 
gels, showed amplified products to be of the expected size and additionally demonstrated the 
difference in amplicon size generated from a cDNA or genomic DNA template when using exon-
spanning primers. There was no visible amplification of multiple products from any of the samples 
(Figure 11, Figure 12).  
Some of the primer pairs could not amplify a product from a genomic template, namely Larp2/3 3, 
Lfat1 and Lmyo5a. Other primer pairs could amplify a genomic product, although the resulting 
amplicon was of a substantial size difference, as seen in Ldia2 ORF, Lfry, Larp2/3 1a, Lcol11a 2/1, 
Lmhc, Lmhc nm, Lmyo18a, Lstau and Lunc93a. The only primer pairs to amplify a genomic product at 
the same size as a transcriptomic product were Ldia1 3’ UTR and Ldia2 3’ UTR (Figure 11, Figure 12). 
The majority of melt temperature (Tm) curves of the qPCR reactions showed distinct peaks for 
experimental samples. A smaller peak at a lower Tm was often visible in the negative controls of 
some genes. Figure 13, Figure 14 and Figure 15 show representative Tm curves for each GOI. The 
presence and height of the lower Tm peaks varied between runs; however, the peak was generally at 
consistent, reduced temperature at a lower intensity and is assumed to represent primer dimer. 
The only qPCRs to produce wide and variable Tm peaks, were the Ldia2 3’ UTR and Ldia2 ORF (Figure 
15). The wide Tm peaks were only seen in the dd embryo samples and not in the DD or Dd embryo 
samples, or in any of the foot or ovotestis samples. These samples also occasionally showed smaller 
peaks at higher temperatures than the specific amplicon. A number of the dd technical replicates of 
Ldia2 were removed after being flagged by the software for the presence of multiple Tm peaks. All 
of the dd samples for Ldia2 ORF and most of the dd samples for Ldia2 3’ UTR were reduced to 
duplicate repeat after data cleaning. Sample 11287 was included still flagged as producing multiple 
Tm peaks for Ldia2 3’ UTR (Table 22). 
The amplicons of a number of primer pairs were sequenced by Sanger sequencing to further verify 
specificity. This was important for Ldia2 3’ UTR and ORF primers because of the multiple Tm peaks 
seen in some of the sinistral homozygote samples. Sequencing has shown the product to be specific 
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to the Ldia2 gene. The spurious peaks are assumed to be various primer dimers resulting from the 
low concentration of target material present in the dd samples. 
Amplification efficiency 
All primer pairs demonstrated amplification efficiency between 1.775 and 1.986 with R2 values 
exceeding 0.98. All primers demonstrated acceptable amplification efficiency in dilutions of up to 
1:75/1.33% of full concentration (Table 20). The working concentrations of 1:15 and 1:30 used in the 
qPCR experiments fall well within these limits. 
Sample quality 
All samples underwent an intronic PCR reaction to check for amplification of genomic DNA specific 
products. Every embryo tissue sample used within this experiment failed to produce a PCR product 
from the intronic PCR. Conversely every ovotestis and foot sample did produce a clear intronic PCR 
product (presented in S5). No multiple products were seen in any of the exon-spanning test PCRs 
(Figure 11, Figure 12). 
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Figure 11 Composite UV visualisations of PCR products from each of the five proximal GOIs from cDNA (cDNA) and 
genomic DNA (DNA) templates, size fractionated through gel electrophoresis. The size of products is inferred from the 
DNA marker of known size (L). The PCR products of another pair of primers not used in this experiment (n/a) also appear 
on the gel.   
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Figure 12 Composite UV visualisations of PCR products from each of the nine functional GOIs from cDNA and genomic 
DNA templates, size fractionated through gel electrophoresis. The size of products is indicated by the DNA marker of 
known size (L). Some gel images include the negative control (H2O), some PCRs included cDNA or DNA samples from 
both homozygote genotypes DD and dd.  
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Figure 13 Representative temperature melt curves of qPCR amplification of Larp2/3 1a (a); Larp2/3 3 (b); Ldia1 3’ UTR 
(c); Lfat1 (d); Lfry (e) and Lmhc (f). Tm curves a-e were produced from DD (blue), Dd (purple) and dd (red) embryo 
samples. Tm curve f was produced from DD (light green) and dd (dark green) foot samples. Negative controls are shown 
in grey. 
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Figure 14 Representative temperature melt curves of qPCR amplification of Lcol11a 2/1 (a); Lmhc nm (b); Lmyo5a (c); 
Lmyo18a (d); Lstau (e) and Lunc93a (f). Tm curves were produced from DD (light green) and dd (dark green) foot 
samples. Negative controls are shown in grey. 
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Figure 15 Representative temperature melt curves of qPCR amplification of Ldia2 3’ UTR (a, c, e) and Ldia2 ORF (b, d, f). 
Tm curves a & b were produced from DD (blue), Dd (purple) and dd (red) embryo samples. Tm curves e & f were 
produced from DD (light green) and dd (dark green) foot samples. Tm curves e & f were produced from DD (magenta), 
Dd (peach) and dd (yellow) ovotestis samples Negative controls are shown in grey. 
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Table 20 Amplification efficiency estimates of each primer pair for the 14 GOIs assessed, represented by their gene 
abbreviation (Abv.). The average efficiency is quoted as the amount each template will increase per qPCR cycle 
(between 1 and 2). The minimum dilution is presented as a percentage of the undiluted original cDNA concentration 
required in the qPCR reaction. Additionally, the number of runs included to generate the average amplification 
efficiency is quoted and the tissue the experiments were performed on: Ovotestis reference sample (O); embryo 
reference sample (E), foot reference sample (F). 
Primer Pair Abv. 
Efficiency 
(R2 > 0.98) 
Minimum 
Dilution (%) 
No. of runs 
included 
ARPI_1-2b Larp2/3 1a 1.847 0.67 3O 
ARPII_1-3a Larp2/3 3 1.775 0.67 2O 
COL2A_3-4a Lcol11a 2/1 1.890 0.67 3O 
MHCI_1-2a Lmhc 1.892 0.13 3O 
MHCII_2-3a Lmhc nm 1.924 0.67 4O 
MV_F2R2 Lmyo5a 1.946 0.13 2O 
UMVIII_F2R2 Lmyo18a 1.913 0.13 2O 
Staufen_3-4a Lstau 1.957 0.67 2O 
UNC-93_FR Lunc93a 1.978 0.13 2O 
PARA_3'_UTR Ldia1 3’ UTR 1.986 0.27 2E 
FOR_3'_UTR Ldia2 3’ UTR 1.912 0.27    4E, F 
FOR_ORF Ldia2 ORF 1.948 1.33 2E 
CAD_F1R1 Lfat1 1.838 0.59 2E 
FURRY_F1R1 Lfry 1.876 0.13 2E 
Q RT PCR 
Raw Cq data 
The 7500 software used to design and run the qPCR experiments, automatically flagged a well when 
it perceived an issue that may compromise the quality of the Cq data. Flags included, multiple Tm 
peaks observed during the melt curve stage or high (>0.5) standard deviation (SD) between technical 
replicates. The majority of flagged wells were removed from the analysis in an attempt to minimise 
erroneous noise in the dataset. However, in some instances this was not deemed appropriate and 
therefore some flagged data points were included in the average Cq values.  
Embryo Cq data 
Average Cq values exported for each embryo sample for the three endogenous control genes and 
seven GOIs assessed are presented in Table 21 & Table 22 respectively, with their associated SD and 
the number of replicates included in the average. All average Cq values were calculated from 3 
replicate Cq values with the exception of the dd samples in Ldia2 3’ UTR and Ldia2 ORF.  
In the Ldia2 3’ UTR experiment all dd samples yielded very high Cq values (>32) with high levels of 
SD. Individual data points exhibiting substantially different values than the other two replicates were 
perceived as outliers and removed, resulting in the reduction of SD to <0.5 and the number of 
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replicates to two. This occurred in all dd samples except 11301, which maintained high SD at 0.804. 
Two samples were additionally flagged for multiple Tm peaks; two replicates of 11287 & one 
replicate of 11301. The removal of the one flagged replicate for 11301 cleared the flags for multiple 
Tm peaks. However, it was not considered appropriate to remove two wells from 11287, leaving 
only one representative Cq value, and as such one flag remains for the presence of multiple Tm 
peaks in 11287 (Table 22, Figure 15). 
The dd samples in the Ldia2 ORF experiment showed higher Cq values than the DD or Dd samples 
(Table 22). Only one well was flagged by the software for multiple Tm peaks and subsequently 
omitted from the dataset leaving sample 11301 with only two replicates. However, when looking at 
the Tm plot for Ldia2 ORF the melt curves created for the dd samples exhibited a number of wide 
peaks indicating variation in the specific size of amplicons (Figure 15). Replicates showing very 
uneven Tm peaks were omitted from the dataset, which resulted in all dd samples being represented 
by only two technical replicates. Clean, single Tm peaks were generated from all of the DD and Dd 
samples (Figure 15). Additionally, sample 11283 bore high SD between its remaining replicates 
(0.524). 
Table 21 Average Cq values (Cq) and associated standard deviation (SD) calculated from technical replicates (n) of 17 
embryo samples and the ovotestis reference sample (OvoRef) for three endogenous control genes; Lhis2a, Lube2 & 
Lywhaz. Including sample ID and genotype (Geno).C sample used as calibrator *amplification observed in negative 
controls 
Embryo samples Lhis2a Lube2 Lywhaz* 
ID Geno Cq SD n Cq SD n Cq SD n 
11289 DD 20.93 0.04 3 24.14 0.13 3 23.20 0.10 3 
11292 DD 20.61 0.02 3 23.61 0.07 3 22.69 0.03 3 
11293 DD 20.36 0.02 3 23.91 0.03 3 22.96 0.02 3 
11295C DD 21.09 0.10 3 24.58 0.16 3 23.82 0.05 3 
11297 DD 20.27 0.12 3 23.67 0.15 3 22.74 0.12 3 
11298 DD 19.98 0.07 3 23.48 0.14 3 22.30 0.03 3 
11358 Dd 20.12 0.01 3 23.19 0.08 3 22.12 0.06 3 
11359 Dd 19.63 0.03 3 22.65 0.06 3 21.55 0.03 3 
11360 Dd 19.35 0.01 3 22.38 0.05 3 21.35 0.05 3 
11361 Dd 19.59 0.01 3 22.52 0.03 3 21.65 0.02 3 
11363 Dd 18.98 0.04 3 21.87 0.06 3 20.94 0.02 3 
11282 dd 20.09 0.05 3 23.12 0.02 3 22.23 0.04 3 
11283 dd 21.36 0.06 3 24.73 0.05 3 23.49 0.03 3 
11284 dd 20.24 0.02 3 23.36 0.09 3 22.39 0.01 3 
11287 dd 21.02 0.05 3 24.37 0.13 3 23.57 0.12 3 
11301 dd 21.20 0.08 3 24.73 0.11 3 23.63 0.07 3 
11303 dd 20.74 0.01 3 23.87 0.06 3 22.86 0.02 3 
OvoRef D/d 21.65 0.04 3 21.47 0.02 3 19.57 0.06 3 
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Table 22 Average Cq values (Cq) and associated standard deviation (SD) calculated from technical replicates (n) of 17 embryo samples and the ovotestis reference sample (OvoRef) for 
seven GOIs. Including sample ID and genotype (Geno).C sample used as calibrator °multiple Tm peaks recorded †high SD observed between replicates. 
Embryo samples Larp2/3 1a Larp2/3 3 Ldia1 3’ UTR Ldia2 3’ UTR Ldia2 ORF Lfat1 Lfry 
ID Geno Cq SD n Cq SD n Cq SD n Cq SD n Cq SD n Cq SD n Cq SD n 
11289 DD 24.00 0.18 3 20.56 0.03 3 23.23 0.08 3 26.44 0.18 3 22.29 0.08 3 28.05 0.16 3 22.30 0.11 3 
11292 DD 23.28 0.08 3 20.01 0.19 3 22.12 0.15 3 25.65 0.09 3 21.57 0.02 3 26.96 0.04 3 21.79 0.09 3 
11293 DD 23.49 0.02 3 20.31 0.31 3 22.84 0.11 3 26.35 0.07 3 22.13 0.14 3 27.22 0.11 3 22.29 0.05 3 
11295C DD 24.42 0.02 3 20.89 0.12 3 23.44 0.06 3 26.78 0.11 3 22.64 0.05 3 27.91 0.05 3 22.80 0.23 3 
11297 DD 23.40 0.14 3 20.27 0.20 3 22.47 0.12 3 25.86 0.15 3 21.89 0.24 3 26.96 0.15 3 21.93 0.04 3 
11298 DD 22.84 0.09 3 19.79 0.24 3 22.36 0.09 3 25.52 0.02 3 21.19 0.21 3 26.80 0.16 3 21.57 0.02 3 
11358 Dd 22.61 0.11 3 19.74 0.13 3 22.45 0.08 3 26.68 0.14 3 22.64 0.08 3 26.77 0.15 3 21.72 0.11 3 
11359 Dd 21.99 0.12 3 19.28 0.08 3 21.56 0.06 3 25.61 0.05 3 21.47 0.15 3 26.01 0.04 3 20.86 0.13 3 
11360 Dd 22.00 0.19 3 19.39 0.07 3 21.47 0.04 3 25.55 0.10 3 21.83 0.33 3 25.64 0.03 3 20.63 0.12 3 
11361 Dd 22.32 0.09 3 19.48 0.03 3 21.62 0.10 3 25.62 0.11 3 21.99 0.13 3 25.91 0.09 3 20.71 0.01 3 
11363 Dd 21.69 0.10 3 18.96 0.20 3 20.77 0.09 3 25.05 0.03 3 21.15 0.13 3 25.00 0.07 3 20.15 0.14 3 
11282 dd 22.92 0.02 3 19.34 0.08 3 21.83 0.06 3 32.51 0.08 3 26.67 0.18 2 26.67 0.08 3 21.68 0.17 3 
11283 dd 24.53 0.13 3 21.01 0.22 3 23.43 0.14 3 36.73 0.43 2 27.26 0.52† 2 27.86 0.10 3 22.86 0.15 3 
11284 dd 23.26 0.06 3 19.98 0.19 3 21.89 0.05 3 32.24 0.07 2 26.64 0.07 2 26.65 0.11 3 21.65 0.04 3 
11287 dd 24.33 0.10 3 21.12 0.17 3 22.91 0.25 3 33.87 0.03° 2 27.24 0.10 2 27.45 0.27 3 22.63 0.17 3 
11301 dd 24.37 0.09 3 21.28 0.11 3 23.72 0.17 3 35.65 0.80† 2 28.68 0.02 2 28.02 0.27 3 23.00 0.35 3 
11303 dd 23.74 0.05 3 20.59 0.14 3 22.61 0.05 3 33.22 0.07 2 28.02 0.40 2 27.26 0.04 3 22.18 0.20 3 
OvoRef D/d 18.52 0.03 3 16.96 0.02 3 18.82 0.02 3 27.05 0.06 3 22.34 0.27 3 23.39 0.04 3 19.71 0.06 3 
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Foot Cq data 
Average Cq values exported for each foot sample for the three endogenous control genes and 14 
GOIs assessed are presented in Table 23 & Table 24 respectively, with their associated SD and the 
number of replicates included in the average. All averages were calculated from three replicate Cq 
values, with the exception of the four individuals described below.  
Firstly, in the Ldia2 3’ UTR experiment, one technical replicate of sample 11351 was flagged as an 
outlier and removed from analysis. Another sample 11347 was flagged for high SD across the three 
replicates. No one replicate appeared to represent an outlier and as such all three replicates were 
included in the average with high SD (0.643). It is important to note that the Cq values for all of the 
foot samples in Ldia2 3’ UTR were fairly high (>28) and as such may be more prone to fluctuations in 
Cq.  
In the Ldia2 ORF experiment, sample 11348 was flagged for high SD across its three replicates. The 
removal of a perceived outlier reduced SD to 0.358 and the average was calculated from the 
remaining two replicates. 
In the Lunc93a experiment, one technical replicate of sample 11356 was flagged by the software as 
an outlier and subsequently removed from the dataset. Sample 11347 was flagged for high SD across 
the three replicates. The removal of one perceived outlier reduced SD to 0.022 and the average was 
calculated from the remaining two replicates.  
 
Table 23 Average Cq values (Cq) and associated standard deviation (SD) calculated from technical replicates (n) of 10 
foot samples and the ovotestis reference sample (OvoRef) for three endogenous control genes; Lhis2a, Lube2 & Lywhaz. 
Including sample ID and genotype (Geno).C sample used as calibrator, *amplification observed in negative controls 
Foot samples Lhis2a Lube2 Lywhaz* 
ID Geno Cq SD n Cq SD n Cq SD n 
11347 DD 26.05 0.04 3 27.12 0.06 3 24.14 0.05 3 
  11350C DD 21.88 0.08 3 22.96 0.04 3 20.58 0.03 3 
11351 DD 24.06 0.03 3 25.53 0.04 3 22.67 0.04 3 
11352 DD 22.60 0.02 3 23.94 0.02 3 21.30 0.01 3 
11357 DD 21.94 0.01 3 23.16 0.04 3 20.90 0.04 3 
11348 dd 23.93 0.02 3 24.56 0.11 3 22.12 0.06 3 
11349 dd 23.35 0.06 3 24.32 0.05 3 22.17 0.02 3 
11353 dd 23.99 0.03 3 24.60 0.06 3 22.29 0.05 3 
11354 dd 22.90 0.02 3 23.40 0.05 3 21.30 0.02 3 
11356 dd 23.80 0.01 3 24.90 0.01 3 22.27 0.04 3 
OvoRef D/d 21.65 0.04 3 21.47 0.02 3 19.57 0.06 3 
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Table 24 Average Cq values (Cq) and associated standard deviation (SD) calculated from technical replicates (n) of 10 foot samples and the ovotestis reference sample (OvoRef) for 14 
GOIs. Including sample ID and genotype (Geno).C sample used as calibrator *amplification observed in negative controls †high SD observed between replicates. 
Foot, GOI 1-7 Larp2/3 1a Larp2/3 3a* Ldia1 3’ UTR Ldia2 3’ UTR Ldia2 ORF Lfat1 Lfry 
ID Geno Cq SD n Cq SD n Cq SD n Cq SD n Cq SD n Cq SD n Cq SD n 
11347 DD 23.76 0.12 3 23.26 0.14 3 23.42 0.19 3 30.60  0.64† 3 26.23 0.14 3 27.58 0.12 3 23.98 0.13 3 
 11350C DD 20.87 0.04 3 18.64 0.20 3 19.85 0.03 3 28.83 0.24 3 24.49 0.12 3 24.92 0.02 3 21.48 0.08 3 
11351 DD 22.27 0.06 3 21.38 0.15 3 21.71 0.19 3 30.06 0.01 2 25.74 0.39 3 26.21 0.05 3 22.73 0.08 3 
11352 DD 21.31 0.07 3 19.58 0.26 3 20.93 0.06 3 29.39 0.21 3 25.11 0.37 3 25.82 0.14 3 22.35 0.06 3 
11357 DD 20.56 0.00 3 19.15 0.21 3 20.18 0.05 3 28.28 0.08 3 24.35 0.09 3 24.68 0.06 3 21.35 0.04 3 
11348 dd 21.54 0.04 3 20.67 0.08 3 21.27 0.07 3 29.65 0.09 3 24.88 0.36 2 25.54 0.08 3 22.72 0.05 3 
11349 dd 21.65 0.05 3 20.26 0.30 3 21.39 0.21 3 29.56 0.35 3 25.21 0.04 3 26.04 0.06 3 22.76 0.05 3 
11353 dd 21.63 0.09 3 20.67 0.21 3 21.54 0.11 3 29.20 0.49 3 24.56 0.31 3 25.68 0.07 3 22.53 0.13 3 
11354 dd 21.05 0.08 3 19.53 0.10 3 20.70 0.03 3 28.78 0.28 3 24.35 0.09 3 24.86 0.02 3 21.63 0.09 3 
11356 dd 21.68 0.05 3 20.83 0.09 3 21.73 0.10 3 29.24 0.27 3 24.63 0.18 3 25.87 0.04 3 22.31 0.10 3 
OvoRef D/d 18.52 0.03 3 16.96 0.02 3 18.82 0.02 3 27.05 0.06 3 22.34 0.27 3 23.39 0.04 3 19.71 0.06 3 
Foot, GOI 8-14 Lcol11 2a* Lmhc* Lmhc nm* Lmyo5a* Lmyo18a* Lstau* Lunc93a 
ID Geno Cq SD n Cq SD n Cq SD n Cq SD n Cq SD n Cq SD n Cq SD n 
11347 DD 22.21 0.18 3 21.22 0.11 3 18.90 0.03 3 21.80 0.06 3 26.78 0.05 3 21.58 0.03 3 25.64 0.02 2 
11350C DD 20.58 0.10 3 18.54 0.05 3 16.05 0.11 3 20.42 0.02 3 24.61 0.10 3 19.82 0.03 3 25.98 0.31 3 
11351 DD 20.42 0.05 3 19.61 0.06 3 17.17 0.15 3 20.70 0.05 3 25.78 0.13 3 20.48 0.03 3 25.68 0.15 3 
11352 DD 20.69 0.11 3 19.34 0.05 3 16.87 0.07 3 20.90 0.03 3 26.18 0.02 3 20.39 0.06 3 25.57 0.39 3 
11357 DD 19.57 0.07 3 18.75 0.04 3 16.84 0.07 3 20.13 0.24 3 23.94 0.19 3 19.68 0.04 3 24.80 0.18 3 
11348 dd 19.63 0.17 3 18.84 0.09 3 17.13 0.33 3 20.69 0.16 3 24.70 0.08 3 20.14 0.14 3 24.71 0.03 3 
11349 dd 19.55 0.14 3 18.40 0.06 3 17.37 0.20 3 21.41 0.04 3 25.44 0.12 3 20.49 0.04 3 25.09 0.23 3 
11353 dd 19.61 0.03 3 19.20 0.11 3 17.40 0.21 3 20.21 0.02 3 25.42 0.15 3 20.14 0.10 3 24.84 0.23 3 
11354 dd 19.53 0.03 3 19.19 0.05 3 17.39 0.11 3 20.01 0.02 3 24.50 0.06 3 20.16 0.19 3 25.46 0.28 3 
11356 dd 20.60 0.04 3 19.48 0.15 3 17.67 0.05 3 20.43 0.08 3 24.66 0.08 3 20.19 0.07 3 25.04 0.30 3 
OvoRef D/d 20.30 0.07 3 19.60 0.06 3 14.72 0.07 3 19.60 0.13 3 23.13 0.32 3 17.97 0.05 3 20.26 0.01 2 
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Ovotestis Cq data 
Average Cq values exported for each ovotestis sample for the three endogenous control genes 
assessed are presented in Table 25. Due to the larger amount of samples in the ovotestis experiment 
the average Cq data for the 14 GOIs assessed are split across three tables (Table 26, Table 27, Table 
28). Each average Cq value is presented with the associated SD and number of replicates included in 
the average. All individual sample averages were calculated from two replicate Cq values, with the 
exception of one individual in the Lrpl14 experiment.  
Because the ovotestis samples were represented by only two technical replicates it was generally 
not possible to identify outliers. Therefore, a number of sample averages were included with high 
SD. However, in the Lrpl14 experiment, a technical replicate of sample 11347 clearly exhibited a 
substandard reaction evident from the amplification curve (data not shown) and was subsequently 
removed from analysis. The Cq value for 11347 in Lrpl14 consequently only represents one reaction 
and therefore has no SD (Table 25). 
The OvoRef sample averages included Cq values from four replicates and as such any outliers were 
easily identified. The only occurrence of an outlier in the OvoRef sample was observed in the Lmhc 
experiment and subsequently removed (Table 27). 
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Table 25 Average Cq values (Cq) and associated standard deviation (SD) calculated from technical replicates (n) of 36 
ovotestis samples and the reference sample (OvoRef) for three endogenous control genes; Lhis2a, Lube2 & Lrpl14. 
Including sample ID and genotype (Geno). C sample used as calibrator *amplification observed in negative controls †high 
SD observed between replicates. 
Ovotestis Lhis2a* Lube2 Lrpl14* 
ID Geno Cq SD n Cq SD n Cq SD n 
8515 DD 23.18 0.04 2 23.50 0.11 2 20.74 0.28 2 
8548C DD 23.18 0.16 2 25.20 0.24 2 21.88 0.07 2 
8582 DD 23.99 0.04 2 24.34 0.21 2 21.42 0.15 2 
8583 DD 23.06 0.03 2 23.66 0.10 2 21.16 0.17 2 
9014 DD 23.93 0.03 2 24.87 0.04 2 21.51 0.09 2 
10627 DD 23.14 0.11 2 23.88 0.23 2 20.23 0.30 2 
10633 DD 22.93 0.00 2 23.34 0.05 2 19.09 0.27 2 
10636 DD 22.57 0.02 2 23.56 0.04 2 19.21 0.25 2 
10638 DD 23.92 0.03 2 24.45 0.08 2 20.11 0.06 2 
11347 DD 22.36 0.03 2 22.74 0.27 2 21.09 n/a 1 
11350 DD 21.54 0.03 2 21.88 0.07 2 19.88 0.10 2 
11351 DD 20.52 0.01 2 21.73 0.01 2 19.68 0.41 2 
11352 DD 23.17 0.01 2 23.82 0.01 2 21.34 0.01 2 
11357 DD 21.87 0.00 2 22.27 0.08 2 20.01 0.41 2 
8554 Dd 23.84 0.00 2 24.91 0.00 2 21.24 0.00 2 
8555 Dd 23.24 0.01 2 23.71 0.05 2 20.93 0.05 2 
8559 Dd 23.78 0.01 2 23.60 0.02 2 20.55 0.04 2 
8562 Dd 21.80 0.02 2 23.92 0.25 2 20.40 0.14 2 
9013 Dd 21.98 0.03 2 23.45 0.04 2 20.81 0.17 2 
10622 Dd 23.46 0.11 2 23.54 0.03 2 20.39 0.17 2 
10629 Dd 23.41 0.03 2 24.01 0.00 2 20.07 0.21 2 
10639 Dd 23.39 0.01 2 24.06 0.09 2 19.98 0.01 2 
8806 dd 22.38 0.01 2 23.65 0.04 2 20.80 0.14 2 
8808 dd 22.02 0.03 2 23.42 0.03 2 20.00 0.01 2 
8996 dd 24.10 0.05 2 24.79 0.15 2 20.94 0.14 2 
9005 dd 22.59 0.03 2 23.44 0.07 2 20.89 0.12 2 
9007 dd 22.97 0.00 2 23.75 0.03 2 20.92 0.07 2 
10626 dd 21.28 0.05 2 21.94 0.00 2 18.42 0.15 2 
10630 dd 23.27 0.04 2 23.63 0.10 2 19.69   0.58† 2 
10640 dd 24.86 0.10 2 25.26 0.08 2 20.80 0.06 2 
10642 dd 22.28 0.04 2 24.40 0.09 2 20.18 0.42 2 
11348 dd 22.46 0.01 2 23.00 0.09 2 20.95 0.03 2 
11349 dd 24.09 0.03 2 25.17 0.08 2 22.26 0.42 2 
11353 dd 22.03 0.04 2 22.22 0.09 2 20.93 0.05 2 
11354 dd 20.80 0.06 2 21.87 0.12 2 20.15 0.10 2 
11356 dd 21.72 0.05 2 21.82 0.00 2 20.34 0.05 2 
OvoRef D/d 20.55 0.05 4 21.39 0.08 4 18.88 0.39 4 
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Table 26 Average Cq values (Cq) and associated standard deviation (SD) calculated from technical replicates (n) of 36 
ovotestis samples and the ovotestis reference sample (OvoRef) for five GOIs (Larp2/3 1a, Larp2/3 3, Ldia1 3’ UTR, Ldia2 
3’ UTR, Ldia2 ORF). Including sample ID and genotype (Geno).C sample used as calibrator *amplification observed in 
negative controls †high SD observed between replicates. 
Ovo, GOI 1-5 Larp2/3 1a Larp2/3 3* Ldia1 3'UTR Ldia2 3’ UTR Ldia2 ORF* 
ID Geno Cq SD n Cq SD n Cq SD n Cq SD n Cq SD n 
8515 DD 24.95 0.00 2 20.31 0.06 2 21.35 0.07 2 28.68 0.01 2 29.27 0.11 2 
8548C DD 26.38 0.04 2 21.45 0.15 2 23.08 0.17 2 30.18 0.05 2 30.27 0.16 2 
8582 DD 25.68 0.34 2 21.32 0.12 2 22.32 0.10 2 29.17 0.56† 2 29.67 0.19 2 
8583 DD 25.42 0.08 2 20.68 0.13 2 21.58 0.09 2 29.34 0.30 2 29.22 0.21 2 
9014 DD 26.53 0.07 2 22.40 0.07 2 23.17 0.09 2 28.85 0.11 2 29.91 0.03 2 
10627 DD 24.87 0.40 2 21.55 0.20 2 22.29 0.09 2 29.22 0.33 2 29.49 0.16 2 
10633 DD 23.72 0.44 2 20.63 0.05 2 21.60 0.05 2 29.62 0.22 2 29.91 0.37 2 
10636 DD 24.57 0.13 2 20.79 0.00 2 21.87 0.07 2 27.95 0.19 2 28.66 0.03 2 
10638 DD 25.24 0.03 2 21.84 0.10 2 22.58 0.11 2 29.46 0.15 2 29.91 0.23 2 
11347 DD 25.18 0.31 2 19.42 0.11 2 21.12 0.12 2 28.28 0.08 2 29.14 0.48 2 
11350 DD 24.64 0.27 2 18.55 0.05 2 20.53 0.01 2 27.39 0.01 2 28.12 0.01 2 
11351 DD 24.15 0.20 2 18.65 0.02 2 20.12 0.07 2 27.04 0.13 2 28.06 0.10 2 
11352 DD 26.06 0.02 2 20.68 0.02 2 22.00 0.18 2 28.18 0.05 2 28.90 0.21 2 
11357 DD 24.99 0.88† 2 19.01 0.00 2 20.95 0.03 2 27.77 0.03 2 28.66 0.03 2 
8554 Dd 26.02 0.26 2 21.38 0.05 2 22.70 0.09 2 29.61 0.20 2 29.71 0.10 2 
8555 Dd 25.45 0.22 2 20.85 0.07 2 21.60 0.04 2 29.02 0.26 2 29.51 0.08 2 
8559 Dd 25.27 0.27 2 20.94 0.04 2 21.59 0.02 2 29.49 0.08 2 30.23 0.13 2 
8562 Dd 25.16 0.36 2 20.06 0.17 2 21.82 0.12 2 28.66 0.14 2 29.27 0.23 2 
9013 Dd 25.69 0.01 2 21.33 0.14 2 22.78 0.10 2 27.93 0.02 2 28.75 0.30 2 
10622 Dd 24.34 0.46 2 21.66 0.20 2 21.97 0.02 2 30.02 0.22 2 30.20 0.37 2 
10629 Dd 24.43 0.64† 2 20.85 0.06 2 21.88 0.03 2 30.15 0.22 2 30.92 0.03 2 
10639 Dd 25.95 0.19 2 23.12 0.22 2 23.48 0.02 2 28.99 0.38 2 29.61 0.24 2 
8806 dd 25.44 0.04 2 20.60 0.13 2 21.87 0.10 2 28.89 0.12 2 29.47 0.10 2 
8808 dd 23.97 0.01 2 20.64 0.42 2 21.59 0.06 2 28.98 0.53† 2 29.47 0.12 2 
8996 dd 25.76 0.03 2 22.02 0.02 2 22.39 0.06 2 30.24 0.04 2 30.14 0.33 2 
9005 dd 25.46 0.02 2 20.71 0.03 2 21.22 0.08 2 29.08 0.04 2 29.73 0.21 2 
9007 dd 25.54 0.27 2 21.38 0.00 2 21.95 0.04 2 29.77 0.07 2 30.15 0.07 2 
10626 dd 23.37 0.22 2 19.27 0.10 2 20.54 0.07 2 28.35 0.02 2 29.00 0.08 2 
10630 dd 24.88 0.57† 2 21.49 0.01 2 22.16 0.24 2 30.23 0.03 2 30.52 0.21 2 
10640 dd 25.44 0.20 2 22.86 0.05 2 23.43 0.00 2 31.79 0.27 2 31.82 0.02 2 
10642 dd 24.03 0.81† 2 20.11 0.18 2 22.64 0.01 2 30.42 0.42 2 30.34 0.34 2 
11348 dd 25.53 0.55† 2 20.19 0.01 2 21.10 0.13 2 28.74 0.31 2 29.33 0.34 2 
11349 dd 27.54 0.02 2 21.88 0.01 2 22.65 0.11 2 30.36 0.27 2 30.69 0.06 2 
11353 dd 24.94 0.07 2 19.35 0.01 2 20.58 0.04 2 28.08 0.11 2 28.56 0.15 2 
11354 dd 25.05 0.06 2 19.94 0.06 2 20.95 0.06 2 26.74 0.31 2 27.70 0.14 2 
11356 dd 25.00 0.14 2 18.71 0.06 2 20.01 0.11 2 28.65 0.29 2 28.98 0.11 2 
OvoRef D/d 23.89 0.32 4 18.12 0.12 4 19.72 0.07 4 26.96 0.10 4 27.72 0.06 4 
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Table 27 Average Cq values (Cq) and associated standard deviation (SD) calculated from technical replicates (n) of 36 
ovotestis samples and the ovotestis reference sample (OvoRef) for five GOIs (Lfat1, Lfry, Lcol11a 2/1, Lmhc, Lmhc nm), 
including sample ID and genotype (Geno).C sample used as calibrator *amplification observed in negative controls †high 
SD observed between replicates. 
Ovo, GOI 6-10 Lfat1 Lfry Lcoll11 2a* Lmhc Lmhc nm 
ID Geno Cq SD n Cq SD n Cq SD n Cq SD n Cq SD n 
8515 DD 20.96 0.04 2 25.82 0.09 2 24.04 0.21 2 19.98 0.01 2 16.96 0.01 2 
8548C DD 22.45 0.19 2 27.27 0.12 2 25.19 0.18 2 21.06 0.29 2 17.76 0.18 2 
8582 DD 22.16 0.05 2 26.54 0.00 2 23.90 0.01 2 20.00 0.07 2 17.55 0.09 2 
8583 DD 21.60 0.07 2 25.83 0.14 2 22.60 0.03 2 20.72 0.20 2 17.25 0.13 2 
9014 DD 23.12 0.28 2 27.69 0.22 2 25.04 0.18 2 21.88 0.03 2 18.05 0.17 2 
10627 DD 22.25 0.07 2 26.52 0.05 2 23.79 0.11 2 19.69 0.03 2 17.75 0.04 2 
10633 DD 22.43 0.19 2 26.20 0.10 2 21.65 0.02 2 18.58 0.01 2 17.11 0.13 2 
10636 DD 22.30 0.09 2 26.65 0.15 2 23.56 0.03 2 19.64 0.10 2 16.77 0.03 2 
10638 DD 23.04 0.13 2 27.25 0.07 2 24.70 0.02 2 19.72 0.06 2 18.10 0.11 2 
11347 DD 21.36 0.07 2 25.80 0.03 2 22.53 0.04 2 18.97 0.06 2 16.47 0.04 2 
11350 DD 20.49 0.09 2 24.72 0.06 2 21.88 0.09 2 20.13 0.35 2 15.72 0.14 2 
11351 DD 20.60 0.07 2 24.75 0.02 2 20.45 0.02 2 17.96 0.28 2 15.48 0.08 2 
11352 DD 22.96 0.22 2 26.54 0.03 2 22.26 0.02 2 19.78 0.01 2 17.32 0.16 2 
11357 DD 20.63 0.03 2 25.54 0.02 2 23.21 0.22 2 20.22 0.30 2 16.25 0.06 2 
8554 Dd 22.55 0.01 2 26.89 0.05 2 23.61 0.20 2 20.81 0.13 2 17.85 0.07 2 
8555 Dd 21.66 0.01 2 25.93 0.01 2 25.17 0.02 2 22.05 0.41 2 17.79 0.02 2 
8559 Dd 22.22 0.07 2 26.52 0.03 2 24.38 0.05 2 21.24 0.06 2 17.75 0.03 2 
8562 Dd 21.76 0.03 2 26.44 0.03 2 24.30 0.04 2 21.67 0.17 2 17.26 0.09 2 
9013 Dd 22.53 0.17 2 26.52 0.11 2 23.39 0.00 2 20.90 0.11 2 16.81 0.12 2 
10622 Dd 22.57 0.06 2 26.48 0.00 2 24.33 0.02 2 19.56 0.04 2 17.10 0.11 2 
10629 Dd 22.96 0.31 2 26.79 0.16 2 22.84 0.13 2 19.62 1.10† 2 16.97 0.03 2 
10639 Dd 23.26 0.02 2 27.39 0.12 2 24.89 0.03 2 19.83 0.07 2 17.76 0.15 2 
8806 dd 22.21 0.08 2 26.16 0.05 2 23.04 0.25 2 20.51 0.01 2 17.17 0.08 2 
8808 dd 21.79 0.02 2 25.75 0.05 2 22.57 0.20 2 19.63 0.10 2 16.90 0.02 2 
8996 dd 22.48 0.10 2 26.98 0.03 2 24.26 0.00 2 22.08 0.31 2 17.75 0.08 2 
9005 dd 21.70 0.08 2 26.19 0.12 2 23.79 0.15 2 21.83 0.04 2 17.29 0.00 2 
9007 dd 22.09 0.22 2 26.57 0.10 2 22.92 0.00 2 21.51 0.02 2 17.14 0.22 2 
10626 dd 20.76 0.05 2 24.91 0.05 2 21.48 0.00 2 17.80 0.01 2 14.95 0.03 2 
10630 dd 22.48 0.01 2 26.95 0.00 2 24.12 0.21 2 19.26 0.00 2 17.32 0.16 2 
10640 dd 23.65 0.06 2 28.63 0.07 2 24.82 0.12 2 19.66 0.13 2 18.78 0.05 2 
10642 dd 23.10 0.19 2 27.82 0.16 2 25.03 0.08 2 20.28 0.01 2 16.49 0.17 2 
11348 dd 22.06 0.11 2 25.94 0.03 2 22.01 0.34 2 20.29 0.13 2 16.85 0.06 2 
11349 dd 23.11 0.11 2 27.45 0.18 2 21.92 0.42 2 21.50 0.01 2 17.89 0.06 2 
11353 dd 21.10 0.10 2 25.42 0.20 2 21.73 0.05 2 21.23 0.42 2 15.78 0.16 2 
11354 dd 21.59 0.05 2 24.99 0.03 2 22.34 0.04 2 20.50 0.21 2 15.68 0.04 2 
11356 dd 20.84 0.07 2 25.05 0.01 2 23.11 0.32 2 19.34 0.05 2 15.85 0.02 2 
OvoRef D/d 19.99 0.15 4 24.27 0.03 4 20.95 0.09 4 17.49 0.37 3 14.72 0.14 4 
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Table 28 Average Cq values (Cq) and associated standard deviation (SD) calculated from technical replicates (n) of 36 
ovotestis samples and the ovotestis reference sample (OvoRef) for four GOIs (Lmyo5a, Lmyo18a, Lstau, Lunc93a), 
including sample ID and genotype (Geno).C sample used as calibrator *amplification observed in negative controls †high 
SD observed between replicates. 
Ovo, GOI 11-14 Lmyo5a Lmyo18a Lstau Lunc93a* 
ID Geno Cq SD n Cq SD n Cq SD n Cq SD n 
8515 DD 25.71 0.02 2 25.92 0.06 2 23.69 0.49 2 22.23 0.05 2 
8548C DD 26.37 0.01 2 26.39 0.15 2 23.94 0.07 2 22.50 0.20 2 
8582 DD 25.78 0.03 2 26.77 0.16 2 23.01 0.48 2 21.73 0.07 2 
8583 DD 25.51 0.02 2 25.57 0.10 2 22.03 0.12 2 20.73 0.04 2 
9014 DD 26.04 0.09 2 27.27 0.17 2 21.80 0.23 2 24.51 0.21 2 
10627 DD 25.94 0.06 2 27.27 0.01 2 22.64 0.12 2 22.87 0.11 2 
10633 DD 25.21 0.03 2 26.87 0.11 2 21.75 0.05 2 21.62 0.03 2 
10636 DD 25.65 0.26 2 26.40 0.08 2 21.33 0.00 2 21.58 0.05 2 
10638 DD 26.28 0.01 2 28.17 0.04 2 22.95 0.04 2 23.41 0.02 2 
11347 DD 25.31 0.05 2 26.22 0.02 2 22.94 0.19 2 21.51 0.18 2 
11350 DD 24.19 0.01 2 25.29 0.09 2 22.37 0.18 2 20.88 0.03 2 
11351 DD 24.08 0.10 2 25.14 0.08 2 21.91 0.39 2 21.38 0.07 2 
11352 DD 26.08 0.08 2 27.26 0.10 2 23.37 0.42 2 22.74 0.11 2 
11357 DD 24.88 0.03 2 26.18 0.06 2 23.09 0.89† 2 21.56 0.02 2 
8554 Dd 25.80 0.04 2 26.55 0.01 2 23.38 0.21 2 22.52 0.28 2 
8555 Dd 25.92 0.18 2 25.26 0.05 2 22.42 0.33 2 21.74 0.09 2 
8559 Dd 25.85 0.09 2 26.21 0.05 2 22.46 0.38 2 22.55 0.39 2 
8562 Dd 25.07 0.11 2 26.06 0.02 2 22.73 0.28 2 22.22 0.02 2 
9013 Dd 24.90 0.21 2 25.52 0.03 2 19.43 0.33 2 22.68 0.17 2 
10622 Dd 25.38 1.63† 2 27.02 0.10 2 21.77 0.20 2 22.65 0.04 2 
10629 Dd 26.24 0.14 2 26.85 0.08 2 22.60 0.01 2 22.42 0.07 2 
10639 Dd 26.08 0.05 2 27.10 0.27 2 21.32 0.22 2 24.79 0.09 2 
8806 dd 25.13 0.07 2 25.84 0.04 2 21.09 0.32 2 22.24 0.09 2 
8808 dd 25.07 0.15 2 25.57 0.11 2 21.24 0.47 2 21.68 0.03 2 
8996 dd 26.04 0.14 2 26.88 0.09 2 23.13 0.33 2 23.23 0.05 2 
9005 dd 25.73 0.01 2 26.56 0.06 2 23.05 1.09† 2 23.17 0.39 2 
9007 dd 25.29 0.02 2 26.06 0.16 2 21.01 0.10 2 22.48 0.00 2 
10626 dd 24.52 0.04 2 24.83 0.11 2 20.76 0.01 2 20.62 0.15 2 
10630 dd 26.33 0.06 2 27.80 0.08 2 22.63 0.02 2 22.55 0.04 2 
10640 dd 27.37 0.18 2 27.99 0.11 2 24.47 0.06 2 23.52 0.27 2 
10642 dd 26.35 0.16 2 27.20 0.00 2 22.41 0.05 2 23.52 0.03 2 
11348 dd 25.00 0.09 2 26.26 0.01 2 22.34 0.15 2 22.17 0.49 2 
11349 dd 26.25 0.08 2 27.55 0.03 2 24.04 0.10 2 22.47 0.17 2 
11353 dd 24.05 0.19 2 25.93 0.04 2 21.86 0.14 2 22.03 0.25 2 
11354 dd 23.26 0.39 2 25.39 0.21 2 19.36 0.11 2 23.33 0.12 2 
11356 dd 24.75 0.07 2 25.85 0.02 2 22.71 0.62† 2 21.14 0.23 2 
OvoRef D/d 24.05 0.06 4 24.55 0.11 4 20.37 0.09 4 20.05 0.21 4 
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Genotype Analysis 
All normalised relative quantity (NRQ) values within the genotype analyses are relative to an 
individual DD calibrator sample of the same tissue type. Additionally, the relative expression data is 
mostly presented and analysed using NRQ values log transformed to the base 10 (LOG NRQ). This is 
important to note when interpreting the observed log-fold changes in gene expression.  
The relative quantities (RQ) of the three endogenous control genes and the subsequent geometric 
mean RQ used to calculate the NRQ values in the embryo, foot and ovotestis tissue analyses are 
presented in Table 29, Table 30 & Table 31 respectively. A summary of the genotypic group means of 
NRQs for each GOI assessed within the three separate genotype analyses is presented in Table 32. 
No statistical analyses were performed on the non-transformed NRQ values, therefore only the 
geometric group mean is presented. 
The LOG NRQs for each of the embryo tissue samples for the seven GOIs assessed are presented in 
Table 33. The LOG NRQs for each of the foot tissue samples for the 14 GOIs assessed are presented 
in Table 34. Due to the larger number of samples included in the ovotestis experiment, the LOG 
NRQs for each of the ovotestis tissue samples for the 14 GOIs assessed are presented across three 
tables (Table 35, Table 36, Table 37). Each of these tables presents the individual sample count data 
and the genotypic group means used within the statistical analyses presented in Table 38, Table 39 
and the boxplot graphs (Figure 16 - Figure 29). Histogram plots of the ovotestis genotype analysis 
data and summary statistics of each genotype analysis are presented in the SI (S10).  
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Table 29 Relative quantity (RQ) values per embryo sample for each of the three endogenous control genes assessed 
(Lhis2a, Lube2 & Lywhaz) and resulting geometric mean (GeoMean), including sample ID (ID) and genotype (Geno). C 
sample used as calibrator. 
Embryo sample description RQ values 
ID Geno Lhis2a Lube2 Lywhaz GeoMean 
11289 DD 1.113 1.339 1.491 1.305 
11292 DD 1.376 1.887 2.083 1.755 
11293 DD 1.622 1.549 1.752 1.639 
11295C DD 1 1 1 1 
11297 DD 1.716 1.819 2.018 1.847 
11298 DD 2.082 2.061 2.683 2.258 
11358 Dd 1.894 2.484 3.018 2.422 
11359 Dd 2.639 3.538 4.388 3.447 
11360 Dd 3.168 4.213 4.972 4.048 
11361 Dd 2.706 3.854 4.090 3.494 
11363 Dd 4.055 5.896 6.528 5.384 
11282 dd 1.943 2.600 2.816 2.423 
11283 dd 0.832 0.905 1.236 0.976 
11284 dd 1.754 2.222 2.531 2.145 
11287 dd 1.046 1.146 1.172 1.120 
11301 dd 0.928 0.908 1.126 0.982 
11303 dd 1.257 1.595 1.864 1.552 
 
Table 30 Relative quantity (RQ) values per foot sample for each of the three endogenous control genes assessed (Lhis2a, 
Lube2 & Lywhaz) and resulting geometric mean (GeoMean), including sample ID (ID) and genotype (Geno). C sample 
used as calibrator. 
Foot sample description RQ values 
ID Geno Lhis2a Lube2 Lywhaz GeoMean 
11347 DD 0.062 0.066 0.098 0.074 
11350C DD 1 1 1 1 
11351 DD 0.234 0.186 0.257 0.223 
11352 DD 0.620 0.528 0.629 0.590 
11357 DD 0.958 0.875 0.815 0.881 
11348 dd 0.255 0.352 0.368 0.321 
11349 dd 0.376 0.411 0.356 0.381 
11353 dd 0.246 0.341 0.328 0.302 
11354 dd 0.506 0.749 0.628 0.620 
11356 dd 0.278 0.281 0.334 0.297 
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Table 31 Relative quantity (RQ) values per ovotestis sample for each of the three endogenous control genes assessed 
(Lhis2a, Lube2 & Lrpl14) and resulting geometric mean (GeoMean), including sample ID (ID) and genotype (Geno). C 
sample used as calibrator. 
Ovotestis sample description RQ values 
ID Geno Lhis2a Lube2 Lrpl14 GeoMean 
8515 DD 0.999 3.036 2.094 1.852 
8548C DD 1 1 1 1 
8582 DD 0.585 1.754 1.352 1.115 
8583 DD 1.085 2.742 1.591 1.679 
9014 DD 0.606 1.238 1.272 0.985 
10627 DD 1.022 2.369 2.909 1.917 
10633 DD 1.182 3.375 6.068 2.893 
10636 DD 1.501 2.928 5.604 2.910 
10638 DD 0.611 1.628 3.139 1.462 
11347 DD 1.721 4.981 1.668 2.427 
11350 DD 2.960 8.765 3.632 4.550 
11351 DD 5.835 9.663 4.154 6.164 
11352 DD 1.005 2.458 1.417 1.518 
11357 DD 2.382 6.786 3.345 3.781 
8554 Dd 0.643 1.208 1.514 1.056 
8555 Dd 0.958 2.645 1.854 1.674 
8559 Dd 0.668 2.840 2.370 1.651 
8562 Dd 2.498 2.313 2.607 2.470 
9013 Dd 2.215 3.134 1.998 2.403 
10622 Dd 0.831 2.958 2.618 1.860 
10629 Dd 0.857 2.183 3.212 1.818 
10639 Dd 0.869 2.106 3.411 1.841 
8806 dd 1.703 2.749 2.009 2.111 
8808 dd 2.156 3.203 3.377 2.857 
8996 dd 0.543 1.305 1.835 1.092 
9005 dd 1.481 3.153 1.892 2.067 
9007 dd 1.148 2.584 1.865 1.769 
10626 dd 3.537 8.435 9.314 6.526 
10630 dd 0.941 2.791 4.106 2.210 
10640 dd 0.327 0.962 2.014 0.859 
10642 dd 1.819 1.686 3.001 2.096 
11348 dd 1.615 4.222 1.820 2.315 
11349 dd 0.545 1.018 0.786 0.758 
11353 dd 2.138 7.033 1.849 3.029 
11354 dd 4.862 8.820 3.065 5.084 
11356 dd 2.631 9.122 2.711 4.022 
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Table 32 Normalised relative quantities (NRQ) of each GOI, presented as a geometric mean per genotypic group (Geno) within the genotype analysis for each tissue, including number of 
samples within each group (n).  
Genotype Analysis NRQ 
Tissue Geno n 
Larp2/3 
1a 
Larp2/3 
3 
Ldia1 
3' UTR 
Ldia2 
3' UTR 
Ldia2 
ORF 
Lfat1 Lfry Lcol11 2a Lmhc Lmhcnm Lmyo5a Lmyo18a Lstau Lunc93a 
Embryo 
DD 6 1.064 0.878 1.019 0.984 1.002 0.906 0.976 x x x x x x x 
Dd 5 1.127 0.645 0.987 0.554 0.477 0.953 0.960 x x x x x x x 
dd 6 0.985 0.843 1.132 0.006 0.029 0.999 0.937 x x x x x x x 
 
Foot 
DD 5 1.508 0.943 1.010 1.755 1.626 1.477 1.474 2.407 1.411 1.249 2.022 1.498 1.766 3.515 
dd 5 1.837 0.993 0.983 2.025 2.317 1.798 1.535 4.507 1.998 1.131 2.490 2.189 2.069 5.220 
 
Ovotestis 
DD 14 1.005 0.814 1.186 1.288 0.956 0.674 0.924 1.697 1.013 0.765 0.849 0.451 1.148 0.631 
Dd 8 1.092 0.617 1.000 1.031 0.773 0.561 0.841 1.107 0.698 0.699 0.894 0.584 2.027 0.487 
dd 14 0.970 0.714 1.206 0.797 0.656 0.571 0.811 1.731 0.694 0.820 0.878 0.447 1.499 0.471 
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Table 33 Log-transformed normalised relative quantities (LOG NRQ) per embryo sample for each of the 7 GOIs assessed and resulting arithmetic mean LOG NRQ (M) and standard error of 
the mean (SEM) per group according to genotype (Geno), including number of individuals within each group (n). C sample used as calibrator. 
Embryo Genotype Analysis Larp2/3 1a Larp2/3 3 Ldia1 3'UTR Ldia2 3’ UTR Ldia2 ORF Lfat1 Lfry 
ID Geno n 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
11289 
DD 6 
0.00 
0.03 0.01 
-0.04 
-0.06 0.02 
-0.05 
0.01 0.03 
-0.02 
-0.01 0.02 
-0.01 
0.00 0.02 
-0.15 
-0.04 0.02 
0.02 
-0.01 0.02 
11292 0.06 -0.03 0.15 0.07 0.07 0.01 0.03 
11293 0.03 -0.07 -0.04 -0.09 -0.06 -0.03 -0.07 
  11295C 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
11297 0.00 -0.12 0.02 -0.01 -0.05 -0.02 -0.03 
11298 0.07 -0.09 -0.03 0.00 0.07 -0.06 -0.02 
11358 
Dd 5 
0.10 
0.05 0.02 
-0.10 
-0.19 0.03 
-0.09 
-0.01 0.03 
-0.36 
-0.26 0.03 
-0.38 
-0.32 0.03 
-0.08 
-0.02 0.02 
-0.09 
-0.02 0.02 
11359 0.11 -0.15 0.02 -0.21 -0.20 -0.04 -0.01 
11360 0.04 -0.24 -0.02 -0.26 -0.37 -0.01 -0.01 
11361 0.02 -0.20 0.00 -0.22 -0.35 -0.02 0.03 
11363 0.00 -0.26 0.06 -0.24 -0.30 0.04 -0.01 
11282 
dd 6 
0.01 
-0.01 0.01 
-0.01 
-0.07 0.02 
0.09 
0.05 0.03 
-2.00 
-2.20 0.15 
-1.55 
-1.54 0.07 
-0.06 
0.00 0.02 
-0.08 
-0.03 0.01 
11283 -0.02 -0.02 0.01 -2.79 -1.33 0.02 -0.01 
11284 -0.02 -0.11 0.13 -1.87 -1.49 0.00 -0.02 
11287 -0.02 -0.11 0.11 -2.04 -1.38 0.07 0.00 
11301 0.02 -0.09 -0.08 -2.49 -1.74 -0.02 -0.05 
11303 -0.01 -0.12 0.06 -2.00 -1.75 -0.02 -0.02 
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Table 34 Log-transformed normalised relative quantities (LOG NRQ) per foot sample for each of the 14 GOIs assessed and resulting arithmetic mean LOG NRQ (M) and standard error of 
the mean (SEM) per group according to genotype (Geno), including number of individuals within each group (n). C sample used as calibrator. 
Foot, GOI 1-7 Larp2/3 1a Larp2/3 3a Ldia1 3’ UTR Ldia2 3’ UTR Ldia2 ORF Lfat1 Lfry 
ID Geno n 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
11347 
DD 5 
0.36 
0.18 0.06 
-0.02 
-0.03 0.01 
0.07 
0.00 0.03 
0.63 
0.24 0.11 
0.63 
0.21 0.11 
0.43 
0.17 0.09 
0.45 
0.17 0.09 
 11350C 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
11351 0.28 -0.03 0.09 0.31 0.29 0.31 0.31 
11352 0.11 0.00 -0.09 0.07 0.05 -0.01 -0.01 
11357 0.14 -0.07 -0.05 0.21 0.09 0.12 0.09 
11348 
dd 5 
0.32 
0.26 0.03 
-0.01 
0.00 0.01 
0.07 
-0.01 0.02 
0.26 
0.31 0.05 
0.38 
0.36 0.06 
0.33 
0.25 0.04 
0.16 
0.19 0.04 
11349 0.21 0.02 -0.04 0.22 0.21 0.12 0.07 
11353 0.32 0.01 0.02 0.42 0.50 0.32 0.23 
11354 0.16 -0.01 -0.05 0.22 0.25 0.22 0.17 
11356 0.31 -0.02 -0.03 0.41 0.49 0.28 0.30 
Foot, GOI 8-14 Lcol11 2a Lmhc Lmhc nm Lmyo5a Lmyo18a Lstau Lunc93a 
ID Geno n 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
11347 
DD 5 
0.68 
0.38 0.14 
0.39 
0.15 0.09 
0.32 
0.10 0.10 
0.73 
0.31 0.14 
0.52 
0.18 0.13 
0.62 
0.25 0.12 
1.23 
0.55 0.21 
11350C 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
11351 0.69 0.35 0.33 0.57 0.32 0.46 0.74 
11352 0.20 0.01 0.00 0.09 -0.21 0.06 0.35 
11357 0.33 0.00 -0.17 0.14 0.25 0.10 0.40 
11348 
dd 5 
0.76 
0.65 0.06 
0.41 
0.30 0.08 
0.19 
0.05 0.06 
0.42 
0.40 0.08 
0.47 
0.34 0.06 
0.40 
0.32 0.06 
0.87 
0.72 0.09 
11349 0.71 0.46 0.04 0.13 0.19 0.22 0.69 
11353 0.79 0.34 0.14 0.58 0.29 0.43 0.86 
11354 0.50 0.03 -0.17 0.33 0.24 0.11 0.36 
11356 0.52 0.27 0.07 0.53 0.51 0.42 0.81 
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Table 35 Log-transformed normalised relative quantities (LOG NRQ) per ovotestis sample for five GOIs (Larp2/3 1a, 
Larp2/3 3, Ldia1 3’ UTR, Ldia2 3’ UTR, Ldia2 ORF) assessed and resulting arithmetic mean LOG NRQ (M) and standard 
error of the mean (SEM) per group according to genotype (Geno), including number of individuals within each group (n). 
C sample used as calibrator. 
Ovo, GOI 1-5 Larp2/3 1a Larp2/3 3a Ldia1 3’ UTR Ldia2 3’ UTR Ldia2 ORF 
ID Geno n 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
8515 
DD 14 
0.11 
0.00 0.04 
0.02 
-0.09 0.04 
0.25 
0.07 0.03 
0.16 
0.11 0.05 
0.02 
-0.02 0.04 
 8548C 0.00 0.00 0.00 0.00 0.00 
8582 0.14 -0.02 0.18 0.24 0.13 
8583 0.03 -0.03 0.22 0.01 0.08 
9014 -0.03 -0.23 -0.02 0.38 0.11 
10627 0.12 -0.31 -0.05 -0.01 -0.06 
10633 0.25 -0.26 -0.02 -0.30 -0.36 
10636 0.02 -0.30 -0.10 0.17 0.00 
10638 0.14 -0.26 -0.01 0.04 -0.06 
11347 -0.07 0.12 0.20 0.15 -0.06 
11350 -0.19 0.06 0.10 0.13 -0.04 
11351 -0.19 -0.09 0.09 0.10 -0.15 
11352 -0.09 0.01 0.14 0.38 0.22 
11357 -0.21 0.03 0.06 0.10 -0.11 
8554 
Dd 8 
0.07 
0.04 0.06 
-0.01 
-0.21 0.08 
0.09 
0.00 0.08 
0.14 
0.01 0.06 
0.14 
-0.11 0.07 
8555 0.03 -0.07 0.22 0.10 0.00 
8559 0.08 -0.09 0.23 -0.02 -0.21 
8562 -0.07 -0.04 -0.02 0.04 -0.10 
9013 -0.19 -0.35 -0.29 0.25 0.06 
10622 0.28 -0.32 0.06 -0.22 -0.25 
10629 0.26 -0.11 0.10 -0.25 -0.45 
10639 -0.15 -0.68 -0.38 0.07 -0.08 
8806 
dd 14 
-0.07 
-0.01 0.05 
-0.11 
-0.15 0.04 
0.04 
0.08 0.04 
0.04 
-0.10 0.05 
-0.09 
-0.18 0.04 
8808 0.19 -0.25 -0.01 -0.12 -0.23 
8996 0.13 -0.18 0.17 -0.05 0.00 
9005 -0.07 -0.13 0.24 -0.01 -0.16 
9007 -0.02 -0.23 0.09 -0.13 -0.21 
10626 -0.01 -0.27 -0.06 -0.30 -0.45 
10630 0.06 -0.35 -0.07 -0.36 -0.42 
10640 0.32 -0.29 -0.04 -0.39 -0.38 
10642 0.31 0.01 -0.19 -0.39 -0.34 
11348 -0.14 -0.05 0.22 0.04 -0.09 
11349 -0.19 0.01 0.25 0.07 0.00 
11353 -0.10 0.04 0.26 0.11 0.01 
11354 -0.35 -0.33 -0.07 0.26 0.04 
11356 -0.24 0.08 0.31 -0.17 -0.23 
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Table 36 Log-transformed normalised relative quantities (LOG NRQ) per ovotestis sample for five GOIs (Lfat1, Lfry, 
Lcol11a 2/1, Lmhc, Lmhc nm) assessed and resulting arithmetic mean LOG NRQ (M) and standard error of the mean 
(SEM) per group according to genotype (Geno), including number of individuals within each group (n). C sample used as 
calibrator. 
Ovo, GOI 6-10 Lfat1 Lfry Lcol11a 2/1 Lmhc Lmhc nm 
ID Geno n 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
8515 
DD 14 
0.13 
-0.17 0.05 
0.13 
-0.03 0.04 
0.05 
0.23 0.06 
0.03 
0.01 0.06 
-0.04 
-0.12 0.03 
8548C 0.00 0.00 0.00 0.00 0.00 
8582 0.03 0.15 0.31 0.25 0.01 
8583 0.00 0.17 0.49 -0.13 -0.08 
9014 -0.17 -0.11 0.05 -0.22 -0.08 
10627 -0.23 -0.08 0.10 0.10 -0.28 
10633 -0.46 -0.17 0.52 0.23 -0.28 
10636 -0.42 -0.29 -0.01 -0.07 -0.18 
10638 -0.32 -0.16 -0.03 0.21 -0.26 
11347 -0.10 0.02 0.35 0.19 -0.02 
11350 -0.14 0.04 0.26 -0.40 -0.08 
11351 -0.30 -0.10 0.52 0.07 -0.14 
11352 -0.32 0.02 0.63 0.17 -0.06 
11357 -0.10 -0.10 -0.03 -0.34 -0.15 
8554 
Dd 8 
-0.05 
-0.25 0.06 
0.08 
-0.08 0.05 
0.41 
0.04 0.09 
0.05 
-0.16 0.10 
-0.05 
-0.16 0.03 
8555 -0.01 0.14 -0.22 -0.50 -0.23 
8559 -0.16 -0.01 0.01 -0.27 -0.21 
8562 -0.21 -0.16 -0.14 -0.56 -0.25 
9013 -0.40 -0.17 0.12 -0.34 -0.11 
10622 -0.30 -0.05 -0.03 0.15 -0.08 
10629 -0.39 -0.13 0.39 0.14 -0.04 
10639 -0.48 -0.30 -0.18 0.08 -0.27 
8806 
dd 14 
-0.26 
-0.24 0.04 
-0.02 
-0.09 0.04 
0.27 
0.24 0.08 
-0.17 
-0.16 0.08 
-0.16 
-0.09 0.03 
8808 -0.28 -0.04 0.27 -0.06 -0.21 
8996 -0.05 0.04 0.22 -0.32 -0.04 
9005 -0.12 -0.02 0.07 -0.53 -0.18 
9007 -0.15 -0.05 0.38 -0.37 -0.07 
10626 -0.37 -0.17 0.21 0.09 -0.02 
10630 -0.35 -0.26 -0.05 0.15 -0.22 
10640 -0.25 -0.30 0.17 0.45 -0.23 
10642 -0.49 -0.47 -0.28 -0.11 0.04 
11348 -0.26 0.00 0.52 -0.15 -0.11 
11349 -0.05 0.07 1.03 0.00 0.08 
11353 -0.12 0.02 0.48 -0.53 0.08 
11354 -0.48 -0.08 0.08 -0.55 -0.12 
11356 -0.18 0.00 -0.03 -0.13 -0.06 
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Table 37 Log-transformed normalised relative quantities (LOG NRQ) per ovotestis sample for four GOIs (Lmyo5a, 
Lmyo18a, Lstau, Lunc93a) assessed and resulting arithmetic mean LOG NRQ (M) and standard error of the mean (SEM) 
per group according to genotype (Geno), including number of individuals within each group (n). C sample used as 
calibrator. 
Ovo, GOI 11-14 Lmyo5a Lmyo18a Lstau Lunc93a 
ID Geno n 
LOG  
NRQ 
M SEM 
LOG  
NRQ 
M SEM 
LOG  
NRQ 
M SEM 
LOG  
NRQ 
M SEM 
8515 
DD 14 
-0.08 
-0.07 0.03 
-0.13 
-0.35 0.06 
-0.20 
0.06 0.07 
-0.19 
-0.20 0.07 
8548 0.00 0.00 0.00 0.00 
8582 0.12 -0.15 0.22 0.18 
8583 0.02 0.01 0.33 0.30 
9014 0.10 -0.24 0.63 -0.59 
10627 -0.16 -0.53 0.10 -0.39 
10633 -0.13 -0.60 0.18 -0.20 
10636 -0.26 -0.47 0.30 -0.19 
10638 -0.14 -0.67 0.12 -0.44 
11347 -0.08 -0.34 -0.10 -0.09 
11350 -0.03 -0.35 -0.20 -0.18 
11351 -0.13 -0.44 -0.20 -0.46 
11352 -0.10 -0.43 -0.02 -0.25 
11357 -0.15 -0.52 -0.33 -0.30 
8554 
Dd 8 
0.14 
-0.05 0.04 
-0.07 
-0.23 0.07 
0.14 
0.31 0.11 
-0.03 
-0.31 0.10 
8555 -0.09 0.10 0.22 0.00 
8559 -0.07 -0.17 0.21 -0.23 
8562 -0.02 -0.30 -0.04 -0.31 
9013 0.04 -0.13 0.93 -0.43 
10622 0.02 -0.45 0.36 -0.31 
10629 -0.22 -0.39 0.13 -0.24 
10639 -0.18 -0.47 0.50 -0.94 
8806 
dd 14 
0.03 
-0.06 0.05 
-0.17 
-0.35 0.04 
0.51 
0.18 0.07 
-0.25 
-0.33 0.07 
8808 -0.08 -0.23 0.33 -0.21 
8996 0.06 -0.18 0.20 -0.25 
9005 -0.13 -0.36 -0.06 -0.51 
9007 0.06 -0.15 0.61 -0.24 
10626 -0.28 -0.38 0.11 -0.26 
10630 -0.33 -0.74 0.04 -0.36 
10640 -0.23 -0.38 -0.09 -0.24 
10642 -0.32 -0.55 0.12 -0.62 
11348 0.03 -0.33 0.10 -0.27 
11349 0.15 -0.21 0.09 0.13 
11353 0.19 -0.35 0.12 -0.34 
11354 0.19 -0.42 0.63 -0.95 
11356 -0.14 -0.45 -0.25 -0.20 
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Figure 16 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Larp2/3 1a in 
embryo, foot and ovotestis tissue, compared between genotypes DD, Dd & dd, calculated relative 
to a conspecific DD individual. 
 
Figure 17 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Larp2/3 3 in embryo, 
foot and ovotestis tissue, compared between genotypes DD, Dd & dd, calculated relative to a 
conspecific DD individual. 
 
 
Figure 18 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Lfat1 in embryo, foot 
and ovotestis tissue, compared between genotypes DD, Dd & dd, calculated relative to a 
conspecific DD individual. 
 
Figure 19 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Lfry in embryo, foot 
and ovotestis tissue, compared between genotypes DD, Dd & dd, calculated relative to a 
conspecific DD individual. 
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Figure 20 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Ldia1 3’ UTR in 
embryo, foot and ovotestis tissue, compared between genotypes DD, Dd & dd, calculated relative 
to a conspecific DD individual. 
 
Figure 21 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Ldia2 3’ UTR in 
embryo, foot and ovotestis tissue, compared between genotypes DD, Dd & dd, calculated relative 
to a conspecific DD individual. 
 
 
Figure 22 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Ldia2 ORF in 
embryo, foot and ovotestis tissue, compared between genotypes DD, Dd & dd, calculated relative 
to a conspecific DD individual. 
 
Figure 23 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Lcol11a 2/1 in foot 
and ovotestis tissue, compared between genotypes DD & dd, calculated relative to a conspecific 
DD individual. 
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Figure 24 Composite boxplot showing Log scale NRQ values 
(LOG10 NRQ) for Lmhc in foot and ovotestis tissue, compared 
between genotypes DD & dd, calculated relative to a 
conspecific DD individual. 
 
Figure 25 Composite boxplot showing Log scale NRQ values 
(LOG10 NRQ) for Lmhc nm in foot and ovotestis tissue, 
compared between genotypes DD & dd, calculated relative to 
a conspecific DD individual. 
 
Figure 26 Composite boxplot showing Log scale NRQ values 
(LOG10 NRQ) for Lmyo5a in foot and ovotestis tissue, 
compared between genotypes DD & dd, calculated relative to 
a conspecific DD individual. 
 
Figure 27 Composite boxplot showing Log scale NRQ values 
(LOG10 NRQ) for Lmyo18a in foot and ovotestis tissue, 
compared between genotypes DD & dd, calculated relative to 
a conspecific DD individual. 
 
Figure 28 Composite boxplot showing Log scale NRQ values 
(LOG10 NRQ) for Lstau in foot and ovotestis tissue, compared 
between genotypes DD & dd, calculated relative to a 
conspecific DD individual. 
 
Figure 29 Composite boxplot showing Log scale NRQ values 
(LOG10 NRQ) for Lunc93a in foot and ovotestis tissue, 
compared between genotypes DD & dd, calculated relative to 
a conspecific DD individual.  
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Table 38 Wilcoxon rank test results for pairwise comparisons between genotypes DD, Dd and dd within embryo, foot and ovotestis tissue for seven GOIs. The total number of individuals 
within each genotype analysis is quoted (n) in addition to the number of individuals within each genotypic group (n, DD; n, Dd; n, dd). The Wilcoxon rank value (W) is presented with the 
associated probability value (p). Statistical significance (sig) is highlighted via * <0.05, ** <0.01. 
Genotype Analysis GOI 1-7, Wilcox.test 
GOI Tissue n 
DD-dd DD-Dd Dd-dd 
n, DD n, dd W p sig n, DD n, Dd W p sig n, Dd n, dd W p sig 
Larp2/3 1a 
Embryo 17 6 6 30 0.065 
 
6 5 10 0.429 
 
5 6 27 0.030 * 
Foot 10 5 5 7 0.310 
 
n/a 
Ovotestis 36 14 14 106 0.735 
 
14 8 50 0.714 
 
8 14 65 0.570 
 
Larp2/3 3 
Embryo 17 6 6 23 0.485 
 
6 5 29 0.009 ** 5 6 3 0.030 * 
Foot 10 5 5 6 0.222 
 
n/a 
Ovotestis 36 14 14 117 0.401 
 
14 8 81 0.095 
 
8 14 50 0.714 
 
Ldia1 3'UTR 
Embryo 17 6 6 12 0.394 
 
6 5 15 1 
 
5 6 7 0.178 
 
Foot 10 5 5 13 1 
 
n/a 
Ovotestis 36 14 14 95 0.910 
 
14 8 61 0.764 
 
8 14 47 0.570 
 
Ldia2 3’ UTR 
Embryo 17 6 6 36 0.002 ** 6 5 30 0.004 ** 5 6 30 0.004 ** 
Foot 10 5 5 8 0.421 
 
n/a 
Ovotestis 36 14 14 155 0.008 ** 14 8 73 0.267 
 
8 14 74 0.238 
 
Ldia2 ORF 
Embryo 17 6 6 36 0.002 ** 6 5 30 0.004 ** 5 6 30 0.004 ** 
Foot 10 5 5 7 0.310 
 
n/a 
Ovotestis 36 14 14 152 0.012 * 14 8 74 0.238 
 
8 14 68 0.441 
 
Lfat1 
Embryo 17 6 6 11 0.310 
 
6 5 14 0.931 
 
5 6 12 0.662 
 
Foot 10 5 5 8 0.421 
 
n/a 
Ovotestis 36 14 14 123 0.265 
 
14 8 70 0.365 
 
8 14 53 0.868 
 
Lfry 
Embryo 17 6 6 25 0.310 
 
6 5 16 0.931 
 
5 6 19 0.537 
 
Foot 10 5 5 11 0.841 
 
n/a 
Ovotestis 36 14 14 112 0.541 
 
14 8 69 0.402 
 
8 14 56 1 
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Table 39 Wilcoxon rank test results for pairwise comparisons between genotypes DD, Dd and dd within foot and ovotestis tissue for seven GOIs. The total number of individuals within 
each genotype analysis is quoted (n) in addition to the number of individuals within each genotypic group (n, DD; n, Dd; n, dd). The Wilcoxon rank value (W) is presented with the 
associated probability value (p). Statistical significance (sig) is highlighted via * <0.05, ** <0.01. 
Genotype Analysis GOI 8-14, Wilcox.test 
GOI Tissue n 
DD-dd DD-Dd Dd-dd 
n, DD n, dd W p sig n, DD n, Dd W p sig n, Dd n, dd W p sig 
Lcoll11a 2/1 
Foot 10 5 5 4 0.095 
 
n/a 
Ovotestis 36 14 14 100 0.946 
 
14 8 81 0.095 
 
8 14 35 0.165 
 
Lmhc 
Foot 10 5 5 6 0.222 
 
n/a 
Ovotestis 36 14 14 138 0.069 
 
14 8 75 0.212 
 
8 14 58 0.920 
 
Lmhc nm 
Foot 10 5 5 13 1 
 
n/a 
Ovotestis 36 14 14 85 0.571 
 
14 8 68 0.441 
 
8 14 33 0.127 
 
Lmyo18a 
Foot 10 5 5 10 0.691 
 
n/a 
Ovotestis 36 14 14 95 0.910 
 
14 8 39 0.267 
 
8 14 73 0.267 
 
Lmyo5a 
Foot 10 5 5 10 0.691 
 
n/a 
Ovotestis 36 14 14 90 0.735 
 
14 8 47 0.570 
 
8 14 55 0.973 
 
Lstau 
Foot 10 5 5 10 0.691 
 
n/a 
Ovotestis 36 14 14 76 0.329 
 
14 8 29 0.070 
 
8 14 77 0.165 
 
Lunc93a 
Foot 10 5 5 8 0.421 
 
n/a 
Ovotestis 36 14 14 130 0.150 
 
14 8 66 0.525 
 
8 14 61 0.764 
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Diaphanous formin, Ldia2 3’ UTR 
Embryo 
The LOG NRQs recorded in the Ldia2 3’ UTR embryo experiment were found to be highly statistically 
significant between all genotype groups (all p values <0.005, Table 38). The heterozygote Dd samples 
exhibited almost exactly half the expression level seen in the DD samples (Table 32). The dd samples 
showed a dramatically reduced expression level at 0.6% of that of the DD calibrator. Alternatively 
considered the DD sample exhibited 167 times higher expression of Ldia2 3’ UTR compared to the dd 
samples (Table 32).  
Ovotestis 
The same pattern of gene expression was observed in the ovotestis tissue however to a much lesser 
extent and with increased variation (Figure 21). The only significant difference in relative gene 
expression was identified between DD and dd samples, yet it was still found to be highly significant 
with a p value of 0.007 (Table 38). The dd samples were observed to express 79.7% of the level of 
Ldia2 3’ UTR expression observed in the DD sample, or alternatively the DD sample expressed 1.25 
times higher expression of Ldia2 3’ UTR compared to the dd samples (Table 32). 
Foot  
The only comparisons possible for the foot tissue were between the homozygote genotypes. No 
significant difference was found between the genotypes. The boxplot shows the Log transformed 
relative expression of the dd group to be slightly higher than that of the DD group (Figure 21); 
however, this small scale difference is negated by the variation seen in the DD samples. 
Diaphanous formin, Ldia2 ORF 
Embryo  
The open reading frame (ORF) of the diaphanous formin showed a very similar expression pattern as 
the 3’UTR in the embryo experiment. The Log transformed relative expression levels of Ldia2 ORF in 
all genotypic groups were found to be highly significantly different (p values <0.005, Table 38). The 
largest difference again, was seen between the two homozygote sample groups, with the dd sample 
group exhibiting 2.9% of the level of expression seen in the DD sample. The level of expression in the 
heterozygote group exhibited just under half of the expression level of the homozygote DD (Table 
32, Figure 22). 
134 
 
Ovotestis 
Similarly to the Ldia2 3’ UTR experiment, the Ldia2 ORF ovotestis expression pattern revealed a less 
pronounced difference than that seen in the embryo samples (Figure 22). Again, a statistically 
significant difference in Log-transformed expression level was only observed between the 
homozygote groups (p value = 0.01, Table 38). The dd samples exhibited 65.6% of the expression 
level recorded in the DD sample (Table 32). 
Foot  
No significant difference was found between the Log-transformed relative levels of expression of 
Ldia2 ORF of homozygote genotypes in the foot tissue. Again the trend seen from the boxplot 
reveals a small increase in the average expression ratio of the dd sample group compared to the DD 
sample group, yet this is not statistically significant (Figure 22, Table 38). 
Actin related protein 2/3 subunit 1a, Larp2/3 1a 
Embryo  
In the embryo tissue, Larp2/3 1a showed an increase in expression of both the DD and the Dd 
samples compared to the dd sample group (Table 32, Figure 16). This difference was only found to 
be statistically significant between the heterozygote Dd and the dd sample groups (p value=0.030, 
Table 38) and not between the homozygote groups (p value = 0.065, Table 38). The boxplot appears 
to show the Log-transformed expression ratio of the heterozygote, Dd also to be increased 
compared to the DD group; however, this is not statistically significant (Figure 16, Table 38). 
No significant expression differentiation was found between any of the genotypes within the other 
tissues. 
Actin related protein 2/3 subunit 3, Larp2/3 3 
Embryo 
Larp2/3 3 in the embryo tissue showed a decrease in expression in the heterozygote, Dd samples 
compared to both the homozygote sample groups (Figure 17). The heterozygote samples expressed 
approximately 70% of the expression level observed in the homozygote groups (Table 32). This 
difference was found to be statistically significant between both groups, however the significance of 
the sinistral, dd, homozygote sample group (p value=0.030) was not as strong as that of the dextral, 
DD, homozygote group (p value =0.009, Table 38). 
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Ovotestis 
Although not statistically significant (p value = 0.095), the boxplot of the ovotestis tissue analysis 
also reveals a reduction in the average Log-transformed expression ratio of Larp2/3 3 of the 
heterozygote group, compared to both homozygote groups. 
Foot 
The foot analysis demonstrated no difference in relative expression between genotypic groups; 
however, the foot analysis compared only homozygote samples. 
Tissue Analysis 
The NRQ values compared in the tissue analysis are all relative to the same ovotestis reference 
sample ‘OvoRef’, which can loosely be considered to represent a heterozygote (see Methods). Again 
the relative expression data is mostly presented and analysed using NRQ values log-transformed to 
the base 10 (LOG NRQ). This is important to note when interpreting the observed log-fold changes in 
gene expression. The relative quantities of the OvoRef sample were not included in the analyses and 
so are not presented in the NRQ data tables. 
The relative quantities (RQ) of the two endogenous control genes, including the geometric mean RQ 
used to calculate the NRQ values in the embryo, foot and ovotestis tissue analyses are presented in 
Table 40 and Table 41. A summary of the genotype and tissue specific group means of NRQs for each 
of the 14 GOIs assessed included in the tissue comparison analysis is presented in Table 42. No 
statistical analyses were performed on the non-transformed NRQ values, therefore only the 
geometric group mean is presented. 
The LOG NRQs for the seven GOIs quantified in all three tissues are presented across the two tables; 
Table 43 and Table 44. The LOG NRQs for the remaining seven GOIs quantified in only the foot and 
ovotestis tissues are presented across the two tables; Table 45 and Table 46. These tables include 
the individual sample count data and the genotype-specific group means according to tissue, that 
were used within the statistical analyses (Table 47, Table 48) and the boxplot graphs (Figure 30 - 
Figure 43). Summary statistics are presented in the SI (S8). 
  
136 
 
 
Table 40 Relative quantity (RQ) values per embryo and foot sample, plus the ovotestis reference sample (OvoRef), for 
both of the endogenous control genes assessed in the tissue analysis (Lhis2a, Lube2) and resulting geometric mean 
(GeoMean), including sample ID (ID) and genotype (Geno). C sample used as calibrator. 
Sample Description RQ values 
ID Geno Tissue Lhis2a Lube2 GeoMean 
11289 DD Embryo 1.619 0.175 0.532 
11292 DD Embryo 2.001 0.247 0.703 
11293 DD Embryo 2.359 0.203 0.691 
11295 DD Embryo 1.454 0.131 0.436 
11297 DD Embryo 2.496 0.238 0.771 
11298 DD Embryo 3.028 0.270 0.904 
11358 Dd Embryo 2.755 0.325 0.946 
11359 Dd Embryo 3.837 0.463 1.333 
11360 Dd Embryo 4.606 0.551 1.593 
11361 Dd Embryo 3.935 0.504 1.408 
11363 Dd Embryo 5.896 0.771 2.132 
11282 dd Embryo 2.826 0.340 0.980 
11283 dd Embryo 1.211 0.118 0.378 
11284 dd Embryo 2.551 0.291 0.861 
11287 dd Embryo 1.520 0.150 0.477 
11301 dd Embryo 1.350 0.119 0.400 
11303 dd Embryo 1.828 0.209 0.618 
11347 DD Foot 0.054 0.025 0.036 
11350 DD Foot 0.860 0.378 0.570 
11351 DD Foot 0.201 0.070 0.119 
11352 DD Foot 0.533 0.199 0.326 
11357 DD Foot 0.824 0.331 0.522 
11348 dd Foot 0.219 0.133 0.171 
11349 dd Foot 0.323 0.155 0.224 
11353 dd Foot 0.211 0.129 0.165 
11354 dd Foot 0.435 0.283 0.351 
11356 dd Foot 0.239 0.106 0.159 
OvoRefC D/d Ovotestis 1 1 1 
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Table 41 Relative quantity (RQ) values per ovotestis sample, plus the ovotestis reference sample (OvoRef), for both of 
the endogenous control genes assessed in the tissue analysis (Lhis2a, Lube2) and resulting geometric mean (GeoMean), 
including sample ID (ID) and genotype (Geno). C sample used as calibrator. 
Sample Description RQ values 
ID Geno Tissue Lhis2a Lube2 GeoMean 
8515 DD Ovotestis 0.175 0.251 0.210 
8548 DD Ovotestis 0.175 0.083 0.120 
8582 DD Ovotestis 0.102 0.145 0.122 
8583 DD Ovotestis 0.190 0.227 0.208 
9014 DD Ovotestis 0.106 0.102 0.104 
10627 DD Ovotestis 0.179 0.196 0.187 
10633 DD Ovotestis 0.207 0.279 0.240 
10636 DD Ovotestis 0.263 0.242 0.252 
10638 DD Ovotestis 0.107 0.135 0.120 
11347 DD Ovotestis 0.301 0.412 0.352 
11350 DD Ovotestis 0.518 0.725 0.613 
11351 DD Ovotestis 1.021 0.800 0.904 
11352 DD Ovotestis 0.176 0.203 0.189 
11357 DD Ovotestis 0.417 0.562 0.484 
8554 Dd Ovotestis 0.113 0.100 0.106 
8555 Dd Ovotestis 0.168 0.219 0.192 
8559 Dd Ovotestis 0.117 0.235 0.166 
8562 Dd Ovotestis 0.437 0.191 0.289 
9013 Dd Ovotestis 0.388 0.259 0.317 
10622 Dd Ovotestis 0.145 0.245 0.189 
10629 Dd Ovotestis 0.150 0.181 0.165 
10639 Dd Ovotestis 0.152 0.174 0.163 
8806 dd Ovotestis 0.298 0.228 0.260 
8808 dd Ovotestis 0.377 0.265 0.316 
8996 dd Ovotestis 0.095 0.108 0.101 
9005 dd Ovotestis 0.259 0.261 0.260 
9007 dd Ovotestis 0.201 0.214 0.207 
10626 dd Ovotestis 0.619 0.698 0.657 
10630 dd Ovotestis 0.165 0.231 0.195 
10640 dd Ovotestis 0.057 0.080 0.067 
10642 dd Ovotestis 0.318 0.140 0.211 
11348 dd Ovotestis 0.283 0.349 0.314 
11349 dd Ovotestis 0.095 0.084 0.090 
11353 dd Ovotestis 0.374 0.582 0.467 
11354 dd Ovotestis 0.851 0.730 0.788 
11356 dd Ovotestis 0.460 0.755 0.590 
OvoRef D/d Ovotestis 1 1 1 
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Table 42 Normalised relative quantities (NRQ) of each GOI, presented as a geometric mean per genotypic group (Geno) and tissue within the tissue analysis, including number of samples 
within each group (n). Each value is relative to the ovotestis reference sample, ‘OvoRef’. 
Tissue Analysis NRQ 
Tissue Geno n 
Larp2/3  
1a 
Larp2/3  
3 
Ldia1  
3' UTR 
Ldia2  
3' UTR 
Ldia2  
ORF 
Lfat1 Lfry Lcol11 2a Lmhc Lmhc nm Lmyo5a Lmyo18a Lstau Lunc93a 
Embryo DD 6 0.069 0.224 0.103 2.835 1.973 0.140 0.336 x x x x x x x 
Embryo Dd 5 0.077 0.175 0.105 1.676 0.988 0.154 0.348 x x x x x x x 
Embryo dd 6 0.065 0.219 0.118 0.019 0.058 0.158 0.330 x x x x x x x 
Foot DD 5 0.652 0.656 0.910 1.012 0.708 1.062 0.880 3.681 5.056 0.956 2.147 1.045 0.930 0.130 
Foot dd 5 0.784 0.682 0.875 1.153 0.997 1.277 0.905 6.809 7.072 0.855 2.611 1.508 1.077 0.190 
Ovotestis DD 14 1.935 1.068 1.049 1.418 1.553 1.339 1.239 1.011 0.926 0.933 1.612 1.215 0.931 1.059 
Ovotestis Dd 8 2.256 0.869 0.950 1.218 1.348 1.196 1.210 0.708 0.684 0.915 1.821 1.687 1.765 0.878 
Ovotestis dd 14 1.820 0.914 1.040 0.855 1.039 1.105 1.060 1.005 0.618 0.975 1.624 1.174 1.185 0.770 
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Table 43 Log-transformed normalised relative quantities (LOG NRQ) for each sample included within the tissue analysis 
of the four GOIs: Larp2/3 1a, Larp2/3 3, Lfat1 & Lfry, with resulting arithmetic mean LOG NRQ (M) and standard error of 
the mean (SEM) per group according to genotype (Geno) within the specific tissue. Also presented is the number of 
individuals within each group (n). The calibrator sample ‘OvoRef’ was not included in analyses. 
Sample and group description Larp2/3 1a Larp2/3 3 Lfat1 Lfry 
ID Geno Tissue n 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
LOG 
NRQ 
M SEM 
11289 
DD 
Embryo 6 
-1.19 
-1.16 0.02 
-0.62 
-0.65 0.02 
-0.96 
-0.85 0.02 
-0.43 
-0.47 0.02 
11292 -1.11 -0.61 -0.79 -0.42 
11293 -1.16 -0.68 -0.85 -0.55 
11295 -1.21 -0.62 -0.84 -0.49 
11297 -1.19 -0.71 -0.83 -0.50 
11298 -1.11 -0.66 -0.86 -0.46 
11347 
Foot 5 
0.04 
-0.19 0.08 
-0.13 
-0.18 0.02 
0.33 
0.03 0.10 
0.27 
-0.06 0.10 
11350 -0.38 -0.18 -0.16 -0.24 
11351 -0.07 -0.18 0.18 0.10 
11352 -0.26 -0.17 -0.16 -0.24 
11357 -0.26 -0.26 -0.06 -0.17 
10627 
Ovotestis 14 
0.47 
0.29 0.06 
-0.13 
0.03 0.02 
0.13 
0.13 0.04 
0.11 
0.09 0.03 
10633 0.66 -0.01 -0.03 0.09 
10636 0.42 -0.07 -0.01 -0.05 
10638 0.56 -0.01 0.11 0.11 
8515 0.40 0.13 0.42 0.26 
8548 0.25 0.09 0.27 0.10 
8582 0.44 0.11 0.34 0.29 
8583 0.28 0.04 0.26 0.25 
9014 0.28 -0.09 0.15 0.05 
11347 0.11 0.13 0.09 0.03 
11350 0.01 0.10 0.08 0.09 
11351 -0.02 -0.09 -0.12 -0.09 
11352 0.15 0.08 -0.06 0.10 
11357 0.02 0.09 0.14 -0.03 
11358 
Dd 
Embryo 5 
-1.06 
-1.12 0.02 
-0.67 
-0.76 0.03 
-0.87 
-0.81 0.02 
-0.53 
-0.46 0.02 
11359 -1.05 -0.70 -0.82 -0.44 
11360 -1.13 -0.81 -0.80 -0.45 
11361 -1.16 -0.78 -0.82 -0.42 
11363 -1.17 -0.83 -0.76 -0.45 
10622 
Ovotestis 8 
0.60 
0.35 0.07 
-0.16 
-0.06 0.08 
0.04 
0.08 0.06 
0.12 
0.08 0.05 
10629 0.64 0.10 0.00 0.09 
10639 0.24 -0.46 -0.08 -0.07 
8554 0.41 0.16 0.30 0.26 
8555 0.30 0.04 0.28 0.26 
8559 0.41 0.08 0.19 0.17 
8562 0.20 0.06 0.07 -0.05 
9013 0.02 -0.30 -0.17 -0.12 
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11282 
dd 
Embryo 6 
-1.16 
-1.18 0.01 
-0.58 
-0.66 0.02 
-0.86 
-0.80 0.02 
-0.53 
-0.48 0.01 
11283 -1.18 -0.59 -0.76 -0.44 
11284 -1.20 -0.69 -0.80 -0.47 
11287 -1.23 -0.72 -0.75 -0.48 
11301 -1.16 -0.68 -0.83 -0.50 
11303 -1.18 -0.70 -0.81 -0.47 
11348 
Foot 5 
-0.04 
-0.11 0.04 
-0.16 
-0.17 0.01 
0.20 
0.11 0.05 
-0.06 
-0.04 0.05 
11349 -0.18 -0.17 -0.05 -0.19 
11353 -0.05 -0.14 0.18 0.01 
11354 -0.22 -0.19 0.07 -0.07 
11356 -0.04 -0.17 0.14 0.09 
11348 
Ovotestis 14 
0.07 
0.26 0.07 
-0.01 
-0.04 0.03 
-0.04 
0.04 0.04 
0.05 
0.03 0.03 
11349 0.08 0.11 0.22 0.18 
11353 0.05 0.02 0.04 0.02 
11354 -0.20 -0.35 -0.32 -0.09 
11356 -0.07 0.08 0.00 0.02 
10626 0.32 -0.10 -0.02 0.01 
10630 0.45 -0.13 0.05 -0.02 
10640 0.76 -0.01 0.20 -0.02 
10642 0.64 0.18 -0.15 -0.30 
8806 0.17 -0.04 0.00 0.07 
8808 0.48 -0.13 0.02 0.09 
8996 0.50 0.02 0.33 0.25 
9005 0.17 -0.06 0.13 0.06 
9007 0.24 -0.13 0.13 0.05 
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Table 44 Log-transformed normalised relative quantities (LOG NRQ) for each sample included within the tissue analysis 
of the three GOIs: Ldia1 3’ UTR, Ldia2 3’ UTR & Ldia2 ORF, with resulting arithmetic mean LOG NRQ (M) and standard 
error of the mean (SEM) per group according to genotype (Geno)within the specific tissue. Also presented is the number 
of individuals within each group (n). The calibrator sample ‘OvoRef’ was not included in analyses. 
Sample and group description Ldia1 3'UTR Ldia2 3’ UTR Ldia2 ORF 
ID Geno Tissue n LOGNRQ M SEM LOGNRQ M SEM LOGNRQ M SEM 
11289 
DD 
Embryo 6 
-1.04 
-0.99 0.03 
0.45 
0.45 0.02 
0.29 
0.30 0.03 
11292 -0.83 0.55 0.38 
11293 -1.04 0.36 0.22 
11295 -1.02 0.44 0.27 
11297 -0.97 0.45 0.24 
11298 -1.01 0.48 0.37 
11347 
Foot 5 
0.06 
-0.04 0.04 
0.44 
0.01 0.12 
0.31 
-0.15 0.13 
11350 -0.06 -0.26 -0.38 
11351 0.06 0.08 -0.06 
11352 -0.14 -0.17 -0.32 
11357 -0.13 -0.06 -0.30 
10627 
Ovotestis 14 
-0.04 
0.02 0.02 
0.09 
0.15 0.04 
0.22 
0.19 0.04 
10633 0.06 -0.13 -0.02 
10636 -0.04 0.32 0.32 
10638 0.07 0.22 0.29 
8515 0.19 0.19 0.23 
8548 -0.08 0.01 0.18 
8582 0.14 0.29 0.35 
8583 0.13 0.01 0.25 
9014 -0.05 0.45 0.35 
11347 0.03 0.08 0.04 
11350 -0.03 0.09 0.10 
11351 -0.08 0.02 -0.05 
11352 0.04 0.38 0.38 
11357 -0.05 0.09 0.04 
11358 
Dd 
Embryo 5 
-1.06 
-0.98 0.03 
0.13 
0.22 0.03 
-0.06 
-0.01 0.04 
11359 -0.94 0.28 0.13 
11360 -0.99 0.22 -0.06 
11361 -0.98 0.26 -0.05 
11363 -0.91 0.23 0.01 
10622 
Ovotestis 8 
0.05 
-0.02 0.08 
-0.14 
0.09 0.05 
0.00 
0.13 0.06 
10629 0.14 -0.12 -0.14 
10639 -0.33 0.22 0.24 
8554 0.09 0.23 0.40 
8555 0.16 0.14 0.20 
8559 0.22 0.07 0.05 
8562 -0.09 0.06 0.09 
9013 -0.41 0.23 0.20 
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11282 
dd 
Embryo 6 
-0.89 
-0.93 0.03 
-1.53 
-1.73 0.14 
-1.25 
-1.23 0.07 
11283 -0.95 -2.30 -1.00 
11284 -0.85 -1.40 -1.18 
11287 -0.90 -1.60 -1.10 
11301 -1.06 -2.02 -1.44 
11303 -0.92 -1.53 -1.44 
11348 
Foot 5 
0.04 
-0.06 0.03 
0.04 
0.06 0.05 
0.03 
0.00 0.07 
11349 -0.12 -0.06 -0.18 
11353 -0.03 0.18 0.14 
11354 -0.11 -0.03 -0.13 
11356 -0.07 0.18 0.13 
11348 
Ovotestis 14 
0.09 
0.02 0.04 
0.00 
-0.07 0.04 
0.04 
0.02 0.03 
11349 0.17 0.09 0.19 
11353 0.07 0.01 0.09 
11354 -0.26 0.17 0.11 
11356 0.14 -0.25 -0.14 
10626 -0.06 -0.21 -0.19 
10630 -0.02 -0.21 -0.10 
10640 0.06 -0.19 -0.02 
10642 -0.20 -0.30 -0.08 
8806 -0.06 0.04 0.08 
8808 -0.06 -0.07 -0.01 
8996 0.20 0.07 0.29 
9005 0.14 -0.01 0.00 
9007 0.02 -0.11 -0.02 
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Table 45 Log-transformed normalised relative quantities (LOG NRQ) for each sample included within the tissue analysis 
of the three GOIs: Lcol11a 2/1, Lmhc & Lmhc nm, with resulting arithmetic mean LOG NRQ (M) and standard error of the 
mean (SEM) per group according to genotype (Geno)within the specific tissue. Also presented is the number of 
individuals within each group (n). The calibrator sample ‘OvoRef’ was not included in analyses. 
Sample and group description Lcol11a Lmhc Lmhc nm 
ID Geno Tissue n LOG NRQ M SEM LOG NRQ M SEM M Mean SEM 
11347 
DD 
Foot 10 
0.91 
0.57 0.15 
0.99 
0.70 0.10 
0.25 
-0.02 0.11 
11350 0.17 0.54 -0.13 
11351 0.89 0.92 0.23 
11352 0.38 0.56 -0.12 
11357 0.48 0.52 -0.32 
10627 
Ovotestis 14 
-0.06 
0.00 0.06 
0.12 
-0.03 0.07 
-0.13 
-0.03 0.02 
10633 0.42 0.32 -0.06 
10636 -0.12 0.00 0.02 
10638 -0.12 0.30 -0.04 
8515 -0.18 -0.01 0.04 
8548 -0.25 -0.07 0.06 
8582 0.10 0.22 0.11 
8583 0.23 -0.21 -0.04 
9014 -0.15 -0.23 0.04 
11347 0.01 0.04 -0.04 
11350 -0.04 -0.52 -0.07 
11351 0.18 -0.09 -0.17 
11352 0.36 0.09 -0.02 
11357 -0.31 -0.44 -0.12 
11348 
dd 
Foot 10 
0.95 
0.83 0.06 
0.98 
0.85 0.08 
0.08 
-0.07 0.07 
11349 0.86 0.98 -0.10 
11353 0.97 0.89 0.02 
11354 0.67 0.57 -0.30 
11356 0.71 0.83 -0.04 
11348 
Ovotestis 14 
0.21 
0.00 0.08 
-0.27 
-0.21 0.10 
-0.10 
-0.01 0.03 
11349 0.78 -0.06 0.15 
11353 0.11 -0.70 0.03 
11354 -0.28 -0.73 -0.17 
11356 -0.37 -0.28 -0.09 
10626 0.03 0.10 0.12 
10630 -0.17 0.22 -0.03 
10640 0.10 0.57 0.02 
10642 -0.45 -0.10 0.17 
8806 0.00 -0.25 -0.11 
8808 0.05 -0.09 -0.12 
8996 0.08 -0.28 0.13 
9005 -0.20 -0.62 -0.15 
9007 0.14 -0.43 0.00 
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Table 46 Log-transformed normalised relative quantities (LOG NRQ) for each sample included within the tissue analysis 
of the four GOIs: Lmyo5a, Lmyo18a, Lstau & Lunc93, with resulting arithmetic mean LOG NRQ (M) and standard error of 
the mean (SEM) per group according to genotype (Geno)within the specific tissue. Also presented is the number of 
individuals within each group (n). The calibrator sample ‘OvoRef’ was not included in analyses. 
Sample and group description Lmyo5a Lmyo18a Lstau Lunc93a 
ID Geno Tissue n 
LOG  
NRQ 
M SEM 
LOG  
NRQ 
M SEM 
LOG  
NRQ 
M SEM 
LOG  
NRQ 
M SEM 
11347 
DD 
Foot 10 
0.80 
0.33 0.16 
0.41 
0.02 0.14 
0.39 
-0.03 0.13 
-0.15 
-0.89 0.22 
11350 0.01 -0.17 -0.30 -1.45 
11351 0.61 0.18 0.19 -0.68 
11352 0.11 -0.37 -0.22 -1.09 
11357 0.13 0.05 -0.22 -1.06 
10627 
Ovotestis 14 
0.18 
0.21 0.03 
-0.04 
0.08 0.05 
0.07 
-0.03 0.08 
-0.11 
0.03 0.06 
10633 0.28 -0.03 0.22 0.15 
10636 0.13 0.08 0.32 0.15 
10638 0.28 -0.10 0.17 -0.07 
8515 0.20 0.29 -0.29 0.03 
8548 0.25 0.40 -0.12 0.20 
8582 0.41 0.29 0.14 0.42 
8583 0.26 0.39 0.20 0.48 
9014 0.41 0.22 0.57 -0.34 
11347 0.09 -0.02 -0.30 0.02 
11350 0.17 0.00 -0.37 -0.03 
11351 0.03 -0.12 -0.40 -0.35 
11352 0.13 -0.04 -0.15 -0.07 
11357 0.08 -0.14 -0.48 -0.13 
11348 
dd 
Foot 10 
0.45 
0.42 0.09 
0.32 
0.18 0.07 
0.13 
0.03 0.07 
-0.55 
-0.72 0.10 
11349 0.13 0.00 -0.09 -0.78 
11353 0.61 0.14 0.15 -0.57 
11354 0.34 0.07 -0.19 -1.08 
11356 0.56 0.37 0.15 -0.62 
11348 
Ovotestis 14 
0.23 
0.21 0.04 
0.02 
0.07 0.05 
-0.07 
0.07 0.07 
-0.13 
-0.11 0.08 
11349 0.41 0.20 -0.02 0.33 
11353 0.33 -0.06 -0.10 -0.25 
11354 0.33 -0.13 0.40 -0.87 
11356 0.03 -0.14 -0.45 -0.09 
10626 0.04 0.10 0.07 0.01 
10630 0.05 -0.21 0.05 -0.03 
10640 0.21 0.20 -0.02 0.15 
10642 0.01 -0.07 0.08 -0.35 
8806 0.27 0.22 0.38 -0.06 
8808 0.20 0.21 0.25 0.02 
8996 0.42 0.34 0.19 0.05 
9005 0.10 0.02 -0.20 -0.34 
9007 0.32 0.26 0.50 -0.03 
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Figure 30 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Larp2/3 1a in 
genotypes DD, Dd & dd, compared between embryo, foot and ovotestis tissue, calculated relative 
to the OvoRef calibrator sample. 
 
Figure 31 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Larp2/3 3 in 
genotypes DD, Dd & dd, compared between embryo, foot and ovotestis tissue, calculated relative 
to the OvoRef calibrator sample. 
 
 
Figure 32 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Lfat1 in genotypes 
DD, Dd & dd, compared between embryo, foot and ovotestis tissue, calculated relative to the 
OvoRef calibrator sample. 
 
Figure 33 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Lfry in genotypes 
DD, Dd & dd, compared between embryo, foot and ovotestis tissue, calculated relative to the 
OvoRef calibrator sample. 
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Figure 34 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Ldia1 3’ UTR in 
genotypes DD, Dd & dd, compared between embryo, foot and ovotestis tissue, calculated relative 
to the OvoRef calibrator sample. 
 
Figure 35 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Ldia2 3’ UTR in 
genotypes DD, Dd & dd, compared between embryo, foot and ovotestis tissue, calculated relative 
to the OvoRef calibrator sample. 
 
 
Figure 36 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Ldia2 ORF in 
genotypes DD, Dd & dd, compared between embryo, foot and ovotestis tissue, calculated relative 
to the OvoRef calibrator sample. 
 
Figure 37 Composite boxplot showing Log scale NRQ values (LOG10 NRQ) for Lcol11a 2/1 in 
genotypes DD & dd, compared between foot and ovotestis tissue, calculated relative to the 
OvoRef calibrator sample.  
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Figure 38 Composite boxplot showing Log scale NRQ values 
(LOG10 NRQ) for Lmhc in genotypes DD & dd, compared 
between foot and ovotestis tissue, calculated relative to the 
OvoRef calibrator sample. 
 
Figure 39 Composite boxplot showing Log scale NRQ values 
(LOG10 NRQ) for Lmhc nm in genotypes DD & dd, compared 
between foot and ovotestis tissue, calculated relative to the 
OvoRef calibrator sample. 
 
Figure 40 Composite boxplot showing Log scale NRQ values 
(LOG10 NRQ) for Lmyo5a in genotypes DD & dd, compared 
between foot and ovotestis tissue, calculated relative to the 
OvoRef calibrator sample. 
 
Figure 41 Composite boxplot showing Log scale NRQ values 
(LOG10 NRQ) for Lmyo18a in genotypes DD & dd, compared 
between foot and ovotestis tissue, calculated relative to the 
OvoRef calibrator sample. 
 
Figure 42 Composite boxplot showing Log scale NRQ values 
(LOG10 NRQ) for Lstau in genotypes DD & dd, compared 
between foot and ovotestis tissue, calculated relative to the 
OvoRef calibrator sample. 
 
Figure 43 Composite boxplot showing Log scale NRQ values 
(LOG10 NRQ) for Lunc93a in genotypes DD & dd, compared 
between foot and ovotestis tissue, calculated relative to the 
OvoRef calibrator sample. 
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Table 47 Wilcoxon rank test results for pairwise comparisons between embryo, foot and ovotestis tissue within genotypes DD, Dd and dd for seven GOIs. The total number of individuals 
within each genotype group is quoted (n) in addition to the number of individuals within each tissue specific genotypic group (n, Embryo; n, Ovotestis; n, Foot). The Wilcoxon rank value 
(W) is presented with the associated probability value (p). Statistical significance (sig) is highlighted via * <0.05, ** <0.01, *** <0.001. Probability values are presented to 3 decimal places, 
thus ‘0.000’ represents <0.001. 
Tissue Analysis GOI 1-7 
GOI Geno n 
Embryo / Ovotestis Embryo / Foot Ovotestis / Foot 
n, Embryo n, Ovotestis W P sig n, Embryo n, Foot W P sig n, Ovotestis n, Foot W P sig 
Larp2/3 1a 
DD 25 6 14 0 0.000 *** 6 5 0 0.004 ** 14 5 67 0.001 ** 
Dd 13 5 8 0 0.002 ** n/a 
dd 25 6 14 0 0.000 *** 6 5 0 0.004 ** 14 5 63 0.007 ** 
Larp2/3 3 
DD 25 6 14 0 0.000 *** 6 5 0 0.004 ** 14 5 70 0.000 *** 
Dd 13 5 8 0 0.002 ** n/a 
dd 25 6 14 0 0.000 *** 6 5 0 0.004 ** 14 5 65 0.003 ** 
Ldia1 3'UTR 
DD 25 6 14 0 0.000 *** 6 5 0 0.004 ** 14 5 48 0.257 
 
Dd 13 5 8 0 0.002 ** n/a 
dd 25 6 14 0 0.000 *** 6 5 0 0.004 ** 14 5 52 0.130 
 
Ldia2 3’ UTR 
DD 25 6 14 79 0.001 *** 6 5 28 0.017 * 14 5 52 0.130 
 
Dd 13 5 8 34 0.045 * n/a 
dd 25 6 14 0 0.000 *** 6 5 0 0.004 *** 14 5 18 0.130 
 
Ldia2 ORF 
DD 25 6 14 59 0.179 
 
6 5 26 0.052 
 
14 5 60 0.019 * 
Dd 13 5 8 9 0.127 
 
n/a 
dd 25 6 14 0 0.000 *** 6 5 0 0.004 ** 14 5 35 1.000 
 
Lfat1 
DD 25 6 14 0 0.000 *** 6 5 0 0.004 ** 14 5 46 0.343 
 
Dd 13 5 8 0 0.002 ** n/a 
dd 25 6 14 0 0.000 *** 6 5 0 0.004 ** 14 5 26 0.444 
 
Lfry 
DD 25 6 14 0 0.000 *** 6 5 0 0.004 ** 14 5 49 0.219 
 
Dd 13 5 8 0 0.002 ** n/a 
dd 25 6 14 0 0.000 *** 6 5 0 0.004 ** 14 5 49 0.219 
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Table 48 Wilcoxon rank test results for pairwise comparisons between foot and ovotestis tissue within genotypes DD 
and dd for seven GOIs. The total number of individuals within each genotype group is quoted (n) in addition to the 
number of individuals within each tissue specific genotypic group (n, Ovotestis; n, Foot). The Wilcoxon rank value (W) is 
presented with the associated probability value (p). Statistical significance (sig) is highlighted via * <0.05, ** <0.01, *** 
<0.001. Probability values are presented to 3 decimal places, thus ‘0.000’ represents <0.001. 
Tissue Analysis GOI 8-14 
GOI Geno n 
Ovotestis / Foot 
n, Ovotestis n, Foot W P Sig 
Lcoll11 2a 
DD 19 14 5 5 0.003 ** 
dd 19 14 5 2 0.001 ** 
Lmhc 
DD 19 14 5 0 0.000 *** 
dd 19 14 5 1 0.000 *** 
Lmhc nm 
DD 19 14 5 39 0.754 
 
dd 19 14 5 41 0.622 
 
Lmyo5a 
DD 19 14 5 36 0.964 
 
dd 19 14 5 11 0.026 * 
Lstau 
DD 19 14 5 33 0.893 
 
dd 19 14 5 38 0.823 
 
Lmyo18a 
DD 19 14 5 39 0.754 
 
dd 19 14 5 23 0.298 
 
Lunc93 
DD 19 14 5 68 0.001 ** 
dd 19 14 5 66 0.002 ** 
 
Comparison to embryonic tissue 
The relative expression levels observed in five of the seven GOI targets assessed in the embryo, 
ovotestis and foot tissue were found to be significantly reduced in all genotypic groups of the 
embryo tissue compared to both the ovotestis tissue and the foot tissue (Figure 30, Figure 31, Figure 
32, Figure 33, Figure 34, Table 47). 
Only the diaphanous formin, Ldia2, targets demonstrated an alternative expression pattern. The DD 
embryo samples showed an increased relative expression of Ldia2 3’ UTR and Ldia2 ORF compared 
to the ovotestis and foot tissue (Figure 35, Figure 36). This increase was found to be statistically 
significant for the 3’UTR target between all tissues, whereas the ORF target expression difference 
was only found to be statistically significant between the embryo and foot tissues (Table 47). 
The dd embryo samples however, showed significantly underrepresented levels of Ldia2 3’ UTR and 
Ldia2 ORF compared to the ovotestis and foot tissue (Figure 35, Figure 36, Table 47), similarly to the 
expression patterns seen in the other GOIs.  
The expression pattern of Ldia2 observed in the Dd samples was a little more convoluted. Ldia2 3’ 
UTR was found to be significantly over-expressed in the Dd embryo samples compared to the 
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ovotestis (the same pattern as seen in the DD embryos, Table 47, Figure 35). However, Ldia2 ORF 
was shown to be under-expressed in the Dd embryo samples compared to the ovotestis, although 
this difference was not found to be significant (Figure 36, Table 47). No comparisons were available 
for the Dd individuals in the foot tissue. 
Comparison of the ovotestis and foot tissues 
Comparisons between the ovotestis and foot were less pronounced than those to the embryo tissue, 
and generally exhibited larger variation. Comparisons could only be made between homozygote 
genotypes.  
A significant difference in the relative expression was identified for the DD samples in the Ldia2 ORF, 
yet not in the Ldia2 3’ UTR target (Table 47). Both targets however, showed relative expression was 
greater in the ovotestis than in the foot (Figure 35, Figure 36). 
The actin related proteins, Larp2/3 1a and Larp2/3 3 both exhibited highly significant increased 
relative expression in the ovotestis tissue compared to the foot tissues (Table 47). Both genotype 
groups showed the same expression pattern (Figure 30, Figure 31). 
Lcol11a 2/1 showed highly significant difference in expression between tissues. The foot tissue 
showed a greater than three-fold increase in expression compared to the ovotestis tissue (Table 42). 
Both genotype groups demonstrated the increased expression, although it was more pronounced in 
the dd samples (Table 48, Figure 37).  
The ovotestis tissue showed a five-fold increase in expression of Lunc93a compared to the foot 
tissue (Table 42, Figure 43). This expression difference was found to be highly significant in both of 
the genotypic groups assessed (Table 48). 
Lmyo5a was found to be significantly differentially expressed only in the dd tissue comparison. The 
dd samples exhibited an increased expression in the foot compared to the ovotestis, whereas the DD 
samples displayed the opposite pattern, although compromised by high variability in the foot 
samples and not statistically significant (Figure 40). The expression difference in the dd represents a 
two-fold increase in expression in the foot tissue. 
Lmhc was found to be over-expressed in the foot tissue compared to the ovotestis, by more than a 
five-fold increase (Table 42). This expression difference was found to be highly statistically significant 
in both genotype comparisons, yet more pronounced in the dd samples (Table 48), although there 
were outliers present in both tissues in dd (Figure 38). 
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Discussion 
Differential gene expression between genotypes 
The general lack of differential expression between genotypes in the majority of GOIs suggests that 
there may be less pleiotropic effects associated with the dd individuals in early development than 
assumed based upon their reduced hatch rate (Davison, Barton et al. 2009). However, it is important 
to note that only the very early developmental stages were assessed here and there may be 
downstream differences in expression associated with genotype not detected here.  
Diaphanous related formin, Ldia2 
The dramatically reduced expression of Ldia2 in the dd embryo samples of both the 3’ UTR target 
and the ORF, coupled with the absence of any differential expression in the other candidate genes 
within the chirality locus, supports the hypothesis that the frameshift mutation in Ldia2 is strongly 
associated with the genetic determinant of LR asymmetry in L. stagnalis.  
The heterozygote, Dd, samples in both the ovotestis and embryo tissue exhibited an expression level 
almost exactly halfway between that observed in DD and dd for both 3’ UTR and ORF. This suggests 
that both copies of the gene are being equally transcribed/regulated, as opposed to the silencing of 
one copy in the homozygote, DD. This expression pattern further supports the tight association of 
this gene with the chirality phenotype. 
The single deletion in the sinistral version of Ldia2 creates a frameshift mutation very early in the 
coding region of the gene. However, it was unknown whether or not this would lead to differences 
in the quantity of transcript because the frameshift would not necessarily prevent or hinder 
transcription, yet simply generate a missense transcript that would likely result in an inability to form 
the required protein. Nonsense mediated mRNA decay (NMD) is known to be triggered by the 
presence of a premature stop codon in the transcript, although this process is still poorly understood 
(Lykke-Anderson and Jensen 2015). The sequence alignment of the Ldia2 gene in L. stagnalis has 
indicated that the frameshift does result in a premature stop codon within the first several amino 
acids (alignments not presented). Therefore, it seems likely that the reduced level of Ldia2 in the dd 
samples is due to NMD of the recessive, d, transcript. This would fit the observed halved quantity 
seen in the Dd samples also. 
The inclusion of the 3’ UTR and the ORF of Ldia2 may be able to provide support to this hypothesis 
based on the expected direction of NMD. In the ovotestis tissue, the 3’ UTR generally showed a 
greater reduction in expression in the Dd and dd samples relative to DD, than the ORF (Table 35). 
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This was also seen in the dd samples in the embryo tissue (Table 33), although the accuracy of these 
fine scale differences may be compromised due to the high Cq values and resulting error rate 
observed in these samples. The pattern observed in the Dd embryo samples conversely showed a 
greater reduction in the ORF compared to the UTR (Table 33). The scale of these differences, are 
generally not very large and therefore the inferences are limited yet show potentially increased 
NDM in the 3’ UTR compared to the ORF. 
Comprehensive studies of NMD have not been performed in molluscs. However, in NMD study 
organisms, from yeast to mammals, decay is observed in both a 5’ to 3’ and 3’ to 5’ direction of the 
mRNA, originating from either the 3’ end or exon-exon boundaries (Elliot and Ladomery 2011). The 
variation in starting position of NMD limits interpretation of the differences between the reduction 
Ldia2 in the 3’ UTR and ORF. 
However, the frameshift in the sinistral Ldia2 will be present in all tissues, and therefore the 
resulting NMD would be expected to be taking place in all tissues. The lack of quantitative 
differences in the foot tissue suggests some other form of regulation may be occurring in the 
embryo and ovotestis tissue. Alternatively, the process of NMD may be obscured in actively 
transcribing tissues. The embryo tissue only contains maternal mRNAs transcribed prior to laying. 
Therefore, in the absence of newly transcribed Ldia2, the process of NMD on the mutated gene has 
enough time to result in significantly different levels of the transcript. And so it is proposed that the 
ovotestis contains both actively transcribing tissues and eggs containing already deposited 
transcripts and subsequently reveals a reduced effect to that seen in just the embryo tissue. 
This hypothesis would be greatly supported by the inclusion of later embryonic stages in the qPCR 
experiments, holding the potential to reveal an increasing reduction of the sinistral Ldia2 until the 
onset of zygotic transcription produces new copies of the transcript which may counteract the low 
levels of the gene or reveal alternative patterns of gene regulation. 
Another explanation for the lack of DE between genotypes in the foot tissue, is that the transcript is 
in very low copy number and effectively not present in the foot, as is the case for the dd embryo 
tissue. This is supported by the similarly high Cq values observed in the foot tissue and dd embryo 
tissue for Ldia2 (Table 22, Table 24). 
Actin-related protein 2/3 complex 
Significant expression differences of actin-related proteins between genotypes were only identified 
in the embryo tissue. This may reflect a downstream effect associated with of the different 
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quantities of Ldia2 present to a greater extent in the embryo tissue. However, the differential 
expression observed only in the heterozygotes does not intuitively fit the linear reduction in Ldia2 
seen across the genotypes. 
 Larp2/3 1a showed increased level of transcript in the heterozygote whereas Larp2/3 3 showed an 
increased level of transcript in the homozygote (Table 32). The alternate direction of differential 
expression observed in the two arp2/3 targets here, support that the arp2/3 subunits are 
differentially regulated (Gournier, Goley et al. 2001). However, the scale of the expression 
differences are very small (<1.5 fold change) and subsequently would require further analysis to 
justly infer any biological meaning of the relationship. 
Differential gene expression between tissues 
Ldia2 3’ UTR and Ldia2 ORF were the only targets not to show significantly reduced expression in the 
wild-type (DD) embryo tissue compared to the somatic tissue. This highlights its functional 
importance in the early developmental stages in L. stagnalis providing strong support for Ldia2 as 
the primary candidate for the chirality gene, above any candidate genes assessed here. The overall 
large reduction of relative quantity of the remaining GOI transcripts in the embryo tissue is assumed 
to reflect an economic strategy of providing sufficient, yet not excessive quantities of maternal 
transcripts per embryo. 
Both of the arp2/3 transcripts were found in greater quantities in the ovotestis than in the foot and 
embryo tissue. This may reflect functional associations of the arp2/3 complex in cell motility and 
ultimately sperm motility (Lee, Kwon et al. 2015) 
The increased relative expression of Lunc93a in the ovotestis compared to the foot tissue is in 
keeping with its previously identified association with the ovarian tissue (Liu, Dodds et al. 2002). 
Additionally, the increase of Lcol11a 2/1 in the foot tissue echoes the contractile muscle functions 
associated with connective tissues abundant in collagen (Rigon, Manica et al. 2010). Similarly, the 
overexpression of Lmhc in the foot tissue demonstrates the expected increase of muscle proteins in 
the foot tissue compared to the ovotestis. 
With the exception of the GOIs described above the expression differences between ovotestis and 
foot were less pronounced than comparisons to the embryo tissue. Over half of the comparisons 
showed no significant difference in expression. These results further highlight the overall greatly 
reduced relative expression level of the transcripts seen in the embryo tissue compared to both the 
ovotestis and foot tissue with the notable exception of Ldia2. 
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Differential expression of GOIs 
Where NRQ values are calculated relative to the same calibrator sample, such as in the tissue 
analysis, the differences in expression level of transcripts can be compared to each other. For 
example, the relative quantities of the two copies of diaphanous formin in the embryo tissue can be 
compared by their expression values relative to the ovotestis tissue. In the wild-type, DD, embryo 
Ldia2 transcripts were found more than 20 times higher than Ldia1 (Table 42). This provides a 
quantitative value for the overexpression observed of Ldia2 in the embryo relative to other GOIs in 
the embryo.  
The relative expression of both the Ldia2 3’ UTR and Ldia2 ORF in the dd embryos is lower than any 
other GOI assessed (Table 32, Table 42). Therefore, it is apparent that Ldia2 is overrepresented in 
the DD embryo samples, yet also underrepresented in the dd embryo samples compared to the 
ovotestis and foot tissue. 
Quality controls 
Many of the issues surrounding the quality assessment of the samples have already been discussed 
in the previous chapter, due to the overlap of samples used. Discussed here are further comments 
relating specifically to the additional samples/GOIs used or their experimental application. 
Extraction method 
Differences between the extraction methods across the tissues, may lead to differences in sample 
quality and composition. The RNeasy extraction kits use columns to bind and extract total RNA from 
tissue. These columns are unable to retain small RNAs <200 bases long (Qiagen 2007), whereas the 
TRI Reagent method theoretically will retain all RNA. The TRI Reagent method also retains carryover 
genomic DNA as seen in the intronic PCRs from the foot and ovotestis samples. These differences 
should not pose a problem in the genotype comparisons as no systemic bias will have been 
introduced given that all samples within the tissue have been treated the same. However, when 
making comparisons between tissues, each tissue has been extracted using different method and 
therefore, differences in sample quality may create an undetected confounding variable, especially 
regarding the differences in genomic carryover. 
Genomic carryover 
Every embryo tissue sample used within this experiment failed to produce a PCR product from the 
intronic PCR and can therefore be assumed to be free of genomic contamination. This eliminates 
potential errors in quantification of expression of Ldia1 3’ UTR and Ldia2 3’ UTR due to amplification 
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of a genomic product at the same size. The foot and ovotestis samples however did amplify genomic 
products. The results of the genomic PCR tests are presented and further discussed in the SI (S5). 
Importantly the positive control test PCRs showed that no cDNA sample amplified two size specific 
products (presented in the SI, S5, and in Figure 11 and Figure 12). Therefore, the genomic carryover 
observed in the foot and ovotestis samples was assumed to be outcompeted by the cDNA product 
and of little concern for the accurate quantification of the majority of GOIs in this experiment. 
However, it must be acknowledged that the Ldia1 3’ UTR and Ldia2 3’ UTR experiments will 
inevitably include quantification of both genomic and transcriptomic templates due to the lack of 
intron-spanning primers for these GOIs. Again this should not affect comparisons within tissues as all 
genotypes have been treated the same, yet due to the difference in level of genomic carryover 
between tissues, this may represent a systemic bias. 
mRNA enrichment 
The ongoing genomic analyses of Ldia1 and Ldia2 in the Davison research group, have revealed both 
to be large genes, more than 7 kilobases (kb) long (Davison et al, awaiting publication) and may be 
up to 9 kb in total (Northern Blot analysis presented in the SI, S1). When designing primers for the 
two genes, the 3’ UTR was selected instead of the 5’ UTR because it lies closer to the poly-A tail 
present at the end of the mRNA molecule. Any mRNA selection when generating cDNA may make it 
difficult to reverse-transcribe the 5’ end of the long gene due to its increased distance from the 
selected poly-A tail (as described in Chapter 2, Introduction, Sample quality).  
The method of cDNA synthesis employed here, utilised a combination of oligo dTs and random 
hexamers and as such should generate a more balanced coverage of the RNA molecules. Still the 
position of the qPCR primers at the 3’ UTR was hoped to reduce the bias of the transcript being 
underrepresented as a result of insufficient reverse-transcription and obscuring true patterns of 
gene expression.  
Primer specificity 
In addition to verifying that the amplicons were of the expected size via gel electrophoresis (Figure 
11, Figure 12), the amplicons of Ldia2 and Ldia1 were sequenced by Sanger sequencing to further 
verify specificity. This was important for Ldia2 3’ UTR and ORF because of the multiple Tm peaks 
seen in some in the dd samples (Figure 15). Additionally, it was unknown whether the Ldia2 ORF 
primer pair would amplify a product only from Ldia2 or also produce products from the highly 
similar Ldia1. The Sanger sequences indicated specificity to Ldia2 (sequences not presented). The 
spurious Tm peaks are assumed to represent various primer dimers resulting from the very low 
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concentration of the target gene present in the dd embryo samples. This is supported by the Sanger 
sequencing of non-quantitative PCR products and the general lack of multiple peaks in the other 
samples (Figure 15). 
Due to the non-specific nature of the SYBR reporter dye, the amplification of primer dimer will 
contribute to the Cq values in these samples. Therefore the NRQs of the dd samples in Ldia2 3’ UTR 
and Ldia2 ORF will contain a level of inaccuracy. To gain a more precise estimate of the fold-change 
difference in expression between genotypes of Ldia2 the experiment could be repeated at a much 
higher cDNA concentration. 
The Tm curves generated from the qPCR experiments for all other GOIs show sharp peaks, with the 
exception of the low levels peaks seen in some of the negative controls (Figure 13, Figure 14). Again, 
because these spurious peaks only occur in the negative controls and not in the experimental 
sample, they are assumed to represent various primer dimers amplified by the primers in the 
absence of the target sequence. Therefore the Cq values of all experimental GOIs (potentially 
excluding the dd samples in Ldia2 3’ UTR & Ldia2 ORF) are not believed to be compromised by the 
amplification of any non-specific products. 
Experimental Design 
Amplification efficiencies and working dilution 
The Cq values generated from the serial dilutions in the amplification efficiency experiments (data 
not shown) indicate the appropriate range of dilutions that can be used for the specific GOI. The 
acceptable range of Cq values (10-35 (AppliedBiosystems 2011)) was mostly included within the 
range of dilutions resulting in an acceptable amplification efficiency. 
The primer efficiencies were calculated from a minimum of two standard curve experiments using a 
sample representing each genotype in the experiment. This is to ensure that the transcript will be 
present. However, for the most part primer efficiencies were only calculated within one tissue (with 
the exception being Ldia2 3’ UTR, Table 20). Therefore, assumptions regarding acceptable sample 
dilutions are strictly only appropriate for the tissue, and even genotype, that the amplification 
efficiency was calculated in. This became apparent when performing the Ldia2 3’ UTR experiment. 
An initial qPCR was performed using a 1:30 working dilution (data not presented). This dilution was 
regarded as acceptable according to the amplification efficiency experiment performed within 
embryo and foot samples (Table 20). However, due to the very low level of transcript observed in 
the dd samples, reliable quantification could not take place and the experiment was repeated at a 
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higher concentration (1:15). Similarly, having established an acceptable working dilution for Lmhc in 
the ovotestis tissue, it could not be assessed in the embryo tissue as the level of the transcript was 
too low for accurate quantification in any of the samples.  
Ideally amplification efficiency experiments would be performed in all tissues they are to be 
assessed in to establish the appropriate working dilution. However this is often not possible due to 
limited sample and resources. The embryo sample in this experiment was very limited and therefore 
could only be used in a subset of amplification efficiency experiments.  
Plate setup 
The sample sizes of the embryo and the foot experiment especially, were small. It was therefore very 
important to minimise error and so technical replicates were performed in triplicate. The ovotestis 
experiment however, had far more samples included. Reducing the technical replicates from 
triplicate to duplicate saved 37 wells per GOI, and collectively 629 wells (7 experimental plates) in 
the whole study. The more informative data from the increased number of biological replicates was 
considered to outweigh the loss of information through reduction in technical replicates. However, 
reducing the technical replicates to two precluded the identification of outliers and therefore the 
cleaning of ‘noisy’ data. Due to the importance of the OvoRef sample, which functioned as the 
calibrator for the whole plate and tissue analysis, it was not reduced to duplicate repeat (Figure 10). 
Targets/GOIs 
Choice of GOIs 
Only four of the fourteen GOIs assessed revealed expression differences between genotypes. Whilst 
this provides good support for the role of the candidate gene in LR asymmetry variation, there may 
be more informative target genes not included here. For example, no tubulins were included in the 
analyses, despite their potential involvement in LR determination (Vandenberg, Lemire et al. 2013). 
Yet the 2004 Shibazaki experiment (Shibazaki, Shimizu et al. 2004), concluded that tubulins were not 
essential for the establishment of asymmetry in L. stagnalis and therefore were not included as a 
priority in this experiment. Additionally, the nine ‘functional targets’ were originally identified 
through DE analysis of the eRAD dataset which has since been corrected and has not identified any 
of the targets here as DE. 
Three additional genes in close proximity to the candidate locus have recently been identified, in the 
latest L. stagnalis genome annotation within the Davison research group (June 2015). These genes 
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will also be assessed for differential expression between genotypes in order to verify the current 
main candidate, Ldia2, however due to time limitations they could not be included in this analysis. 
Two regions of the same GOI, Ldia2 were included in this experiment, the 3’ UTR and the ORF. 
Including both regions was hoped to elucidate any bias in patterns of gene regulation or directional 
degradation, such as nonsense mediated decay. Additionally, the inclusion of the two regions 
provided a form of repeat analysis and therefore greatly reduced the probability of the identified 
differential expression being identified as statistically significant due to chance.  
Because of the reduced amount of embryo sample available, eight priority GOIs had to be selected 
for assessment within the embryo tissue. To support the role of the primary candidate Ldia2 as the 
causal gene in LR determination, firstly Ldia2 itself was a priority for assessment of differential 
expression between genotypes (both the 3’ UTR and ORF were included for reasons above). 
Subsequently the other genes surrounding the chirality locus, Ldia1, Lfat1 and Lfry, aimed to be 
excluded as candidates, through demonstrating no significant difference in expression. In addition to 
the proximal targets, both of the actin-related proteins were included in the embryo tissue. This was 
due to the previous studies specifically highlighting the importance of actins in early developmental 
stages of L. stagnalis (Shibazaki, Shimizu et al. 2004, Davison et al, awaiting publication), and to 
identify potential functional interactions with the diaphanous-related formin, Ldia2. Lmhc was 
included as the final GOI to be assessed in the embryo tissue. This decision was based on preliminary 
qPCR experiments in the ovotestis tissue (data not presented), which indicated potential differential 
expression between genotypes. The unforeseen low expression levels of Lmhc in the embryo tissue 
negated the inclusion of this GOI in the embryo study and further emphasises the importance of 
performing amplification efficiency experiments in representatives of all samples/tissues.  
Choice of endogenous controls 
The major caveat of the tissue comparison experiment is that the endogenous control genes were 
not tested for stability between tissues. Again due to finite timescales and resources not all controls 
can be performed. The stability assessment of the endogenous control genes revealed each of those 
used within this experiment to be stable across genotypes within each tissue and generally showed 
the same genes to be the most stable in all three tissues (Table 14). It seems unlikely therefore that 
there would be substantial variation in gene expression in the selected endogenous control genes 
between tissues. Furthermore, the tissue analysis did not appear to show substantially higher levels 
of within group variation than the genotypes analysis.  
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More importantly any confounding variation of the endogenous control genes has not resulted in an 
apparent systematic bias, in light of the bidirectional patterns of differential gene expression 
observed across tissues. For example, if both of the endogenous control genes used in the tissue 
comparison happened by chance, to be overrepresented in the embryo tissue compared to the foot 
tissue, this could create the observed reduced relative expression of the majority of the GOIs 
quantified in the embryo tissue (Figure 30-Figure 34). However, the increased relative expression of 
Ldia2 in the embryo tissue compared to the foot tissue makes this highly unlikely (Figure 35, Figure 
36). 
The endogenous control genes included were selected based principally on the results of the 
geNorm stability assessment in order to ascertain the three best stability genes to include (Table 11, 
Figure 8). The foot and embryo tissue samples were quantified on the same experimental plate. This 
necessitated the use of the same endogenous control genes across the two tissues, or alternatively 
performing separate experiments for the endogenous control genes although this was not an 
economical option. Because all of the endogenous control genes were found to be highly stable in 
the embryo tissue the priority for gene selection was based largely on the foot tissue stability 
assessment. Therefore, Lywhaz, Lube2 and Lhis2a were selected. 
The endogenous controls selected for the ovotestis experiment employed the two most stable genes 
identified by geNorm Lrpl14 and Lube2. However, Lhis2a was included instead of Lywhaz due to 
having the best individual stability score (Table 11). Although the genotype analysis allowed for 
different endogenous control genes to be employed between the tissues, the tissue analysis 
required all samples to be normalised to the same control genes. This reduced the number of 
endogenous controls used in the tissue analysis to two genes. With the exception of Lef1a, all of the 
endogenous control genes tested were considered to be stably expressed in all tissues.  Therefore, 
employing the same three control genes in all tissues may have provided a better method. 
Choice of Tissues 
The choice of tissue in which to assess differential expression will be based on which target 
genes/functions are being explored. A priority in this experiment was supporting candidate genes as 
the maternal effect gene known to determine chirality in L. stagnalis. Therefore, unfertilised eggs 
(ovotestis) and single cell embryos were essential to isolate maternal transcripts.  
Embryo tissue 
The single cell embryo tissue provided an ideal sample tissue, in that it was very clean. Following 
decapsulation the chance of any somatic tissue carryover was minute. It has also been documented 
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that zygotic expression does not begin until the 24 cell stage (Morrill 1982) and therefore will only 
contain maternal transcripts transcribed prior to egg-laying. This was essential for looking at 
expression patterns of the causal gene, however there may be downstream effects of chirality on 
gene expression only apparent at later stages, for example after the third cell cleavage, which 
signposts a ‘point of no return’ for the development of LR asymmetry (Kuroda, Endo et al. 2009). It 
would be highly informative to include later developmental stages, especially the 4-8 cell stage, and 
possibly post-zygotic transcription stages. However, because the embryo collection process was very 
time and labour intensive these additional experiments were not possible within this project.  
Foot tissue 
The foot tissue appears to have provided a successful somatic tissue control due to the lack of any 
significant difference in gene expression found between genotypes. However, the small sample size 
and high levels of variation observed within the group may have obscured possible small scale 
differences in gene expression. It is unclear why the foot tissue presented such variable data. All 
samples within the genotype groups were from the same homozygote population and prepared 
within days of each other following the same protocols (Table 16). The foot tissue is also easily 
distinguishable from other tissues during extraction, yet there may be problems associated with the 
presence of mucous in the tissue (AppliedBiosystems 2010). It is probable that the high levels of 
variability relate to the TRI Reagent RNA extraction observed to produce variable levels of chemical 
and genomic material carryover. The 260/230 ratios recorded for the foot tissues do show a range of 
values generally lower than seen in the embryo samples yet not as low as those of the ovotestis 
samples (Table 15, Table 16, Table 17). 
Ovotestis tissue 
The ovotestis tissue was included to assess differences in gene expression of actively transcribing 
maternal RNAs. As previously discussed, the timing of ovotestis extraction was unable to be 
controlled beyond the individual snail being reproductively mature. Additionally, due to the internal 
organisation of L. stagnalis, this tissue is impossible to isolate without the inclusion of contaminating 
liver tissue (Figure 9). Both of these factors are likely contributors to the higher levels of within-
group variation seen in the ovotestis samples.  
Data Analysis 
There are numerous ways of determining relative Cq values (Livak and Schmittgen 2001, Pfaffl 2001, 
Schefe, Lehmann et al. 2006, Hellemans, Mortier et al. 2007). The updated Pfaffl method 
(Hellemans, Mortier et al. 2007) was employed here because it is the only method which readily 
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incorporates primer amplification efficiency and enables normalisation to multiple endogenous 
control genes. This method can also include the SD of the average Cq throughout the calculations. 
Technical SD was not included in the creation of the NRQs here. Due to the generally low SD of the 
majority of raw average Cq values (<0.5), the effect of this technical variation is assumed to be 
negligible.  
There are a number of software packages available to analyse relative qPCR data in addition to that 
which is included in the ABi 7500 qPCR fast Real-Time PCR system (Hellemans, Mortier et al. 2007, 
Pfaffl, Vandesompele et al. 2009), including the freely available REST software (Pfaffl, Horgan et al. 
2002). Due to the limited flexibility of this software, often assuming that the requirements for 
parametric statistical tests are met, and the relative simplicity of the statistics undertaken to 
establish significance of differential expression, the statistical analyses here were performed using R 
software.  
Statistical analyses were only performed on log transformed NRQ values. This is advised due to the 
non-linear distribution of relative Cq data (Rieu and Powers 2009). An NRQ value of 1 indicates a 1:1 
expression ratio, therefore no difference in expression. Any gene that is down-regulated will be 
represented by a value between 0 and 1, whereas upregulated genes will be presented by any 
number greater than 1, which skews the distribution and often results in heterogeneity of variance 
(Rieu and Powers 2009). 
Genotype Analysis 
Because all samples of each tissue were included on the same experimental plate, any sample could 
be utilised as the calibrator for within tissue comparisons (Figure 10). An individual DD sample was 
used as a calibrator for the genotype analysis as this represents the wild-type condition. It is possible 
to include multiple samples as calibrators in order to minimise variation, similar to employing 
multiple endogenous controls (Vandesompele, De Preter et al. 2002, Hellemans, Mortier et al. 2007), 
although only one sample was utilised here. The single cell embryo pool was not included in any 
statistical analyses. It was originally included to function as a calibrator sample, although a DD 
sample provided a more intuitive relative value representing the homozygote dominant genotype. 
Because the single cell embryo pool was generated from the existing Dd embryo samples it would 
have presented a pseudo-replicate if included in the group means.  
Non-parametric Wilcoxon-Mann-Whitney tests were performed for all group comparisons. The 
sample sizes of the embryo and foot experiments were too small to be considered normally 
distributed and so the more robust non-parametric test was performed to compare group means. 
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The ovotestis data however, had a greater sample size and potentially may have been appropriate 
for a parametric T-test. Histograms were generated of the NRQs of the ovotestis samples for each of 
the GOIs (presented in the SI, S10). Although for some GOIs a general bell-curve could be seen across 
all samples, this was not maintained within the genotype groups and so the more robust non-
parametric test was employed. 
The ovotestis data exhibited fairly high levels of variation shown in the generally wide boxplots in 
the majority of GOIs (Figure 16 -Figure 29). The ovotestis experiment included samples from 
different mating crosses, and a range of storage times and DNase treatments (Table 17). For a 
cleaner analysis the ovotestis samples could have been split according to the three main 
extraction/population groups (8515-9014; 10627-10640; 11347-11357). Furthermore, an analysis of 
variance (ANOVA) test could be performed to indicate whether there is an effect of extraction group 
on the group means. It should be noted however that the most variable data group was the foot 
tissue, which represented ten individual samples prepared within the same week and received 
equivalent extraction protocols, therefore the reduction of variance may not be improved through 
separating the dataset. 
Tissue Analysis 
The only sample able to function as a calibrator sample across tissues was the OvoRef sample, which 
comprised a pool of multiple ovotestis samples. Therefore, all NRQ values in the tissue analysis are 
relative to the ovotestis tissue and can loosely be considered as relative to a Dd sample.   
Incorporating the two fixed factors within the tissue analysis, genotype and tissue, a two-way 
factorial ANOVA was considered in order to establish whether tissue or genotype was having a 
significant effect on the gene expression of each GOI. However, the data failed to meet the 
requirements of the model, and so more robust, pairwise comparisons were performed between the 
group means. In the knowledge that genotype has a significant effect on the expression of Ldia2 and 
the Larp2/3 targets, the pairwise comparisons were performed between the means of genotype 
specific groups (Table 43 - Table 48). By separating the data according to genotype and tissue, the 
sample sizes again became too small for appropriate use of parametric statistical tests. The NRQ 
data from GOIs that were not found to be significantly different between genotypes (10 out of the 
14 GOIs in this experiment) could have been pooled across genotypes and perhaps enabled the use 
of the more powerful parametric tests. Yet, the majority of significant differences in gene expression 
between tissues were found to be highly significant (<0.005) and therefore the risk of false negatives 
due to using a less sensitive statistical test is not a strong concern. Two of the expression differences 
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identified in Ldia2 3’ UTR and Ldia2 ORF were very close to the significance boundary (Table 47). 
However, these targets were found to be highly significantly different between genotype and 
therefore could not have been pooled for a parametric test. 
Performing pair-wise comparisons between each genotype within a tissue and between each tissue 
within a genotype, a total of 140 pairwise comparisons were performed. Therefore, inferring 
significance from a p value of <0.05 would lead to significant differences in expression being 
identified in nearly seven of these comparisons simply by chance. Significance corrections have not 
been formally applied to the results of pairwise comparisons, however inferences regarding the 
strength of the relationship can be made from the p value itself. The majority of significant 
differences identified in the analyses were <0.01. Obtaining a p value of <0.01 would occur less than 
twice simply by chance within the 140 comparisons. Therefore, the statistical significance of these 
results are not believed to represent false positives. There were in fact seven occurrences of 
statistical significance only <0.05 and >0.01. Therefore, caution may be advised when inferring 
biological meaning from these differences, especially the tissue comparison of Ldia2 3’ UTR 
expression between Dd ovotestis and embryo tissues bearing a p value of 0.045 (Table 47). 
Conclusion 
The qPCR experiments have succeeded in highlighting significant differential gene expression within 
and between embryo, ovotestis and foot tissues in chiral variants of L. stagnalis. The only GOIs found 
to be significantly DE between chiral genotypes were the primary candidate gene, Ldia2 and arp2/3 
complex genes, which are directly linked to the function of the primary candidate. Furthermore 
significant differences between chiral genotypes were substantially more pronounced in the embryo 
tissue than the ovotestis tissue, and absent in the somatic foot tissue. 
The frameshift mutation in the sinistral copy of Ldia2 appears to have resulted in a pronounced 
reduction in the quantity of the transcript, although due to the relative nature of the quantitative 
comparison it is difficult to infer direction of regulation. Interestingly the Dd samples showed an 
expression level of Ldia2 almost exactly halfway between that of the homozygote groups in both the 
embryo and the ovotestis tissue, indicating equal regulation of the two gene copies. 
The lack of DE observed in the remaining GOIs and especially the alternate diaphanous formin, 
Ldia1, strongly supports the frameshift mutation being responsible for the tight association of Ldia2 
with chirality determination in L. stagnalis. The patterns of gene expression identified in the arp2/3 
transcripts however, require further analysis in order to propose reliable biological interpretations. 
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All GOIs, with the exception of Ldia2, were found to be greatly underrepresented in the single-cell 
embryo compared to the ovotestis and foot tissue. The comparative relationships of gene expression 
indicated that the sinistral copy of Ldia2 is significantly under-represented in the embryo compared 
to the somatic tissue, whereas the functional Ldia2 in the wild-type embryo is over-represented 
compared to the somatic tissues. Thus regulation is apparently occurring in both versions of the 
transcript.  
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Chapter 4: 
Expression-RAD: a reduced 
representation next-generation 
sequencing method for transcriptomic 
analysis 
Introduction 
When embarking on the search for the chirality determining gene (or closely linked group of genes) 
in Lymnaea stagnalis, the mechanism of chirality determination was largely unknown, although the 
genetic mode of inheritance was well described and observed (reviewed in Chapter 1, Lymnaea as a 
model system). Therefore, the Davison research group adopted a purely genetic approach to initially 
identifying candidate genes. L. stagnalis does not currently have a reference genome; however 
recent advances in high-throughput DNA sequencing facilitated genome-wide comparative analyses 
in L. stagnalis. 
Next generation sequencing 
Over the last 10 years there has been a surge of so called ‘next-generation sequencing’ (NGS) 
technologies, representing their advancement from traditional Sanger sequencing (Sanger, Air et al. 
1977, Sanger, Nicklen et al. 1977). Many different methods have been employed to perform 
massively parallel sequencing of whole genomes, including pyrosequencing: Roche 454 (Margulies, 
Egholm et al. 2005)), sequencing by ligation: SOLiD (McKernan, Peckham et al. 2009), ion 
semiconductor sequencing: Ion Torrent, Life Technologies (Rothberg, Hinz et al. 2011), and the 
current leading market method, sequencing-by-synthesis: Illumina (Bentley, Balasubramanian et al. 
2008). These technologies each have their own variable capabilities and limitations discussed in 
many previous reviews (Mardis 2011, Loman, Misra et al. 2012, Quail, Smith et al. 2012, Reuter, 
Spacek et al. 2015) and most recent capabilities quoted on their respective websites. Yet they each 
represent a platform for sequencing a massive number of DNA molecules simultaneously, from 
(almost) random start sites across the genome, within an automated instrument. They also share the 
major limitation of short reads. 454 sequencing produces longer reads of ~400 base pairs (bp) 
(although new systems to be released quote ~1 kilobases (kb)) compared to Illumina, SOLiD and Ion 
Torrent reads, all of which are generally less than 150 bp (Mardis 2011, Loman, Misra et al. 2012, 
Quail, Smith et al. 2012). This has previously been the highlighted benefit of 454 sequencing, 
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allowing for better genome assembly due to the longer sequence reads. However, each of these 
sequencers still requires the assembly of short reads to generate sufficient descriptive sequence 
data. Furthermore, each of these technologies requires an amplification step of the library to enable 
detection by the sequencer introducing a substantial source of sequencing error.  
New techniques are emerging able to generate substantially longer sequencing reads from single 
molecules in real-time negating the process of library amplification (Eid, Fehr et al. 2009, Pushkarev, 
Neff et al. 2009, Mikheyev and Tin 2014). The currently available PacBio (Pacific Biosystems) 
sequencer can already produce average read lengths of 1,500 bp far exceeding that of its 
competitors, however demonstrates a much higher error rate (Quail, Smith et al. 2012). The MinION 
(Oxford Nanopore Technologies) sequencer promotes a ‘handheld’ sequencer able to sequence DNA 
molecules up to a giga-base in read length in real-time for a fraction of the running costs of other 
sequencers (Eisenstein 2012). Ultimately the maximum read-length can only meet the length/quality 
of the molecule input to the system. These ‘third generation sequencing’ methods are expected to 
revolutionise, yet again, the current applications of whole genome sequencing (WGS). The first 
publications of the MinION early access programme are emerging and reveal that the MinION can 
achieve read lengths comparable to the input DNA, yet the sequencing error rate needs improving 
(Mikheyev and Tin 2014, Quick, Quinlan et al. 2014, Ashton, Nair et al. 2015). Currently Illumina 
sequencing is still considered to attain the best balance of read lengths, error rates and costs 
(Loman, Misra et al. 2012, Mikheyev and Tin 2014). The term NGS is used throughout this thesis to 
refer to all high-throughput sequencing, although strictly most of the technologies discussed here 
are now largely considered to represent ‘second-generation’ sequencing. 
The data output of the currently available technologies has dramatically increased since their 
introduction (Mardis 2011). Currently a single Illumina HiSeq 2000 run can generate up to 600 
gigabases (Gb) of sequence data, the equivalent of >5 human genomes at 30 times coverage 
(Illumina 2011) (note that Illumina’s latest sequencer HiSeq 4000 has increased this to 12 human 
genomes (Illumina 2015)). The capacity to gain such a wealth of sequence data de novo has enabled 
a new scale of genome-wide screening for genetic variation within organisms with or without a 
reference genome. The continuing fall in costs of NGS technologies coupled with the increasing 
sequencing coverage is bridging the gap between model and non-model organisms in genetic 
research. 
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Applications of NGS data 
The advent of NGS technologies has generated a shift of genomic studies from controlled laboratory 
based model-organisms to ecologically well characterised species, enabling exploration of the 
genetic basis of ecologically and evolutionarily important questions. The high-throughput of NGS 
data facilitates the identification of hundreds of microsatellite loci and thousands of single-
nucleotide polymorphisms (SNPs) in a fraction of a single run, permitting the inclusion of many 
individuals. Thus dramatically increasing the capabilities of large-scale comparisons of genetic 
variation and marker discovery in relation to phenotypic traits, such as quantitative trait loci (QTL) 
mapping and genome wide association studies (GWAS) in addition to population analyses evaluating 
inter-relatedness and genetic structure of groups of individuals (reviewed in Ekblom and Galindo 
2011). The high throughput of NGS data can be spread further to perform metagenomics, able to 
rapidly analyse species diversity via pooled environmental samples through species specific 
‘barcodes’ (eg. Fonseca, Carvalho et al. 2010). NGS data is also being applied to reveal epigenetic 
modifications characterised by methylation patterns (eg. Taylor, Kramer et al. 2007, Cokus, Feng et 
al. 2008) and the structure of DNA and chromatin packing (eg. Johnson, Tan et al. 2006, Barski, 
Cuddapah et al. 2007), which both play significant roles in the regulation of gene expression. The 
analytical possibilities of NGS data are immeasurable, such that deep sequencing projects represent 
a hypothesis-free experimental design, generating results available for a vast number of subsequent 
queries. 
The accessibility of WGS through NGS has promoted re-sequencing of some already available 
reference genomes and the generation of new reference genomes assembled de novo. A growing 
number of species now have a reference genome available, and some have multiple reference 
genomes, most notably the human genome, which is preparing to describe 1000 genomes 
(www.1000genomes.org). However, even with the increasing availability of NGS sequence data, 
assembling the genome without a reference, de novo, is still a significant challenge beyond the 
capabilities of most molecular ecology research groups.  
Reduced representation sequencing methods 
For the majority of applications of NGS data, the whole genome is not required. Shorter sequence 
contigs can provide the sequence information necessary to identify genetic variation and 
subsequent linkage markers. SNPs represent the most abundant genetic markers within the genome, 
and subsequently facilitates rapid linkage-mapping across individuals and populations (Baird, Etter et 
al. 2008). However, single base changes in genetic sequence are common errors within the current 
NGS platforms (Mardis 2011). Therefore, it is essential to have sufficient sequence data to verify the 
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occurence of SNPs in the presence of occasional sequencing error. In organisms lacking a reference 
genome this will necessitate acquiring a good depth of sequencing at the same genetic loci in 
multiple individuals.  
Although NGS provides a cost-effective method to obtain substantial amounts of sequence data, it 
still represents a significant financial investment for a research group. As such many experiments are 
limited to one or two lanes of sequencing. Therefore, prioritising sequencing effort is an important 
part of experimental design. Reducing the complexity of the genome will result in an increased 
depth of sequencing at a smaller number of loci. These ‘reduced-representation’ methods also 
increase the likelihood of sequencing the same loci in multiple samples. A number of approaches 
have been appropriated, most of which involve high-throughput sequencing of restriction enzyme 
fragmented DNA (Miller, Dunham et al. 2007, Baird, Etter et al. 2008, Huang, Feng et al. 2009, 
Andolfatto, Davison et al. 2011, Elshire, Glaubitz et al. 2011, Etter, Preston et al. 2011).  
Restriction-site associated DNA Sequencing (RAD Seq) 
The restriction-site associated DNA Sequencing (RADSeq) method as described by Baird et al. (2008), 
combines Illumina paired-end sequencing and the disruption of restriction endonuclease recognition 
sites to initiate sequencing only at genomic regions which flank a particular restriction enzyme 
recognition site. In this manner the same specific regions across the genomic are ‘over-sequenced’ in 
multiple individuals, providing sufficient depth of sequencing to permit the identification, 
verification and scoring of a large number of SNPs simultaneously within the experiment enabling 
genetic mapping (Baird, Etter et al. 2008), population genomics (Hohenlohe, Bassham et al. 2010) 
and phylogeography (Emerson, Merz et al. 2010) analyses, amongst others (Rowe, Renaut et al. 
2011).  
RADSeq is at present the most popular reduced-representation sequencing technique (Henri, Cariou 
et al. 2015) with 185 associated publications currently listed in the Web of Science since the first 
experimental papers were published in 2010 (search results recorded 11th November 2015). 
However, for clarity, an overview of the method is described here and summarised in Figure 44. 
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Figure 44. Overview of RADSeq method. 1. Restriction enzyme fragments DNA at the specific recognition sites (indicated 
in yellow). P1 Illumina sequencing adaptor (indicated in red) and molecular identifier (MID) (indicated in blue) are 
ligated to the cut site overhang. 2. Ligation of P2 Illumina sequencing adaptor (indicated in green) following random 
shearing of fragments. 3a. Arrows indicate sequencing direction originating from P1 adaptor in single-end sequencing.  
3b. Arrows indicate sequencing direction originating from P1 and P2 adaptors in paired-end sequencing. 4a. Over-
sequencing originating from the same P1 adaptor flanking a specific restriction site. 4b. Overlapping paired-end contigs 
assembled to the same P1 adaptor sequence. 5. Visual representation of the focused sequencing power of RADSeq (a) 
compared to shot-gun whole genome sequencing (b). Partially redrawn and adapted from Rowe et al. 2011. 
 
Firstly, the individual sample DNA is digested with the restriction enzyme of choice, resulting in DNA 
fragments with a ‘sticky-end’ overhang. The fragments are then ligated to a P1 Illumina sequencing 
adaptor (both P1 and P2 adaptors are required for sequencing within the Illumina platform) and a 
unique molecular identifier (MID) sequence (which specifies the fragments to the sample), 
specifically tailored to complement the restrict fragment overhang. The DNA fragments now contain 
a sequencing adaptor and MID and so multiple samples can be pooled according to the 
requirements of the sequencing experiment. Provided that MIDs are not reused within the same 
sequencing lane, each sequenced read can be ascribed to the sample it was generated from. The 
pooled library is then sheared randomly to generate fragments within an average length of a few 
hundred base pairs (to fit the input requirements of the Illumina sequencing platform). P2 Illumina 
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adaptors are then ligated to the sheared fragments. The library of DNA fragments is then amplified 
via a PCR utilising primers specific to both of the Illumina sequencing adaptors. Due to a modification 
on the end of the P2 adaptor, only fragments containing both a P1 and P2 adaptor are amplified. 
This ensures that every sequence within the sequencing library contains both Illumina sequencing 
adaptors and the essential MID. Because the Illumina P1 sequencing adaptors are only associated 
with the restriction site overhangs, sequencing will only originate from these regions. Following 
paired-end sequencing, overlapping P2 sequence reads, which originate from the random sheared 
ends of the DNA fragments, can be assembled to form mini-contigs associated with the specific RAD 
tag P1 sequence. 
The methodology of RADSeq is suitable for any organism containing restriction recognition sites and 
therefore an accessible method for genome-wide marker discovery in organisms lacking any prior 
sequence information. Furthermore, the methodology is highly versatile. The depth of sequencing 
can be prioritised over the overall span of the genome sequenced by using a restriction enzyme with 
a less frequently occurring recognition sequence, or vice versa. Additionally, double-digest RADSeq 
(dd-RADSeq) has since been developed to increase the number of sequenced loci (Peterson, Weber 
et al. 2012). Ultimately however, the capacity to accurately design the RADSeq genome coverage is 
dependent on prior knowledge of predicted restriction recognition sites within the genome to 
estimate frequency of sequenced loci. 
RNA Seq 
NGS technologies have since been applied to transcriptome analyses, both descriptive and 
quantitative. RNA sequencing (RNA Seq), the most common method of NGS transcriptome analysis, 
involves sequencing complementary DNA (cDNA) reverse-transcribed from RNA and subsequently 
fragmented into suitably-sized inserts for the specified NGS platform. Alternatively, the high-
throughput power of NGS can be applied to tag based approaches such as expression sequence tags 
(ESTs) (Bouck and Vision 2007) and serial analysis of gene expression (SAGE) (Velculescu, Zhang et al. 
1995, Harbers and Carninci 2005, Nielsen, Hogh et al. 2006). A less frequented transcriptomic 
sequencing approach is that of ‘exome-capture’ to preferentially sequence the coding regions from 
DNA, as a result this method cannot provide quantitative gene expression data (Choi, Scholl et al. 
2009, Teer and Mullikin 2010).  
The availability of RNA Seq has greatly increased the possibilities of gene expression analysis in both 
model and non-model organisms. One of the major breakthroughs of RNA Seq is the ability to 
perform experimental comparisons of differential gene expression without prior knowledge of the 
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target sequence, one of the principle limitations of tag-based approaches (Bouck and Vision 2007). 
Relative gene expression levels can subsequently be inferred from the sequencing depth of specific 
transcripts (Marioni, Mason et al. 2008). Thus RNA Seq offers incredibly high-throughput descriptive 
and quantitative transcriptome experiments, simultaneously able to identify sequence variation, 
such as SNPs and splice-variants, and differential gene expression between conditions. Furthermore, 
variant marker discovery within mRNA sequences are expected to be of greater interest when 
exploring adaptive differences due to their functional association with protein-coding genes. As a 
consequence, RNA Seq can be considered a form of reduced representation sequencing. 
RNA Seq does not suffer the same high background noise and cross hybridisation as is common in 
microarray experiments, and shows a greater dynamic range of transcript detection, better able to 
detect rare transcripts and differences in gene expression with increased resolution (Ekblom and 
Galindo 2011). The ability to detect differences in expression of previously unknown transcripts 
across the whole range of the transcriptome allows for a more complete comparison of gene 
expression patterns between species, conditions or tissues being compared. Additionally, known 
candidate genes can be extracted from the RNA Seq data and examined after the experiment has 
taken place. However, the ability to do this will depend on whether the sequencing coverage of the 
transcriptome was sufficient to capture the candidate gene in question. 
The sequencing depth will be divided across the number of samples included within the sequencing 
reaction. Therefore, RNA Seq can become an expensive option if intending to compare a large 
numbers of samples at a sufficient level of coverage to confidently describe transcripts in organisms 
lacking a reference genome. Although RNA Seq appears to have surpassed its predecessors as the 
method of choice for identification of transcriptomic variation (McGettigan 2013), further analyses 
using more ‘in-house’ techniques such as microarrays or quantitative real-time PCR (qPCR) provide 
valuable tools to increase power of predicted differential gene expression in an increased number of 
replicates or conditions. 
RNA Seq generates a tremendous amount of sequence data, however there are still significant 
challenges in assembling the reads de novo (Haas and Zody 2010). In addition to the computational 
issues in assembling short sequence reads common to all NGS data, transcriptome data suffers 
unbalanced coverage across both the whole transcriptome due to quantitative gene expression 
patterns, and the individual transcripts due to sequencing biases such as Illumina’s GC bias 
(Minoche, Dohm et al. 2011) and the 3’ sequencing bias known to occur from mRNA selection and 
the cDNA fragmenting process (Wang, Gerstein et al. 2009). Additionally, functionally conserved 
172 
 
sequences between genes may create ambiguity in the assembly. The assembler must also be able 
to generate multiple transcripts per locus to accommodate splice variants. Subsequently errors may 
be incorporated due transcripts encoded by adjacent loci which may overlap and be misrepresented 
as chimeric loci. Alternatively, a highly expressed transcript containing a sequencing error may 
dominate the assembly over a correct but lowly expressed sequence (summarised in Grabherr, Haas 
et al. 2011). 
A number of transcriptome assemblies have already been successfully generated completely de novo 
(eg. Vera, Wheat et al. 2008). The increase in sequencing depth and read length of NGS platforms 
now available, in addition to the growing capabilities of assembly programs, are continuously 
improving de novo transcriptome analyses (Grabherr, Haas et al. 2011), however for the reasons 
outlined above, RNA Seq without a reference genome remains a challenge. 
Expression RADSeq (eRAD) 
Similarly, to genomic analyses, informative gene expression analyses can be performed that do not 
require a complete assembly of the transcriptome. Therefore, it is of interest to explore the 
possibilities of reduced-representation sequencing methods within the transcriptomic analyses. The 
novel technique of expression RAD sequencing (eRAD) was presented by members of the Cresko 
laboratory (University of Oregon) at a conference in 2010 (National Center for Research Resources 
2010). No analyses have yet been published regarding eRAD from this group.  
A comparative analysis was proposed by the Davison research group in collaboration with the 
Genome Analysis Centre (TGAC) and contributions from Dr Susan Bassham of the Cresko Laboratory 
(University of Oregon) to assess whether the RADSeq method could be applied to double-stranded 
cDNA to perform reduced-representation transcriptome sequencing and assess the output in 
contrast to traditional RNA Seq in an organism lacking reference genome: L. stagnalis. 
RADSeq was developed and is primarily employed to identify large numbers of small scale sequence 
variations, such as SNPs by reducing the complexity of the genome in order to focus sequencing 
efforts. eRAD would also provide this capability, yet reducing further the complexity of the genome 
by only examining protein coding regions. This may limit the potential to find sequence variation, 
due to functional restraints on genetic variation within protein coding sequences. However, the 
identified sequence variation is also more likely to be indicative of adaptive processes due to such 
functional constraints. Consequently, eRAD may facilitate rapid genetic linkage mapping in 
organisms with complex or polyploid genomes by further reducing the search area. 
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It was hoped that the eRAD method may provide a quantitative as well as descriptive, transcriptomic 
sweep, to assess gene expression across the transcriptome. The expected increased depth of 
sequencing of a smaller number of loci via the eRAD method was intended to improve the reliability 
of, sequence and count data. A number of features of RNA Seq data question its suitability of use for 
quantitative DE analysis (discussed in Bullard, Purdom et al. 2010, Robinson and Oshlack 2010, and 
Tarazona, Garcia-Alcalde et al. 2011 amongst others). Some of the key features are introduced here 
and how eRAD may influence such effects.  
The count data from RNA Seq results from sub-sampling of the ‘population’ of total transcripts 
within individuals and inferring differences in counts as relating to the grouping factors. In light of 
reasonably high level of reproducibility of RNA Seq DE analysis (Marioni, Mason et al. 2008) this does 
not appear to be a large cause for concern, however the extent of the error will ultimately depend 
on the sequencing effort and variability of the transcriptome assessed. The focussed sequencing 
effort in eRAD may reduce unevenness and the erroneous effects of subsampling, due to the 
increased likelihood of sequencing the same loci across individuals. 
More reliable comparisons of read counts between individuals are expected with higher sequencing 
depth, as it becomes more likely that the transcript has received sufficient sequencing effort across 
all individuals, consequently reducing variability. However, expression estimates can still be 
problematic when coverage is high (McIntyre, Lopiano et al. 2011, Tarazona, Garcia-Alcalde et al. 
2011). Higher depth of sequencing also provides increased statistical power due to the greater 
sampling size (Oshlack and Wakefield 2009). It has been previously estimated that to gain accurate 
quantification of >95% of transcripts in a mammalian transcriptome would require ~700 million 
reads, although this is reduced to <10 million for 80% of reads (Blencowe, Ahmad et al. 2009). 
Therefore, the increased depth of sequencing provided for fewer transcripts by eRAD was predicted 
to improve reliability of quantification via read counts. Additionally, many RNA Seq DE analyses 
suffer from reduced statistical power by the inclusion of a minimal number of replicates. The 
increased sequencing depth per locus gained from eRAD would also allow for the inclusion of more 
individuals, thus improving statistical power.  
One of the most common biases in short read RNA Seq count data is that longer transcripts have a 
much higher probability of being sequenced than shorter ones, simply due to the increased range 
available to initiate sequencing (Oshlack and Wakefield 2009). Increased sequencing depth results in 
increased statistical power due to reasons described above. Therefore, longer transcripts are more 
likely to be recognised as DE than shorter transcripts. It is unknown how the eRAD method will affect 
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this bias. Although all transcripts will initiate from the same restriction recognition site, there is a 
greater probability of a recognition site being present in a longer transcript. Therefore this bias will 
likely affect eRAD count data in a similar fashion. 
There are however, capabilities of RNA Seq, which eRAD will not be able to fulfil such as strand 
specific analyses  (Levin, Yassour et al. 2010). Furthermore, although unable to generate a fully 
assembled transcriptome due to the reduced representation method of sequencing, eRAD intended 
to improve the quality of de novo assembled contigs compared to RNA Seq through the increased 
depth and therefore reliability of the sequenced loci. As described earlier, many of the functional 
uses of sequence data do not require a fully assembled transcriptome/genome, yet sequence 
accuracy is of great importance. 
NGS in Lymnaea stagnalis 
The Davison research group has generated both genomic and transcriptomic resources for the 
inbred chirally dimorphic lines of L. stagnalis. As introduced in Chapter 1, successful RADSeq has 
been performed, leading to the identification of tightly linked chirality markers and ultimately the 
chirality locus (Liu, Davey et al. 2013). Additionally, transcriptomic data has been acquired from both 
one cell and 32 cell L. stagnalis embryos, via RNA Seq on the 454 sequencing platform, although 
quantitative analyses were not performed on this data (Liu, Davey et al. 2014). Accordingly, there is 
a considerable amount of both genomic and transcriptomic sequence data available for L. stagnalis 
within the Davison research group, though still in the process of assembly. Collaborative efforts are 
continuing on the L. stagnalis genome sequencing project based in France (Genoscope-CEA, de la 
recherche à l’industrie). As of this year 3/4 of the genome (946 Mb) has been captured at 20 times 
depth (project update, January 2015 pers. comm.). 
As described previously, the chiral determinant is known to be a maternal transcript and so in order 
to assess causative transcripts as opposed to downstream gene expression associated with chiral 
variation the ovotestis was selected for sequencing. The eRAD data was hoped to provide improved 
de novo quantitative gene expression data across the transcriptome in addition to a descriptive 
transcriptomic resource for the ovotestis tissue. When the eRAD/RNA Seq project was commenced, 
the Davison research group was yet to identify the primary candidate, Ldia2. In light of the recent 
progress in the genomic data analysis, which has finely mapped the chirality locus and associated 
sequence variation, the transcriptome data analysis was prioritised for quantitative gene expression 
differences. The quantitative abilities of the transcriptomic data would allow variation to be 
characterised in genes that do not exhibit sequence variation and potentially reveal functional 
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processes associated with chiral dimorphism unobtainable from the genomic data analysis ongoing 
within the Davison research group. 
The overall aim of this project however, was not only to generate sequence information contributing 
to the characterisation of the chirality determinant in L. stagnalis but also to develop a novel 
sequencing method to improve transcriptomic analyses in non-model organisms.  
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Methods 
Samples 
Each individual used in the eRAD experiment were offspring from a single, self-fertilised Lymnaea 
stagnalis (5995) bearing the sinistral phenotype with heterozygous (Dd) genotype. It is important to 
note that because L. stagnalis is hermaphroditic, genetic recombination still occurs when self-
fertilising. 
The entire ovotestis (ranging from 10 - 25 mg, data not shown) was dissected from a fresh individual 
adult snail and snap-frozen within a microcentrifuge tube using a dry ice/ethanol slurry to minimise 
RNA degradation whilst the remaining samples were extracted. Total RNA was extracted within an 
hour of freezing the fresh tissue, using TRI Reagent® solution (Applied Biosystems) according to the 
standard protocol and eluted into 100 μl RNase free water. 
The genotypes of the snails were inferred firstly from the coiling direction of their offspring. The 
individuals producing sinistral offspring were scored as homozygote recessive, dd. Those producing 
dextral offspring however, required additional DNA extractions and PCRs using genetic linkage 
markers previously established for this population to specify chiral genotype. The specific PCR used 
was ‘b3g FP1 F8R8’. The PCR reaction followed the protocol outlined in Box 2, and the primer 
sequences are described in the SI (S2). Twenty-two samples were selected for the eRAD sequencing 
experiment. These comprised four DD, ten Dd and eight dd samples. 
Total RNA samples were enriched for mRNA using the Poly(A) PuristTM kit (Ambion/Applied 
Biosystems) according to the kit specified protocol. Due to the relatively low starting quantity of 
total RNA, ~10 μg (Table 49) (note that the Poly(A) kit allows for 2 - 400 μg), the final mRNA was 
reprecipitated in the minimum appropriate volume: 10 μl of RNA storage solution. The mRNA 
samples were quantified using spectrophotometer (Nanodrop 2000, ThermoFisher Scientific). Due to 
the low quantity of sample, extensive quality assessments of the RNA could not be performed, 
however the 260/230 and 260/280 ratios from the Nanodrop data provide an indication of sample 
quality (ThermoScientific 2010). 
Double-stranded complimentary DNA (ds cDNA) was synthesised from approximately 500 ng of 
mRNA using the protocol provided by Susan Bassham, Oregon University (2011, pers. comm.) 
described in Box 4. The ds cDNA samples were then purified and concentrated using the MinElute® 
reaction clean-up kit (Qiagen) and eluted into 12 μl. The samples were then quantified via 
fluorometer (Qubit®, ds DNA broad-range BR assay, Invitrogen). The remaining mRNA not used in 
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cDNA synthesis was stored at -80°C and subsequently sent to TGAC to be prepared for RNA 
Sequencing (August 2012).  
eRAD Library Preparation 
The eRAD library preparation protocol was adapted from the original RAD sequencing method 
(Baird, Etter et al. 2008) in accordance with advice from Simon Baxter (University of Adelaide), 
Natalie Lowe (University of Edinburgh), Darren Heavens (TGAC) and Mengning (Maureen) Liu 
(previous Davison research group member). The libraries were prepared by both Mengning 
(Maureen) Liu and me. Two eRAD libraries were prepared independently. The 22 samples were split 
into two groups of 11 allocating 2 DD, 5 Dd & 4 dd individuals in each library. The two libraries are 
referred to here as Library 3 and Library 4. The generalised library preparation protocol is described 
in Box 5 - Box 8. The initial sample preparation and digest steps of the protocol (Box 5) were adapted 
to correct for the reduced amount starting material. Additionally, the amount of P1 adaptor was 
adjusted to the variable input quantity of samples within Library 4. The specific volumes are 
presented in Table 49. 
Throughout the eRAD library preparations, a number of steps require the product to be purified and 
concentrated to a smaller volume. Throughout the protocols this is often abbreviated to ‘purify and 
concentrate’. This was performed using the MinElute® kit, which employs DNA binding spin columns 
(Qiagen), using either the reaction clean-up kit, gel extraction kit or the PCR clean-up kit. In all cases 
the protocol was followed as specified by the supplier, although an additional waiting time of 1 
minute was included prior to each centrifugation to allow for maximum binding to the column 
membrane. Where possible, the final elution was performed in two steps, each using half of the 
desired final volume, provided that the reduced elution volume did not contradict the minimum 
required volume for elution. For example, if the final elution volume was 20 μl, two elutions of 10 μl 
would have been performed.  The final gel extraction of the entire prepared library was performed 
twice on Library 4, in attempt to further clean the high level of primer dimer (gel images of each size 
selection step are presented in the SI, S11.3). 
Each library preparation was completed over three consecutive days. The two libraries were sent to 
the Genome Analysis Centre (TGAC) and sequenced by paired-end Illumina sequencing on two HiSeq 
lanes. Library 3 was sequenced on lane 6 and Library 4 was sequenced on lane 7, the sequencing 
data is hereafter referred to as ‘L006’ and ‘L007’ respectively. The library samples were spiked with 
20% PhiX. This is a much higher concentration than the standard 1%, recommended due to expected 
highly repetitive nature of the dataset (Matthew Clark, TGAC, pers. comm. December 2012). 
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Double stranded cDNA synthesis protocol 
Combine: 
2 μl Random Primer Mix (NEB) 
0.8 μl 10 mM dNTP mix 
X μl (up to 0.5 μg) RNA 
X μl (if necessary) RNase free water to bring total to 13 μl  Total: 13 μl 
Heat to 65°C for 5 minutes, then ice 
Collect contents at bottom of tube by brief centrifugation. 
Add: 
4 μl 5x First-Strand Buffer (Invitrogen) 
1 μl 0.1 mM DTT (Invitrogen) 
1 μl RNase inhibitor (RNAseOUTTM 40 U/μl, Invitrogen) 
1 μl Superscript III reverse transcriptase (200 U/μl, Invitrogen)   Total: 20 μl 
Mix by gentle aspiration 
Incubate at 25°C for 10 min. 
First strand synthesis: Incubate at 50°C for 50 minutes. 
Inactivation: 85°C for 5 minutes. Chill on ice, collect contents to bottom by short spin. 
Add (on ice): 
106.6 µl water 
15 µl 10x Second-Strand Synthesis Reaction Buffer (B6117S, NEB) 
3 µl dNTP mix (10 mM) 
1 µl E. coli ligase (10 U/µl) 
4 µl E. coli DNA polymerase I (10 U/µl) 
0.4 µl E. coli RNase H (5 U/µl)       Total: 150 μl 
Mix by aspiration on ice 
Second strand synthesis: incubate at 16˚C for 2 hours (not allowing to warm above 16˚C) 
[Reaction can be scaled up to accommodate more starting RNA] 
Box 4 Generalised protocol for generating double-stranded complementary DNA (cDNA) from RNA. 
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eRAD library protocol. Part 1: Sample preparation 
1. Sample preparation 
Purify and concentrate double-stranded cDNA using the MinElute® reaction cleanup kit (Qiagen) 
and quantify using a fluorometer (Qubit, Invitrogen). 
2. Restriction Digest 
Digest 100 ng double-stranded cDNA (or maximum possible within 10 μl volume) with PstI.  
Add [No mastermix]: 
 8.7 µl  ds cDNA 
    1 µl  NEB3 (10x) 
 0.1 µl  BSA (100x) 
 0.2 µl PstI (20 U/ µl) 
    X µl water (if necessary to bring total to 10 µl)     
Total:   10 µl 
Incubate: 37 °C for 2 hrs, 80 °C for 20 min, 0.1 °C / sec ramp down to 20 °C 
3. Ligation of P1 adapter 
Ligate the specific barcode including P1 adaptor to individual samples. Adjust the amount of 
adapter to account for reduced input quantity of cDNA. 
  1 reaction Master Mix (14) Per sample 
NEB2 (x10) 0.2 µl 2.8 µl 
1.6 µl 
rATP (100 mM) 0.2 µl 2.8 µl 
H20 1.2 µl 16.8 µl 
Mix by aspiration,  then add: 
Library 3: specific barcode (100 nM) 0.15 µl   
Library 4: specific barcode (20 nM) 0.1-0.3 µl   
Mix by aspiration, 15 minute incubation at room temp, then add: 
T4 Ligase (2 MU/mL)  0.1 µl   
Total 2 µl   
Incubate: 22 °C for 1 hr, 65 °C for 20 min, 0.1 °C / sec ramp down to 20 °C 
 
Box 5 Generalised protocol for the generation of an expression RAD sequencing library, part one of four. 
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Figure 45 Specific sequence and cut sites (indicated by red triangles) recognised by restriction digest 
enzymes SbfI and PstI. Resulting overhang (‘sticky ends’) are indicated by coloured text. 
 
 
 
eRAD library protocol. Part 2: Library shearing & size selection 
Pool samples, now ligated to a unique sequence identifier, prior to shearing. 
4. Shear fragments via sonication 
Fragment approximately 125 l of the library (capacity of Covaris® tube) using the Covaris® 
ultrasonicator.   
Settings: Duty cycle: 5%; Intensity: 3; Cycles/Burst: 200; Mode: Freq sweeping; Duration: 30 sec.   
These settings should result in a fragment size of approximately 400 bp 
Purify & concentrate: Elution volume: 20 μl EB 
5. Gel electrophoresis and size extraction 
Load 20 µl of sheared product with 5 µl of loading dye (Qiagen) into a 0.5x TBE and 2% agarose gel 
with ethidium bromide for UV visualisation. Run at 100V for 90 minutes. 
Excise sheared DNA sized between 300-700 bp from the gel. Extract DNA from the gel fragment 
using Qiagen Gel Extraction Kit (dissolve gel at room temperature). Elution volume: 20 μl EB 
 
Box 6 Generalised protocol for the generation of an expression RAD sequencing library, part two of four. 
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eRAD library protocol. Part 3: Ligate P2 adapter 
6. Quick Blunt 
‘Polish’ the ends of the DNA using the Quick Blunting Kit (NEB). Note: it is assumed 1 μl is lost 
through elution through column. 
Add: 
 19 l  DNA 
2.5 l Buffer 
2.5 l dNTP 
1.0 l Enzyme 
Total:   25 l 
Incubate: room temperature, 30 minutes. 
Purify & concentrate: Elution volume: 24 μl EB 
7. Add dATP 
Add: 
 23 l DNA 
   3 l Buffer NEB2 
   1 l dATP (10 mM) 
   3 l Klenow exo- (15 Units) 
Total:  30 µl 
Incubate: 37 °C for 30 minutes. Allow reaction to cool slowly (within the inactivated heat block) to 
room temperature (approximately 15 minutes). 
Purify & concentrate: Elution volume: 26 μl EB 
8. Ligate P2 Adapter 
Add: 
   25 l DNA 
     3 l Buffer NEB2 
 0.5 l rATP (100 mM) 
     1 l P2 Adapter (10 M) 
 0.5 l T4 Ligase 
Total:   30 µl 
Incubate: room temperature, 30 minutes. 
Purify & concentrate: Elution volume: 20 μl EB 
 
 
Box 7 Generalised protocol for the generation of an expression RAD sequencing library, part three of four. 
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eRAD library protocol. Part 4: PCR amplification 
9. Trial PCR   
Trial PCR: 20 l volume. Positive control: nRAD7. Negative control: water. 
Add: 
  1 l DNA library 
10 l Phusion® High fidelity PCR master mix (NEB) 
  1 l P1-PCR primer (10 µM) 
  1 l P2-PCR primer (10 µM) 
    7ul H2O 
Total:  20 µl  
Thermocycling parameters:  
1. 98°C  30 secs 
2. 98°C  10 secs  
3. 65°C  30 secs  
4. 72°C  30 secs    
5. Cycle from step 2, 29 more times  
6. 72°C   5 mins 
10. Visualise PCR products on agarose gel: 
Load the entire PCR product with 5 µl of 6x loading dye (Qiagen), into a 0.5x TBE and 2% agarose gel 
with ethidium bromide for UV visualisation. Run at 100V for 1 hour.  
11. Bulk PCR 
Following successful test PCR perform the bulk PCR, made in 120 l volume and split into 6 x 20 µl 
reactions. Negative control: water 
Add: 
 63 l H2O 
 24 l Phusion® buffer (5x) (NEB) 
4.8 l dNTP (5 μM) 
   6 l P1-PCR primer (10 μM) 
   6 l P2-PCR primer (10 µM)  
 15 l DNA library 
1.2 l Phusion® polymerase 
Total:  120 µl  6 x 20 µl reactions 
Thermocycling parameters:  as above but reduced to 18 cycles. 
Purify & concentrate: Elution volume: 20 μl EB 
12. Visualise PCR products on agarose gel: 
Load the entire PCR product with 5 µl of 6x loading dye (Qiagen), into a 0.5x TBE and 2% agarose gel 
with ethidium bromide for UV visualisation. Run at 100V for 1 hour. 
Excise the PCR product sized between 300-700 bp from the gel. Extract DNA from the gel fragment 
using Qiagen Gel Extraction Kit (gel dissolved at room temperature). Elution volume: 20 μl EB  
 
Box 8 Generalised protocol for the generation of an expression RAD sequencing library, part four of four. 
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Data Analysis 
The raw RNA Seq data of the mRNA samples was received in October 2015. Therefore, due to time 
limitations, the RNA Seq data analysis was unable to be included within this thesis. The following 
methods and results are only in relation to the eRAD sequencing data. 
Raw data preparation 
The sequence data was received from TGAC as multiple fasta format sequence files labelled 
according to sequencing lane and either R1 (forward/primary sequence read) or R2 (paired-end 
sequence read). Quality control (QC) summary reports were generated using FastQC (Andrews 
2010). 
The multiple fasta files were then concatenated into 4 large fasta files according to library and read 
direction; L006 R1 reads, L006 R2 reads, L007 R1 reads and L007 R2 reads. The resulting collated raw 
sequence data fit the format required for use in the stacks analysis program (Catchen, Amores et al. 
2011, Catchen, Hohenlohe et al. 2013).  
Stacks analysis 
The stacks program builds a catalogue of ‘radtags’ using only the R1 reads. The R2 reads are used to 
enable the clone filter program and to assemble the transcriptomic contigs, however do not directly 
contribute to the radtag count data. 
Process Radtags 
The program ‘process_radtags’ identifies raw sequence reads containing the specified restriction 
cut-site sequence and unique barcode at the start of the sequence and converts them into ‘radtags’ 
per individual. Any read without the specific cut site or barcode identifier is removed from the 
dataset. R2 reads are matched to their R1 read using the information provided in the raw sequence 
fasta file. Both libraries were processed independently, using the same parameters, which were as 
follows. The function -c was enabled to remove any read with an uncalled base. The quality scores 
were specified as encoded using the Illumina ‘Phred33’ cut off and the function -q was enabled to 
discard reads with low q scores. The function -r was enabled to ‘rescue barcodes’ where possible, 
the minimum sequence difference between all barcodes was specified as 3 (calculation presented in 
the SI, S11.4). Finally, all reads were truncated to 70 bases using the -t function, specified at 70. 
Once completed the program output a new fasta format file containing the radtags specific within 
each individual barcode. The 11 files generated were then renamed according to the individual snail 
ID they were derived from. Ultimately 22 individual files containing the cleaned radtags sequenced 
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within each sample were generated. A log data file was also produced providing summaries of read 
counts per library. 
Clone filter 
The initial data analysis employed the ‘clone_filter’ program, which removes any R1 and R2 read pair 
which has an identical sequence to another R1 and R2 pair within an individual sequence file. The 
original R1 and R2 reads remain and only the duplicate pair is removed. These datasets are referred 
to with the prefix ‘SUPER’. In order to assess the effects of using the clone filter, a second method of 
data analysis, which employed the same process_radtags parameters but did not utilise the clone 
filter step, was performed. These datasets are referred to with the prefix ‘FULLFAT’. 
The results from process radtags and the clone filter were used to calculate descriptive information 
for each library. Proportional representation of individuals and libraries were calculated as 
percentages within Microsoft Excel 2010. 
Catalogue assembly 
The ‘denovo_map’ program was employed, which computes the three core Stacks programs, 
ustacks, cstacks and sstacks sequentially. All datasets were analysed as a mapping cross, using a 
‘superparent’ generated by concatenating the processed individual RAD tag files of all samples used 
within the dataset. The catalogue loci were generated only from stacks created from the 
superparent. Stacks created from each of the individual samples were then mapped to the catalogue 
loci. This then generates a form of count data, providing tag counts corresponding to the sequencing 
depth of specific stacks at each locus within an individual.  
The only stacks parameter that was altered from the default settings was the minimum sequencing 
depth required to create a stack in the parent (-m). A number of varied settings, including the 
default value of 3, were trialled to best suit the novel eRAD data and are presented in the SI (S14). 
The minimum sequencing depth to create a stack in the progeny (-P) was kept at the default value of 
3. Six different stacks catalogues were chosen for further analysis, which are described briefly here 
and summarised in Table 52.  
Firstly, three separate datasets were created from the sample files which employed the clone filter. 
One catalogue was generated using all 22 samples from both libraries, using a superparent created 
from collating all 22 samples as the ‘parent sample’. This dataset is referred to as ‘SUPER’. Another 
was generated using only the samples from L006 and using a superparent created by concatenating 
all 11 samples from that library. This dataset is referred to as ‘SUPER6’. The third dataset was 
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generated using only the samples from L007 and using a superparent created by concatenating all 11 
samples from that library. This dataset is referred to as ‘SUPER7’. 
By the same rationality, three datasets were created from the samples which did not employ the 
clone filter. These are referred to as ‘FULLFAT’, ‘FULLFAT6’ & ‘FULLFAT7’ and are also summarised in 
Table 52. 
The datasets generated with a superparent created from 22 individuals (SUPER and FULLFAT) were 
analysed using an -m value of 15. The datasets generated with a superparent created from 11 
individuals (SUPER6, SUPER7, FULLFAT6, FULLFAT7) were analysed with an -m value of 12. 
Paired-end contig assembly 
The paired-end reads were first allocated to individuals and stacks using the Stacks program 
‘sort_read_pairs.pl’. The paired sequence reads were then assembled into paired-end contigs (pe 
contigs) de novo within the program ‘Velvet’ (Zerbino and Birney 2008). Contig assemblies were 
generated for all three of the clone-filtered datasets (SUPER, SUPER6 and SUPER7). The superparent 
was not included in the contig assembly. The minimum contig length was specified to be -150 bases. 
Differential expression analysis 
Count data from the superparent and from any multi-allelic loci were excluded from the differential 
gene expression analysis. 
The ‘raw’ count data exported from Stacks of each of the six catalogues (SUPER, SUPER6, SUPER7, 
FULLFAT, FULLFAT6 & FULLFAT7) were analysed in the program ‘edgeR’ (version 3.12.0, a freely 
available package within R) (Robinson and Smyth 2007, Robinson and Smyth 2008, Robinson, 
McCarthy et al. 2010, Robinson and Oshlack 2010). A range of parameters can be altered within the 
analysis. The analyses were performed here using the advice provided in the edgeR user’s guide 
(Robinson, McCarthy et al. 2012) to identify differentially expressed (DE) RAD tags between the 
three genotypic groups: DD, Dd, dd. A number of variations of the datasets were assessed, which are 
described below and summarised in Table 55. The specific individuals included within each dataset 
are presented within the summary statistics in the SI (S15).  
full dataset 
Each sample sequenced within the eRAD library was included in the initial DE analysis. This resulted 
in two datasets of 22 individuals (SUPER & FULLFAT) and 4 datasets of 11 individuals (SUPER6, 
SUPER7, FULLFAT6 & FULLFAT7). 
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3Q 
With the aim to reduce high variation within groups caused by predicted large numbers of zero 
counts, only those samples with the upper third quartile of tag counts >0 were included in the ‘3Q’ 
analysis. This resulted in one dataset of 17 individuals (SUPER_3Q), one dataset of 16 individuals 
(FULLFAT_3Q) and four datasets of nine individuals (SUPER6_3Q, SUPER7_3Q, FULLFAT6_3Q & 
FULLFAT7_3Q). The SUPER7_3Q and FULLFAT7_3Q datasets necessitated the removal of one of the 
two DD samples. Thus statistical comparisons of group means were not included for this group due 
to the lack of available replicates.  
Bd 
With the aim to omit sample group number bias, balanced ‘Bd’ datasets were generated which 
included equal numbers of each genotype within the DE analysis. This resulted in two datasets of 12 
individuals (SUPER_Bd & FULLFAT_Bd) and four datasets of six individuals (SUPER6_Bd, SUPER7_Bd, 
FULLFAT6_Bd & FULLFAT7_Bd). Where required, the first samples omitted were those with third 
quartile count data of 0. The remaining samples were removed without known bias, although in the 
case of SUPER_Bd and FULLFAT_Bd equal numbers were removed from each library. 
Rm 
To test the biological inferences of findings and the capabilities of the FDR corrections, a final 
dataset was created from the SUPER catalogue to test a random ‘Rm’ DE analysis. Three groups were 
created; A, B & C, each containing one DD, one Dd and one dd individual sample. 
EdgeR analysis 
EdgeR is based on a negative binomial model. It first automatically calculates library sizes from the 
total of counts within the sample. The tags were filtered to a minimum of 1 count per million (cpm) 
for the maximum number of samples representative of a genotypic group, therefore this filter 
ranged from 2-4 (Table 55). Each sample’s count data was made relative, ‘normalised’, using the 
trimmed mean of M values (TMM) method via the inbuilt algorithm ‘calcNormFactors’ (Robinson 
and Oshlack 2010).  
EdgeR calculated the dispersion using the quantile-adjusted maximum likelihood (qCML) method 
across the entire dataset (common dispersion) and for each tag within the dataset (tagwise 
dispersion). Subsequently the biological coefficient of variation (BCV) was calculated, which 
represents total variation between replicates. Mean variance plots were also generated to assess 
whether the dataset appropriately fits the model. Multi-dimensional scaling (MDS) plots were 
generated to explore clustering of overall gene expression patterns across samples. 
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Pairwise comparisons of normalised RAD tag counts were performed between each pair of 
genotypes: dd - DD; Dd - DD & dd - Dd. EdgeR identified DE of RAD tags between genotype groups 
using the ‘exact test’. Based on the qCML methods the exact test incorporated the tagwise 
dispersion for each comparison. Statistical probability values were automatically adjusted using the 
Benjamini and Hochberg algorithm (Benjamini and Hochberg 1995) to account for multiple 
comparisons and control the false discovery rate (FDR).  
The tags identified as differentially expressed within the ‘SUPER’, ‘SUPER6’ and ‘SUPER7’ datasets, 
were assessed for associated function by performing an NCBI Blastx online 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) on their associated paired-end contigs. If a Blast hit was not 
acquired for the pe contig or if the consensus sequence lacked a pe contig, the consensus sequence 
was Blasted firstly against the SUPER assembly and then the local L. stagnalis genomic assembly 
(version 10) to identify a related contig. The top contig was then assessed for function via Blastx 
online. 
Gene Ontology 
Blast2GO® was used to assess the gene ontology of the pe contigs (Conesa, Gotz et al. 2005). The 
functional annotation was performed by Dr. Teri Evans within the Blast2GO Pro software. Each of 
the three assemblies; SUPER, SUPER6 and SUPER7 were analysed separately. Firstly, each contig was 
characterised via Blastx, using an e value limit of 0.01, to a non-redundant protein database 
prepared by Dr Evans, including all vertebrate and invertebrate sequences downloaded from NCBI 
(20th June 2011) and subsequently run through Cd-hit (Li and Godzik 2006) to ensure it was non-
redundant. The final protein database contained 407,788 sequences (the protein database was 
originally developed in Evans, Wade et al. 2014). The contigs were then annotated with likely 
associated Gene Ontology (GO) terms within Blast2GO®.  Following the generation of the Blast2GO 
annotated assemblies, the remaining analyses were performed by me. 
A number of the RAD tags generated multiple paired-end contigs. The annotations for each contig 
were pooled according to the RAD tag ID they were generated from. Therefore, each consensus RAD 
tag is represented only once within the functional annotation of the assembly. Descriptive 
summaries of the annotation of each of the transcriptomic assemblies were created, however 
further analyses within Blast2GO were limited by user licence access. 
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Results 
Library preparation 
Once enriched for mRNA, the RNA samples retained on average, 10% of their original concentration 
(data presented in the SI, S11.1). The ds cDNA samples, although all generated from approximately 
500 ng of mRNA as advised, were of a generally low concentration, such that for the majority of 
individuals, the entire sample had to be used in the restriction digest reaction and did not reach the 
desired 100 ng per sample (Table 49). This was more pronounced in library 4 (L007), where the cDNA 
concentrations were more variable. 
The eRAD libraries showed a reasonably high level of primer dimer, although this was removed 
through gel extraction. The second gel extraction of Library 4 showed no obvious primer dimer 
remaining in the library (gel images are presented in the SI, S11.3). 
eRAD sequence data 
Fast QC 
The Fast QC output showed generally low quality sequence data was generated from the two eRAD 
libraries. L006 was considerably worse quality the L007. This is reflected in the per base quality 
scores along the sequence read shown in Figure 46. 
Each library failed the QC check for ‘overrepresented sequences’. These sequences were often 
classed by the program as the Illumina sequencing primers. Second to the Illumina sequence 
primers, the most common overexpressed sequence was identified as relating to soma ferritin or 
ferritin.  
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Table 49 Sample information for the 22 L. stagnalis ovotestis samples used in eRAD library 3 and 4. Information includes sample identifier (ID) and genotype (Geno), the mRNA sample 
quantity (ng/µl) with associated 260/280 and 260/230 ratios and the resulting total yield (µg) according to the sample volume (10 µl). The ds cDNA synthesis information includes the 
amount of mRNA used in the reaction (µl mRNA and ng mRNA), and the resulting cDNA concentration (ng/µl) and total yield (ng) in resulting the 12 µl sample volume. The library sample 
preparation shows in which library the sample was included, the amount of cDNA used per sample (µl & ng), the specific five nucleotide sequence identifier (Barcode) and the amount of 
P1 adaptor (µl P1) added to each sample. Note: P1 was used at 100nM concentration in Library 3, and 20nM in Library 4. 
Sample Info mRNA, sample volume 10 µl ds cDNA synthesis, sample volume 12 µl Library sample preparation 
ID Geno ng/μl  260/280 260/230 
Total yield 
(μg) 
μl 
mRNA 
ng 
mRNA 
ng/μl  
Total yield 
(ng) 
Library 
µl 
cDNA 
ng 
cDNA 
Barcode µl P1 
9014 DD 77.00 1.66 1.84 0.77 6.5 499.7 8.99 107.88 3 10.0 89.9 ATGCT 0.15 
8515 DD 94.04 1.71 1.89 0.94 5.3 500.3 11.75 141.00 3 8.5 100.0 CCAAC 0.15 
8869 Dd 142.16 1.84 2.23 1.42 3.5 500.4 23.85 286.20 3 4.2 99.9 AGCTG 0.15 
9013 Dd 111.74 1.69 2.03 1.12 4.5 500.6 9.62 115.38 3 10.0 96.2 CATGA 0.15 
8562 Dd 87.88 1.71 1.85 0.88 5.7 500.0 10.80 129.60 3 10.0 108.0 GCCGG 0.15 
8559 Dd 103.57 1.70 1.92 1.04 4.8 500.2 8.85 106.20 3 10.0 88.5 GAGAT 0.15 
8544 Dd 150.08 1.68 1.96 1.50 3.3 499.8 9.67 115.98 3 10.0 96.7 TGCAA 0.15 
8862 dd 96.23 1.69 1.98 0.96 5.2 499.4 9.32 111.78 3 10.0 93.2 ACGTA 0.15 
8808 dd 116.94 1.69 1.98 1.17 4.3 500.5 10.40 124.80 3 10.0 104.0 CGTAT 0.15 
9007 dd 83.43 1.66 1.93 0.83 6.0 500.6 8.83 105.90 3 10.0 88.3 GTACA 0.15 
9009 dd 91.31 1.69 1.62 0.91 5.5 500.4 14.50 174.00 3 6.9 99.8 TAATG 0.15 
8582 DD 103.35 1.59 1.43 1.03 4.8 496.1 2.47 29.64 4 10.0 24.7 TACGT 0.1 
8502 DD 100.02 1.60 1.51 1.00 5.0 500.1 7.74 92.88 4 10.0 77.4 GTTGT 0.2 
9001 Dd 115.58 1.64 1.63 1.16 4.3 497.0 9.30 111.60 4 10.0 93.0 TGACC 0.3 
8522 Dd 125.53 1.63 1.47 1.26 4.0 502.1 10.70 128.40 4 10.0 107.0 GGTTC 0.3 
8500 Dd 118.02 1.67 1.73 1.18 4.2 495.7 10.30 123.60 4 10.0 103.0 CAGTC 0.3 
8530 Dd 115.69 1.63 1.42 1.16 4.3 497.5 7.09 85.08 4 10.0 70.9 CCTTG 0.2 
8560 Dd 109.62 1.59 1.50 1.10 4.6 504.3 7.28 87.36 4 10.0 72.8 ATTAG 0.2 
8531 dd 88.99 1.67 1.66 0.89 5.6 498.3 9.10 109.20 4 10.0 91.0 TCTCT 0.3 
9000 dd 107.10 1.59 1.44 1.07 4.7 503.4 4.67 56.04 4 10.0 46.7 ATCGA 0.15 
8867 dd 86.72 1.59 1.83 0.87 5.7 494.3 3.83 45.96 4 10.0 38.3 CTTCC 0.15 
8587 dd 55.25 1.74 1.91 0.55 9.0 497.3 5.06 60.72 4 10.0 50.6 AGAGT 0.15 
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Figure 46 Quality scores per base along the length of Illumina sequencing reads (1-101) for L006 and L007 primary 
sequence reads (R1) and paired-end reads (R2). Q40 represents the best currently available quality score. The green, top 
zone indicates good quality reads, the bottom dark pink zone indicates poor quality reads. The error bars indicate the 
variability of sequence quality at this base position across all reads. 
 
Figure 47 Bar chart shows percentage of reads retained of the original total reads per individual. L006 is shown in black. 
L007 is shown in grey. 
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Process radtags & clone filter 
The summarised input and output data from the process radtags program is presented in Table 50. 
Each library produced a similar amount of retained reads. L006 and L007 represented 48% and 52% 
of the total combined dataset respectively. Yet the individual sample sequencing coverage within 
libraries was highly variable, with a number of individuals representing less than 1% of the dataset 
and notable one sample, Dd 9001, represented nearly half of the total sequences of L007 (Table 50, 
Figure 48). 
The proportion of retained sequence reads prior to the clone filter reflected the overall quality of 
the library as indicated by the FastQC report. The samples in L007 retained more reads than those in 
L006. Averages are presented in Table 50 of the total retained reads across libraries. Both libraries, 
on average, retained over 77% of total reads, although substantial variation was observed between 
individuals, ranging from 60.99% - 95.01% retained (Figure 47). 
The input and output of the clone filter program is summarised in Table 51. Firstly, it shows that of 
the retained reads, on average, over 75% had a paired-end (pe) read. Again variation between 
individuals was high, ranging from 46.10% - 95.69%. L007 generally showed higher levels of pe reads 
in individuals, and also higher levels of PCR clones.  
The clone-filtered data resulted in greater differences between the sequencing effort of each library 
(Table 51). The clone filter identified, on average, over 65% of read pairs to be PCR clones. This was 
more pronounced in L007, such that following the clone filter, L007 represented only 32% of the 
combined dataset and retained only a quarter of its original sequencing reads (Table 51, Figure 47). 
However, the proportional representation of individuals within each dataset following the clone 
filter was somewhat more balanced, with dominance of high proportion individuals reduced (Figure 
48, Table 51). 
The sample sequencing bias which resulted in the highly varied representation of samples within the 
datasets was not found to be correlated with percentage GC composition of the five nucleotide 
sequence barcode, nor the cDNA starting concentration, quantity or quality, nor the amount of P1 
sequence adaptor added (correlations are presented in the SI, S13).  
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Table 50 Summarised output from the process_radtags data preparation. Sample descriptions include sample ID (ID) and 
genotype (Geno) and library. Total reads input for each sample are presented (Total reads) with those retained after 
process_radtags (Ret. Reads). The amount of reads retained from the total input for each individual are presented as a 
percentage (% Ret./total). Finally the proportional representation of each individual within the library (% lib) and across 
the combined dataset (% dt) is presented as a percentage of the total reads. Totals and averages (Av) are presented for 
each library and across the whole dataset. 
Sample description process_radtags summary 
Library ID Geno Total reads Ret. reads % Ret./total % lib % dt 
L006 9014 DD 41,527,216 26,837,862 64.63 11.79 5.69 
L006 8515 DD 55,050,824 48,120,113 87.41 21.15 10.20 
L006 8869 Dd 11,326,668 8,824,349 77.91 3.88 1.87 
L006 9013 Dd 16,606,626 12,434,572 74.88 5.46 2.64 
L006 8559 Dd 16,173,978 12,402,370 76.68 5.45 2.63 
L006 8562 Dd 10,247,336 8,453,365 82.49 3.71 1.79 
L006 8544 Dd 3,047,000 2,588,442 84.95 1.14 0.55 
L006 8862 dd 73,417,832 44,775,198 60.99 19.68 9.49 
L006 8808 dd 4,797,174 3,460,814 72.14 1.52 0.73 
L006 9007 dd 37,313,460 30,796,771 82.54 13.53 6.53 
L006 9009 dd 33,755,044 28,878,053 85.55 12.69 6.12 
Total per library 11 
2 DD, 
5 Dd, 
4 dd 
303,263,158 227,571,909 Av: 77.29 100.00 48.23 
L007 8502 DD 30,564,502 29,037,979 95.01 11.89 6.15 
L007 8582 DD 3,210,450 2,759,419 85.95 1.13 0.58 
L007 8560 Dd 24,488,372 22,579,501 92.20 9.24 4.79 
L007 8500 Dd 34,298,456 31,215,375 91.01 12.78 6.62 
L007 8530 Dd 5,573,926 4,938,501 88.60 2.02 1.05 
L007 8522 Dd 11,695,918 10,625,576 90.85 4.35 2.25 
L007 9001 Dd 111,770,998 105,076,155 94.01 43.01 22.27 
L007 8587 dd 29,755,458 25,049,071 84.18 10.25 5.31 
L007 9000 dd 2,166,416 1,672,050 77.18 0.68 0.35 
L007 8867 dd 5,752,952 5,042,771 87.66 2.06 1.07 
L007 8531 dd 6,922,482 6,283,512 90.77 2.57 1.33 
Total per library 11 
2 DD, 
5 Dd, 
4 dd 
266,199,930 244,279,910 Av: 82.82 100.00 51.77 
Total in dataset 22 
4 DD, 
10 Dd, 
8 dd 
569,463,088 471,851,819 Av: 83.07 - 100.00 
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Table 51 Summarised output from the clone filter program. Sample descriptions include sample ID (ID) and genotype (Geno) and library. The proportion of retained reads per individual including a 
paired end sequence are presented as a percentage (% pe/Ret.) in addition to the number of pairs of reads input and output. Also shown are; the proportion of input pairs identified as clones presented 
as a percentage (% clones/pe); the total number of reads retained per individual after the clone filter (Ret. After cf); the proportional representation of each individual within the library (% lib after cf) 
and across the combined dataset (% dt after cf) presented as a percentage of the original total reads prior to process_radtags; totals and averages (Av) for each library and across the whole dataset. 
Sample description clone filter summary 
Library ID Geno % pe/Ret. input (pairs) output (pairs) % Clones/pe Ret. after cf % Lib. after cf % dt after cf % Ret after cf/total reads 
L006 9014 DD 54.01 7,247,847 2,852,694 60.64 18,047,556 15.82 10.74 43.46 
L006 8515 DD 88.29 21,241,905 4,449,997 79.05 14,536,297 12.74 8.65 26.41 
L006 8869 Dd 76.81 3,389,104 1,650,905 51.29 5,347,951 4.69 3.18 47.22 
L006 9013 Dd 72.15 4,485,636 1,622,757 63.82 6,708,814 5.88 3.99 40.40 
L006 8559 Dd 75.06 4,654,751 1,636,189 64.85 6,365,246 5.58 3.79 39.35 
L006 8562 Dd 83.23 3,518,067 1,219,602 65.33 3,856,435 3.38 2.29 37.63 
L006 8544 Dd 85.81 1,110,594 468,252 57.84 1,303,758 1.14 0.78 42.79 
L006 8862 dd 46.10 10,320,373 3,325,375 67.78 30,785,202 26.99 18.32 41.93 
L006 8808 dd 77.56 1,342,118 535,407 60.11 1,847,392 1.62 1.10 38.51 
L006 9007 dd 82.93 12,770,129 3,650,671 71.41 12,557,855 11.01 7.47 33.66 
L006 9009 dd 86.55 12,496,571 4,420,583 64.63 12,726,077 11.16 7.57 37.70 
Total per library 11 2 DD, 5 Dd, 4 dd Av: 75.32 82,577,095 25,832,432 Av: 64.25 114,082,583 100.00 67.88 Av: 39.00 
L007 8502 DD 95.69 13,893,495 1,823,011 86.88 4,897,011 9.07 2.91 16.02 
L007 8582 DD 85.69 1,182,275 225,825 80.90 846,519 1.57 0.50 26.37 
L007 8560 Dd 92.84 10,481,626 1,413,584 86.51 4,443,417 8.23 2.64 18.15 
L007 8500 Dd 92.62 14,456,511 2,622,990 81.86 7,548,333 13.98 4.49 22.01 
L007 8530 Dd 89.72 2,215,354 563,807 74.55 1,635,407 3.03 0.97 29.34 
L007 8522 Dd 92.61 4,920,152 1,418,285 71.17 3,621,842 6.71 2.15 30.97 
L007 9001 Dd 95.02 49,923,502 6,446,509 87.09 18,122,169 33.57 10.78 16.21 
L007 8587 dd 83.80 10,495,084 1,948,894 81.43 7,956,691 14.74 4.73 26.74 
L007 9000 dd 74.09 619,415 160,432 74.10 754,084 1.40 0.45 34.81 
L007 8867 dd 88.73 2,237,114 659,425 70.52 1,887,393 3.50 1.12 32.81 
L007 8531 dd 91.87 2,886,324 880,379 69.50 2,271,622 4.21 1.35 32.82 
Total per library 11 2 DD, 5 Dd, 4 dd Av: 89.33 113,310,852 18,163,141 Av: 78.59 53,984,488 100.00 32.12 Av: 26.02 
Grand Total 22 4 DD, 10 Dd, 8 dd Av: 82.33 195,887,947 43,995,573 Av: 71.42 168,067,071 ~ 100.00 Av: 32.23 
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Figure 48 Pie charts show proportional representation of each individual sample’s retained reads within each library and 
dataset, presented as a percentage of the total reads within each dataset. FULLFAT (1a) includes all samples prior to the 
clone filter. FULLFAT6 (2a) and FULLFAT7 (3a) include each sample from L006 and L007 respectively, prior to the clone 
filter. SUPER (1b) includes all samples after the clone filter. SUPER6 (2b) and SUPER7 (3b) include each sample from L006 
and L007 respectively, after the clone filter. Colour identifiers are reused in chart 1a and 1b. Samples run clockwise from 
top.  
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Stacks analysis 
A summary of the six Stacks catalogues; SUPER, SUPER6; SUPER7; FULLFAT; FULLFAT6 & FULLFAT7 is 
presented in Table 52. A similar summary of the catalogues generated through the alternative 
parameters trialled is presented in the SI (S14). 
Each of the non-clone-filtered catalogues produced more unique stacks/loci than their clone-filtered 
equivalent (Table 52). The extent of this difference varied between individuals. Because the 
catalogue is generated only from the superparent, the stacks generated within each 
individual/progeny sample did not vary as the minimum stack depth for progeny was consistently 
‘3’. Therefore, the total unique stacks generated within each individual is presented only once for 
the clone-filtered (SUPER) and non-clone-filtered (FULLFAT) data (Table 53, Table 54). Some 
individuals such as 9001 and 8587 showed almost twice as many unique stacks in the FULLFAT 
analysis compared to the SUPER analysis, whereas others such as 8808 and 8869 showed only a 
couple thousand tags different (Table 53, Table 54). 
There was a discrepancy between the total number of stacks in the SUPER catalogue (56,899) and 
the number present in the parent (56, 8967). The ‘missing’ two stacks also appeared in the SUPER6 
catalogue, yet not in any others (Table 52). The sum of the number of unique loci identified in the 
library specific datasets was approximately 55% higher than that of the combined dataset (for both 
clone-filtered and non-clone-filtered data, Table 52). It is therefore assumed that L006 and L007 
have a reasonable level of overlap of transcriptome coverage. 
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Table 52 Summary of the six Stacks eRAD catalogues. The total number of individuals included per catalogue (n) is 
shown in addition to the number of each genotype (n, DD; n, Dd & n, dd). The minimum sequencing depth to create a 
stack is quoted per catalogue (m). The total number of loci/stacks created in the catalogue is shown (Unique stacks), 
with the number single-nucleotide polymorphisms (SNPs) found. Also shown are the number of ‘blacklisted’ stacks and 
subsequent final number of stacks within the catalogue (Total). The radtags corresponding to a catalogue locus within 
the Superparent (Parent) and increasing numbers of progeny (prog1 – prog20). Finally, the numbers of unique radtags, 
which contain a minimum of one SNP in one to five progeny are listed (prog1-5). 
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Catalogue  SUPER SUPER6 SUPER7 FULLFAT FULLFAT6 FULLFAT7 
Library  L006 & L007 L006   L007 L006 & L007 L006   L007 
Clone filter Yes Yes Yes No No No 
Total n 22 11 11 22 11 11 
n, DD 4 2 2 4 2 2 
n, Dd 10 5 5 10 5 5 
n, dd 8 4 4 8 4 4 
m 15 12 12 15 12 12 
C
at
al
o
gu
e
 
su
m
m
ar
y 
Unique stacks 59,259 51,557 40,275 82,475 60,930 67,109 
SNPs found 4,148,130 3,608,990 2,819,250 5,773,250 4,265,100 4,697,630 
Blacklisted 2,360 1,649 1,945 2,765 1,906 2,341 
Total 56,899 49,908 38,330 79,710 59,024 64,768 
U
n
iq
u
e 
ra
d
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gs
 
Parent 56,897 49,906 38,330 79,710 59,024 64,766 
prog 1 56,393 49,485 38,205 79,368 58,632 64,544 
prog 2 53,241 45,958 35,547 73,088 54,636 53,018 
prog 3 46,557 38,651 29,192 62,320 45,143 39,966 
prog 4 39,987 32,227 23,809 51,592 36,637 30,691 
prog 5 34,988 27,458 19,922 43,758 30,602 24,555 
prog 6 31,341 23,519 16,839 38,014 25,665 20,137 
prog 7 28,291 19,598 14,039 33,598 21,178 16,552 
prog 8 25,638 16,102 11,388 29,969 17,162 13,279 
prog 9 23,395 12,623 8,614 27,105 13,390 9,951 
prog 10 21,362 8,744 4,351 24,601 9,263 5,588 
prog 20 4,915 - - 5,573 - - 
U
n
iq
u
e 
ra
d
ta
gs
, 
SN
P
 =
 1
+ 
prog 1 3,172 2,731 1,577 4,968 3,526 3,247 
prog 2 2,819 2,335 1,381 4,449 3,019 2,611 
prog 3 2,298 1,789 1,047 3,563 2,292 1,762 
prog 4 1,761 1,284 768 2,703 1,632 1,156 
prog 5 1,389 963 547 2,046 1,192 772 
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Table 53 Total unique stacks and single-nucleotide 
polymorphisms (SNPs) found in each of the clone-
filtered samples, used in catalogue SUPER; SUPER6 & 
SUPER7. 
SUPER 
ID Unique Stacks SNPs Found 
8500 32,044 2,243,080 
8560 23,089 1,616,230 
9001 54,079 3,785,530 
8522 23,390 1,637,300 
8530 14,705 1,029,350 
8582 7,298 510,860 
8502 25,154 1,760,780 
8531 19,002 1,330,140 
9000 6,324 442,680 
8867 17,129 1,199,030 
8587 36,721 2,570,470 
9013 24,085 1,685,950 
8559 28,674 2,007,180 
8869 28,188 1,973,160 
8562 21,616 1,513,120 
8544 12,538 877,660 
9014 44,362 3,105,340 
8515 40,417 2,829,190 
8862 41,704 2,919,280 
8808 13,022 911,540 
9007 39,071 2,734,970 
9009 46,996 3,289,720 
 
Table 54 Total unique stacks and single-nucleotide 
polymorphisms (SNPs) found in each of the non-clone-
filtered samples, used in catalogue FULLFAT; FULLFAT6 
& FULLFAT7. 
FULLFAT 
ID Unique Stacks SNPs Found 
8500 50,483 3,533,810 
8560 37,221 2,605,470 
9001 97,395 6,817,650 
8522 27,168 1,901,760 
8530 18,491 1,294,370 
8582 11,586 811,020 
8502 39,171 2,741,970 
8531 21,738 1,521,660 
9000 10,170 711,900 
8867 22,719 1,590,330 
8587 70,412 4,928,840 
9013 28,673 2,007,110 
8559 36,206 2,534,420 
8869 30,511 2,135,770 
8562 25,421 1,779,470 
8544 15,020 1,051,400 
9014 60,497 4,234,790 
8515 50,516 3,536,120 
8862 52,177 3,652,390 
8808 14,893 1,042,510 
9007 47,787 3,345,090 
9009 59,788 4,185,160 
Differential expression analysis 
A summary of the multiple edgeR analyses of the eRAD tag count data is presented in Table 55. 
Summaries of the descriptive statistics of the count data included in each of the analyses are 
presented in the SI (S15). Overall variation was high and count data sets included 27,000 - 57,000 
tags for pairwise comparisons. An overview of the data distribution of the clone-filtered (SUPER) and 
non-clone-filtered (FULLFAT) datasets is presented in Figure 49. Both count datasets exhibited 
similar patterns of data distribution, yet the SUPER dataset presented lower average levels of 
variation compared to FULLFAT. 
No clear clustering was seen in the multi-dimensional scaling (MDS) plots of the expression patterns 
of individuals (Figure 49.1), although there was a potential bias of the library specific samples to one 
side of the plot. L006 samples appear generally on the left hand side of the SUPER dataset and L007 
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samples appear more on the right side. This pattern was reversed in the FULLFAT data (Figure 49.1). 
Furthermore, sample 9001 represented a potential outlier in both datasets. The biological coefficient 
of variation (BCV) plots revealed very high levels of variation in the majority of tags (Figure 49.2). 
This was more pronounced in those tags with lower average expression levels. The Mean-Variance 
plots clearly show that the variance of the data does not fit the Poisson distribution of variance 
(Figure 49.3). The tagwise dispersion was used within all exact tests to compare group means. Due 
to the similarities of the data distribution of the clone-filtered and non-clone-filtered data, only the 
clone-filtered results are presented in detail here. 
The MDS plots of SUPER6 and SUPER7 also did not show any apparent clustering, although sample 
9009 and 9001 represented potential outliers in SUPER6 and SUPER7 respectively (Figure 50.1). The 
BCV plots revealed a similar pattern of tagwise variation within SUPER6 and SUPER7 compared to 
the combined SUPER dataset, yet the overall BCV was reduced in SUPER7 (Figure 49.b, Figure 50.b). 
The Mean-Variance plots again failed to fit the Poisson distribution, although were generally closer 
to the fit-line than those of SUPER (Figure 49.c, Figure 50.c).  
Very few tags were identified as significantly differentially expressed (DE) between genotypes 
following correction for false discovery rate (FDR). Furthermore, two tags were identified as 
significantly DE between randomised groups (containing an equal number of individuals of each 
genotype) (Table 55). Due to the lack of any substantial differences in the data variance or DE results 
in the reduced datasets, only the full SUPER, SUPER6 and SUPER7 datasets are described in detail 
here. Further details of the reduced datasets can be viewed in the SI (S15, S16). 
The SUPER dataset identified only one tag as significantly DE between genotypes, catalogue tag 
38405. This tag was found to be significantly underrepresented in the DD samples compared to both 
Dd and dd samples (Table 55, Figure 51). The top NCBI Blastx hit of the associated pe contig was to 
an uncharacterised protein, the second hit, however of significantly reduced quality was to a von 
Willebrand factor-like protein (Table 57).  
The SUPER6 dataset identified four tags as significantly DE between genotypes, catalogue tags 
14295, 49725, 34376 and 49600. Each of these tags was found to be significantly underrepresented 
in the DD samples compared to both Dd and dd samples (Table 55, Table 56, Figure 52). The top 
NCBI Blastx hits of the associated pe contigs were as follows. Tag 14295 initially blasted to an 
uncharacterised protein in Biomphalaria glabrata, another freshwater snail. An alternative Blast hit 
with a good E value identified a involucrin-like protein in the sea slug, Aplysia californica (Table 57). 
Tag 49725 top hit described a leucine-rich repeat serine/threonine-protein kinase in B. glabrata 
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(Table 57). Tag 34376 had two separate contigs within the SUPER6 assembly. Subsequently both 
were included in the Blastx. The top hit of the shorter contig was an elongation factor 2 - like protein 
described in B. glabrata (Table 57). The longer contig did not generate a significant Blast hit. Finally, 
tag 49600 identified a hypothetical protein described in the bacteria Escherichia coli (Table 57). 
The SUPER7 dataset identified two tags as significantly DE only between genotypes DD and dd 
catalogue tags 11332 and 14621. Contrary to the findings in the other datasets, each of these tags 
were found to be significantly underrepresented in the dd samples compared to the DD (Table 55, 
Table 56, Figure 52). Tag 11332 did have an associated pe contig within the SUPER7 assembly 
however no significant Blast hit was generated. The following top Blastx hits of the genomic contig 
associated with SUPER7 pe contig 11332, were a repetitive proline-rich cell wall-like protein in B. 
glabrata and a number of keratin-related proteins (only top hit shown, from the bird Opisthocomus 
hoazin) (Table 57). Tag 14621 did not have an associated pe contig. The consensus sequence was 
found to be related to a pe contig in the SUPER assembly and in the L. stagnalis genomic assembly. 
However, both contigs were relatively short and failed to acquire a significant Blastx hit (Table 57).  
All bar one of the top hits within the NCBI Blastx analysis of the DE contigs was to a sequence 
described in another gastropod (Table 57). 
De novo transcriptome assembly and Gene Ontology 
The SUPER6 assembly produced a total of 30,438 contigs, whereas the SUPER7 assembly produced 
25624 contigs, although the average length of contigs were slightly longer in SUPER7 (310, compared 
to 306). The highest number of contigs at the greatest length however came from the combined 
SUPER assembly producing 35,696 contigs with an average length of 313. The majority of contigs in 
the assemblies did not get a significant Blast hit (Figure 53, Figure 54, Figure 55). Approximately 30% 
of the contigs in each assembly were able to be annotated. The average length of contigs with 
annotation in the SUPER, SUPER6 and SUPER7 assembly were 352, 341 and 351 respectively (Figure 
53.a, Figure 54.a, Figure 55.a). A quantitative summary is presented in the SI (S17). 
The top tags species allocations presented in Figure 53.d, Figure 54.d and Figure 55.d, all include 
‘Lymnaea stagnalis’ twice. Listed firstly as ‘Lymnaea stagnalis’ and second as ‘Lymnaea stagnalis,’. 
Combining the counts for both of the listings puts L. stagnalis in 11th position, after Gallus gallus in 
the SUPER assembly (Figure 53.d) and 12th position, after Salmo salar in both SUPER6 and SUPER7 
(Figure 54.d, Figure 55.d).  
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Figure 49 Data distribution of SUPER (a) and FULLFAT (b) count datasets visualised in edgeR. MDS plots (1) indicate the 
relatedness of overall expression pattern of individual samples within the dataset. Samples are labelled with a prefix of 
their sequencing library (6 or 7) and their genotype represented here as (DD = DD, DS = Dd or SS = dd). BCV plots (2) 
show the dispersion of each tag (represented by a black dot at the average log transformed level of expression in counts 
per million (cpm)) compared to the common dispersion of the whole dataset (red line). Mean-Variance plots (3) show 
the log transformed variance per ‘gene’ (eRAD tag), including raw variance of counts (grey dots) and variance using the 
tagwise dispersion (blue dots), the common dispersion (solid blue line) and Poisson variance (solid black line), all plotted 
against log transformed average gene expression level. 
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Figure 50 Data distribution of SUPER6 (a) and SUPER7 (b) count datasets visualised in edgeR. MDS plots (1) indicate the 
relatedness of overall expression pattern of individual samples within the dataset. Samples are labelled with a prefix of 
their genotype represented here as (DD = DD, DS = Dd or SS = dd). BCV plots (2) show the dispersion of each tag 
(represented by a black dot at the average log transformed level of expression in counts per million (cpm)) compared to 
the common dispersion of the whole dataset (red line). Mean-Variance plots (3) show the log transformed variance per 
‘gene’ (eRAD tag), including raw variance of counts (grey dots) and variance using the tagwise dispersion (blue dots), the 
common dispersion (solid blue line) and Poisson variance (solid black line), all plotted against log transformed average 
gene expression level. 
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Table 55 Summary of multiple analyses within edgeR, A description of the individuals included within the dataset (Description) is presented in addition to the total number of individuals 
included (n) and the number specific to each genotype (DDn, Ddn, ddn). The total number of RAD tags within each count dataset (Tags), the number of tags with a sum total of zero (Zero 
Tags), the number of retained tags following filtering (Ret. Tags) and the proportion of tags filtered (% filt.) is shown, plus the number specified in the cpm filter (Filt.). The common 
dispersion (Disp) and biological coefficient of variation (BCV) is presented. Finally the number of tags identified as significantly up (+1) or down (-1) regulated according to the genotype 
group comparison specified and adjusted for false discovery rate (FDR) are summarised.  
EdgeR analysis n 
Tags 
Zero 
Tags 
Filt. 
Ret. 
Tags 
% filt. 
Variance 
deTags (FDR <0.05) 
dd-DD Dd-DD dd-Dd 
Dataset Description 
Total 
n 
DDn Ddn ddn Disp BCV +1 -1 +1 -1 +1 -1 
SUPER All samples in 
catalogue included. 
Clone-filtered 
22 4 10 8 53,589 0 4 38,226 28.67 1.663 1.290 1 0 1 0 0 0 
SUPER6 11 2 5 4 46,995 0 2 43,623 7.18 1.736 1.317 4 0 4 0 0 0 
SUPER7 11 2 5 4 36,706 0 2 34,166 6.92 1.111 1.054 0 2 0 0 0 0 
FULLFAT All samples in 
catalogue included. 
Non-clone-filtered 
22 4 10 8 74,496 0 4 48,332 35.12 2.206 1.485 0 0 0 0 1 0 
FULLFAT6 11 2 5 4 55,222 0 2 51,617 6.53 1.942 1.394 3 0 2 0 0 0 
FULLFAT7 11 2 5 4 61,372 0 2 49,894 18.70 1.690 1.300 0 0 0 1 1 0 
SUPER_3Q 3rd quartile of count 
data > 0. 
Clone-filtered 
17 3 8 6 53,589 417 3 43,985 17.92 1.752 1.324 1 0 1 0 0 0 
SUPER6_3Q 9 2 4 3 46,995 321 2 43,387 7.68 1.624 1.274 4 4 4 0 0 6 
SUPER7_3Q 9 1 5 3 36,706 90 3 28,029 23.64 0.948 0.974 n/a n/a n/a n/a 1 0 
FULLFAT_3Q 3rd quartile of count 
data > 0. 
Non-clone-filtered 
16 3 8 5 74,496 376 3 56,872 23.66 2.187 1.479 0 1 0 0 0 1 
FULLFAT6_3Q 9 2 4 3 55,222 227 2 51,282 7.13 1.947 1.395 3 1 1 0 0 0 
FULLFAT7_3Q 8 1 4 3 61,372 281 3 36,791 40.05 1.355 1.164 n/a n/a n/a n/a 1 0 
SUPER_Bd Equal n per 
genotype. 
Clone-filtered 
12 4 4 4 53,589 2,115 4 30,882 42.37 1.307 1.143 5 0 4 0 0 0 
SUPER6_Bd 6 2 2 2 46,995 1,142 2 39,753 15.41 1.420 1.192 2 0 0 0 0 0 
SUPER7_Bd 6 2 2 2 36,706 2,639 2 27,026 26.37 1.103 1.050 0 0 0 0 0 0 
FULLFAT_Bd Equal n per 
genotype. 
Non-clone-filtered 
12 4 4 4 74,496 4,078 4 38,344 48.53 1.756 1.325 0 0 1 0 0 0 
FULLFAT6_Bd 6 2 2 2 55,222 1,160 2 47,106 14.70 1.768 1.330 0 0 0 0 0 0 
FULLFAT7_Bd 6 2 2 2 61,372 7,085 2 37,809 38.39 1.507 1.227 0 0 0 0 0 0 
Dataset Description Total 
n 
A B C Tags Tags 
= 0 
Filt. Ret. 
Tags 
% filt. Disp BCV AvsB AvsB AvsC AvsC BvsC BvsC 
SUPER_Rm Randomised groups. 
Clone-filtered 
9 1 DD, 1 Dd, 1 dd 
in each group 
53,589 3,306 3 33,827 36.88 1.258 1.122 0 0 2 0 1 0 
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Figure 51 Log fold change in eRAD tag sequence counts between genotypes DD & dd (1); DD & Dd (2) and Dd & dd (3) in 
datasets SUPER (a) and FULLFAT (b).The direction of relative expression is indicated in the title of each plot. Each data 
point (shown in black) represents an eRAD tag. Significantly differentially expressed tags are shown in red and 
emphasized by a circle. The blue lines indicate a two-fold difference in expression.  
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Figure 52 Log fold change in eRAD tag sequence counts between genotypes DD & dd (1); DD & Dd (2) and Dd & dd (3) in 
datasets SUPER6 (a) and SUPER7 (b).The direction of relative expression is indicated in the title of each plot. Each data 
point (shown in black) represents an eRAD tag. Significantly differentially expressed tags are shown in red and 
emphasized by a circle. The blue lines indicate a two-fold difference in expression. 
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Table 56 Statistically significant differentially expressed Radtags between genotypic groups. The dd-DD, 1+ shows the cat ID of the tag 
counts which were higher in the dd genotype compared the DD genotype, whereas 1- indicates the opposite expression pattern. In the 
Dd-DD comparison 1+ shows the cat ID of the tag counts which were higher in the Dd genotype compared to the DD genotype. Dt 
denotes which dataset the tags were identified in. The average log transformed counts per million (logCPM) and log transformed fold-
change in tag counts (logFC) is shown for each tag. The probability value (p) is shown for each comparison with the probability value 
corrected for false discovery rate (FDR). An FDR of 0.000 refers to a value <0.001. 
 
dd-DD Dd-DD 
Dt 1+ 1- logFC logCPM p FDR 1+ 1- logFC logCPM p FDR 
SUPER 38405 - 6.13 7.04 1.12E-06 0.043 38405 - 6.85 7.04 4.01E-08 0.002 
 
SUPER6 14295 - 11.49 8.37 5.71E-09 0.000 14295 - 10.62 8.37 5.66E-08 0.002 
 
49725 - 11.32 8.39 2.22E-08 0.000 49725 - 10.80 8.39 7.74E-08 0.002 
 
34376 - 11.17 8.46 6.80E-07 0.010 34376 - 11.04 8.46 8.47E-07 0.012 
 
49600 - 10.55 7.92 1.91E-06 0.021 49600 - 10.53 7.92 1.85E-06 0.020 
 
SUPER7 - 11332 -8.41 5.54 9.55E-07 0.033 - - - - - - 
 
- 14621 -5.21 6.12 2.68E-06 0.046 - - - - - - 
 
Table 57 Annotation of the differentially expressed Radtags (Cat ID) identified within each dataset (Dt) and the length of their 
associated paired-end contig (Ln), * indicates contig is a genomic contig. Annotation information shows the top Blastx hits, with 
percentage query sequence cover (Q), and associated E value and gene accession number (Acc.). 
Tag description Annotation 
Dt Cat ID Ln Blastx Q E value Acc. 
SUPER 38405 159 
PREDICTED: uncharacterized protein 
LOC106071482 [Biomphalaria glabrata] 
96% 0.002 XP_013087059.1 
PREDICTED: von Willebrand factor A domain-
containing protein 2-like [Biomphalaria glabrata] 
43% 3.2 XP_013087030.1 
 
SUPER6 
14295 345 
PREDICTED: uncharacterized protein 
LOC106053297 isoform X2 [Biomphalaria glabrata] 
82% 6.00E-43 XP_013064285.1 
PREDICTED: involucrin-like [Aplysia californica] 81% 3.00E-24 XP_005091491.2 
49725 355 
PREDICTED: leucine-rich repeat serine/threonine-
protein kinase 1-like isoform X1 
 [Biomphalaria glabrata] 
99% 5.00E-58 XP_013066303.1 
34376 
154 
PREDICTED: elongation factor 2-like  
[Biomphalaria glabrata] 
64% 9.00E-10 XP_013091168.1 
185 No sig. - - - 
49600 188 hypothetical protein UC40_25285 [Escherichia coli] 68% 1.00E-20 KJG94335.1 
 
SUPER7 
11332 
367 No sig. - - - 
*1964 
PREDICTED:  
repetitive proline-rich cell wall protein 2-like  
[Biomphalaria glabrata] 
29% 1.00E-06 XP_013074751.1 
 
PREDICTED: keratin-associated protein 4-3-like 
[Opisthocomus hoazin] 
25% 8.00E-05 XP_009942640.1 
14621 
x - - - - 
177 No sig. 
   
*212 No sig. 
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Figure 53 Descriptive summary of the 'SUPER' assembly and annotation. (a) shows the distribution of lengths of the 313 
contigs, including average (Av) length of contigs. (b) provides a summary of the annotation analysis of the assembly, 
including the ‘total’ number of contigs, the number of contigs ‘without analysis’, the number of contigs without a blast 
hit following analysis ‘with Blast (without hits)’, the number of contigs ‘with blast hits’ without annotation, and the 
number of contigs ‘with GO annotation’ in addition to the Blast hit. (c) shows the distribution of E Values of the Blast 
hits within the assembly, starting from 0.1. (d) shows the number top Blast hits associated with a species. (f) shows the 
distribution of contig sequence similarity within the alignment. This is represented as a percentage, calculated from 
number of positive hits divided by the length of alignment. (f) shows the distribution of GO terms within the annotated 
dataset. ‘Parent’ (P) terms are shown in green, ‘Fake’ (F) terms are shown in blue and ‘child’ (C) terms are shown in 
yellow. 
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Figure 54 Descriptive summary of the 'SUPER6' assembly and annotation. (a) shows the distribution of lengths of the 306 
contigs, including average (Av) length of contigs. (b) provides a summary of the annotation analysis of the assembly, 
including the ‘total’ number of contigs, the number of contigs without a blast hit following analysis ‘with Blast (without 
hits)’, the number of contigs ‘with blast hits’ without annotation, and the number of contigs ‘with GO annotation’ in 
addition to the Blast hit. (c) shows the distribution of E Values of the Blast hits within the assembly, starting from 0.1. (d) 
shows the number top Blast hits associated with a species. (f) shows the distribution of contig sequence similarity within 
the alignment. This is represented as a percentage, calculated from number of positive hits divided by the length of 
alignment. (f) shows the distribution of GO terms within the annotated dataset. ‘Parent’ (P) terms are shown in green, 
‘Fake’ (F) terms are shown in blue and ‘child’ (C) terms are shown in yellow. 
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Figure 55 Descriptive summary of the 'SUPER7' assembly and annotation. (a) shows the distribution of lengths of the 310 
contigs, including average (Av) length of contigs. (b) provides a summary of the annotation analysis of the assembly, 
including the ‘total’ number of contigs, the number of contigs without a blast hit following analysis ‘with Blast (without 
hits)’, the number of contigs ‘with blast hits’ without annotation, and the number of contigs ‘with GO annotation’ in 
addition to the Blast hit. (c) shows the distribution of E Values of the Blast hits within the assembly, starting from 0.1. (d) 
shows the number top Blast hits associated with a species. (f) shows the distribution of contig sequence similarity within 
the alignment. This is represented as a percentage, calculated from number of positive hits divided by the length of 
alignment. (f) shows the distribution of GO terms within the annotated dataset. ‘Parent’ (P) terms are shown in green, 
‘Fake’ (F) terms are shown in blue and ‘child’ (C) terms are shown in yellow. 
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Discussion 
Experimental design and library preparation 
This experiment was intended to be a comparative analysis of the capabilities of eRAD and 
traditional RNA Seq. However, the RNA Seq data was not received until October 2015 and therefore 
could not be included within the analyses here or discussion. This has limited the ability to 
distinguish failings in the data as a result of the samples generated for sequencing or the eRAD 
method itself. 
Sample quality 
The samples were of very low starting concentration, subsequently the eRAD libraries were intended 
to be generated from 100 ng ds cDNA, one tenth of the 1 µg reaction in the RADSeq library 
preparation instructed by Etter et al. (2011) (100 ng was the minimum starting quantity utilsed in 
Baird, Etter et al. 2008). However, some samples were still unable to meet the requirements of the 
reduced setup (Table 49). To account for the more variable starting quantities of individual cDNA 
samples in library 4/L007, the amount of P1 adaptor was altered. This was with the aim of reducing 
the level of excess primer present within the reaction, which can result in primer dimer within the 
library. In light of the increased primer dimer visible in Library 4/L007 this is unlikely to of had much 
influence (gel images of libraries are presented in the SI, S11.3). 
The starting concentration was firstly limited by the finite and relatively small amount of starting 
material, the ovotestis organ (<30 mg). Further mRNA selection reduced the total RNA samples to 
approximately 10% of their original concentration (data presented in the SI, S11.1). Initial trials of 
the library preparation using total RNA instead of mRNA (Library 1 and Library 2, data not 
presented), showed general failure to produce a good library concentration when visualised via gel 
electrophoresis. Although total RNA holds the potential to show informative regulatory mechanisms 
in gene expression (as introduced in Chapter 1, Gene expression analysis), the overabundance of 
ribosomal RNA (rRNA) was predicted to dominate the sequence library and obscure information 
from more informative protein-coding mRNAs. Poly-adenylation is not entirely limited to protein-
coding genes, and is present on both long and short ncRNAs (Carninci, Kasukawa et al. 2005, 
Grzechnik and Kufel 2008, plus additional examples summarised in Tarazona, Garcia-Alcalde et al. 
2011), although the size-selection step should omit the majority of ncRNAs (<300 bases). 
Furthermore, rRNA represents approximately 80% of the total RNA sample therefore it is likely there 
will be some carryover following the mRNA enrichment (AppliedBiosystems 2008). As such it is 
assumed that some non-coding RNAs will still be present within the eRAD sequence data, provided 
that they contain a PSTI recognition site. 
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Although all ds cDNA samples were generated from approximately 500 ng mRNA (494.3 ng - 504.3 
ng), the ds cDNA sample yields were substantially varied (29.64 ng - 286.20 ng) (Table 49). This may 
be a reflection of sample quality differences. No correlation was apparent between mRNA yield or 
260/230 ratios and the final ds cDNA yield, yet a potential positive relationship was observed 
between the 260/280 ratios and the total ds cDNA yield (R2 = 0.6041, plots shown in the SI, S11.2).  
Choice of samples 
The ovotestis tissue was selected for this experiment, with the aim to limit sequencing to unfertilised 
eggs, thereby capturing maternal RNAs known to contain the heritable chiral determinant. However, 
this tissue has produced a number of confounding variables as discussed in previous chapters. 
Firstly, due to the internal organisation of the L. stagnalis, it is impossible to extract the ovotestis 
without some level of carryover of liver tissue (Figure 9). No subsequent treatment or washing steps 
were performed on the extracted ovotestis tissue in order to minimise handling of the tissue prior to 
the RNA extraction. Therefore, it is assumed that some sequences within the eRAD libraries are in 
fact specific to the liver tissue, not the ovotestis. The extent of this carryover is discussed further in 
section: ‘eRAD Sequencing data, QC’. Secondly, there was no way to control the biological timing of 
the tissue extraction.  
As seen from the qPCR data in previous chapters, the ovotestis exhibited more variable gene 
expression than the embryo tissue. This is likely due to variation in both the probable liver tissue 
carryover and in the sampling time. In hindsight the single-cell embryo tissue would have provided a 
cleaner and better controlled tissue to use within the eRAD experiment. However, at the time of this 
experiment, I did not yet have the skills to prepare embryo RNA samples. Additionally, the samples 
would have required a much larger number of embryos than used in the qPCR experiments to 
generate an mRNA enriched sample of sufficient quantity. 
A total of 22 individuals were included in the eRAD libraries. It was initially thought that both library 
preparations would be sequenced on one lane, however each library was allocated an entire lane. 
Therefore, it may have been beneficial to include more individuals due to the increased amount of 
sequencing capacity. Moreover, the reduced number of DD individuals inhibited downstream DE 
analyses. If repeated, it would be recommended to include equal numbers of individuals from the 
comparable groups. Additionally, the unbalanced representation of genotypes within the sequenced 
libraries may have resulted in a biased transcriptome assembly, due to potential sequence 
differentiation in the underrepresented samples being dismissed as error. This was not believed to 
be a large issue in this dataset due to the relatively low amount of sequence variation observed, 
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however to combat this bias, genotype specific contig assemblies could have been generated 
including only individuals of that genotype. 
Choice of enzyme 
PstI was chosen as the restriction enzyme for the eRAD sequence library. This was due in large part 
to the availability of specific barcode sequence adaptors. The end of each adaptor was 
complementary to the PstI cut site overhang (5’- TGCA -3’) and therefore could only be used with the 
restriction enzyme PstI or SbfI, which generates the same sequence overhang. The frequency of PstI 
recognition sites within the L. stagnalis transcriptome was unknown prior to this experiment, yet 
PstI was selected for the digest instead of SbfI as it is predicted to be a more frequent cutter due to 
its recognition sequence being two bases shorter than that of SbfI (Figure 45). Alternatively, both 
enzymes could have been used together in a double digest reaction to further increase the number 
of sequencing start sites within the libraries. The choice of restriction digest within the RAD library 
preparation depends on whether capturing an increased number of sequence loci or an increased 
depth of sequencing of a smaller number of loci is a priority. Again because the number of PstI sites 
across the L. stagnalis transcriptome was unknown, the single PstI digest represented a mid-range of 
the three possible digests.  
eRAD Sequencing data 
QC 
L007 generally showed higher sequence quality but also higher sample sequence bias and PCR 
clones, than L006. There were two key differences in the library preparations of L006 and L007, 
which could have resulted in these differences. Firstly, L007 was gel extracted twice to reduce the 
level of primer dimer within the library, whereas L006 was only extracted once. This may account for 
the increased sequence quality in L007. 
Secondly, the starting quantity of input cDNA (and subsequent volume of P1 adaptor added) was 
much more varied in L007. The sample representation bias did not however, show any strong 
correlation with the input cDNA quantity or concentration or the amount of P1 adaptor added to the 
reaction (correlation plots are presented in the SI, S13). The Illumina sequencing platform is 
observed to show a GC sequencing bias resulting in increased coverage of GC rich sequences 
(Minoche, Dohm et al. 2011). It is possible that the sequencing method exhibited variable 
preferences for the five base unique identifier sequence at the start of all individual transcripts. 
However, no strong correlation was observed between the total retained sequences of each 
individual and the percentage GC of their specific barcode adaptor (S13). This phenomenon of 
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sample sequencing bias has been observed in other RADSeq libraries within the Davison research 
group and other publications, and remains largely unexplained. Degradation of DNA samples has 
recently been implicated as a cause for reduced sequence depth of samples in RADSeq (Graham, 
Glenn et al. 2015). Here, no strong correlation was seen between 260/230 or 260/280 ratios of 
mRNA samples and total retained reads (S13). However, no quality values are available for the ds 
cDNA; therefore, there may have been differences in the ds cDNA quality not detectable in the 
quantification which could explain the difference in sample sequencing effort. 
Each of the four raw sequence files failed the Fast QC check for overexpressed sequences. The 
majority of these in L006 were described as the Illumina sequencing primers, whereas in L007 the 
primer sequences were reduced (data not presented). This may reflect the effectiveness of the 
second gel extraction performed in the preparation of L007. The overexpressed reads were flagged 
in the raw reads and therefore still contain the 5 base unique barcode. As such many of the 
overexpressed sequences are in fact the same sequence but from a different individual. The Fast QC 
failed to provide a descriptive hit for any sequence other than the Illumina primers, due to the short 
50 base sequence presented. Local Blasts to the SUPER assembly revealed the pe contigs associated 
with the highest overexpressed sequences were described as ‘ferritin-like’ or ‘soma ferritin’.  
Ferritin represents the primary yolk storage protein in L. stagnalis (Bottke 1986). Therefore 
identifying ferritins within the overexpressed sequences provides support that the sequences were 
generated from the ovotestis. However, L. stagnalis contains two types of the iron storage protein 
ferritin: soma-ferritin and yolk- or vitellogenic - ferritin (Bottke and Crichton 1984, Vondarl, Harrison 
et al. 1994). Identifying soma ferritin specifically, would indicate there were high levels of somatic 
tissue contributing to the dataset. Due to the short reads provided in the Fast QC summary, the 
appropriate level of sequence specificity is lacking in order to determine which of the ferritins is 
overexpressed. There is no reason to my knowledge why soma ferritin would be present in high 
levels in the probable carryover liver tissue and even so the level of carryover tissue relative to the 
extracted ovotestis tissue is minimal. It therefore seems likely that the overrepresented sequences 
reflect the L. stagnalis yolk protein. 
Overall the sequencing data was not of high quality. The low starting quantity of the samples within 
the library preparation is believed to have contributed in large part to this. The RNA Seq experiment 
used the remaining mRNA of each of the individuals within the eRAD libraries. These samples were 
of even lower starting quantity, therefore if the sequence quality of the RNA Seq data is improved, 
the generally poor quality sequence data here can be more confidently attributed the eRAD library 
preparation and methodology as opposed to the sample quality. 
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Descriptive analysis  
Throughout the data analysis accommodations had to be made to account for the fact that the 
sequence data neither represents RADSeq or RNA Seq data.  
Process radtags 
In addition to the basic commands within the process_radtags program to allocate sequences to the 
individual samples, such as specifying the paired-end data and restriction enzyme, a number of 
flexible parameters were included, which are discussed here.  
All sequence reads were truncated to a length of 70 bases using the function ‘-t’. This was performed 
to accommodate the substantial reduction in quality of sequence reads greater than 70 bases in 
L006 (Figure 46). Due to the improved quality of sequence reads in L007, the individual reads in this 
library could have been truncated to 90 bases, or not at all. However, the individuals of each library 
were intended to be compared to each other in downstream analyses and as such were treated 
using the same parameters. 
Sequencing reads containing a barcode which did not match those specified in the experiment were 
able to be ‘rescued’ and included in the dataset if the program could confidently match the barcode 
using the function ‘-r’. This required the distance between barcodes to be specified. Of all the 
barcodes used in the experiment the maximum aligned sequence similarity was calculated as two 
bases (calculation shown in SI, S11.4). Therefore, the barcode distance was specified as three. This 
function may increase the inclusion of sequences from the multiple individuals through coincidental 
sequencing error, although avoids the discarding large amounts of the sequence data. For a more 
rigorous analysis this function could have not been included. Due to the relatively low number of 
individuals included on each sequencing lane, each individual likely received enough coverage to 
withstand some loss of sequencing reads. However, in light of the high level of sample sequencing 
bias this was not the case and therefore rescue barcodes function was incorporated to retain as 
many reads as possible per individual. 
The function ‘-q’ discards reads with low quality scores (as specified within the raw data file). 
Similarly, the function ‘-c’ cleans the data by removing any read containing an uncalled base. These 
filters could result in low quality individuals containing lower sequence counts for tags, however due 
to the short sequence length of the reads, sequence specificity is highly important. Additionally, the 
poor quality sequence reads should be equally distributed across the individual’s total reads and 
therefore should not result in a systemic bias in the resulting count data. 
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Process_radtags was performed independently for each of the sequenced libraries. When 
performed on all individuals from both libraries simultaneously (data not shown), the output was 
varied indicating that a number of individual were allocated reads from the other sequencing lane, 
likely through coincidental sequencing errors or the rescue barcodes function. 
Clone filter 
The clone_filter program removes any read which contains a R1 and R2 sequence pair identical to 
one already identified in the individual. In traditional RADSeq data analysis this aims to reduce 
sequencing errors amplified through PCR. There is some debate however as to the appropriate use 
of the clone filter in quantitative sequence data and the removal of PCR duplicates has been advised 
against in RNA Seq data analysis (RNA Seq data analysis short course, University of Leicester, pers. 
comm. Nov 2014).  
Because the lengths of mRNA transcripts are substantially shorter than those of genomic DNA 
sequences, there is a greater probability of duplicated sequence reads by chance. The presence of 
PCR duplicates should affect all individuals equally and therefore their inclusion would not create a 
systemic bias. Shorter genes would be more likely to contain duplicates by chance, again all 
individuals should experience this bias equally and therefore it will not systemically bias count data 
comparisons between genotypic groups. Thus the clone filter could potentially remove genuine 
counts from individual tags and obscure DE patterns. Subsequently the analyses were performed on 
both clone-filtered and non-clone-filtered datasets to compare the effect of the clone filter on 
quantitative gene expression analysis 
The eRAD libraries were size selected to include only sequences of 300-700 base-pairs long. 
Therefore 1 in every 400 reads per tag per individual could hold an identical paired-end (pe) read by 
chance alone. Thus the clone filter would have identified on average 0.25% of pe reads to be clones 
by chance, however the average percentage pe reads identified as clones was >70% (Table 51).  
Although the eRAD libraries may contain a higher proportion of shorter fragments, resulting in more 
than 1 in every 400 pe contigs representing a clone, it is unlikely that the high number of removed 
duplicate counts were present due to chance. Furthermore, the individuals did not show an equal 
proportion of clones within their pe reads, which ranged from 51.29% clones to 87.09% (Table 51). 
Therefore, it is assumed that the FULLFAT dataset contains a large proportion of counts generated 
from PCR clones with substantial variation between individuals. 
Overall, following the sequence data preparation only ~30% of the original total reads was retained 
for analysis. Thus the eRAD sequencing has not provided a very efficient use of NGS power. The 
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majority of RAD sequencing publications only quote total read counts following process_radtags and 
clone filter, and so it is difficult to ascertain whether this is common. 
Stacks parameters 
The individual samples within the eRAD sequencing datasets were all offspring from a self-fertilised 
Dd snail. Subsequently the data was treated as a genetic cross experiment, although there was no 
sequence data for the parent. This was combated by creating a ‘superparent’ sample. In order to 
produce two independent datasets for downstream analyses, L006 and L007 were analysed 
separately. Statistical power of the genotypic group comparisons was expected to be hindered due 
to the low number of DD individuals present within each library, and so a combined catalogue 
including every individual within the experiment was also generated.  
Whilst the only parameter altered from the default settings in the denovo_map stacks program was 
the minimum depth required to create a stack in the catalogue, ‘-m’. The central parameter settings 
are briefly discussed here. 
Firstly, the number of sequence differences (SNPs) allowed within a stack was kept at the default 
value of two. Any stack containing more than two base differences was classified as a new stack. It 
was not expected that there would be more than two naturally occurring SNPs present within the 70 
base consensus RAD tag sequence. Therefore, these sequences represent either sequence error or a 
new stack. Following this, the maximum number of stacks allowed per locus was kept at the default 
value of three. Theoretically, due to the self-fertilisation of the diploid heterozygote individual snail, 
there was a maximum of two possible different stacks (alleles) per loci. However, this was kept at 
three to allow some room for error.  The number of differences allowed between loci was kept at 
the default value of zero. Because the catalogue was generated by the superparent, in the event of 
differentially fixed loci being present between individuals, they will have already been included 
within the superparent as one locus and classified as polymorphic. 
The default minimum sequencing depth required to create a stack, ‘-m’, is three. This default value 
was maintained for the progeny, however due to the extremely large number of reads within the 
superparent, the minimum stacks depth of three was expected to include a high number of 
erroneous tags. Of course it is impossible to know the ‘correct’ parameters to use to assess the eRAD 
sequencing data, however summaries of the total catalogue loci generated from varying the -m 
value provided inferences into what may represent sequencing error and what is true variation 
(Stacks summaries are presented in the SI, S14).  
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When -m was small, this generated far higher numbers of unique stacks. However, a large number of 
these stacks were only present in the parent and not the progeny. This demonstrates that these 
sequences were not present in any one individual to the minimum stacks depth of 3 and were 
therefore likely generated from the combined sum of few erroneous reads across multiple 
individuals. When -m was increased, this generally increased the number of stacks present in a larger 
number of progeny, providing far more informative tags. Additionally, due to the level of inbreeding 
of the samples included, it is unlikely that there will be substantial biological variation in the tags 
present within individuals.  
Another indication of the increased error produced when -m was small, was demonstrated by the 
discrepancy between total number of stacks in the catalogue and those present within the 
superparent. The catalogue was generated from the superparent consequently every stack should 
be identified within the parent.  The chosen -m value was selected to maximise the number of stacks 
generated, whilst minimising large differences in the number of stacks present within the parent and 
increasing numbers of progeny (S14). This was believed to signify a more stable and biologically 
feasible dataset.  
The large differences shown in the number of unique stacks generated in the SUPER and FULLFAT 
datasets raise questions about the use of the clone-filter. The clone filter removes only the duplicate 
sequence and leaves the original copy (Julian Catchen, pers. comm. April 2015, Stacks Google group). 
Therefore, the SUPER and FULLFAT catalogues should show the same unique stacks, but hold 
different counts. This is clearly not the case as the FULLFAT dataset identified many more unique 
stacks than the SUPER dataset (Table 52). It is assumed that following removal via the clone filter, 
these additional unique sequences fall below the minimum stack depth threshold to generate a new 
stack and are therefore not present in the clone-filtered catalogue. This suggests that they are in low 
unique/true quantity and likely the product of PCR generated sequencing errors. 
Paired-end contig assemblies 
The pe contig assemblies were generated only from the clone-filtered data. Although losing a large 
number of sequence reads, this data was chosen to generate a more robust assembly in light of the 
likely increased sequencing error within the non-clone-filtered data. Additionally, the superparents 
were not included in the assemblies to avoid pseudo replication of the input sequences. 
The de novo assembler Velvet was used as advised in the stacks tutorial (‘building mini-contigs from 
paired-end sequences’, Available at: http://catchenlab.life.illinois.edu/stacks/pe_tut.php). 
Importantly the Velvet aligner allows for multiple contigs per locus and is therefore suitable for the 
transcriptomic sequence data here. The standard Velvet aligner has however been shown to not 
217 
 
represent the best de novo contig assembler (Davey, Cezard et al. 2013). Assemblers are available, 
which better incorporate the variable nature of the coverage and heterozygosity of RAD data, such 
as ‘VelvetOptimiser’ (Victorian Bioinformatics Consortium, Copyright 2009 - Simon Gladman). This is 
a wrapper script which can be added to the Velvet aligner and has been identified to produce the 
best de novo assemblies, although requires a substantially greater computing effort, quoted as 200 
times longer than other assemblers (Davey, Cezard et al. 2013).  
The contigs generated through the Velvet assembly of the eRAD sequence data have provided 
successful templates for the qPCR genes of interest described in Chapter 3 and identified intron-
exon junctions successfully (Figure 12). Thus the quality of assembly is assumed to be of acceptable 
quality for use within this project. However, one final reference assembly generated from the 
combined SUPER dataset may be repeated using a higher quality assembler for publication. 
Because eRAD is a reduced representation method, the gene ontology (GO) does not provide a true 
summary of the functional processes within the ovotestis. DE tags were intended to be tested for 
enrichment of cell function compared to the overall GO of the dataset however due to the overall 
lack of DE, this was not performed. 
Differential expression analysis 
In performing DE analysis, the sequencing depth of eRAD tag data was treated as the equivalent of 
RNA Seq raw count data lacking a reference genome. As previously introduced, a number of 
important facets will affect the appropriateness of DE comparisons derived from sequence read 
depth. This subject has been addressed in many publications (including Bullard, Purdom et al. 2010, 
Robinson and Oshlack 2010, Tarazona, Garcia-Alcalde et al. 2011). The main considerations are 
discussed here in relation to the current eRAD DE analysis within edgeR. 
EdgeR was selected to test the count data for DE between genotypic groups because it has been 
shown to be one of the most stable software packages available for DE analysis and the most 
appropriate for RNA Seq data with low numbers of replicates (Kvam, Lu et al. 2012, Schurch, 
Schofield et al. 2015). DE results were originally intended to be supported by repeated analysis using 
DESeq (Anders and Huber 2010), another top ranked DE analysis software (Kvam, Lu et al. 2012, 
Schurch, Schofield et al. 2015). DESeq has been shown to be better suited to datasets with more 
than 12 replicates and has a tendency for false positives, therefore was only intended to support 
results from the more appropriate edgeR analysis (Schurch, Schofield et al. 2015). Due to the lack of 
significant results from the edgeR, the DESeq analysis was not considered informative and therefore 
is not presented here. 
218 
 
One of the primary factors when comparing count data is normalisation. As in the qPCR comparisons 
of gene expression, comparisons will have to standardise for starting quantity, yet NGS data must 
also account for varied sequencing effort. Normalisation strategy continues to be debated (eg. Li, 
Piao et al. 2015), however it is generally agreed that more sophisticated methods of normalisation 
are need than simply dividing by total read counts per individual. For example, if sample A expresses 
all genes in equal quantity to sample B yet expresses a selection of genes that are absent in sample 
B, this will result in sample A having higher overall read counts and inaccurate ‘normalisation’ of the 
expression of genes present in both samples (Robinson and Oshlack 2010). The TMM (trimmed 
mean of M values) normalisation method employed in edgeR generates a global fold-change gene 
expression estimate between each individual for all genes/tags with the assumption that the 
majority of genes are not DE. Thus generating relative library sizes for each sample (Robinson and 
Oshlack 2010). Comparisons of normalisation strategies have demonstrated the method of 
normalisation to be critical to identifying DE. In light of edgeR ranking as one of the most reliable 
methods to identify DE (Schurch, Schofield et al. 2015) supports this strategy of normalisation. 
Accurate assumptions about the distribution of the count data are essential for appropriate use of 
statistical modelling. EdgeR assumes a negative binomial distribution of the data to account for the 
expected high number of zero counts present. A recent study performing RNA Seq with 48 replicates 
has enabled testing of assumptions regarding the distribution RNA Seq count data. The observed 
read counts were consistent with both log-normal and negative binomial distributions providing 
further support for the use of edgeR (Gierlinski, Cole et al. 2015). EdgeR employs parametric tests 
when comparing count data for DE. However, the small number of replicates in NGS experiments 
usually prohibits testing the fit of the data for use in parametric tests. The eRAD data here had 
extremely high levels of variance which did not follow a Poisson distribution (Figure 49.3, Figure 
50.3). Although tagwise dispersion was employed rather than assuming equal variance, the 
appropriateness of parametric testing in this dataset is questionable. Non-parametric RNA Seq DE 
analysis methods are available such as NOISeq (Tarazona, Garcia-Alcalde et al. 2011). However, this 
method has not been recommended for use due its lack of consistency with other methods 
(Schurch, Schofield et al. 2015).  
The removal of individual samples did not result in a large reduction in variance of the overall 
dataset and in some cases increased variance (represented by the BCV values, Table 55), although 
this is believed to be partly due to the counts per million (CPM) filter being relaxed to account for 
the reduced number of individuals within the smallest group (Table 55). Each dataset had one 
potential outlier individual, namely 9001 and 9009 (Figure 49, Figure 50). The analyses could have 
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been repeated following the removal of these individuals however, one outlier in one genotypic 
group does not provide an explanation for the high levels of variation and lack of significant DE in 
group comparisons in which it is not included. 
Only monoallelic RAD tags were included in the DE analysis. This was due to the inability to export 
allele-specific count data from stacks. Pooling of the counts was considered, as a number of the 
multi-allelic tags likely represent sequencing errors of an invariable sequence tag. Yet this would not 
be appropriate for all tags due to the risk of obscuring true allele specific DE (Wood, Nones et al. 
2015). Those tags which likely represented sequencing error could be inferred from the distribution 
of counts across the alleles (i.e. very low reads counts of the erroneous transcript); however, the 
number of multi-allelic tags would require an automated method to perform this which was not 
developed. 
As previously stated, higher count transcripts have greater statistical power. The log-fold change 
plots reveal clusters of tags with clear fold-change differences, likely representing presence/absence 
relationships between the genotypic groups. The few tags identified as DE are generally found to be 
of the highest counts per million (CPM) in the comparison (Figure 51, Figure 52). In light of the 
massive reduction in the probability value required for significance through corrections for FDR, no 
transcript with a relatively small fold-change will be identified as DE. Furthermore, the low number 
individuals within the DD sample group, and unbalanced sequencing efforts between groups further 
inhibited statistical power of comparisons. 
Differential expression results 
Of the complete SUPER datasets, only seven tags were identified as DE, five of which identified a 
characterised function (Table 56, Table 57). The associated functions of the tags identified as DE are 
briefly discussed here, although it is unlikely that these relationships reflect a true biological 
meaning given that the random group dataset (Rm) identified a comparable number of DE tags as 
the experimental group data (Table 55). Furthermore, the majority of DE tags were identified as 
absent in the DD individuals, or present in very low count in only one DD sample (normalised count 
data not presented). The DD group contained the lowest number of replicates and therefore 
absence in DD group is the most likely occurrence by chance. 
The von Willebrand factor A domain is involved in cell adhesion, extracellular matrix proteins, and in 
integrin receptors essential for cell-cell interactions (Whittaker and Hynes 2002). These functions 
hold the potential for important functional associations with chirality. The von Willebrand factor C, 
also referred to as ‘brorin’ has been characterised as an antagonist of bone-morphogenetic proteins 
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(BMP) which are essential for morphogenesis and development (Miwa, Miyake et al. 2009). If the 
transcript functions as an inhibiting factor, overexpression may be associated with the sinistral 
developmental vulnerability and provide an explanation for the absence in the DD group. 
Involucrin is a soluble protein and provides a marker for keratinocyte terminal differentiation and 
ultimately cross-links to form part of the cornefied envelope (Watt 1983, Eckert, Yaffe et al. 1993, 
Steinert and Marekov 1997). Thus it represents a gene present in stem cells, is functional in early 
developmental stages and holds structural properties, and subsequently could be involved in LR 
organisation. 
The leucine-rich repeat serine/threonine-protein kinase 1-like gene relates to a number of functions 
activated by GTP binding (Korr, Toschi et al. 2006). The diaphanous formins are known to act as 
effectors of Rho GTPase binding, which may play a role in cell polarisation (Nakano, Imai et al. 2002, 
Wallar and Alberts 2003); therefore, it is possible that the GTPase activated kinases may exhibit 
downstream consequences from the loss of Ldia2. Additionally, a gene ‘RPK1’ in Arabidopsis, listed 
in Uniprot (http://www.uniprot.org/uniprot/Q9ZRF9) as a ‘probable LRR receptor-like 
serine/threonine-protein kinase RPK1’ has been implicated in embryonic pattern formation (Nodine, 
Yadegari et al. 2007).  
Elongation factors are required for protein synthesis, and therefore unlikely to truly be absent in the 
DD individuals, however elongation factor 2 has been observed to co-localise with actin filaments, 
which could relate potential differential expression to chirality (Shestakova, Motuz et al. 1993). The 
identification of an elongation factor in the DE tags is of additional interest due to their frequent use 
as normalising control genes within relative quantification experiments such as qPCR. 
The only tag with a description in the SUPER7 analysis was a keratin associated gene. In addition to 
the involucrin-like gene, the presence of two DE tags associated with keratinisation would provide 
greater support for a biological cause of the observed DE if each tag hadn’t demonstrated the 
expression differentiation in opposite directions (Table 56). 
Each of these tags holds the potential to be functionally associated with chiral dimorphism and as 
such should be tested further to explore differential expression relationships. As the majority of tags 
contain a pe contig, L. stagnalis qPCR assays could readily be designed to test the DE relationships 
with a greater number of replicates and also in the better controlled single-cell embryo tissue. 
Overall the pattern of gene expression was very similar in both the FULLFAT and SUPER datasets 
(Figure 49, Figure 51). Due to the expected prevalence of PCR duplicates present in the FULLFAT 
datasets, only the SUPER datasets were presented here. However, it should be noted that generally 
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the SUPER datasets contained less tags and identified more DE tags than the FULLFAT datasets 
(Table 55). It is possible that the increase in significantly DE tags may result from the relaxing of the 
FDR correction due the reduced number of multiple comparisons performed in the SUPER datasets. 
Another possibility is that the sequence counts without flagged PCR duplicates fall below the 
detectability threshold in the SUPER datasets resulting in more presence/absence relationships. 
Although the clone-filtered and non-clone-filtered datasets showed a general similar pattern of gene 
expression, the SUPER6 and SUPER7 datasets showed notable differences in the overall distribution 
of gene expression. As seen in the dd-Dd fold-change expression clusters of presence/absence 
relationships between dd and Dd groups, which are in opposite directions (Figure 52.3). This 
variation coupled with the potential library segregation shown in the MDS plots (Figure 49) 
highlights potential bias in the library sequencing and supports the analysis of library specific 
datasets. 
The overall lack of DE likely indicates a failing of the eRAD sequence data to generate adequate 
quantitative gene expression data to identify statistically significant variation. However, it has 
additionally shown that the sinistral individuals have not shown a large-scale reduction of gene 
expression. Therefore, the pleiotropic effects known to occur in the sinistral developing L. stagnalis 
(Davison, Barton et al. 2009) do not appear to of stemmed from loss of function across a large 
number of genes. 
Further analyses 
As signposted throughout this chapter, there are apparently endless ways to analyse the wealth of 
bioinformatics data received from the eRAD libraries. The eRAD data was initially analysed as a 
genetic cross as this is how the snail samples were generated. In doing so, the stacks program only 
generates catalogue loci that are present within the parent. Consequently, an artificial superparent 
was used to generate the library catalogue without loss of information. However, the use of a 
superparent results in very high sequence counts and the inevitable inclusion of high counts of 
erroneous reads pooled from all individuals. Alternatively, the data could have been analysed as a 
population. Stacks population analysis generates the catalogue from all individuals and therefore 
would not have required the superparent and maintained restrictions of sequencing depth per 
individual. Although as the populations program has been designed specifically for population 
genetics applications it did not represent the relevant option for analysis. 
Although not presented in the results it has been possible to identify candidate genes within the 
eRAD count data by performing local Blasts. This has revealed that the Ldia2 candidate was captured 
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by the eRAD method yet failed to identify DE, further highlighting the inability of the current eRAD 
data analysis to identify DE. However, any candidate gene identified presently or in the future can be 
retrospectively checked against the eRAD sequence data to infer sequencing depth and possibly a 
transcriptomic sequence contig. It is also possible to export the normalised count data from edgeR 
and subsequently view relative expression of the specified tag. 
In light of the potential differences revealed in L006 and L007 expression data a general linear model 
(GLM) approach could have been employed to assess the combined datasets including both 
genotype and sequencing library as factors (this is an option available in edgeR). However, the data 
would be unlikely to fit the model parameters due to the high and varied dispersion (Figure 49). 
Furthermore, as the libraries were analysed for DE separately, L006 and L007 raw data could have 
been prepared using different parameters in process_radtags. Due to the higher sequence quality of 
L007, sequence reads could have been trimmed to only 90 bases as opposed to 70 (Figure 46). 
The RNA Seq data has recently been received (October 2015) and consequently the comparative 
analysis of sequence data can now be performed. This will provide essential information as to 
whether the limited capabilities of the eRAD sequence data here was due to the eRAD method itself 
or inherent limitations of the L. stagnalis ovotestis samples. It is possible that the eRAD method in 
general may not be able to provide reliable count data. A recent publication described the use of a 
novel sequencing method restriction-site associated RNA sequencing (RARseq), which is in principle 
the same as eRAD (Alabady, Rogers et al. 2015). RARseq was employed with the aim to facilitate 
genotype by sequencing methods in the pitcher plant with a large genome and do not appear to 
have utilised the quantitative capabilities of the RNA sequence data. The omission of quantitative 
analyses may be due to lack of interest or preparing for a second publication, although the lack of 
publications on eRAD from the Cresko group may indicate that reduced representation RNA 
sequencing data may not provide the quantitative capabilities anticipated. 
The genotype analysis was not a priority for the eRAD data due the ongoing genomic analyses within 
the Davison research group. However, to perform a comprehensive assessment of the capabilities of 
the eRAD method this will have to be included, particularly in light of the apparent failings in DE 
analysis. 
Conclusion 
The eRAD trial was intended to be a comparative analysis with traditional RNA Seq. In the absence of 
the RNA Seq data the extent of the evaluation has been limited. The eRAD trial alone has provided 
some insight into the appropriate use of the technique, although it is difficult to identify where 
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failings are due to the samples or the method. Following preparation of the raw data and the 
removal of PCR clones, over 50% of reads were discarded per individual and some individuals over 
80%. Coupled with the sample sequencing bias of unknown cause known to occur in RADSeq, the 
benefits of increased sampling depth per individual were variable. The high variability in sample 
sequencing representation may be one of the principle sources of the high variation observed in the 
count data. 
The DE analysis failed to identify with confidence DE tags between chiral genotypes. This may reflect 
a true lack of DE between genotypes, however due to the high levels of variability within the count 
data this remains inconclusive. The lack of DE does reveal that sinistrals are not exhibiting a large-
scale loss of function as may have been predicted from the adverse consequences of the sinistrality 
observed in developing L. stagnalis. Although the DE analysis was not highly informative, the eRAD 
sequencing data has enabled successful de novo assembly of transcriptomic contigs >700 bases in 
length. The contigs have been verified through further analyses, including the primer design in 
Chapter 3. 
In the years that have passed since this project was initiated, the capabilities of de novo RNA Seq 
have improved as has the output of sequencing platforms. Consequently, the proposed benefits of 
eRAD to transcriptomic analyses may have diminished. However, no matter how much data can be 
gained from a sequencing lane, there will always be a benefit of reduced representation approaches 
enabling more samples to be analysed in less space. Furthermore, as demonstrated by ‘RARseq’ 
(Alabady, Rogers et al. 2015), reduced representation transcriptomic approaches have proven 
effective for genotyping complex genomes.   
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Chapter 5:  
General discussion and conclusions 
Biological inferences from observed patterns of gene expression 
As introduced previously, the Davison research group finely mapped the chirality locus and 
subsequently identified seven candidate genes within the region (Liu, Davey et al. 2013, Davison et 
al. awaiting publication). One of the candidate genes, diaphanous related formin, Ldia2, was found 
to contain a frameshift mutation in the sinistral copy of the gene. The quantitative differences of 
Ldia2 mRNA observed from the qPCR experiments described here indicate that the sinistral missense 
Ldia2 transcript is rendered non-functional and is almost absent in the single-cell embryo.  
Only a specific gene knockout experiment will prove that the loss of function of Ldia2 results in 
sinistrality in L. stagnalis. Because such methods remain out of reach for this system, multiple 
experiments have been undertaken to prove that Ldia2 is tightly associated with LR asymmetry 
determination and indicate beyond reasonable doubt that this association contributes to the 
observed phenotype. 
Loss of function of Ldia2 in developing L. stagnalis embryos has been demonstrated through drug-
treatment experiments performed within the Davison group (Davison et al. awaiting publication). 
Application of SMIFH2, a drug that acts on formin FH2 domains, to dextral embryos prior to the third 
cell cleavage produces a phenotype that mimics that in sinistral development (Figure 3). The drug 
treatments strongly indicate that formin is directly involved in dominant spiral cleavage patterning 
and ultimately LR asymmetry determination. SMIFH2 however, will affect any gene bearing an FH2 
domain. The lack of quantitative mRNA differences observed in the alternative formin candidate, 
Ldia1, tested in the qPCR experiments described here, coupled with the fine linkage-mapping of the 
chirality locus have provided valuable support that the loss of Ldia2 alone results in the sinistral 
phenotype.  
Of the seven candidate genes identified within the chirality locus only four were assessed in the 
qPCR experiments here (Ldia1, Ldia2, Lfat1 and Lfry). This was due to the late identification of three 
additional candidate genes at the locus (June, 2015). All potentially associated genes within the 
chirality locus must be ruled out as candidates in order to support the phenotypic association of 
Ldia2. The lack of DE between chiral genotypes of any of the alternative proximal candidates in the 
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qPCR experiments here, has gone part of the way to achieving this. Further quantitative experiments 
recently performed in the Davison research group have not found evidence of DE in the remaining 
alternative candidates.  
In addition to the experimental evidence supporting the association of Ldia2 in LR asymmetry 
determination in L. stagnalis, the functional properties of diaphanous formin fit into a biological 
mechanism of symmetry-breaking. As previously described, diaphanous formin mediates the self-
assembly of actin filaments, whilst the FH2 domain remains continuously associated with the 
elongating barbed-end of growing actin filaments (Kovar 2006 and references therein). It has 
recently been demonstrated that the actin cytoskeleton can self-organise into chiral patterning at 
the cellular level, a process which was additionally found to be dependent on formin function (Tee, 
Shemesh et al. 2015). This observation has provided a proven mechanism for intracellular symmetry-
breaking via the formin-mediated actin-cytoskeleton.  
The two actin-related proteins included in the qPCR experiments, were the only targets other than 
those of Ldia2 to be identified as DE between chiral genotypes. Although the observed pattern of 
quantitative differences will require further experiments to define, the actin-related proteins were 
the only targets included in the experiment with a direct functional association with the formin. 
Therefore, their differential expression may provide insight into the predicted consequences of the 
non-functional formin in sinistral L. stagnalis and support for formin mediated symmetry-breaking. 
Further to the suggested biological mechanism to support the association of Ldia2 in chirality 
determination in L. stagnalis, an evolutionary mechanism has also been proposed. L. stagnalis 
belongs to the monophyletic group Lymnaeoidea, which contains four families, two dextral and two 
sinistral (Dayrat, Conrad et al. 2011). A recently constructed phylogeny placed L. stagnalis as a sister 
species to Physa with Biomphalaria as an outgroup, both of which are sinistral coiling snails (Davison 
et al. awaiting publication). Due to the conserved sequence similarity of Ldia1 with the diaphanous 
formin sequence present in Physa acuta and Biomphalaria glabrata, Ldia2 was predicted to be the 
result of a gene duplication having occurred in an ancestral Lymnaea. For these reasons it has been 
proposed that expression of Ldia2 results in the dextral morph seen in L. stagnalis, and the 
subsequent loss results in reversion to the predicted ancestral sinistral morph (Davison et al, 
awaiting publication). 
Aside from the specific findings contributing to the growing evidence of the association of 
diaphanous formin with LR asymmetry determination in L. stagnalis, for the most part the gene 
expression analyses presented have not identified significant differences between chiral genotypes. 
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Although the quantitative capabilities of the eRAD analyses are uncertain, they have demonstrated 
that the sinistral L. stagnalis are not exhibiting a wide-spread loss of gene function, which may have 
been predicted through the apparent pleiotropic effects of sinistrality in development, such as low 
hatch rate (Davison, Barton et al. 2009). Therefore, it may be that the negative consequences of 
sinistrality observed in development result from the single chirality locus. It is proposed that the 
expression of Ldia1 in the developing sinistral embryo is providing a compensatory mechanism in the 
absence of the diaphanous-related formin, Ldia2. This provides an expanlation for why the knock-
out of Ldia2 is not fatal in all of the developing sinistral L. stagnalis, whilst some form of lag or 
inefficiency in this compensatory process, results in the negative consequences exhibited in some. 
Further analyses 
Expression patterns in later developmental stages 
Possibly the most informative extension of this study would test for DE in later stage embryos. The 
lack of DE seen in the majority of GOIs in the single-cell embryo qPCR experiments may reflect 
insufficient developmental time to reveal consequences of the chiral genotype. The single-cell 
embryo was the most informative for identifying causal relationships and to support the role of 
Ldia2 in LR asymmetry determination. However, many expression patterns resulting from the lack of 
Ldia2, or another mechanism, may only be apparent in later embryonic stages, especially around the 
definitive third-cell cleavage. 
For example, the expression patterns observed in the actin-related proteins likely result from the 
varying levels of Ldia2 present, due to the role of diaphanous formin in the self-regulation of actin 
assembly (Kovar 2006). Quantification experiments at later developmental stages would indicate 
whether this effect is amplified during the predicted extended time in the absence of diaphanous 
formin. 
The assumption that the missense transcript of Ldia2 is reduced due to NMD would predict a greater 
reduction in the transcript with increased time since egg-laying. This could be supported by 
quantitative assays of Ldia2 present in sinistral embryos at successive cell cleavage steps and 
following the onset of zygotic transcription when it is predicted that new copies of Ldia2 will be 
transcribed.  
Localisation of gene expression 
Due to the fundamental spatial component within the problem of LR asymmetry determination, 
localisation experiments will be essential to ascribe functional consequences of differential gene 
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expression. Although the in situ experiments I performed whilst at the Jackson laboratory proved 
inconclusive (a summary report is presented in the SI: S1), more recent experiments performed by 
Dr Daniel Jackson have shown asymmetric distribution of Ldia2 and other early developmental 
transcripts from the two-cell stage (data in preparation). These findings are compelling indicators 
that the establishment of LR asymmetry occurs very early in development. Furthermore, the 
accessibility of whole-mount in situ hybridisation in early stage L. stagnalis embryos is improving 
thanks to ongoing optimisation within the Jackson group. Accordingly, the DE transcripts identified 
here, such as the actin-related proteins may be later supported with localisation analysis. 
Validation of high-throughput differential expression analysis 
Although the few DE expressed tags identified in the eRAD analysis appear unlikely to have resulted 
from true biological patterns of gene expression, the associated protein functions do hold potential 
to be involved in LR patterning in development. Therefore, the eRAD transcripts will be investigated 
further. Most of the DE tags generated a pe contig and subsequently tag-specific qPCR assays can be 
developed with relative ease. 
The RNA Seq data has now been received (October 2015) facilitating the completion of the 
comparative analysis with eRAD. In addition to performing DE analyses, which may confirm or 
negate the conclusions regarding overall lack of DE between genotypes, the transcriptome assembly 
will be of interest. Once assembled, comparisons can be made regarding the quality of the contigs 
generated from each technique, such as average contig length and extent of annotation. These 
comparisons will hopefully indicate whether the increased depth of sequencing proposed by eRAD 
resulted in a higher quality de novo assembly. 
Possibilities for gene-knockout 
As previously stated, to prove Ldia2 is the causal chirality gene would require gene-knockout. Due to 
the maternal effect of chirality determining factor in L. stagnalis, RNA interference mechanisms such 
as morpholinos will not be effective as the transcripts, and likely the gene products, are already 
present in the single cell embryo. The emerging capabilities of CRISPR-cas9 techniques have offered 
genome editing as a possibility in non-model organisms such as L. stagnalis. As the modified 
transcripts resulting from the CRISPR-cas method are irreversible, the ideal delivery would be to 
apply the CRISPR-cas modified transcript (cas-crRNA) to the ‘mother’ snail and subsequently observe 
the resulting offspring. However, delivery of the cas-crRNA to the reproductive organs remains a 
challenge due to their internal organisation within the external shell. Consequently, these methods 
will require a substantial investment to perform, beyond the current scope of the Davison research 
group, however the results would be highly informative.  
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Protein analyses 
Throughout this thesis, gene expression has been inferred through the relative quantities of specific 
mRNA transcripts. Subsequently, differences in the relative quantity of mRNA between conditions 
have been used to indicate patterns of transcriptional regulation and link these to the observed 
phenotype. Whilst expression level analyses are highly informative, it is important to acknowledge 
that the quantity and structure of the resulting protein will hold greater functional consequences in 
relation to the phenotype. As previously described, it is possible that a missense mRNA transcript 
does not result in a reduction in the quantity of the transcript but produces a non-functional protein, 
detectable only via protein analysis. Alternatively, it possible that when the level of transcript 
available is reduced, translation will simply be increased in order to compensate. Consequently, it 
could be that a significant difference in the quantity of mRNA transcript does not result in a 
difference in the level of protein. Additional protein analyses would be ideal to support the findings 
here, especially with regards to the missense sinistral Ldia2 transcript.  
Candidate gene approaches vs whole transcriptome sequencing 
The DE analyses within this project were performed over two different scales. The qPCR study 
assayed specific candidate genes under more controlled settings, whereas the eRAD study 
performed an explorative sweep of the (reduced) transcriptome. With the exception of the proximal 
candidates identified through previous linkage-mapping, the GOIs assessed through qPCR could be 
considered to represent a candidate gene approach to identifying associated genes. Each of the 
targets was chosen for their predicted function in LR asymmetry determination. Inevitably however, 
this can lead to ‘closed-minded’ experimental designs and ultimately wasted time on a ‘wild-goose 
chase’ to identify functional gene associations. 
Alternatively, with the increasing availability of NGS technologies, the whole transcriptome can be 
scanned to identify DE patterns in thousands of targets simultaneously. However, such methods, as 
exemplified in the present study, can be riddled with uncertainty due to inherent errors such as 
unknown sequencing error, biased sequencing depth between transcripts and conditions, and 
perhaps the most challenging: false discovery rate due to multiple comparisons. Owing to these 
factors, the majority of DE patterns identified through high-throughput sequencing experiments 
require validification via alternative methods such as qPCR or microarrays, perhaps diminishing the 
high-throughput capabilities of the technique. 
Of course candidate gene approaches can only be performed with prior knowledge of both the 
candidate gene’s sequence and function. Accordingly, NGS methods can provide a valuable initial 
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investment to gain exploratory sequence information and an overall representation of expression 
patterns within the study system, simply not possible through previously available methods. 
Moreover, the necessity for validification of findings through multiple experimental methods does 
not negate either method, but increases support of both. In this study, the candidate gene approach 
was successful in highlighting DE in the actin-related proteins, which are directly related to the 
primary candidate gene, and a lack of DE within the other genes. However, to infer that the sinistral 
genotype is not demonstrating a wide-spread loss of function from a lack of DE in ten target genes 
would demand further evidence. Support for this interpretation was indicated through the lack of DE 
identified across >30,000 sequence tags in the eRAD data. 
Applications of findings 
This project has described five endogenous control genes confidently verified as stable in the single-
cell embryo, ovotestis and foot tissue of chirally dimorphic L. stagnalis. The specified targets can 
provide other researchers of L. stagnalis rapid access to endogenous control genes suitable for 
relative qPCR in keeping with the MIQE guidelines (Bustin, Benes et al. 2009) which were previously 
lacking. 
The trial of eRAD although awaiting comparison with RNA Seq, will provide an informative overview 
of the capabilities of this technique. The recently published paper on ‘RARseq’ (Alabady, Rogers et al. 
2015) as previously stated, has not employed the quantitative capabilities of the technique, and as 
there are currently no publications of eRAD from the Cresko group, DE analysis via reduced 
representation RNA sequencing remains undescribed in the scientific literature. Finally, since the 
publication of the ‘RARseq’ paper it is arguable that the presently used term ‘eRAD’ should be 
changed to adhere to the term ascribed in the first publication of data analysis. However, eRAD has 
been used here in keeping with the term used by the Cresko group following the conference in 
which it was described in 2010 (National Center for Research Resources 2010).   
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S1. Whole-mount in situ hybridisation experiments 
Whole mount in situ hybridisation techniques were developed for a number of the GOIs assessed in 
Chapter 3 during a research trip to the Jackson laboratory at the Georg-August-Universität 
Göttingen. The technique however, required a significant amount of optimisation and consistent 
results were not obtained during the time available. Included here is the final report submitted to 
the funding body, summarising the findings. The primary candidate genes have not yet been 
published and so the genes of interest (GOIs) were anonymously referred to as GOI A – GOI D. The 
corresponding gene descriptions are presented in Table S1. 
Table S1 Gene name and associated protein description corresponding to the anonymous GOI IDs throughout the report. 
Anonymous ID Candidate Gene and description 
GOI A Lmhc, heavy chain myosin 
GOI B Larp 2/3 1a, actin-related protein 2/3 complex 
GOI C 
Ldia2, diaphanous related formin (includes frameshift mutation in the 
sinistral copy) 
GOI D Ldia1, diaphanous related formin 
 
BOEHRINGER INGELHEIM FONDS TRAVEL GRANT: FINAL REPORT 
Awardee: Harriet F Johnson, 2014 
 
SUMMARY 
This research trip was intended to measure the localised expression of a set of candidate genes 
associated with left-right asymmetry during development of the pond snail Lymnaea stagnalis. The 
results of the whole mount in situ experiments were too variable to assume any significance and it is 
apparent that this technique necessitates rigorous optimising, which was beyond the scope of this 
research stay. However, I have gained a wealth of experience in the manipulation of developmental 
stages of L.stagnalis, which has provided a substantial contribution to further work since returning 
to the University of Nottingham. In addition to gaining laboratory skills, this research exchange has 
enhanced collaborative relationships with the Jackson lab, whilst also forming new networks with 
those at the Georg-August-Universität Göttingen. 
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KEY SKILLS GAINED 
• Cloned  gene of interest 
• Staging of L.stagnalis embryos 
• Decapsulation and fixing of L.stagnalis embryos 
• Whole-mount in situ hybridisation technique including riboprobe synthesis 
• Use of automated robot - InsituPro VSi 
• Northern blot analysis 
• RNA extraction from L.stagnalis embryos 
DESCRIPTION OF SCIENTIFIC ACTIVITIES 
Aims 
Consistent left-right (LR) asymmetry of the visceral organs is a highly conserved feature of animal 
development. Deviations from normal LR patterning can result in serious clinical consequences and 
may affect 1 in 5000 live births (Casey and Hackett 2000), yet much uncertainty remains regarding 
the mechanisms of LR axis specification during development. To gain a deep evolutionary 
understanding of development, a wide variety of model organisms are required. We are using snails 
to understand LR asymmetry, because their “chirality” is variable and determined at a very early 
stage in development.  
Through collaboration with Daniel Jackson within the Courant Research Centre at the Georg-August-
Universität Göttingen, I intended to use in situ expression techniques to reveal localisation and 
potential changes in gene expression that take place during the early development of LR variable, or 
“mirror image” snails.  
In Situ Experiments 
Riboprobe Synthesis 
I arrived with several candidate gene sequences identified from previous analyses of Lymnaea 
stagnalis ovotestis tissue, to provide targets for whole-mount in situ hybridisation (WMISH) 
experiments in L.stagnalis embryos. 
I was able to successfully clone specific cDNA fragments from four genes of interest (hereafter 
referred to as GOI A-D), from which complementary RNA binding probes (riboprobes) for use in 
WMISH were then synthesised. The riboprobe is a specific sequence of single-stranded RNA, labelled 
with digoxigenin-UTP (DIG), generated from a directional polymerase. The direction/orientation of 
the riboprobe is essential for it to complement correctly to the transcript in the tissue. 
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Sample preparation 
WMISH allows for whole embryos to be analysed in the experiment. To prepare the tissues for 
analysis, eggs must first be decapsulated to isolate the embryos, which are then preserved/ fixed in 
paraformaldehyde. 
In order for the gene-specific riboprobes to bind to their complimentary RNA transcripts within the 
embryo, the tissue must be permeable. Depending on the size of the embryo, further steps in the 
fixation protocol are required to increase permeability of the tissue. Generally early cleavage stage 
embryos do not require permeabilisation, however the fixation protocol is still being optimised for 
L.stagnalis. 
Whole-mount in situ hybrisidation 
The lengthy hybridisation steps were carried out via an automated robot: the Intavis ‘InsituPro VSi’. 
To briefly summarise the protocol here, the prepared samples were first incubated with a 
hybridisation buffer at 50°C to which the gene-specific riboprobes were then added. Following a 
minimum incubation of ten hours allowing the riboprobes to hybridise to their complimentary 
targets, the excess riboprobe was washed away. The sample was then incubated with an antibody 
(anti-DIG), which was incorporated into the riboprobe bound to the specific transcript within the 
tissue. 
Outside of the automated robot the sample was treated with a stain mix of NBT (nitro-blue 
tetrazolium chloride) and BCIP (5-bromo-4-chloro-3'-indolyphosphate). The stain produces a purple-
blue colour in the presence of the antibody and consequently provides a signal of localised 
expression of the specific transcript in the tissue. A darker stain generally infers a higher level of 
transcription. This step is highly variable and time sensitive and so is performed manually, allowing 
for continuous observation. 
Results 
The results from the WMISH experiments were highly variable and it became apparent that this 
technique requires optimising specific for each riboprobe and developmental stage.  
In developmental stages more than 24 hours post-cleavage, positive control genes performed as 
expected and showed consistent staining patterns, whereas the early cleavage stages, although 
exhibiting well preserved morphology, predominantly failed to stain or demonstrated unreliable 
staining patterns (Figure S1). 
Analyses of the genes of interest in later developmental stage embryos were also more successful 
than those of early cleavage stages. GOI A in late stages displayed a consistent staining pattern 
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focused around the defined foot and mantle tissue. Embryos of 1-3 days post-cleavage, show a 
concentrated stain, however it is difficult to identify any key features or consistent staining pattern 
(Figure S2).  
GOI B in late stages showed a weaker signal but a staining pattern similar to that of GOI A (Figure 
S3). It was in the early cleavage stages that GOI B gave an interesting signal. It appeared that GOI B 
was expressed ubiquitously in the early two-cell stage, yet this was reduced to one-sided expression 
in the late two-cell stage (Figure S4, c & d). However, it was difficult to reproduce this result, or in 
fact any staining in the early cleavage stages (Figure S4, e & f). 
GOI C exhibited a potential sided difference in signal intensity in the four-cell stage embryo (Figure 
S5) and also demonstrated the same one-sided staining pattern as GOI B at the two-cell stage. 
However there were also difficulties in successful staining of this GOI from two alternative 
riboprobes. GOI D failed to produce a signal in any of WMISH experiments. 
The one-sided staining pattern was also observed at the two-cell stage for the positive controls 
genes, which were expected to be ubiquitously expressed (Figure S1, d & e). It is unknown the 
reason for this effect, however due to the low intensity of the signal, coupled with the fact that 
approximately 50% of embryos failed to stain, it is unlikely to be a true signal. As such the staining 
patterns of all the early cleavage stages are considered inconclusive. 
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Figure S1. In situ expression staining of various positive control genes for appropriate developmental stages of L.stagnalis. 
Anonymous control gene in 1-3 day old embryo (a). Beta tubulin expression in 5-6 day old embryo (b). No signal from 
anonymous maternal transcript in 1 cell embryo (c). One-sided signal at 2-cell stage from anonymous maternal transcript 
(d, e). Scale bar represents 50μm in all images. 
 
 
 
 
Figure S2. In situ expression staining of GOI A in L.stagnalis 5-6 day old embryos (a, b, c) and 1-3 day old embryos (d, e, f, 
g). Scale bar represents 50μm in all images. 
278 
 
 
Figure S3. In situ expression staining of GOI B in L.stagnalis 4-6 day old embryos. Scale bar represents 50μm in all images. 
 
 
 
Figure S4. In situ expression staining of GOI B in L.stagnalis in early cleavage stages; one cell (a, b), early two cell (c), late 
two cell (d, e) and four cell (f) embryos. Scale bar represents 50μm in all images. 
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Figure S5. In situ expression staining of GOI C in L.stagnalis in early cleavage stages; four cell (a, b) & late two cell (c, d). 
Scale bar represents 50μm in all images. 
 
 
 
 
Figure S6. Seven step serial dilutions of riboprobes for GOI C (ii), GOI D (iii) & GOI B (iv) at dilution factor 1:5 indicated by 
numbers 1 (full concentration) to 8, compared to control DIG-labelled RNA (i) at dilution factor 1:2. 
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Experimental Controls 
In addition the positive controls run in the WMISH experiments, further experimental controls were 
performed to verify the riboprobe function and attempt to ascertain the reason for the repeated 
failure in some of the WMISH experiments.  
Dot-blot test 
Firstly, if the riboprobe has not successfully incorporated the DIG-label required for successful 
antibody hybridisation and staining, there will be no signal from the WMISH experiment. Equally, 
failure can occur if the riboprobe is at a too low concentration to be detected.  
A ‘dot-blot’ test was carried out to verify the concentration of the riboprobes (Figure S6). Seven-step 
serial dilutions at a dilution factor of 1:5 were prepared of each DIG-labelled riboprobe. These were 
applied to a nylon membrane, treated with the anti-DIG containing hybridisation buffer and finally 
stained with the NBT/BCIP stain solution. The darker stain indicates a higher riboprobe 
concentration. The concentration of the riboprobes for the GOIs could then be compared to that of 
an RNA control (Figure S6). All of the riboprobes tested showed a clear signal at dilutions 
comparable to the concentrations used in the WMISH experiments (quantified using a Nanodrop 
spectrophotometer) and consequently indicate a functional DIG-label concentration. It can therefore 
be assumed that this is not the reason for failure in the WMISH experiments. 
Northern blot test 
Having confirmed the riboprobes contain the label required for successful staining, Northern blot 
analyses were performed in order to test whether the riboprobes can successfully hybridise to their 
complimentary RNA transcripts.  
Total RNA isolated from three different tissues (buccal mass, foot & mantle) of adult L.stagnalis were 
each heat denatured and size differentiated via electrophoresis through a formamide-agarose gel 
(Figure 7, a, b, c). The size-segregated bands of RNA were then transferred onto a nylon membrane 
to be treated with a specific riboprobe, antibody and finally NBT/BCIP stain, essentially following the 
WMISH protocol. The resulting stain firstly indicates that the riboprobe is functional and the 
transcript is present in the sample, but also allows the size of the transcript to be inferred by 
comparing the distance travelled to that of an RNA marker of known size (Table 1). The size of the 
transcript can be more accurately predicted by semi-log plotting of the distance travelled relative to 
a marker of known size (plots available on request). 
A previously successful riboprobe was tested on the first Northern blot test to provide a positive 
control, which produced a strong, discrete banded stain (Figure S7, ai (right)). The experimental 
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riboprobe for GOI B however, produced a much fainter and less distinct stain (Figure S7, ai (left)). It 
should be noted that the stain is in a very common size region for transcripts, as can be seen by the 
bright smear on the fluorescent gel scan (Figure S7, a, b, c). The stain could be a result of non-
specific binding due to the high density of transcripts in this region, or it could be less distinct 
because the transcript has not been able to segregate effectively due to the cluster of fragments. 
No stain was produced for GOI C (Figure S7, bi (left)) indicating either that the riboprobe is not 
functional or that the transcript is not present in the sample. This riboprobe was removed from 
further experiments and provides a possible explanation for failure in the WMISH, whereas the 
riboprobe for GOI D (which failed all WMISH experiments) did produce a banded stain, which 
appears to be too discrete to be background noise, however it is very light (Figure S7, bi (right)). This 
could indicate the transcript is in low abundance and may require an increased concentration of the 
riboprobe. 
Alternative riboprobes for GOI B and GOIC were also tested. The riboprobe for GOI B produced the 
same smeared stain and as such remains inconclusive (Figure S7, ci (left)). The riboprobe for GOI C 
did produce a discrete but faint stain (Figure S7, ci (right)), similar to that produced by GOI D. It is 
likely therefore that the transcript is present within the sample yet is in low abundance. It must be 
acknowledged that the final lane in the GOI C analysis contained approximately half the 
concentration of RNA as the adjacent lanes (Figure S7, c). This was due to having insufficient sample 
available. 
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Figure S7. Northern blot analysis: Top: a, b & c show size differentiated total RNA from adult L.stagnalis tissues (left-right: 
SS RNA Ladder, buccal mass, foot, mantle, no sample, buccal mass, foot, mantle). Bottom: NBT/BCIP staining of; GOI B 
(left) and positive control (right) (ai); GOI C (left) and GOI D (right) (bi); GOI B (left) and GOI C (right) (ci). 
 
 
 
Table S2. Northern blot measures of distance migrated in millimetres (mm) via gel electrophoresis of single stranded RNA 
of known length (SS RNA Ladder) in kilobases (KB) and riboprobe-specified transcripts (GOI (left) GOI (right)) for each gel 
depicted in Figure S7 a, b & c. 
Gel a b c 
SS RNA Ladder (KB) Distance (mm) Distance (mm) Distance (mm) 
9 10 9.5 10 
7 12 11.5 12.5 
5 16 15.5 15.5 
3 22.5 22.5 22.8 
2 27 27 27.5 
1 35 36.5 35.5 
0.5 41.8 44.5 43 
GOI (left) 29.5 n/a 28.3 
GOI (right) 12.5 11 9.2 
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RNA extraction from embryos 
Another possible reason for failure may be that the transcript is not present in the tissue used in the 
WMISH experiment. The riboprobes were generated from sequences originally obtained from 
ovotestis tissue from adult L.stagnalis. The Northern blot tests were also performed on RNA from 
adult tissues. As such, it is possible that the specific transcript may not be present in the early stage 
embryos.  
To verify the transcripts are in fact present in the early stage embryos, total RNA was extracted from 
a pool of one to four cell stage embryos. Complementary DNA (cDNA) was then synthesised from 
the resulting total RNA using random hexamers. Fragments specific to the riboprobes of GOI B, C & D 
were successfully amplified via a standard PCR reaction from embryonic and adult tissue (the same 
adult samples used in the Northern blot analysis, which functioned as a positive control) (Figure S8). 
It was therefore confirmed that all of the GOIs which failed WMISH experiments were present in the 
early stage embryos, and that was not the reason for failure.  
It is interesting to note that the sequence specific to the riboprobe for GOI C, which failed the 
Northern blot, displays a very faint band in the embryonic sample, only clearly visible with increased 
UV exposure (Figure S8, 2). This could indicate that the transcript is in very low abundance in the 
embryo. It is also important to note that the PCR of the alternative riboprobe sequence GOI C, 
amplified a different sized fragment in the embryonic sample, compared to that of the adult tissue 
sample (Figure S8, 4 & 8). When the gel scan is over-exposed, it is apparent that the adult sample 
has amplified multiple fragments from the same primer pair. This may highlight a true difference in 
transcripts present in embryonic and adult tissues, although the PCR products must be sequenced to 
confirm specificity.  
 
Figure S8. Riboprobe specific cDNA sequences amplified via PCR from embryonic (2-5) and adult (6-9) tissues of L.stagnalis 
at UV exposure 0.2 seconds, 0.5 seconds & 1.3 seconds. 1: 1 Kb ladder. 2 & 6: GOI C. 3 & 7: GOI D. 4 & 8: GOI C (alternative 
riboprobe). 5 & 9: GOI B. 10: 100bp ladder. 
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CONCLUSIONS  
The results of WMISH can be highly variable and the method requires optimising, which is very time 
intensive and beyond the scale of this visit. In light of the successful experimental controls, it 
appears reasons for failure in the early cleavage stages may reside in the fixing technique. When 
fixing later stage embryos, which demonstrated the expected positive controls (Figure S1, a & b), the 
samples were gently shaken during incubations, whereas the more sensitive early cleavage stage 
embryos were not, in the hope to minimise potential damage. It is possible that the viscous ooplasm 
which surrounds the embryo within the egg may have not been completely removed, resulting in 
inefficient fixing treatment. Although this seems unlikely due to the extremely well preserved 
morphology throughout the WMISH experiments (for example see Figure S1, c). 
ADDITIONAL BENEFITS 
Overall from the research visit, I have gained not only new laboratory expertise but also experience 
working in a foreign research department, which has been both enlightening and rewarding. 
During my time in Göttingen, I was welcomed by all in the department and learned a lot more about 
the higher education and research system in Germany, including attending the successful PhD 
defence of one of the students (now a postdoctoral fellow) in the Jackson group. However my time 
was not only spent working. I was able to enjoy many aspects of the city of Göttingen and take back 
with me a new love for spätzle and hefeweizen. 
REFERENCES 
Casey, B. and B. P. Hackett (2000). "Left–right axis malformations in man and mouse." Current 
opinion in genetics & development 10(3): 257-261. 
 
S2. Genotyping PCR primers 
Chapter 2: PCR: 1315-507 
F: 5′-GAGGAGAGGTTTGATTTCATTGAT-3′ 
R: 5′-CATTCCGCAAACTCTCCATT-3′ 
Marker RAD04, developed in Liu, Davey et al. (2013) 
Chapter 3: PCR: b3g FP1, F8R8 
F: 5′-YGGRCCAACATTTATTTYCGTTAC-3′ 
R: 5′-GTCATGGAMATGGTGCAGAG-3′ 
Developed in Davison et al, awaiting publication. Non-standard bases represent IUPAC ambiguity 
codes.   
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S3. Total RNA visual quality assessment 
Following each RNA extraction method an aliquot (2 µl) of total RNA was visualised via agarose gel 
electrophoresis, using ethidium bromide as a fluorescent marker. It has been stated that molluscs 
(amongst other organisms) do not demonstrate the same sized 18S and 28S rRNA bands commonly 
found in total RNA of mammals (Barcia, Lopez-Garcia et al. 1997). However, the gels run here were 
not performed as RNA degradation gels, which are required to specifically size the fragments and 
therefore the actual size of the bands is unknown. The RNA was examined for quality via presence of 
distinct bands representing the abundant rRNA (Figure S9). If the sample was degraded these 
specific sizes would be variable and seen as a smear down the gel. The presence of distinct bands 
indicated that the samples were of good quality. 
A selection of total RNA samples extracted from the ovotestis via TRI Reagent protocol is presented 
in Figure S9: 1. In order to test the stability of the RNA, an aliquot of each sample was incubated at 
65°C for 2 hours, whilst the remaining sample was stored at -80°C (the method of storage employed 
for all RNA samples). This rather extreme test resulted in overall degradation of the RNA (Figure 
S9:1b).The RNA extracted from a pooled single-cell embryo sample via the RNeasy kit is shown in 
Figure S9: 2. Although present at a much lower concentration than those shown from ovotestis, two 
distinct bands can be seen.  
 
Figure S9 UV visualisation of total RNA via agarose gel electrophoresis. Representative samples are shown from two 
different methods of RNA extraction and storage conditions. 
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S4. Predicted expression level of endogenous control genes 
Following research in the Davison lab of conserved maternal transcripts across species (Liu, Davey et 
al. 2014), the genes identified as present in the one cell L. stagnalis embryo had information 
available regarding their associated human housekeeping gene data and expression levels. The 
expression levels for the six genes selected as candidates for endogenous controls were found to 
show neither very high nor very low levels of gene expression. 
 
Table S3 Expression level of the human housekeeping gene associated with the six candidate endogenous control genes 
in L. stagnalis. The sequence description and gene abbreviation (Abv.) are presented in addition to the accession number 
of each human housekeeping gene NCBI Blast hit and expression level calculated from data published in (Eisenberg and 
Levanon 2013). 
Abv. Sequence description Human housekeeping blast hit Expression level 
Lube2 ubiquitin protein NM_003336 0.467 
Lhis2a histone-like NM_012412 0.490 
Lef1a elongation factor 1 alpha NM_006620 0.649 
Lywhaz 14-3-3 zeta NM_006761 0.697 
Lacads acyl-coenzyme a c-2 to c-3 short chain NM_014049 0.706 
Lrpl14 ribosomal protein l14 NM_003973 0.938 
 
 
 
 
Figure S10 Histogram plot showing log geometric mean gene expression level for conserved (red) and non-conserved 
(blue) maternal transcripts. The range of expression level of the six candidate genes selected for endogenous controls in 
L.stagnalis is indicated by the shaded area. Human gene expression data originally from (Eisenberg and Levanon 2013). 
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S5. Sample assessment PCRs:  
Two PCRs were used to test samples for genomic DNA carryover. The intron-specific primer 
sequences are as follows:  
 
CAND F1: 5’- CAAAACCTGGCAATGCTACTG -3’ 
CAND R1: 5’- ACGTAGGGTTGAAAGTCATGC -3’ 
PARA F1: 5’- ACCTCTCAGCAACCTTAGGC -3’ 
PARA F1: 5’- TGAAAGTATCCCAGTCCATGC -3’ 
All cDNA samples were tested firstly for cDNA amplification to verify the functionality of the cDNA. 
Following the positive control for cDNA amplification, another PCR tested for the presence of 
genomic carryover by attempting to amplify a sequence specific to the intron. 
S5.1 Ovotestis 
Each ovotestis sample amplified a bright product in the intronic PCR experiment indicating the 
presence of genomic DNA carryover, however no sample amplified two products in the qPCR 
primers test and so any genomic contamination is believed to be outcompeted by the more 
abundant cDNA template. There was a notable exception in sample 10629, where no band was 
detectable in the intronic PCR, however this is assumed to be due to loading error. Amplification was 
observed in the negative control of the Lmhc reaction in Figure S11.2a, however there were no 
issues of cross-contamination apparent in the qPCR experiments. Therefore this is assumed to be a 
result of the specific primer dilution or water aliquot used in this individual PCR.  
Sample 10630 and 10631 were not included in the PCR experiment shown in Figure S11. However 
positive amplification of the samples had already been observed, although 10631 did suffer from 
what is assumed to be low concentration, resulting in a failure to amplify in a number of 
experiments. Due to the unanimous presence of genomic carryover in the ovotestis samples it is 
assumed that these two samples also had a similar level of genomic carryover. 
S5.2 Foot 
Each foot sample amplified a product in the intronic PCR experiment indicating the presence of 
genomic DNA carryover, however the bands appeared less bright than that of the genomic control 
sample (Figure S12.b) and compared to those in the ovotestis (Figure S11.2b, although it should be 
noted that these are two separate gels and therefore have some level of variation in the UV 
exposure and amount of ethidium bromide included and as such are not a direct comparison).  
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Again no sample amplified two products in the qPCR primers test and so any genomic contamination 
is believed to be outcompeted by the more abundant cDNA template. There was a notable 
exception in sample 11352, where no band was detectable in the intronic PCR. Although this could 
represent a complete absence of genomic carryover in this sample, it is more likely a consequence of 
loading error or PCR failure. 
S5.3 Embryo 
Each embryo sample PCR is presented in Figure S13. No sample produced a PCR product detectable 
via UV gel electrophoresis (gels were examined for longer UV exposure time to ensure no product 
was present – images not presented). The sinistral samples (11282, 11284, 11287, 11283, 11301, 
and 11303) showed notably fainter bands for the amplification of Ldia2.  
Amplification was again observed in the negative control in Lmhc experiment shown in Figure 
S13.3a, again due to the lack of issues of cross-contamination apparent in the qPCR experiments and 
the same problem observed in the ovotestis and foot Lmhc test PCR, this is assumed to be a result of 
the specific primer dilution or water aliquot used. A band was also seen in the negative control of 
Figure S13.2b, due to the lack of any bands in the other wells this is assumed to be due to well 
crossover within the gel loading as opposed to contamination within the reaction. 
 
 
Figure S11 UV visualisation via agarose gel electrophoresis of PCR products amplified from each of the ovotestis cDNA 
samples with the exception of (10630, 10631) a genomic control sample (755) and a negative control (H2O), specific to 
Lmhc qPCR target (1a, 2a) and intron specific target (1b, 2b) and 100 bp DNA size marker (L). 
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Figure S12 UV visualisation via agarose gel electrophoresis of PCR products amplified from each of the foot cDNA 
samples with an additional genomic control sample (755) and negative control (H2O), specific to Lmhc qPCR target (a,) 
and intron specific target (b) and 100 bp DNA size marker (L). 
 
 
 
Figure S13 UV visualisation via agarose gel electrophoresis of PCR products amplified from each of the embryo cDNA 
samples (11282-11303; 11358-11363, including the one cell pooled sample P1c), a genomic control sample (755) and a 
negative control (H2O), specific to Ldia2 (1a, 2a) and Lmhc (3a) qPCR targets and intron specific targets (1b, 2b, 3b) and 
100 bp DNA size marker (L). 
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S5.4 DNase treatments across tissues 
Every embryo tissue sample used within these experiments failed to produce a PCR product from the 
intronic specific PCR whereas each of the ovotestis and foot samples exhibited genomic 
contamination via the amplification of intron-specific PCR products, with the exception of one foot 
sample 11352, and one ovotestis sample 10629. However due to the intensity of the bands in the 
other samples, it is more likely that the absence of amplification represents a PCR fail as opposed to 
a genuine lack of genomic DNA within the sample. 
The failure of the DNaseI treatment to remove all genomic DNA from the foot tissue yet succeeded 
in the embryo tissue, is of note. One key difference between the samples is their extraction method. 
The embryos were extracted via the RNeasy micro kit, having been stored in RNA later, whereas the 
foot tissue samples were firstly extracted using TRI Reagent® and subsequently re-extracted using 
the RNeasy kit. The TRI Reagent® RNA extraction method used to isolate the foot tissue RNA samples 
will inevitably to result in some level of phenol carryover and potential ethanol carryover. The level 
of such impurities can be inferred from the nanodrop 260/230 values (Table 2 – main document).  
Although some of the foot samples 260/230 values are below the recommended 1.8 value 
(ThermoScientific 2010) the embryo sample values are generally far lower. It may be more 
informative to look at the Nanodrop data of the foot samples prior to the re-extraction. These are 
presented in Table S4 and show similarly, the 260/230 values are often lower than the 
recommended values yet not as low as those seen in the embryo samples. It is important to note 
that the values for the embryo samples may be skewed by the generally much lower RNA 
concentration; due to the relative measure of the spectrophotometer peaks, the same amount of 
carry over impurities will impact a low RNA concentration sample more than a high RNA 
concentration sample.  
The DNase treatment within the RNeasy extraction protocol has a limited loading capacity (although 
this was not exceeded according to the user manual, (Qiagen 2007)) which may have limited its 
effectiveness in the foot samples. It is probable, therefore that the absence of genomic carryover in 
the embryo samples may simply be due to the lower starting quantity. 
It is acknowledged by the suppliers of DNase treatments that no DNase is capable of removing all 
traces of genomic DNA. However, the failure of two alternative DNase treatments to remove 
carryover genomic DNA from ten of the ovotestis samples is somewhat surprising (Figure S11). The 
failure may be due to residual phenol from the TRI Reagent protocol inhibiting the active enzyme. 
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The generally low 260/230 ratios seen in the ovotestis samples (Table 17 – main document) supports 
this (AppliedBiosystems 2010).  
Finally, the low concentration of the embryo samples may be the sole reason for their apparent lack 
of genomic carryover. As opposed to the samples genuinely being purer than the foot or ovotestis 
samples, it may be that the starting material is reduced such that the level genomic carryover is 
insufficient to generate a PCR product detectable via gel electrophoresis.  
 
 
Figure S14 Intronic PCR test of DNase treated ovotestis samples 11347-11357, with genomic DNA positive control (755) 
and negative control (H2O). PCR products amplified from cDNA generated fromTRI Reagent extracted total RNA (a), 
DNA-freeTM (Ambion) treated TRI Reagent extracted total RNA (b) and Precision DNase (PrimerDesign) treated following 
DNA-freeTM treated TRI Reagent extracted total RNA (c). 
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Table S4 Summary of RNeasy re-extraction of foot samples. Table shows: Sample descriptive information including sample ID (ID) and genotype (Geno). A summary of the Nanodrop 
quantification of the untreated TRI Reagent extracted total RNA. A summary of the volume (µl added) and mass (µg added) of total RNA added to the RNeasy extraction protocol. 
Nanodrop data is presented for the following RNeasy re-extracted total RNA and a final summary of the µg of total RNA eluted into 14 µl, and the percentage retained of the RNA input (% 
ret.). Finally the difference between the 260/280 and 260/230 ratios from the re-extracted sample compared to the original sample are presented (Δ260/280, Δ260/230). A positive value 
indicates the ratios are higher in the re-extracted samples. 
Sample Description Untreated total RNA RNeasy extraction RNeasy re-extracted Efficiency 
ID Geno ng/µl 260/280 260/230 µl added µg added ng/µl 260/280 260/230 
µg eluted 
(14µl) 
% ret. Δ260/280 Δ260/230 
11355 dd 194.24 1.96 1.40 25.0 4.86 207.17 2.08 1.52 2.90 59.73 0.12 0.12 
11355 dd 194.24 1.96 1.40 5.0 0.97 24.89 2.10 1.23 0.35 35.88 0.14 -0.17 
11355 dd 194.24 1.96 1.40 10.0 1.94 56.77 2.31 1.16 0.79 40.92 0.35 -0.24 
11347 DD 379.55 1.95 2.06 5.3 2.00 72.02 1.95 1.40 1.01 50.41 0.00 -0.66 
11348 dd 335.73 1.92 2.22 6.0 2.00 74.69 2.03 2.12 1.05 52.28 0.11 -0.10 
11349 dd 415.29 1.91 2.27 4.8 2.00 70.75 2.05 2.03 0.99 49.53 0.14 -0.24 
11350 DD 296.31 1.98 1.12 6.7 2.00 49.54 1.96 1.51 0.69 34.68 -0.02 0.39 
11351 DD 254.38 1.97 1.55 7.9 2.00 85.33 2.19 2.26 1.19 59.73 0.22 0.71 
11352 DD 552.47 2.01 1.41 3.6 2.00 67.62 2.10 1.95 0.95 47.33 0.09 0.54 
11353 dd 511.76 1.99 1.82 3.9 2.00 69.20 2.41 1.36 0.97 48.44 0.42 -0.46 
11354 dd 646.13 1.99 2.15 3.1 2.00 78.20 2.07 1.72 1.09 54.74 0.08 -0.43 
11356 dd 234.32 1.92 1.84 8.5 2.00 76.98 2.09 1.98 1.08 53.89 0.17 0.14 
11357 DD 255.02 1.95 1.35 7.8 2.00 62.15 2.23 1.25 0.87 43.51 0.28 -0.10 
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S6. Description of omitted data points from qPCR raw data 
Chapter 2: Endogenous control gene experiments 
To reduce experimental noise in the final dataset, data points resulting in an average Cq value with 
high SD were omitted from the final analyses. All bar one of the omitted data points were from the 
Lef1a assessment. In the embryo analysis, samples 11295, 11287 and 11303 each exhibited high SD 
for the amplification of Lef1a. One perceived outlier of each sample was omitted from analysis, 
resulting in an average Cq value calculated from only two data points without high SD (Table 7). In 
the foot tissue analysis, perceived outliers were removed from five samples which exhibited high SD 
in Lef1a, namely 11348, 11350, 11351, 11352, 11357. In sample 11347, two replicates failed to 
amplify a product for Lef1a and therefore only one Cq value contributed to the average Cq value, 
and as such it does not strictly represent an average Cq (Table 8). In the ovotestis analysis, one of the 
technical repeats for sample 10642 in Lef1a was flagged as an outlier and subsequently removed 
from the final dataset (Table 9). 
In the Lrpl14 analysis, one of the technical repeats for embryo sample 11292 was flagged as an 
outlier and subsequently removed from analysis (Table 7). 
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S7. Sanger sequencing protocol 
No cloning was performed in order to sequence the qPCR amplification products. Sanger sequencing 
initiated from both the forward and reverse primers enabled sufficient capture of the full qPCR 
amplicon sequence. Sanger sequencing was performed on pooled single cell embryo samples. The 
six endogenous control gene amplicons were sequenced from a pool of Dd samples. Ldia1 3’UTR and 
Ldia2 3’UTR were sequenced from a pool of DD samples, whereas Ldia2 ORF was sequenced from a 
pool of DD samples and another of dd samples to ensure that the same transcript was being 
amplified from both genotypes. 
The qPCR amplicons were amplified via standard non-quantitative PCR as described in Box 2 (main 
document) using the specified primer pair (10 mM) and 3 µl cDNA (1:30 dilution). PCR products were 
then cleaned using exonuclease SAP (shrimp alkaline phosphatase) protocol to remove leftover 
primers and dNTPs. 1 µl SAP (NEB), 0.15 µl Exo I (NEB) and 1.35 µl 10x buffer (provided with Exo I) 
was added to each 20 µl PCR reaction and incubated at 37 °C for 40 minutes followed by heat 
inactivation at 80 °C for 15 minutes.  
Cleaned PCR products were prepared for Sanger sequencing using the BigDye® Terminator kit v.3.1 
(ThermoFisher Scientific). 3 µl of PCR product was added to 1 µl Big Dye, 2 µl 5x buffer, 0.5 µl specific 
primer, each reaction was made up to 10 µl with PCR grade water. 6 µl of the Ldia2 ORF, dd 
template PCR product was added to the sequencing reaction to accommodate the low quantity 
transcript. Samples were then incubated for 25 cycles of 95 °C for 30 seconds; 50 °C for 20 seconds 
and 60 °C for 3 minutes. Prepared templates were then set to The GenePool (University of 
Edinburgh) to be sequenced. 
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S8. qPCR analysis; summary statistics 
S8.1 Genotype Analysis 
S8.1.1 LOGNRQ, embryo, genotypic groups 
 
S8.1.2 LOGNRQ, foot, genotypic groups 
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S8.1.3 LOGNRQ, ovotestis, genotypic groups 
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S8.2 Tissue Analysis 
S8.2.1 Three tissues, DD 
 
S8.2.2 Three tissues, dd 
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S8.2.3 Two tissues, DD 
 
S8.2.4 Two tissues, Dd 
 
S8.2.5 Two tissues, dd 
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S9. QPCR average amplification efficiency 
After performing the Cq data analysis, it became apparent that a geometric mean may have been 
more appropriate for estimating average primer efficiencies because of the non-linear distribution of 
a percentage value. However there was little difference between the arithmetic mean and the 
geometric mean and it is assumed this variation would have a negligible effect on the comparative 
Cq calculations (Table S5). 
Table S5 Comparison of calculated arithmetic mean and geometric mean 
calculated for average percentage amplification efficiency 
Endogenous Controls 
Primer Name Arithmetic mean Geometric mean 
ACA_11210_F1R1 91.215 91.202 
EF1_8940_F1R1 115.544 115.239 
HiS_8200_F1R1 94.319 94.317 
RPL_2341_F2R2 90.649 90.554 
UB_3288_F2R2 92.325 92.322 
YWHAZ_562_F1R1 91.825 91.798 
Experimental GOIs 
Primer Name Arithmetic mean Geometric mean 
ARPI_1-2b 84.705 84.488 
ARPII_1-3a 77.477 79.019 
COL2A_3-4a 88.992 88.763 
MHCI_1-2a 89.181 89.076 
MHCII_2-3a 92.437 92.122 
MV_F2R2 94.609 94.608 
Staufen_3-4a 95.706 95.703 
UMVIII_F2R2 91.295 91.295 
UNC-93_FR 97.845 97.714 
FOR_3'_UTR 91.234 91.179 
FOR_ORF 94.846 94.195 
PARA_3'_UTR 98.577 98.565 
CAD_F1R1 83.789 83.024 
FURRY_F1R1 87.614 87.601 
 
S10. QPCR genotype analysis, Ovotestis histograms 
Histograms are presented on the following pages for the LOG NRQ values for each of the GOIs within 
the genotype analysis of the ovotestis (Figure S15 - Figure S28). 
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Figure S15 LOGNRQ values of Larp2/3 1a in ovotestis 
(a) and genotype specific ovotestis (b). 
 
Figure S16 LOGNRQ values of Larp2/3 3 in ovotestis (a) 
and genotype specific ovotestis (b). 
 
Figure S17 LOGNRQ values of Lcol11a 2/1 in ovotestis 
(a) and genotype specific ovotestis (b). 
 
Figure S18 LOGNRQ values of Ldia1 3’ UTR in ovotestis 
(a) and genotype specific ovotestis (b). 
 
Figure S19 LOGNRQ values of Ldia2 3’UTR in ovotestis 
(a) and genotype specific ovotestis (b). 
 
Figure S20 LOGNRQ values of Ldia2 ORF in ovotestis (a) 
and genotype specific ovotestis (b).
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Figure S21 LOGNRQ values of Lfat1 in ovotestis (a) and 
genotype specific ovotestis (b). 
 
Figure S22 LOGNRQ values of Lfry in ovotestis (a) and 
genotype specific ovotestis (b). 
 
Figure S23 LOGNRQ values of Lmhc in ovotestis (a) and 
genotype specific ovotestis (b). 
 
Figure S24 LOGNRQ values of Lmhc nm in ovotestis (a) 
and genotype specific ovotestis (b). 
 
Figure S25 LOGNRQ values of Lmyo5a in ovotestis (a) 
and genotype specific ovotestis (b). 
 
Figure S26 LOGNRQ values of Lmyo18a in ovotestis (a) 
and genotype specific ovotestis (b).
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Figure S27 LOGNRQ values of Lstau in ovotestis (a) and 
genotype specific ovotestis (b). 
 
Figure S28 LOGNRQ values of Lunc93a in ovotestis (a) 
and genotype specific ovotestis (b).
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S11. eRAD Library preparation 
S11.1 mRNA enrichment 
Total RNA samples retained a varying proportion of RNA once selected for mRNA ranging from 
4.55% - 17.90% (Table S6). This did not appear to be related to sample starting concentration of 
quality. 
 
Table S6 Nanodrop quantification of TRI Reagent extracted total RNA and sunsequent Poly(A) purified mRNA, Showing 
Sample descriptive information (Sample Info) including library preparation (Lib.), sample ID (ID) and genotype (Geno). 
Also provided is a calculated percentage sample retained (% ret.) of the total RNA following mRNA purification. 
Sample Info Total RNA (100μl) mRNA (10μl) Ratio 
Lib. ID Geno ng/μl 260/280 260/230 total yield μg ng/μl 260/280 260/230 Total yield μg % ret 
3 8515 DD 89.36 1.76 1.00 8.94 94.04 1.71 1.89 0.94 10.52 
3 9014 DD 169.69 1.81 1.84 16.97 77.00 1.66 1.84 0.77 4.54 
3 8544 Dd 115.45 1.86 1.30 11.55 150.08 1.68 1.96 1.50 13.00 
3 8559 Dd 136.98 1.81 1.12 13.70 103.57 1.70 1.92 1.04 7.56 
3 8562 Dd 140.96 1.81 1.25 14.10 87.88 1.71 1.85 0.88 6.23 
3 8869 Dd 294.76 1.89 1.93 29.48 142.16 1.84 2.23 1.42 4.82 
3 9013 Dd 149.34 1.78 1.79 14.93 111.74 1.69 2.03 1.12 7.48 
3 8808 dd 110.26 1.77 1.48 11.03 116.94 1.69 1.98 1.17 10.61 
3 8862 dd 211.62 1.90 1.48 21.16 96.23 1.69 1.98 0.96 4.55 
3 9007 dd 107.33 1.77 1.12 10.73 83.43 1.66 1.93 0.83 7.77 
3 9009 dd 104.97 1.79 0.61 10.50 91.31 1.69 1.62 0.91 8.70 
4 8502 DD 55.87 1.59 1.15 5.59 100.02 1.60 1.51 1.00 17.90 
4 8582 DD 61.42 1.67 1.40 6.14 103.35 1.59 1.43 1.03 16.83 
4 8500 Dd 96.10 1.70 1.39 9.61 118.02 1.67 1.73 1.18 12.28 
4 8522 Dd 98.62 1.72 1.52 9.86 125.53 1.63 1.47 1.26 12.73 
4 8530 Dd 82.78 1.73 1.40 8.28 115.69 1.63 1.42 1.16 13.98 
4 8560 Dd 78.62 1.82 1.17 7.86 109.62 1.59 1.50 1.10 13.94 
4 9001 Dd 105.17 1.74 1.41 10.52 115.58 1.64 1.63 1.16 10.99 
4 8531 dd 83.81 1.67 1.43 8.38 88.99 1.67 1.66 0.89 10.62 
4 8587 dd 56.78 1.70 0.87 5.68 55.25 1.74 1.91 0.55 9.73 
4 8867 dd 68.92 1.75 0.51 6.89 86.72 1.59 1.83 0.87 12.58 
4 9000 dd 78.42 1.72 1.19 7.84 107.10 1.59 1.44 1.07 13.66 
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S11.2 cDNA yield 
The variable cDNA yield was explored by simple correlations with associated mRNA quality 
measures. The 260/280 showed a potential cause with a positive correlation between 260/280 ratio 
and resulting total cDNA yield (R2: 0.6041), however this relationship was reduced following the 
removal of the one sample of much higher quantity (R2: 0.3241) (Figure S29). 
 
Figure S29 Correlations between mRNA sample quality and resulting cDNA yield, including total yield of mRNA (a), 
260/230 ratio (b) and 260/280 ratio including all samples (c) and following the removal of the high quantity individual 
8869 (d). 
 
S11.3 Gel extraction 
The final step of the eRAD library preparation involves size selection through gel electrophoresis. 
This step also provides a visual measure of the quality of the sequencing libraries. Library 3/L006 
showed a reasonably high level of primer dimer (indicated by the smaller sized distinct band below 
the main library smear) which is assumed to be removed from the library following extraction 
(Figure S30, 1b). Library 4/L007 showed a greater problem of primer dimer (Figure S30, 2a). The 
library was assessed again via gel electrophoresis to ensure the removal of primer dimer following 
the first size extraction. The lack of primer dimer detectable in the already gel extracted library 
(Figure S30, 2a), provides support that the size selection through gel electrophoresis is adequate to 
remove the majority of primer dimer. 
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Figure S30 Visualisation of eRAD libraries via agarose gel electrophoresis before 
(a) and after (b) extraction. Library 3/L006 is shown in 1. The first size selection of 
Library 4/L007 is shown in 2, and the re-extraction in 3. 
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S11.4 eRAD Barcode distance calculation 
Table S7 shows sequence similarity between each unique barcode within the two eRAD libraries. The highest number of in sequence identical bases was 
two. Therefore the barcode distance was three. 
Table S7 Calculation of sequence distance between the 22 barcodes/MIDs used within the eRAD libraries 
Barcodes ATGCT CCAAC AGCTG CATGA GCCGG GAGAT TGCAA ACGTA CGTAT GTACA TAATG TACGT GTTGT TGACC GGTTC CAGTC CCTTG ATTAG TCTCT ATCGA CTTCC AGAGT 
ATGCT 11111                      
CCAAC xxxxx 11111                     
AGCTG 1xxxx xxxxx 11111                    
CATGA xxxxx 1xxxx xxxxx 11111                   
GCCGG xxxxx x1xxx xx1x1 xxx1x 11111                  
GAGAT xx1x1 xxx1x xxxxx x1xxx 1xxxx 11111                 
TGCAA xxxxx xxx1x x11xx xxxx1 xx1xx xxx1x 11111                
ACGTA 1x1xx x1xxx 1xx1x xxxx1 x1xxx xx1xx xxxx1 11111               
CGTAT xxxx1 1xx1x x1xxx 1x1xx xxxxx xxx11 x1x1x xxxxx 11111              
GTACA x1x1x xx1xx xxxxx xxxx1 1xxxx 1xxxx xxxx1 xxxx1 xxxxx 11111             
TAATG xxxxx xx1xx xxx11 x1xxx xxxx1 x1xxx 1xxxx xxx1x xxxxx xx1xx 11111            
TACGT xxxx1 xxxxx xx1xx x1x1x xx11x x1xx1 1x1xx xxxxx xxxx1 xxxxx 11xxx 11111           
GTTGT x1xx1 xxxxx xxxxx xx11x 1xx1x 1xxx1 xxxxx xxxxx xx1x1 11xxx xxxxx xxx11 11111          
TGACC xxx11 xx1x1 xxxxx xxxxx xxxxx xxxxx 11xxx xxxxx x1xxx xx11x 1x1xx 1xxxx xxxxx 11111         
GGTTC xxxxx xxxx1 x1x1x xx1xx 1xxxx 1xxxx xxxxx xxx1x x11xx 1xxxx xxx1x xxxxx 1x1xx xxxx1 11111        
CAGTC xx1xx 1xxx1 xxx1x 11xxx xxxxx x11xx xxxxx xx11x 1xxxx xxxxx x1x1x x1xxx xxxxx xxxx1 xxx11 11111       
CCTTG xxxxx 11xxx xxx11 1x1xx x1xxx xxxxx xxxxx x1x1x 1x1xx xxxxx xxx11 xxxxx xx1xx xx1xx xx11x 1xx1x 11111      
ATTAG 11xxx xxx1x 1xxx1 xx1xx xxxx1 xxx1x xxx1x 1xxxx xx11x x1xxx xxxx1 xxxxx x11xx xxxxx xx1xx xxxxx xx1x1 11111     
TCTCT xxx11 x1xxx xxxxx xx1xx x1xxx xxxx1 1xxxx x1xxx xx1x1 xxx1x 1xxxx 1xxx1 xx1x1 xxx1x xx1xx xxxxx x11xx xx1xx 11111    
ATCGA 11xxx xxxxx 1x1xx xxx11 xx11x xxxxx xx1x1 1xxx1 xxxxx x1xx1 xxxxx xx11x x1x1x xxxxx xxxxx xxxxx xxxxx 11xxx xxxxx 11111   
CTTCC x1x1x 1xxx1 xxxxx 1x1xx xxxxx xxxxx xxxxx xxxxx 1x1xx x1x1x x11xx xxxxx x11xx xxx11 xx1x1 1xxx1 1x1xx x11xx xx11x x1xxx 11111  
AGAGT 1xxx1 xx1xx 11xxx xxx1x xxx1x xxxx1 x1xxx 1xxxx x1xx1 xx1xx xx1xx xxx11 xxx11 x11xx x1xxx xxxxx xxxxx 1xxxx xxxx1 1xx1x xxxxx 11111 
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S12. eRAD library sequencing Fast QC output 
A summary of the FastQC reports for each of the raw sequence data files in shown in Figure S31. As 
can be seen many parameters failed the quality standards. However some of these factors are 
filtered later in the RAD data analysis. For example, duplicated sequences were removed via the PCR 
clone filter and per base sequence quality is improved through trimmed reads. 
 
Figure S31 Summary of FastQC report for the eRAD raw sequence data. A green tick represents a pass for quality 
whereas a red cross indicates data has failed to meet quality standards. An amber exclamation mark advises caution 
regarding the quality of the data. 
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S13. Sample representation bias correlations 
Potential causes of the sample representation bias were explored by assessing correlation of a 
number of factors associated with the sample and library preparations by simple scatter plots and R2 
values. No significant correlations were identified (Figure S32, Figure S33). 
 
 
Figure S32 Scatter plots show library specific correlations of library preparation factors and the resulting total retained 
reads before (a) and after (b) the clone filter. Factors shown include the percentage representation GC bases within the 
unique sample identifier/barcode (1), the volume (µl) of P1 adaptor added to the sample preparation (2) and the 
starting quantity (ng) of ds cDNA added to the initial sample digest (3). 
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Figure S33 Scatter plots show library specific correlations of cDNA quality factors and the resulting total retained reads 
before (a) and after (b) the clone filter. Factors shown include the total yield (ng) of the ds cDNA sample (1), the 
concentration (ng) of the ds cDNA sample (2) and the quality of mRNA prior to cDNA synthesis, inferred from 260/280 
ratios (3) and 260/230 ratios (4). 
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S14. Stacks, denovo parameters trial 
Full table description: The minimum sequencing depth to create a stack is quoted per catalogue (m) 
was increased by factor of three to mimic the minimum stack depth required within an individual 
(n). The total number of loci/stacks created in the catalogue is shown (Unique stacks), with the 
number single-nucleotide polymorphisms (SNPs) found. Also shown is the number of ‘blacklisted’ 
stacks and subsequent final number of stacks within the catalogue (Total). The total counts of RAD 
tags specific to a catalogue locus within the Superparent (Parent) and increasing numbers of progeny 
(prog1 – prog20). Finally the number of tag counts, which contain a minimum of one SNP in one to 
five progeny are listed (prog1-5). 
Table S8 Summary of the six trialled Stacks eRAD ‘SUPER’ catalogues. Please see main text for the full table description. 
SUPER 
Catalogue 
summary 
m 3 6 9 12 15 33 
eg. n 1 2 3 4 5 11 
Unique stacks 220,523 110,418 82,013 68,038 59,259 38,634 
SNPs found 15,436,610 7,729,260 5,740,910 4,762,660 4,148,130 2,704,380 
Blacklisted 11,890 5,737 3,862 2,926 2,360 1,153 
Total 208,633 104,681 78,151 65,112 56,899 37,481 
Tag 
Counts 
Parent 208,610 104,675 78,151 65,112 56,897 37,479 
prog 1 89,281 80,704 71,658 63,319 56,393 37,418 
prog 2 50,660 55,977 57,194 55,993 53,241 37,355 
prog 3 38,791 43,929 45,673 46,513 46,557 37,076 
prog 4 31,867 36,873 38,548 39,445 39,987 36,299 
prog 5 27,024 31,949 33,570 34,441 34,988 34,639 
prog 6 23,535 28,363 29,968 30,803 31,341 32,142 
prog 7 20,640 25,376 26,952 27,779 28,291 29,398 
prog 8 18,109 22,757 24,309 25,132 25,638 26,783 
prog 9 15,988 20,561 22,093 22,902 23,395 24,521 
prog 10 14,073 18,564 20,070 20,865 21,362 22,470 
prog 20 1,060 3,271 4,247 4,712 4,915 5,061 
Tag 
Counts, 
SNP = 1 
prog 1 5,440 5,246 4,504 3,702 3,172 1,706 
prog 2 2,567 2,952 3,155 3,031 2,819 1,673 
prog 3 1,817 2,011 2,170 2,284 2,298 1,622 
prog 4 1,386 1,482 1,570 1,677 1,761 1,541 
prog 5 1,130 1,188 1,239 1,318 1,389 1,425 
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Table S9 Summary of the six trialled Stacks eRAD ‘SUPER6’ catalogues. Please see main 
text for the full table description. 
SUPER6 
Catalogue 
summary 
m 3 6 9 12 15 
eg. n 1 2 3 4 5 
Unique  
stacks 
163,195 83,180 61,887 51,557 45,295 
SNPs  
found 
11,423,650 5,822,600 4,332,090 3,608,990 3,170,650 
Blacklisted 7,319 3,352 2,230 1,649 1,322 
Total 155,876 79,828 59,657 49,908 43,973 
Tag 
Counts 
Parent 155,866 79,828 59,655 49,906 43,971 
prog 1 76,250 67,361 57,477 49,485 43,821 
prog 2 44,460 47,914 48,142 45,958 42,622 
prog 3 33,913 37,198 38,254 38,651 38,214 
prog 4 27,542 30,683 31,662 32,227 32,515 
prog 5 22,911 25,975 26,926 27,458 27,755 
prog 6 19,115 22,083 23,009 23,519 23,807 
prog 7 15,350 18,218 19,113 19,598 19,865 
prog 8 12,032 14,787 15,651 16,102 16,332 
prog 9 8,881 11,461 12,258 12,623 12,758 
prog 10 5,726 7,952 8,558 8,744 8,791 
prog 20 1 - - - - 
Tag 
Counts, 
SNP = 1 
prog 1 4,423 4,195 3,433 2,731 2,298 
prog 2 1,960 2,368 2,495 2,335 2,110 
prog 3 1,323 1,552 1,720 1,789 1,774 
prog 4 979 1,097 1,191 1,284 1,350 
prog 5 753 836 904 963 1,018 
 
Table S10 Summary of the six trialled Stacks eRAD ‘SUPER7’ catalogues. Please see main 
text for the full table description. 
SUPER7 
Catalogue 
summary 
m 3 6 9 12 15 
eg. n 1 2 3 4 5 
Unique  
stacks 
103,657 59,684 47,134 40,275 35,998 
SNPs  
found 
7,255,990 4,177,880 3,299,380 2,819,250 2,519,860 
Blacklisted 7,646 3,732 2,543 1,945 1,543 
Total 96,011 55,952 44,591 38,330 34,455 
Tag 
Counts 
Parent 96,005 55,944 44,591 38,330 34,455 
prog 1 59,183 51,840 43,989 38,205 34,407 
prog 2 33,173 36,954 37,262 35,547 33,302 
prog 3 23,879 27,540 28,711 29,192 29,109 
prog 4 18,487 22,088 23,242 23,809 24,194 
prog 5 14,697 18,243 19,358 19,922 20,324 
prog 6 11,714 15,192 16,288 16,839 17,229 
prog 7 9,083 12,441 13,499 14,039 14,416 
prog 8 6,704 9,868 10,877 11,388 11,732 
prog 9 4,398 7,272 8,189 8,614 8,844 
prog 10 1,515 3,518 4,151 4,351 4,420 
prog 20 - - - - - 
Tag 
Counts, 
SNP = 1 
prog 1 2,524 2,335 1,877 1,577 1,365 
prog 2 1,190 1,429 1,470 1,381 1,280 
prog 3 794 911 1,012 1,047 1,050 
prog 4 575 659 735 768 801 
prog 5 421 481 524 547 583 
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Table S11 Summary of the six trialled Stacks eRAD ‘FULLFAT’ catalogues. Please see main text for the full table 
description. 
FULLFAT 
Catalogue 
summary 
m 3 6 9 12 15 33 
eg. n 1 2 3 4 5 11 
Unique Stacks 301,514 160,363 117,786 95,752 82,475 52,059 
SNPs Found 21,105,980 11,225,410 8,245,020 6,702,640 5,773,250 3,644,130 
Blacklisted 13,257 6,616 4,513 3,426 2,765 1,380 
Total 288,257 153,747 113,273 92,326 79,710 50,679 
Tag 
Counts 
Parent 288,233 153,731 113,264 92,324 79,710 50,679 
prog 1 194,660 141,228 110,710 91,621 79,368 50,518 
prog 2 77,130 83,241 82,657 78,481 73,088 50,231 
prog 3 54,263 59,976 62,026 62,768 62,320 49,129 
prog 4 42,518 47,985 49,918 50,967 51,592 46,805 
prog 5 34,913 40,249 42,088 43,100 43,758 43,183 
prog 6 29,422 34,636 36,426 37,378 38,014 38,950 
prog 7 25,182 30,306 32,059 32,991 33,598 34,845 
prog 8 21,709 26,733 28,458 29,378 29,969 31,221 
prog 9 18,990 23,921 25,614 26,525 27,105 38,323 
prog 10 16,601 21,451 23,135 24,033 24,601 25,781 
prog 20 1,397 3,754 4,840 5,351 5,573 5,703 
Tag 
Counts, 
SNP = 1 
SNPs 1 prog 1 10,869 9,500 7,365 5,903 4,968 2,704 
SNPs 1 prog 2 4,662 5,539 5,449 4,944 4,449 2,640 
SNPs 1 prog 3 2,758 3,179 3,515 3,604 3,563 2,497 
SNPs 1 prog 4 2,023 2,225 2,409 2,574 2,703 2,304 
SNPs 1 prog 5 1,615 1,723 1,815 1,929 2,046 2,044 
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Table S12 Summary of the six trialled Stacks eRAD ‘FULLFAT6’ catalogues. Please see main 
text for the full table description. 
FULLFAT6 
Catalogue 
summary 
m 3 6 9 12 15 
eg. n 1 2 3 4 5 
Unique  
Stacks 
197,518 98,440 73,146 60,930 53,411 
SNPs  
Found 
13,826,260 6,890,800 5,120,220 4,265,100 3,738,770 
Blacklisted 8,053 3,744 2,524 1,906 1,552 
Total 189,465 94,696 70,622 59,024 51,859 
Tag 
Counts 
Parent 189,459 94,692 70,616 59,024 51,859 
prog 1 117,450 86,169 69,212 58,632 51,604 
prog 2 55,594 59,506 58,522 54,636 49,976 
prog 3 40,045 43,677 44,847 45,143 44,276 
prog 4 31,504 34,939 36,025 36,637 36,922 
prog 5 25,684 29,005 30,031 30,602 30,943 
prog 6 20,911 24,140 25,134 25,665 25,968 
prog 7 16,613 19,721 20,674 21,178 21,459 
prog 8 12,836 15,797 16,709 17,162 17,383 
prog 9 9,437 12,205 13,042 13,390 13,509 
prog 10 6,066 8,478 9,092 9,263 9,295 
prog 20 2 - - - - 
Tag 
Counts, 
SNP = 1 
SNPs 1 prog 1 6,974 5,850 4,360 3,526 2,980 
SNPs 1 prog 2 2,717 3,336 3,325 3,019 2,708 
SNPs 1 prog 3 1,674 1,965 2,211 2,292 2,232 
SNPs 1 prog 4 1,222 1,356 1,511 1,632 1,689 
SNPs 1 prog 5 957 1,023 1,111 1,192 1,261 
 
Table S13 Summary of the six trialled Stacks eRAD ‘FULLFAT7’ catalogues. Please see main 
text for the full table description. 
FULLFAT7 
Catalogue 
summary 
m 3 6 9 12 15 
eg. n 1 2 3 4 5 
Unique 
Stacks 
173,399 107,893 82,063 67,109 57,927 
SNPs 
Found 
12,137,930 7,552,510 5,744,410 4,697,630 4,054,890 
Blacklisted 8,830 4,558 3,055 2,341 1,846 
Total 164,569 103,335 79,008 64,768 56,081 
Tag 
Counts 
Parent 164,561 103,326 79,003 64,766 56,079 
prog 1 144,085 101,996 78,637 64,544 55,916 
prog 2 52,697 56,885 56,112 53,018 49,688 
prog 3 34,123 38,075 39,492 39,966 39,829 
prog 4 24,833 28,675 30,037 30,691 31,156 
prog 5 18,828 22,597 23,922 24,555 25,031 
prog 6 14,509 18,205 19,525 20,137 20,601 
prog 7 11,093 14,677 15,961 16,552 17,001 
prog 8 8,109 11,490 12,718 13,279 13,679 
prog 9 5,331 8,375 9,486 9,951 10,215 
prog 10 2,434 4,646 5,374 5,588 5,680 
prog 20 - - - - - 
Tag 
Counts, 
SNP = 1 
SNPs 1 prog 1 6,012 4,989 3,922 3,247 2,747 
SNPs 1 prog 2 2,637 3,074 2,906 2,611 2,342 
SNPs 1 prog 3 1,423 1,595 1,737 1,762 1,726 
SNPs 1 prog 4 954 1,032 1,106 1,156 1,190 
SNPs 1 prog 5 664 706 743 772 802 
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S15. EdgeR: summary statistics 
S15.1 SUPER 
 
S15.2 SUPER_3Q 
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S15.3 SUPER_Bd 
 
S15.4 SUPER_Rm 
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S15.5 SUPER6 
 
S15.6 SUPER6_3Q 
 
S15.7 SUPER6_Bd 
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S15.8 SUPER7 
 
S15.9 SUPER7_3Q 
 
S15.10 SUPER7_Bd 
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S15.11 FULLFAT 
 
S15.12 FULLFAT_3Q 
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S15.13 FULLFAT_Bd 
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S15.14 FULLFAT6 
 
S15.15 FULLFAT6_3Q 
 
S15.16 FULLFAT6_Bd 
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S15.17 FULLFAT7 
 
S15.18 FULLFAT7_3Q 
 
S15.19 FULLFAT7_Bd 
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S16. EdgeR: Additional differential expression analyses 
The removal of individuals from datasets generally did not reduce the amount of variation within the 
datasets (Figure S34, Figure S35).It did however result in a reduction of individuals within the dataset 
and in most cases, an increased number of presence/absence relationships in gene expression 
(Figure S37, Figure S38). The balanced datasets provide interesting insight into the clusters of 
presence/absence relationships as they should be equally likely in each direction. Clusters were seen 
indicating a greater tendency for one genotypic group to have absence of expression than the other. 
However these clusters were observed in both directions and therefore are unlikely to be caused by 
genuine biological differences (Figure S39, Figure S40). 
The additional tags found to be significantly DE in the filtered datasets were all presence/absence 
relationships. These are assumed to have arisen from the removal of individuals, especially in the DD 
group as opposed to a genuine biological signal and are therefore not discussed further. 
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Figure S34 Biological coefficient of variation plots for SUPER (1), SUPER6 (2) and SUPER7 
(3), the full dataset (a), the filtered ‘3Q’ (b) and ‘Bd’ (c) datasets. Each black dot 
represents the variation for each tag (tagwise variation) and the red line indicates the 
overall level of variation (common). 
 
Figure S35 Biological coefficient of variation plots for FULLFAT (1), FULLFAT6 (2) and 
FULLFAT7 (3), the full dataset (a), the filtered ‘3Q’ (b) and ‘Bd’ (c) datasets. Each black 
dot represents the variation for each tag (tagwise variation) and the red line indicates 
the overall level of variation (common). 
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Figure S36 Log fold change in eRAD tag sequence counts between genotypes DD & dd (1); DD & Dd (2) and Dd & dd (3) in 
datasets FULLFAT6 (a) and FULLFAT7 (b).The direction of relative expression is indicated in the title of each plot. Each 
data point (shown in black) represents an eRAD tag. Significantly differentially expressed tags are shown in red and 
emphasized by a circle. The blue lines indicate a two-fold difference in expression. 
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Figure S37 Log fold change in eRAD tag sequence counts between genotypes DD & dd 
(1); DD & Dd (2) and Dd & dd (3) in datasets SUPER (a), SUPER6 (b) and SUPER7 (c).The 
direction of relative expression is indicated in the title of each plot. Each data point 
(shown in black) represents an eRAD tag. Significantly differentially expressed tags are 
shown in red and emphasized by a circle. The blue lines indicate a two-fold difference in 
expression. The pairwise comparisons to SUPER7_3Q DD group were not statistically 
valid however are presented to depict presence/absence relationship. 
 
Figure S38 Log fold change in eRAD tag sequence counts between genotypes DD & dd 
(1); DD & Dd (2) and Dd & dd (3) in datasets FULLFAT (a), FULLFAT 6 (b) and FULLFAT 7 
(c).The direction of relative expression is indicated in the title of each plot. Each data 
point (shown in black) represents an eRAD tag. Significantly differentially expressed tags 
are shown in red and emphasized by a circle. The blue lines indicate a two-fold 
difference in expression. The pairwise comparisons to FULLFAT7_3Q DD group were not 
statistically valid and subsequently not presented (n/a).
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Figure S39 Log fold change in eRAD tag sequence counts between genotypes DD & dd 
(1); DD & Dd (2) and Dd & dd (3) in datasets SUPER_Bd (a), SUPER6_Bd (b) and 
SUPER7_Bd (c).The direction of relative expression is indicated in the title of each plot. 
Each data point (shown in black) represents an eRAD tag. Significantly differentially 
expressed tags are shown in red and emphasized by a circle. The blue lines indicate a 
two-fold difference in expression. 
 
Figure S40 Log fold change in eRAD tag sequence counts between genotypes DD & dd 
(1); DD & Dd (2) and Dd & dd (3) in datasets FULLFAT_Bd (a), FULLFAT 6_Bd (b) and 
FULLFAT 7_Bd (c).The direction of relative expression is indicated in the title of each 
plot. Each data point (shown in black) represents an eRAD tag. Significantly differentially 
expressed tags are shown in red and emphasized by a circle. The blue lines indicate a 
two-fold difference in expression. 
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 S17. Blast2GO quantitative values 
A summary of the quantitative descriptions of each of the three assemblies generated through 
Blast2GO is presented in Table S14. One tag was labelled ‘without analysis’. Interestingly this same 
sequence was not analysed in the SUPER and SUPER7 assemblies. 
Table S14 Quantitative summary of the Blast2 GO assessed de novo transcriptome assemblies 
Assembly SUPER SUPER6 SUPER7 
Total contigs 35,696 30,438 25,654 
without analysis 1 0 1 
With Blast no hits 22,169 18,390 15,447 
With Blast hits 3,110 2,682 2,275 
With Blast2GO Annotation 10,416 9,366 7,931 
Average length (all contigs) 313 306 310 
Average length (annotated contigs) 352 341 351 
Percentage Annoted (%) 29.18 30.77 30.92 
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